Plant Kinases: Methods and Protocols (Methods in Molecular Biology 779)

Methods

in

Molecular Biology™

Series Editor John M. Walker School of Life Sciences University of Hertfordshire Hatfield, Hertfordshire, AL10 9AB, UK



For further volumes: http://www.springer.com/series/7651

wwwwwwwwwwwwwwwww

Plant Kinases Methods and Protocols

Edited by

Nico Dissmeyer Leibniz Institute of Plant Biochemistry (IPB), Halle (Saale), Germany

Arp Schnittger Institut de Biologie Moléculaire des Plantes Centre National de la Recherche Scientifique (IBMP-CNRS), Strasbourg, France

Editors Nico Dissmeyer, Ph.D. Leibniz Institute of Plant Biochemistry (IPB) Independent Junior Research Group on Protein Recognition and Degradation Weinberg 3, D-06120 Halle (Saale) Germany [email protected]

Arp Schnittger, Ph.D. Institut de Biologie Moléculaire des Plantes Centre National de la Recherche Scientifique (IBMP-CNRS) Unité Propre de Recherche 2357 12, rue du Général Zimmer F-67000 Strasbourg, France [email protected]

ISSN 1064-3745 e-ISSN 1940-6029 ISBN 978-1-61779-263-2 e-ISBN 978-1-61779-264-9 DOI 10.1007/978-1-61779-264-9 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2011933668 © Springer Science+Business Media, LLC 2011 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Humana Press, c/o Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Cover illustration: The title image is a collage of three different Arabidopsis thaliana plants. The endogenous activity of one of the major cell cycle kinases cyclin-dependent kinase A;1 (CDKA;1) increases from left to right. The two left individuals are cdka;1 homozygous null mutants that were partially complemented by phosphorylation-site substituted CDKA;1 variants and are compared to a wild type plant of the accession Columbia-0 on the right. The phosphosite mutants were expressed from the endogenous CDKA;1 promotor. The CDKA;1 variant on the left carries the double phospho-mimetic substitution T14D/Y15E in the ATP-binding pocket (P-loop) and that one in the center the single amino acid substitution T161D in the activation loop (T-loop). Both domains of CDKA;1 are required for catalysis and substitutions lead to a tremendous reduction in kinase activity. For reference, see Dissmeyer N. et al., Plant Cell (2007), Dissmeyer N. et al., Plant Cell (2009), and Chapter 6 of this book. Photographs by MAret-Linda Kalda, Max Planck Institute for Plant Breeding Research, Köln, Germany. Printed on acid-free paper Humana Press is part of Springer Science+Business Media (www.springer.com)

Preface Modification of target protein properties by reversible phosphorylation events has been found as one of the most prominent cellular control processes in all organisms. Recent advances in the area of molecular biology and biochemistry, for instance mass spectrometrybased phosphoproteomics or fluorescence spectroscopical methods are opening new possibilities to reach an unprecedented depth and a proteome-wide understanding of phosphorylation processes in plants and other species. Moreover, the growing number of model species now allows deepening evolutionary insights into kinase/phosphatase systems and extracting general principles of regulation through phosphorylation. The book Plant Kinases from the Methods in Molecular Biology™ series focuses on plant protein kinases and provides a compendium of state-of-the-art techniques that are written by experts in the field having hands-on experience with the particular methods. The major goal is to provide the experimentalist with a detailed account of the practical steps necessary for carrying out each protocol successfully in his or her own laboratory. We hope that both novice and seasoned researchers will find Plant Kinases a useful lab companion for years to come and that Plant Kinases will facilitate the practical work leading to new and exciting insights. Plant protein kinases specifically addressed in this book are members of the plant MAP kinase cascade, cyclin- and Calcium-dependent protein kinases, and plant sensor and receptor kinases. We greatly acknowledge the contribution of the authors in writing this book and thank for the clear and detailed descriptions of the procedures and for many useful hints in the notes sections. We wish to acknowledge John M. Walker, the series editor, for his support, and the team at Humana Press and Springer for their help in producing this volume. Let us get started: To the bench! Halle (Saale), Germany Strasbourg, France

Nico Dissmeyer Arp Schnittger

v

wwwwwwwwwwwwwwwww

Contents Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

v ix

Part I  Overview   1 Guide to the Book Plant Kinases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nico Dissmeyer and Arp Schnittger   2 The Age of Protein Kinases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nico Dissmeyer and Arp Schnittger

3 7

Part II  Kinase Expression, Purification and Activity Assays   3 Expression and Purification of Active Protein Kinases from Wheat Germ Extracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 Boglárka Sonkoly, Viola Bardóczy, and Tamás Mészáros   4 Measurement of Plant Cyclin-Dependent Kinase Activity Using Immunoprecipitation-Coupled and Affinity Purification-Based Kinase Assays and the Baculovirus Expression System . . . . . . . . . . . . . . . . . . . . . . . 65 Hirofumi Harashima and Masami Sekine   5 Mitogen-Activated Protein Kinase Activity and Reporter Gene Assays in Plants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79 Róbert Dóczi, Elizabeth Hatzimasoura, and László Bögre   6 Use of Phospho-Site Substitutions to Analyze the Biological Relevance of Phosphorylation Events in Regulatory Networks . . . . . . . . . . . . . . . . 93 Nico Dissmeyer and Arp Schnittger   7 Bacterial Assay to Study Plant Sensor Histidine Kinases . . . . . . . . . . . . . . . . . . . . . 139 Lukáš Spíchal   8 Substrate Analysis of Arabidopsis PP2C-Type Protein Phosphatases . . . . . . . . . . . . 149 Julija Umbrasaite, Alois Schweighofer, and Irute Meskiene

Part III Studying Kinase Function at the Cellular Level   9 Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165 Shutian Li and Vernonica E. Franklin-Tong 10 Sensitizing Plant Protein Kinases to Specific Inhibition by ATP-Competitive Molecules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185 Dor Salomon, Chao Zhang, Kevan M. Shokat, and Guido Sessa 11 Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization . . . . . . . . . . . . 199 Mark A. Hink, Sacco C. de Vries, and Antonie J.W.G. Visser

vii

viii

Contents

12 Quantifying Degradation Rates of Transmembrane Receptor Kinases . . . . . . . . . . . 217 Niko Geldner 13 Fluorescence Correlation Spectroscopy and Fluorescence Recovery After Photobleaching to Study Receptor Kinase Mobility In Planta . . . . . . . . . . . . 225 Mark Kwaaitaal, Marieke Schor, Mark A. Hink, Antonie J.W.G. Visser, and Sacco C. de Vries

Part IV Identification of Kinase Substrates and Phosphorylation-Site Detection 14 Bimolecular-Fluorescence Complementation Assay to Monitor Kinase–Substrate Interactions In Vivo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Stefan Pusch, Nico Dissmeyer, and Arp Schnittger 15 Chemical Genetic Analysis of Protein Kinase Function in Plants . . . . . . . . . . . . . . . Maik Böhmer, Michael Bölker, and Tina Romeis 16 Modified Metal-Oxide Affinity Enrichment Combined with 2D-PAGE and Analysis of Phosphoproteomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Thomas Colby, Horst Röhrig, Anne Harzen, and Jürgen Schmidt 17 Phosphoproteomics Using iTRAQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Alexandra M.E. Jones and Thomas S. Nühse Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

245 259

273 287 303

Contributors Viola Bardóczy  •  Department of Applied Biotechnology and Food Science, Budapest University of Technology and Economics, Budapest, Hungary László Bögre  •  School of Biological Sciences, Royal Holloway University of London, Surrey, UK Maik Böhmer  •  Institute for Biology and Biotechnology of Plants, University of Münster, Münster, Germany Michael Bölker  •  Fachbereich Biologie, Philipps Universität Marburg, Marburg, Germany Thomas Colby  •  Proteomics Unit, Max-Planck-Institut für Pflanzenzüchtungsforschung (MPIPZ), Köln (Vogelsang), Germany Nico Dissmeyer  •  Leibniz Institute of Plant Biochemistry (IPB), Independent Junior Research Group on Protein Recognition and Degradation , Halle (Saale), Germany Róbert Dóczi  •  Agricultural Research Institute of the Hungarian Academy of Sciences, Martonvásár, Hungary Veronica E. Franklin-Tong  •  School of Biosciences, University of Birmingham, Birmingham, UK Niko Geldner  •  Department of Plant Molecular Biology (DBMV), University of Lausanne, UNIL-Sorge, Lausanne, Switzerland Hirofumi Harashima  •  The International Center for Biotechnology, Osaka University, Suita, Osaka, Japan Anne Harzen  •  Proteomics Unit, Max-Planck-Institut für Pflanzenzüchtungsforschung (MPIPZ), Köln (Vogelsang), Germany Elizabeth Hatzimasoura  •  Centre for Cutaneous Research, Institute of Cell and Molecular Sciences, Queen Mary University of London, London, UK Mark A. Hink  •  Department of Molecular Cytology, van Leeuwenhoek Centre for Advanced Microscopy (LCAM), University of Amsterdam, Amsterdam, The Netherlands Alexandra M.E. Jones  •  The Sainsbury Laboratory, Norwich Research Park, Norwich, UK Mark Kwaaitaal  •  Laboratory of Biochemistry, Wageningen University, Wageningen, The Netherlands Shutian Li  •  Department of Botany, University of Osnabrück, Osnabrück, Germany; School of Biosciences, University of Birmingham, Edgbaston, Birmingham, UK Irute Meskiene  •  Max F. Perutz Laboratories, University of Vienna, Wien, Austria; Institute of Biotechnology, University of Vilnius, Lithuania Tamás Mészáros  •  Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary Thomas A. Nühse  •  Faculty of Life Sciences, University of Manchester, Manchester, UK

ix

x

Contributors

Stefan Pusch  •  German Cancer Research Center (DKFZ), Ruprecht-Karls Universität Heidelberg, Heidelberg, Germany Horst Röhrig  •  Institut für Molekulare Physiologie und Biotechnologie der Pflanzen (IMBIO), Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany Tina Romeis  •  Biochemistry of Plants, Institute of Biology, Department of Biology, Chemistry and Pharmacy Free University of Berlin, Berlin, Germany Dor Salomon  •  Department of Plant Sciences, Tel-Aviv University, Tel-Aviv, Israel Jürgen Schmidt  •  Proteomics Unit, Max-Planck-Institut für Pflanzenzüchtungsforschung (MPIPZ), Köln (Vogelsang), Germany Arp Schnittger  •  Institut de Biologie Moléculaire des Plantes, Centre National de la Recherche Scientifique (IBMP-CNRS), Unité Propre de Recherche, Strasbourg, France Marieke Schor  •  Laboratory of Biochemistry and Microscopy Centre, Wageningen (MSCWU), Wageningen University, Wageningen, The Netherlands Alois Schweighofer  •  Signaling Proteomics, Department of System Regulation, Max-Planck-Institute für Molekulare Pflanzenphysiologie (MPIMP), Golm, Germany Masami Sekine  •  Department of Bioproduction Science, Faculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University, Ishikawa, Japan Guido Sessa  •  Department of Plant Sciences, Tel-Aviv University, Tel-Aviv, Israel Kevan M. Shokat  •  Howard Hughes Medical Institute, Chevy Chase, MD, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA Boglárka Sonkoly  •  Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary Lukáš Spíchal  •  Laboratory of Growth Regulators, Institute of Experimental Botany AS CR & Palacký University, Olomouc, Czech Republic Julija Umbrasaite  •  Max F. Perutz Laboratories, University of Vienna, Wien, Austria Antonie J.W.G. Visser  •  Laboratory of Biochemistry and Microscopy Centre, Wageningen (MSCWU), Wageningen University, Wageningen, The Netherlands Sacco C. de Vries  •  Department of Biochemistry, Wageningen University, Wageningen, The Netherlands Chao Zhang  •  Howard Hughes Medical Institute, Chevy Chase, MD, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA

Part I Overview

wwwwwwwwwwwwwwwww

Chapter 1 Guide to the Book Plant Kinases Nico Dissmeyer and Arp Schnittger The growing number of fully annotated genomes of model and nonmodel plant species, such as Arabidopsis, Brachypodium, ­grapevine, maize, rice, rape seed, soybean, tomato, and others, has led to a tremendous increase in sequence information. The novel genome information has been translated into the putative proteomes and set the ground for a wealth of yet to be explored kinomes. At the same time, cellular pathways are now analyzed in model plants with an unprecedented depth revealing new ­mechanisms of regulation and integration of individual modules into regulatory networks. These studies are promoted by new developments in biochemical, molecular, and cell biological techniques of which we provide a comprehensive and state-of-the-art overview in the present methods book (Fig. 1). Plant Kinases is intended to be a benchtop manual and guide for both those who are new to the techniques and for those who wish to compare their approaches with established ones from other laboratories. It equally aims to further methodological inspiration. By providing a compendium of methods adapted to be successfully used in plants, this volume addresses scientists who desire to test their results and expand their analyses into further research areas. Plant Kinases is laid out to provide the experimentalist with a full account of the practical steps that are necessary for the successful completion of each protocol. Thus, the Materials as well as the Methods sections contain detailed step-by-step descriptions of all procedures. Moreover, each chapter opens with an Introduction which describes the basic theory underlying both the biology and the method being used to present each technique in the context of a particular biological question. The final Notes section complements the protocol with hands-on comments as suggested by ­experienced users.

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_1, © Springer Science+Business Media, LLC 2011

3

4

N. Dissmeyer and A. Schnittger

Fig. 1. Approaches to the study of protein kinase function found in this book. All examples are taken from this book, indicating in which chapter the respective methodologies can be found.

Plant Kinases is divided into four major sections comprising a total of 17 chapters. It starts with (I) an introductory chapter (Chapter 2) where we review general structural and functional aspects of protein kinase function highlighting several regulatory signaling networks related to this methods book. In addition, we provide a compendium of databases and Web tools for plant kinase research. Part (II) covers expression, purification, activity monitoring, and reporter gene assays of plant protein kinases; part (III) addresses the study of kinase function at the cellular level by chemical genetics, microscopy- and spectroscopy-based techniques; and part (IV) provides information on the identification of kinase substrates and phosphorylation-site detection via interaction assays, substrate labeling protocols, and proteomics (Fig. 1). Part II (Chapters 3–8) starts off by providing several methods for protein production and isolation, for instance, through immunoprecipitation from plant extracts (Chapters 4 and 5). Of particular relevance to the study of kinases and substrates for which only low amounts can be isolated from plant extracts, in vitro protein production, such as cell-free systems (Chapter 3), or bacterial and viral expression systems (Chapter 4), might be considered.

1  Guide to the Book Plant Kinases

5

Protein expression is typically followed by protein purification steps and protocols are provided in Chapters 3 and 4. The ultimate step is a functional assay, for instance, by affinity-coupled kinase (Chapters 4 and 6) and phosphatase assays (Chapter 8). In parallel, activity can be monitored in planta by reporter gene assays (Chapter 5) or in heterologous systems such as bacteria (Chapter 7; Fig. 1). Part (III) (Chapters 9–13) addresses the study of kinase ­function at the cellular level through the lens of chemical genetics (Chapters 9 and 10), microscopy, and spectroscopy (Chapters 11–13). The modulation of kinase activity with inhibitor molecules has become a very powerful tool as outlined in Chapter 9. Recent advances in inhibitor studies make use of ATP-competitive molecules and engineered inhibitor-sensitive protein kinase variants that are replacing the wild-type copy (Chapter 10). Highly sensitive microscopical techniques are applied to reach a quantitative level in detecting and monitor protein–protein interactions. Standard fluorescence or confocal laser scanning microscopy (CLSM; Chapters 12 and 14) are used to elaborate the transient associations of proteins by Förster/fluorescence resonance energy transfer measurements (FRET; Chapters 11 and 13) and fluorescence lifetime imaging microscopy (FLIM; Chapter 11). These techniques were further specialized and new spectroscopical ­methods have evolved such as fluorescence fluctuation analysis (FFA; Chapter 11), fluorescence correlation or cross-correlation spectroscopy (FCS/FCCS; Chapters 11 and 13), photon counting histogram analysis (PCH; Chapter 11), and fluorescence recovery after photobleaching (FRAP; Chapter 13; Fig. 1). Part (IV) (Chapters 14–17) provides information on the ­identification of kinase substrates and phosphorylation-sites via interaction assays, substrate labeling protocols, and mass spectrometry (MS)-based proteomics. Chapter 14 describes a procedure for bimolecular fluorescence complementation (BiFC or split YFP) which allows detecting kinase–substrate interactions in vivo. Following a chemical genetics approach, the use of ATP-analogous compounds enables the researcher to specifically mark substrates of kinase X among the pool of other kinases (Chapter 15). The preservation, detection, and identification of the actual site(s) of phosphorylation are experimentally difficult but fundamentally important for the characterization of a kinase cascade. Therefore, strategies for both the isolation of plant phosphopeptides and their identification by mass spectrometry in combination with 2D-PAGE and MS-related technologies have been developed. Recent modifications of existing MS-based protocols such as metal oxide affinity chromatography (MOAC), isobaric tags for relative and absolute quantization (iTRAQ), and stable isotope labeling (SILAC) allow the researcher to further purify and enrich the phosphorylated ­target sequences for subsequent spectrometric analysis (Chapters 16 and 17; Fig. 1).

wwwwwwwwwwwwwwwww

Chapter 2 The Age of Protein Kinases Nico Dissmeyer and Arp Schnittger Abstract Major progress has been made in unravelling of regulatory mechanisms in eukaryotic cells. Modification of target protein properties by reversible phosphorylation events has been found to be one of the most prominent cellular control processes in all organisms. The phospho-status of a protein is dynamically controlled by protein kinases and counteracting phosphatases. Therefore, monitoring of kinase and phosphatase activities, identification of specific phosphorylation sites, and assessment of their functional significance are of crucial importance to understand development and homeostasis. Recent advances in the area of molecular biology and biochemistry, for instance, mass spectrometry-based phosphoproteomics or fluorescence spectroscopical methods, open new possibilities to reach an unprecidented depth and a proteome-wide understanding of phosphorylation processes in plants and other species. In addition, the growing number of model species allows now deepening evolutionary insights into signal transduction cascades and the use of kinase/phosphatase systems. Thus, this is the age where we move from an understanding of the structure and function of individual protein modules to insights how these proteins are organized into pathways and networks. In this introductory chapter, we briefly review general definitions, methodology, and current concepts of the molecular mechanisms of protein kinase function as a foundation for this methods book. We briefly review biochemistry and structural biology of kinases and provide selected examples for the role of kinases in biological systems. Key words: Kinase, Phosphorylation, Phosphatase, Development, Cascade, Signalling, Plant

1. A Primer on Protein Kinase Biochemistry 1.1. Phosphotransfer

Kinases or phosphotransferases are per definitionem enzymes that catalyze the transfer of the g-phosphate group from high-energy donor molecules such as adenosine-5′-triphosphate (ATP; sometimes guanosine-5′-triphosphate, GTP) preferentially to alcohol or hydroxy groups (OH) but also to nucleophilic centres of other functional groups of acceptor molecules, i.e. oxygen-, sulphur-, and nitrogen-containing ones (for details, see below; (1)). The process of attaching such a phosphorous-containing group is termed phosphorylation and leads to a phosphono or, in short, a

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_2, © Springer Science+Business Media, LLC 2011

7

8

N. Dissmeyer and A. Schnittger

phospho group in the acceptor molecule and is derived from phosphonic or phosphorous acid (H3PO3). This functional group is often also called a “phosphoryl” group which is not correct but regarded as acceptable (2). Together with the eight other families such as amino- and glycosyltransferases, kinases form the “transferase group” of enzymes classified as EC 2 according to the enzyme commission (EC). One of the largest groups of kinases are protein kinases (PKs), which act on and modify the activity of specific proteins. Depending on the species, PKs represent about 2–4% of all eukaryotic genes (Table 1 and references therein; (3, 4)) and it has been estimated that approximately one-third of all proteins in animal and yeast cells are phosphorylated on at least one position (5, 6). PKs, as phosphorous-transferring enzymes, constitute the group EC 2.7 which is further broken up with respect to the acceptor sites (Table  2): It is the hydroxy (OH), the carboxy(COOH), or nitrogenous (nitrogen-, N-containing) group of the side chains of the basic amino acids histidine (His; H), arginine (Arg; R), and lysine (Lys; K) as well as the sulphur-containing group of cysteine (Cys; C) side chains that serve as phosphoacceptors typically located on the surface of specific target molecules or substrates. In His, it is the imidazole (C3H3N2+) sidechain, in Arg, a guanidinium (CH6N3+) group, in Lys, the terminal amino (NH2) group, and in Cys, the sulfhydryl or hydrosulphide group (SH). Besides phosphorylation on the OH-groups of Ser/Thr and Tyr that forms a phosphate ester bond (O-phosphono group or O-phosphate; Fig. 1a, b), phosphorylation of the nitrogen of His, Arg, and Lys forming a phosphoramidate linkage (N-phosphono group or N-phosphate; Fig.  1c), the sulphur of Cys forming a phosphate thioester (S-phosphono group, thio or S-phosphate), and the carboxy group of aspartate (Asp; D) and glutamate (Glu; E) forming an acid anhydride (acyl phosphate) can also occur. In eukaryotic cells, hydroxy-linked phosphorylation is by far the most studied and thio and acyl phosphates are extremely rare (7). Analysis of the abundance of phosphorylation sites revealed that the most prominent phospho acceptors of a typical PK are the three amino acids with side chains containing hydroxy groups: Ser, Thr, and Tyr (7). Accordingly, kinases have been classified into protein serine/threonine kinases (PSTKs) and protein–tyrosine kinases (PTKs). In all organisms studied so far, protein phosphorylation does not occur to the same extent at all potential acceptor side chains; serine phosphorylation occurs much more frequently than threonine or tyrosine phosphorylation. Phosphorylation of eukaryotic proteins occurs mainly on Ser (86%) and Thr (12%) residues and to a lesser extent on Tyr (2%) (8). Despite the fact that Tyr phosphorylation seems to be underrepresented compared to Ser/Thr phosphorylation, it appears to be very dynamic (9, 10) and crucial in building extensive networks

Scientific name

Schizosaccharomyces pombe

Saccharomyces cerevisiae

Monosiga brevicollis

Cyanidioschyzon merolae

Ostreococcus tauri

Dictyostelium discoideum

Strongylocentrotus purpuratus

Caenorhabditis elegans

Drosophila melanogaster

Mus musculus

Rattus norvegicus

Homo sapiens

Canis lupus

Gallus gallus

Arabidopsis thaliana

Oryza sativa

Common name

Fission yeast

Budding yeast

Choanoflagellate

Red alga

Green alga

Slime mold

Sea urchin

Nematode

Fruit fly

Mouse

Rat

Human

Dog

Chicken

Mouse-ear/thale cress

Rice

Table 1 Kinome sizes by organism

1,637

1,112

546

656

518

521

540

377

454

353

285

104

67

331

130

119

No. of kinasesa

5.8

4.1

3.0

3.3

2.0

2.2

1.8

2.8

2.3

1.2

3.1

2 .6

1.3

3.6

2.1

2.4

Percent of kinasesa

28,236

27,361

18,119

19,835

25,667

24,135

29,252

13,601

19,427

28,881

9,226

4,003

5,331

9,171

6,275

4,929

No. of genesa

(continued)

(71), The Institute for Genomic Research (TIGR, release 3; http:// www.tigr.org/) (72, 73, 78)

(70, 72, 76, 146)

Kinomer; KEGG GENOME

Kinomer; KEGG GENOME

(67), KinBase; (145)

Kinomer; (144); KEGG GENOME

(68, 143)

(3, 142)

(139–141)

(138)

(137)

Kinomer

Kinomer

(136)

(3, 77, 135)

(3, 134)

References

2  The Age of Protein Kinases 9

Zea mays

Brachypodium distachyon

Populus trichocarpa

Vitis vinifera

Maize

Grass

Black cottonwood

Grapevine

1,485

919

1,177

2,585

No. of kinasesa

3.8

2.3

5.7

12.3

Percent of kinasesa

39,423

40,484

20,562

20,948

No. of genesa

(89)

PoplarDB, (86); (87), KEGG GENOME

(88)

MaizeGDB; (147)

References

Overall classification (43); general data about plants (4, 74, 75); genome sizes: Kimball’s Biology Pages at http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/, Royal Botanic Gardens, Kew Plant DNA C-values database at http://data.kew.org/cvalues/, Animal Genome Size Database Home at http://www.genomesize.com/, dictyBase at http://dictybase.org/, DOGS – Database Of Genome Sizes at http://www.cbs.dtu.dk/databases/DOGS/, and Kyoto Encyclopaedia of Genomes and Genes (KEGG) at http://www.genome.jp a  The absolute numbers of both kinases and genes varies according to the source and reference

Scientific name

Common name

Table 1 (continued)

10 N. Dissmeyer and A. Schnittger

Nucleotidyltransferases

2.7.7

2.7.8

Other substituted phosphor groups

Nucleotidyl

Diphosphate/pyrophosphate/P2O74−

Diphosphotransferases

2.7.6

2.7.5

Carboxyl/COOH− Nitrogenous/N Phosphor/phosphate /PO43− Intramolecular

Alcohol/hydroxyl /OH−

Monophosphotransferases

2.7.1

2.7.2 2.7.3 2.7.4

Acceptor

Group

Class

Table 2 Transferases: phosphotransferases/kinases (EC 2.7)

Recombinase (integrase), exonucleases (Rnase PH), transposase

RNA nucleotidyltransferase

DNA polymerase

DNA-directed DNA polymerases: DNA polymerase I, II, and III holoenzyme, reverse transcriptase (telomerase) RNA polymerase/DNA-directed RNA polymerases: RNA polymerase I, II, III, and IV, primase, RNA-dependent RNA polymerase; polynucleotide phosphorylase

(continued)

Transferases: N-acetylglucosaminephosphotransferases, phosphatidylcholine synthase

Other

Polymerase

Diphosphotransferases: ribose-phosphate and thiamine diphosphokinase

Phosphotransferases: hexo-, gluco-, fructo-, galacto-, phosphofructo kinase; thymidine, NAD+, glycerol, pyruvate, phosphatidylinositol 3-kinase; glucose-1,6-bisphosphate synthase Phosphotransferases: phosphoglycerate and aspartate kinase Phosphotransferases: creatine and arginine kinase Phosphotransferases: polyphosphate kinase; phosphomevalonate, adenylate, guanylate, and nucleoside-diphosphate kinase Phosphotransferases catalyzing intramolecular transfers; mutases. Now listed as EC 5.4.2: phosphogluco-, phosphoglycerate, and bisphosphoglycerate mutase; phosphopentomutase

Examples

2  The Age of Protein Kinases 11

Protein, tyrosine, and serine/threonine Protein, histidine Other

2.7.12

Protein Tyr kinases (PTKs): receptor protein–tyrosine kinase and non-specific protein– tyrosine kinase Protein Ser/Thr kinases (PSTKs): cAMP/cGMP-dependent protein kinases, PKC, b-adrenergic-receptor kinase, CaMK, PhK, polo, Cdk, MAPK, and MAP3K/ MAPKKK/MEKK, tau, receptor PSTKs Dual-specificity kinases (DSKs): acting both on Ser/Thr and Tyr residues; DSK, and MAP2K/MAPKK/MEK Protein His kinases: pros- and tele-kinases and His kinase Triphosphate protein phosphotransferase

Two phospho groups are transferred from a donor to two different acceptors. Phosphotransferases/dikinases: pyruvate, phosphate/water dikinases; phosphoglucan, water dikinase

Examples

For more information, refer to the home page of the International Union of Biochemistry and Molecular Biology (IUBMB) at http://www.chem.qmul.ac.uk/iubmb/ and The Braunschweig Enzyme Database (BRENDA) – The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/

2.7.13 2.7.99

Protein, serine/ threonine

Protein, tyrosine

Protein kinases

2.7.10

2.7.11

Paired acceptors

Dikinases

2.7.9

Acceptor

Group

Class

Table 2 (continued)

12 N. Dissmeyer and A. Schnittger

2  The Age of Protein Kinases

13

Fig. 1. Transition states for phospho or phosphoryl transfer. (a) Dissociative mechanism with a metaphosphate intermediate transition state. (b) The associative mechanism proceeds through a pentavalent transition state in which the incoming group has substantial bond formation before the leaving group has left. In the dissociative mechanism, there is accumulation of charge on the phosphoryl oxygen that links the b- and g-phosphate groups of ATP. In the associative mechanism, there is an accumulation of charge on the peripheral oxygens of the departing g-phosphate. Both mechanisms lead to a phosphate ester or phosphodiester bond. Transition states are shown in brackets. (c) Minimal reaction mechanism of phosphoramidate formation in phosphohistidine. (a) and (b) redrawn from ref. 166, (c) modified from ref. 167.

with interaction partners through their specific binding domains (11). When discussing this issue, one has to keep in mind that also the general abundance of the amino acid Tyr is much lower than that for Ser and Thr. In plants, however, it was assumed for a long time that there is no Tyr phosphorylation at all. This was due to the lack of classic PTKs. But recent studies clearly show that Tyr phosphorylation is as extensive in plants (12–14) as it is in mammals (15, 16) and most probably performed by dual-specificity kinases (DSKs). Still, it remains open if there are Tyr-specific kinases in plants (17). His phosphorylation has been reported in all kingdoms, and His kinases are prominent in plants and bacteria. However, N-linked phosphorylation is highly acid-labile and remained undiscovered for a long time due to the harsh experimental methods of N-terminal sequencing (Edman degradation) used in conventional protein chemical studies. Its relative contribution to the total phosphoamino acids of eukaryotic cells has now been estimated at 5–10% of total protein phosphorylation (for examples, see refs. 18, 19). However, this is up to roughly 10- to 100-fold more than tyrosine phosphorylation in eukaryotic cells, whereas Arg and Lys phosphorylation constitute less than 0.1% (20). 1.2. Biochemical and Structural Changes upon Phosphorylation

A phospho group has a pKa of approximately 6.7 and appears predominantly dianionic at physiological pH, i.e. it forms two negative charges. Noteworthy, dianions do not occur within any of the protein-coding amino acids. The addition of a phosphoryl

14

N. Dissmeyer and A. Schnittger

group can have major impacts on the net charge of the substrate (21, 22) and can thus change the conformation of a protein (23, 24). Therefore, this often has profound effects on its functional properties such as activity, localization, and stability. The transferred phosphoryl oxygens impart a high negative charge to the target protein that on the one hand might cause a repulsion of other negative charges and on the other hand enables the formation of ion pairs with positively charged amino acid side chains, such as Arg that contains a positively charged guanidinium group with a pKa of >12. This positively charged planar moiety interacts perfectly with the phosphoryl oxygens and is able to form multiple hydrogen bonds producing very strong bidentate interactions (25). Further interactions of the phosphoryl group predominantly involve main-chain nitrogens at the start of a-helices attracted by the positive charge of the helix dipole. The conformational and structural consequences of phosphorylation result from the sum of the newly formed and broken hydrogen bonds. Phosphorylation can further change a protein’s activation state, alter the binding efficiency for other proteins (substrates, regulators, interactors, or other kinases) and influence protein stability. For example, phosphoserine or -tyrosine residues, located within particular amino acid sequence motifs, may constitute binding sites for recognition (26). Some kinases require a hierarchical substrate phosphorylation with the first phosphorylation creating a recognition site for the kinase catalyzing the second phosphorylation and so on. Conversely, removal of a phosphate group can of course also change and reverse, for example, the catalytic activity of an enzyme and all the other aforementioned effects. Often the conformational changes result in an activation or inactivation of the protein itself which holds true both for enzymes and substrates as well, thereby regulating protein functions. For example, the conversion of an inactive to an active kinase can involve conformational changes at multiple loci in the enzyme structure, enabling the enzyme to bind substrates, orient catalytic groups, and release steric blocking of catalytic or ATP-binding sites. Intramolecular movements of the activation segment upon phosphorylation, especially of the activation loop, play key roles in kinase activation. But it is also very common that proteins are phosphorylated in order to target them to the destination site where they function in the cell, and phosphorylation sites can connect the members of a cascade with downstream events by interaction with signalling proteins that themselves contain specific phosphomotif-binding domains (11). In contrast, phosphorylation can lead to the dissociation of protein/protein complexes, e.g. in the case of Retinoblastoma protein (Rb) complexed with E2F/DP transcription factors upon phosphorylation by Cdk1 (27). Kinases may themselves require activation by phosphorylation by another upstream kinase (e.g. cyclin-dependent kinase 1 [Cdk1]

2  The Age of Protein Kinases

15

by CDK-activating kinase 1 [Cak1]) (28) or by autophosphorylation (e.g. cAMP-dependent PK [cAPK]). In all these cases, activatory phosphorylation of the kinase introduces a structurally required double negative charge in form of the phosphono group in the activation loop. This leads to a critical re-orientation and proper alignment of catalytic residues such as aspartate and arginine that can be found in the catalytic cores or active sites of each and every eukaryotic PK (EPK). Only after having undergone these intramolecular changes, these sites together with the phosphorylated activation loop can support a nucleophilic attack of the donor phosphate (e.g. from ATP) to be finally transferred to the acceptor-site of the substrate by the kinase. However, inhibitory phosphorylation can regulate enzyme activity by initiation of conformational changes which may directly block access to the active site and/or the ATP-binding pocket, a catalytic core domain of kinases (e.g. for Cdk1; (29)), or lead to reduced substrate binding of the kinase (30). However, phosphoryl groups may also act solely as steric blocking agents without any conformational change such as in the case of isocitrate dehydrogenase (31). Other needs for phosphorylation are when a potential phosphoacceptor site in a substrate must be brought into the proper orientation in order to be fully phosphorylated in a subsequent kinase reaction, and thus can regulate the interaction among protein partners that are required to – at least transiently – form complexes in order to function (e.g. mitogen-activated PKs (MAPKs); (32, 33)). 1.3. Kinase Structure and Function

All EPKs are structurally related to one another (34, 35); all harbour a conserved catalytic domain which consists of approximately 200–300 residues that can be further subdivided into certain characteristic domains. While the catalytic core can be separated by large amino acid insertions, the residues involved directly in catalysis are always 100% conserved. In all cases, the catalytic domain consists of two lobes where the typically small amino-terminal lobe binds and orientates ATP, and the typically large, predominantly a-helical, carboxy-terminal lobe is required for substrate binding and the initiation of the phosphoryl transfer (Fig. 2). This structural feature of EPKs is also known as the protein kinase fold. The amino-terminal domain is composed of a five-stranded b-sheet and one a-helix (the C-helix) which serves as an interaction domain and harbours a catalytic glutamate. The small lobe contains a glycine (Gly; G)-rich loop with the consensus Rossmann motif GxGxxG located in the phosphate binding loop (P-loop) which lies within the ATP-binding pocket. This structure is required for anchoring the non-transferable a- and b-phospho groups of ATP via backbone interactions and to orient the g-phospho group for catalysis (Fig. 2). Structural analyses of the ATP-binding site and the catalytic lobes revealed that EPKs exist mainly in two conformations,

Fig. 2. Structural comparison of the catalytic cores of PEKs from different kinase families. All EPKs share highly conserved domains and catalytic residues required for their enzymatic function. (a) Schematic representation of catalytic EPK domains and residues, i.e. the N-terminal b-sheet with Rossmann motif in the P-loop and the a- or C-helix; the P + 1 and T-loop, the HRD (eponymous with the “RD kinases”), DFG, and APE motifs in the central part of the EPKs and several highly conserved Lys, Asp, Arg, and Glu residues including the catalytic base (shaded in grey). (b)–(l) Structural representations of

2  The Age of Protein Kinases

17

i.e. open and closed (36). In the open conformation, ATP can easily access and ADP is released from the binding pocket, and in the closed form, both substrate and kinase residues are brought into proper orientation to enable catalysis. A closer look at the ATP-binding site demonstrated that five further and much more distinct pockets can be exploited for binding of chemical inhibitors by interaction with specific functional groups (37). These pockets are those utilized for adenine- and ribose-binding, the so-called p38 or gatekeeper pocket, the lysine or hydrophobic pocket below the adenine and the type II inhibitor pocket between the C-helix and the activation segment (38). The structural and atomic mechanistics of regulation of kinase activation/inactivation via protein phosphorylation are resolved on an atomic level and are reviewed by Johnson (39). Many inhibitor studies involve chemical compounds capable of specifically targeting the ATP-binding pocket of a specific kinase, which is so highly conserved throughout this enzyme family. EPKs share a conserved catalytic domain containing likewise highly conserved lysine and aspartate residues such as Lys30, Asp125, or Asp143 (numbering refers to an approximate location within most EPK sequences, for more details see refs. 35, 40–42). The sequences of these cores serve to determine the relationships between kinases (43) and, interestingly, catalytic residues and domains of various kinases have been evidenced to adopt strikingly similar structures in their active conformation (40). In human cyclin-dependent kinase 2 (Cdk2), the phosphate contacts three arginine residues in the C-helix (Arg50), in the catalytic strand (Arg126), and in the start of the activation segment (Arg150). In Cdks, the C-helix is also known as the Cyclin-binding PSTAIRE domain and represents a vital element of the kinase core Fig. 2. (continued) the kinase folds of entire or catalytic regions of 11 representative members of the six major kinase families AGC, CaMK (two examples shown), CMGC (five examples shown), conventional PTK, TKL, and others. (b) Indicated are the small and large lobes with the N-terminal uppermost and C-terminal lowermost in the cartoon. (c) TK: human protooncogene PTK Src-c (PDB ID: 1FMK; (168)). Src has an uncommon T-loop-like structure which is significantly reduced in length and missing critical elements, and is located at the backside of the kinase fold. (d) TKL: human B-Raf protooncogene PSTK in complex with an inhibitor (PDB ID: 3C4C; (169)). Raf has an uncommon T-loop-like structure which is significantly reduced and lacking a clear P-loop. (e) AGC: catalytic subunit of human PKA/cAPK complexed with a peptide inhibitor (PDB ID: 1ATP; (170)). The P-loop-like structure is located at the backside of the kinase fold. (f, g) CaMK. (f) Human cell cycle checkpoint kinase (Chk1; PDB ID: 1IA8; (171)). (g) Regulatory apparatus of CDPK from Arabidopsis thaliana (PDB ID: 2AAO; (172)). This structure is very small and only a fragment. (h–l) CMGC class. (h) T-loop-phosphorylated human Cdk2 bound to cyclin A (cyclin moiety not shown, PDB ID: 1JST; (28)). (i) Binary complex of the catalytic subunit of maize CK2a (PDB ID: 1LP4; (173)). (j) Phosphorylated human MAPK ERK2 (PDB ID: 2ERK; (174)). (k) Phosphorylated human MAPK p38-g (PDB ID: 1CM8; (175)). The P-loop-like structure is located at the backside of the kinase fold. (l) Human GSK-3b (PDB ID: 1H8F; (176)). (m) Others: kinase domain of human Wee1 complexed with an inhibitor (PDB ID: 1X8B; (177)). The P- and T-loops and conserved motifs such as active clefts, and catalytically active sites or their equivalent positions in the sequence are indicated by shading and labels as follows. P ATP-binding or P-loop, T activation segment or T-loop, D DFG motif. Open gaps in the visualized structure result from the masking of subunits and/or other binding partners within the crystal. The structures were derived from the RCSB Protein Data Bank (PDB) and Pymol (178) used for visualization. This figure is displayed in greyscale in the print edition but available in color in the electronic version.

18

N. Dissmeyer and A. Schnittger

involved in peptide-substrate recognition together with the “activation segment.” In EPKs, this sequence starts with the conserved region extending from the DFG (Asp-Phe-Gly) to the APE (Ala-Pro-Glu) motif that swings down upon activatory phosphorylation to allow access to the catalytic cleft (44–46). The activation segment usually has a size of roughly 20–40 amino acids and includes, from the N- to C-terminus, secondary elements serving as Mg2+-binding loop containing the DFG motif, b9, an activation loop (T-loop) and a P + 1 loop that includes the APE motif. In many but not all EPKs, a highly conserved threonine residue plays a pivotal role in functional activation of the activation loop, therefore, named the T-loop. In cAPK, this is a Thr-197 residue beside another autophosphorylation site, i.e. in Cdks a threonin close to the residue 160. The so-called “invariant aspartate” (Asp166 in cAPK) within the HRDLKxxN motif (in short: HRD) of the catalytic loop functions as the “catalytic base” and “proton trap,” most likely by activating the incoming substrate hydroxy group (Fig. 2). Most PSTKs and all TPKs belong to the group of RD kinases (47) which are defined as those kinases in which the conserved catalytic aspartate is preceded by an arginine residue. The arginine builds up ionic interactions with a phosphate or a carboxylate group (see above). Most, but not all RD kinases are activated by activation loop phosphorylation; these always contain an RD motif at the invariant aspartate (Table 3). Crystallography revealed that a cluster of basic residues, partially originating from the RD motif, is involved in charge neutralization of the phosphorylated amino acid of the activation loop. The dianionic phosphoryl group of such a phosphothreonine functions in stabilization of the previously mentioned positively charged cluster of Arg, Lys, and His side chains and directs the orientation of the catalytic base aspartate by producing the required electrostatic environment (35). Interestingly, phosphorylase kinase (PhK) has a negative charge through the presence of the glutamate side chain and protein kinase CK1 accomplishes charge neutralization of the catalytic arginine in the HRD motif by binding a sulphate (SO42−) dianion in close proximity both replacing a phosphoamino acid dianion. In CK2a, the catalytic subunit of the holoenzyme protein kinase CK2, the activation segment is unphosphorylated. Under crystallization conditions, a sulphate anion occupies the activation segment and marks the site that recognizes the acidic side chain in CK2 substrates at P + 3 (48). The catalytic base is possibly involved in forming an alcoholate or phenolate anion with the hydroxy rest coming from a serine, threonine, or a tyrosine that is going to be phosphorylated. This anion then further attacks the g-phospho group of ATP and results in phospho transfer. The activation loop undergoes enormous conformational changes upon phosphorylation and virtually

2  The Age of Protein Kinases

19

Table 3 RD kinases and EPKs dependent and independent on phosphorylation in the activation segment Phosphorylated activation segment

Unphosphorylated activation segment

RD kinases

RD kinases CaMK family: PhK, Chk1, CaMII

Single phospho-site a

AGC family: PKA/cAPK , PKB, PKC

CK1 family: CK1

CMGC family: PSTAIRE-Cdks, Cak/Cdk7, GSK-3b (phosphorylation at secondary siteb)

CMGC family: CK2a, some non-PSTAIRE-Cdks (human Cdk5/6)

TK family: VEGFR and PDGFR TKs, Src family membersa

CaMK family: CaMKI

TKL family: Raf

TK family: EGFR TK

STE family: MAPKK/MEK1 Dual phospho-site

Non-RD kinases

AGC family: Aurora A

CaMK family: SKY1, MLCK

CMGC family: p38/MAPK/ERK2

CMGC family: DAPK

TK family: IRAK

Others: Wee1

RD kinases: the conserved catalytic aspartate is preceded by an arginine residue Details are taken from refs. 35, 41, 148 a  Autophosphorylation b  In all the phosphorylated kinases, phosphorylation occurs at the “primary site,” if not mentioned

leads to a switch from an inactive to an active form of the kinase. In many cases, an unphosphorylated activation loop serves as a blocking structure, sterically hindering both ATP and the substrate from entering the catalytic cleft and distorting the Mg2+-anchor of the DFG motif (41). Also unphosphorylated kinase with a deformed activation segment might still bind to ATP (49). However, conformational plasticity of switching EPK activation and deactivation is one of the major reasons for the rapid response of kinase cascades. The invariant aspartate residue of the DFG motif chelates the Mg2+ and helps to position the phosphate for transfer (40, 50). Moreover, the phenylalanine serves as an intramolecular binding interface for the C-helix and this region often contains further conserved phosphoacceptor sites such as the signature T-x-Y of MAPKs and those of MAPK kinases (MAPKKs/MAP2Ks) and Cdks (51). Phosphorylation of serine/threonine and/or tyrosine residues in these segments has the capacity to modify the overall fold between the DFG and APE motifs. This, in turn, is a key event necessary for the correct positioning of the two kinase lobes to form an active conformation ready for catalysis (40).

20

N. Dissmeyer and A. Schnittger

For successful phosphoryl transfer, kinases require on the one hand consensus target amino acid sequences at the phosphoacceptor site. For Cdk1, this is K/RS/TPxK/Rx with S/TP being the minimal motif (52, 53). Substrate recognition, on the other hand, is mediated through the primary sequence surrounding the phosphorylatable residues in the target sequence, as well as through other docking sites further apart in the substrate’s structure (54). Cdks, for example, are proline (Pro; P)-directed kinases, i.e. their its consensus target phosphorylation sites must not only contain a Pro residue but also have to be positioned at a very specific site immediately after the S/T residue to allow modification. As an example from the CMGC kinases, in human Cdk2, a valine (Val; V)-rich segment of the highly preferred phosphoacceptor site in the activation loop 160-TxxVVTL-166 is part of the P + 1 loop and contributes to an unusual left-handed conformation. Here, the side chain is recognized C-terminally of the phosphoacceptor site. This results in a tight association with two main-chain carbonyl oxygen atoms of another conserved Arg and forms a pocket that solely accommodates a Pro residue. Any other amino acid side chain containing a peptide amino group would need a supplementary hydrogen-binding partner in order to be properly accommodated (55, 56). The activation segment of kinases is also known to literally form “assembly platforms” whereby catalytic residues of the kinase and substrate phosphoacceptors can approach in the closest proximity for a successful nucleophilic phosphoryl transfer (40, 46). With some of the early crystal structures of human EPKs, such as for Cdk2 and MAPK, it was shown that the activation loop reduces access to the substrate site (Cdk2 (57) and MAPK (58)). However, with other EPKs, e.g. PKA (protein kinase A/cAMPdependent PK/cAPK), a different role was proposed. Dephosphoand phosphomimetic substitutions of the activation loop Thr showed little change in peptide-substrate affinity, highlighting a more crucial role of phosphorylation at this residue in catalysis than that in substrate recruitment (59). Contrarily, bimolecular fluorescence complementation (BiFC) experiments demon­ strated that hypomorphic alleles and dephospho variants with modified T-loops of Arabidopsis thaliana CDKA;1 displayed reduced binding to bona fide substrates (60, 61) (see also Chapter 14 in this book). Some eukaryotic kinases, such as Cdks, appear to contain little more than the PK catalytic core and are almost fully inactive as monomer (62). In addition, EPKs exhibit to some extent variability in parts of the kinase domain and may contain additional domains, additional subunits, divergent intramolecular regulation mechanisms, or all of these. Thus, EPKs can be controlled through various means such as by binding to additional subunits (cyclin, Cdk subunit), domains (cyclin, SH2 and SH3, 14-3-3; (63, 64)),

2  The Age of Protein Kinases

21

ligands (cyclic adenosine monophosphate (cAMP), Ca2+/calmodulin, diacyl glyerol), by controlling the abundance and/or stability of these factors (cyclin degradation by the anaphase-promoting complex/cyclosome (APC/C)), by inhibitor proteins, by phosphorylation/dephosphorylation, or via subcellular localization. Outside their catalytic domain, PKs possess a wide diversity of recognition/interaction domains, including those for dimerization, (auto)phosphorylation, docking, acylation (membrane targeting), and recruitment (membrane, nucleus, cytosol), but also for rapid degradation (for instance, a PEST domain, a motif consisting of a hydrophilic stretch of at least 12 amino acids in length with a high local concentration of the amino acids Pro, Asp, or Glu, and Ser or Thr; PEST domains critically reduce the halflife of proteins). Phosphorylation is a sub-stoichiometric process. This means that not the entire pool of a certain substrate protein is phosphorylated at the same time. Consequently, both quantification and even detection can be extremely difficult for low abundance phosphorylation sites. Besides that, protein phosphorylation is very abundant in multicellular eukaryotes containing a high number of kinases (Table 1) that target a multitude of substrates. This enzyme– substrate interaction can be either specific in a one-to-one fashion or, which is very common, in a much more complex way where one protein is substrate of multiple kinases with different consensus and target sites. However, it is also common that one site in one substrate is operated by a number of distinct kinases (65).

2. Kinase Classification and Abundance

At the moment, more than 17,000 kinases have been described overall, including more than 10,000 protein kinases, the class of enzymes with other proteins as a target (66). Thus, PKs in general are one of the largest families of kinases, and indeed one of the largest of all protein families, and are highly conserved across species. With as many as 518 in humans and 540 putative members in mice, PKs constitute the largest single enzyme family in mammalian genomes (http://kinase.com/, (67, 68)), and are also highly abundant in other model species (Table  1). In yeast, Drosophila, mammals, and Arabidopsis, it has been predicted that PKs phosphorylate 30% of cellular proteins (69). Plants, for example, Arabidopsis or rice, have about twice the number of PKs found in mammals, i.e. more than 1,000, which is a significantly higher number of genes than in any of the aforementioned organisms (Fig. 4, Table 5; (67, 70–73)). The PlantsP database already holds 1,112 (as of July 2010) entries for Arabidopsis kinases and in this species, protein phosphorylation utilizes more than 5% of the genes: 4.5% encode PKs, 0.5% encode protein phosphatases, and

22

N. Dissmeyer and A. Schnittger

the PSTKs themselves represent about 4% of the entire Arabidopsis genome, i.e. almost 1,000 different enzymes (74, 75). The high abundance of PSTKs seems to be limited to multicellular eukaryotes and if one takes into account that approximately 30% of the proteome is phoshorylated, each of the thousand plant kinases should be responsible for modification of seven proteins on average. This is probably an underestimation since many proteins are regulated by multisite phosphorylation, closely related PKs might overlap in their specificities, some PKs are highly specific for one or a few substrates only (e.g. MAP2K), and many phosphorylation sites are known to have no function (76). The EPK superfamily can be broadly split into two groups according to their molecular phylogeny: conventional and atypical PKs (APKs). The conventional group is the largest and its members have further been sub-classified, first into five (43), then into seven (3), and finally into eight major phylogenetic groups according to sequence similarity between catalytic and accessory domains, and their mode of regulation (Table  4). The eight conventional EPK groups are: (1) AGC, (2) CaMK, (3) CMGC, (4) CK1, (5) RGC, (6) STE, (7) conventional PTK, and (8) TKL ((77); for abbreviations, see Table 4 and Appendix). CMGC, CaMK, AGC, and STE belong to the large paraphyletic clade of non-receptor PSTKs. The Arabidopsis and Oryza sativa (rice) kinomes contain members of six of these, but lack members of the Tyr kinase group. A total of 75% of all rice kinases are TKLs (Tyr kinase-like PKs), which includes the large Interleukin-1 receptor associated kinase (IRAK) family and both receptor and cytoplasmic TKs (78). The Atypical PKs (APKs) group is composed of a small set of EPKs whose kinase domains do not share significant sequence similarity with conventional EPKs. APKs have been sorted into four groups having PK activity: (1) alpha, (2) phosphatidyl inositol 3′ kinase-related kinase (PIKK), (3) pyruvate dehydrogenase kinase (PDHK), and (4) RIO (right open reading frame; Table  4). Sequence similarity networks are useful tools for exploration of the kinase superfamily and visually display related kinases in proper relation (Fig. 3; (79)). Some Arabidopsis PSTKs do not fall into either category, including the Raf (“rapidly growing fibrosarcoma or rat fibrosarcoma”) or the receptor-like kinase (RLK) families, but instead constitute small clusters such as the Cdk-like kinases (CKL/ CLK)/LAMMER clade (named after a short conserved stretch of Leu-Ala-Met-Met-Glu-Arg residues), CK1, and NIMA (Never in mitosis A)/NIMA-related kinase (NEK), or represent orphan sequences such as Cdk-activating kinase 1 (Cak1), phosphatidylinositol-4-phosphate 5' kinase (PPK1) and TOUSLED. The modules of the MAPK cascade MAPK (MPK) > MAP2K (MKK/ MEK) > MAP3K (MEKK) > MAP4K all belong to the CMGC family (for MAPK nomenclature, please see Note 1).

Table 4 Eukaryotic protein kinase classificationa Group

Definition

Examples

Conventional EPKs AGC

The name of the AGC kinases is derived from the member as PKA/cAPK (PKACa), PKG, follows: cyclic nucleotide-dependent family (PKA/cAPK and PKC, Akt, MAST, PKG), the “PKC” family, PKB/Akt/RAC-alpha PSTK, MASTL, PVPK bARK, the ribosomal S6 kinase family, and other close relatives. These kinases have a strong preference for phosphorylation of Ser/Thr residues that are located in a consensus sequence containing the basic amino acids Lys and Arg

CaMK

The members of the CaMK group take their name from CaMK, CaMK-like, CDPK, Ca2+/CaM-regulated kinases and structurally related MAPK-associated PK, families including CaMK and SNF1/AMP-activated PKs. MLCK, TRIBBLES, Most of the members of this group exhibit activation by KIN1/SNF1/Nim1, and the binding of Ca2+ or CaM to a small C-terminal domain in AMPK, EF2K, PhK close proximity to the catalytic core. These kinases tend to be directed towards substrates containing basic residues. Plant CDPKs contain an intrinsic CaM-like domain allowing these enzymes to self-activate in the presence of Ca2+

CMGC

This group is named after the member families of Cdks and Cdk1, MAPK/ERK, MAPKs/ERK, SHAGGY/GSK-3b, Prk, and the Cdc2-like GSK-3b/SHAGGY, kinases (CLK/CKL or LAMMER) to which the CK2 family CLK/CKL, CK2a, SRPK, also belongs to. The CMGC kinases are an essential and DYRK typically large group of kinases found in all eukaryotes. CMGC kinases display unique features such as the “CMGDarginine” which is located right before the APE motif (i.e. “RAPE”) near the substrate phosphorylation site in the activation loop. This Arg plays a role in substrate recognition and kinase activation. The so-called “CMGC-insert region” in the C-terminal lobe is a CMGC family specific docking region to anchor proteins. This region can be found between the APE motif and the C-terminus and is typical for all CMGC kinases. It is also called the “CDK insert” region as Cak binds here for T-loop activation by phosphorylation [41, 149]

CK1

The protein kinase CK1 (formerly called Casein Kinase 1) group represents a typically small but essential group of EPKs found in all eukaryotes

CK1, Tau tubulin kinase

RGC

The members of the small group of receptor guanylate cyclases (RGCs) are similar in sequence to the metazoan Tyr kinases which are lacking in plants, fungi, and protists. Their properties are distinct from other known EPKs; the RGC kinase domains appear to be all but catalytically inactive. It is thought that this group evolved late in the expansion of the EPK superfamily

Photoreceptor membrane guanylate cyclase

STE

The STE group includes homologs of the S. cerevisiae sterile Ste7-like (MAP2K/ kinases sterile 7, sterile 11, and sterile 20. This group MAPKK/MEK, NIMA/ contains the MAPK cascade kinases that act upstream of NEK and NEK-like), MAPKs of the CMGC group, where a MAPK is phosphoSte11-like (MAP3K/ rylated and activated by a MAP2K/MAPKK/MEK, which MAPKKK/MEKK, Cdc7), itself is activated by a MAP3K/MAPKKK/MEKK. The Ste20-like (MAP4K/ family of Raf-related MAP4K/MAPKKKK is structurally MAPKKKK) distinct from the Ste20 family, and is contained in the TKL group

(continued)

24

N. Dissmeyer and A. Schnittger

Table 4 (continued) Group

Definition

Examples

TK

The Tyr kinase (TK) group contains conventional phospho- EGFR, Jak, VEGFR, Src, tyrosine kinases (PTKs). The active members specifically LRR-TK, Abelson kinase phosphorylate tyrosine residues of proteins, are distinct from (c-Abl), LCK DSKs which also phosphorylate Ser/Thr and are scattered within other kinase groups. TKs are found in metazoans but not in single celled fungi and play important roles in intracellular signalling cascades. Proteins phosphotyrosine were first characterized in plants and algae

TKL

The Tyr kinase-like (TKL) group is the most diverse of all LRR kinases, MLKs, groups, is closely related to TKs, and is integrated within TGFbR1, Raf, IRAK, important signalling pathways. However, TKLs are in fact RLK/PELLE family serine/threonine protein kinases and present in metazoans (RTK-like, Pti1-like, and plants but virtually absent from fungi. TKLs represent WAK-like) the largest group of EPKs in land plants, whe re they often constitute up to 80% of the kinome

Atypical EPKs Alpha

The Alpha group of kinases is a small and only recently EEF2K, Dictyostelium discovered group of atypical EPKs (APKs). In mammals, MHCK, two channelchannel-kinases are members of Alpha APKs. Alpha kinases kinases, TRPMs ion contain both a fold similar to EPKs and key amino acid channel-kinases residues known to be important for catalysis from EPKs

PIKK

The members of the small phosphatidyl inositol 3¢ kinaserelated kinase (PIKK) family are involved in signalling of DNA damage and cell growth. PIKK kinases have a high molecular weight and in mammals, five of the six members act as PSTKs

PDHK

The pyruvate dehydrogenase kinases (PDHKs) are a small and PDHK, PKAK1 ubiquitous group of APKs; five members were identified in humans. PDHKs phosphorylate a subunit of the pyruvate dehydrogenase multienzyme complex and this plays an important role in oxidative metabolism, i.e. in controlling glucose and lipid oxidation

RIO

The RIO (“right open reading frame”) group is named after Rio1-family and Rio2 the divergently transcribed founding member which was one of the two adjacent genes. RIO is a small group of essential eukaryotic APKs. They share the overall EPK fold, however, distinct substrate-binding domains were not yet discovered and the mode of ATP-binding also seems to be different from other kinases. Some RIO kinases autophosphorylate

Others

This group contains several kinases and families that do not fit within any of the other main kinase groups

PIKK, ATM, ATR, mTOR, DNA-PK, SMG-1

Wee1, Myt1/Mik1, Caks, CAKAK, Aurora, Mos, CaMKK, NIMA/NEK, TOUSLED, PPK1

Further references available at http://kinase.com/, http://www.compbio.dundee.ac.uk/kinomer/, and http://www. bio.unipd.it/molbinfo/PTKtable.html a  For abbreviations, see this table and Appendix

2  The Age of Protein Kinases

25

Fig. 3. A sequence similarity network visualizing the human kinome by kinase class. The network is composed of 513 human kinase domains and results from the analysis of sequences of a published phylogenetic tree (3) generated from alignments using pairwise BLAST E-values. Such networks visualize functional trends across protein superfamilies based on sequence similarity. Accordingly, functional themes and outliers can be identified. In the presented network, each kinase class appears in different greyscales according to the kinase classification listed in Table 4. This network highlights the relationship of kinase classes as well as sequence similarities and conservation. Modified and reprinted with permission from The Public Library of Science (PLoS) according to the Creative Commons Attribution License (CCAL) (79). For abbreviations, see Table 4 and Appendix. This figure is displayed in greyscale in the print edition but available in color in the electronic version.

The first plant protein kinase sequences were reported in 1989, and 10 years later more than 500 had been identified, including 175 in Arabidopsis (80). Nowadays, it is known that some of the Arabidopsis kinase families are specific to or largely expanded in the plant genomes, such as the approximately 600 members of the RLKs, the 30 members related to Cdks, the 34 CDPKs, 8 CRKs, 2 phosphoenolpyruvate carboxylase kinases (PPCKs), 2

26

N. Dissmeyer and A. Schnittger

PPCK-related kinases (PEPRK), 39 AGC members, the 25 CBLinteracting PSTKs, 16 His kinases, the RKL gene family which counts 307 members, the 38 Snf1-related kinases (SnRKs), the 123 genes coding for putative MAPK signalling components (including 20 MAPKs, 10 MAPKKs, 80 MAPKKKs, 10 MAPKKKKs), and the 29 CLK/CKL or LAMMER kinases (TAIR and PlantsP database; (74, 75, 81–85)). In the wild grass Brachypodium distachyon, protein kinase gene families consist of 140 kinase subfamilies with 1,177 predicted members of which 904 are PSTKs. Comparison of the kinomes of rice (1,637 members, Rice Kinase Database), Arabidopsis (1,112 members, KinBase), and poplar (black cottonwood, Populus trichocarpa; 919 results for “kinase” in PopulusDB in July 2010 (86, 87)) to the Brachypodium kinome (a total of 1,440 PKs for annotated PSTKs and TKs/TKLs, with DSKs counted in both groups (88)) demonstrates similar composition to rice but with fewer members. Both rice and Brachypodium encode the same kinase subfamilies of a very similar size, with the exception of eight RLK subfamilies. These subfamilies account for nearly all (252 of 268) of the total difference in kinome size. The greatest differences were found among the non-RD kinase subclass, predicted to encode pattern recognition receptors. In another example from the plant kingdom, 1,485 protein kinase-like (PKL) genes were annotated in grapevine (Vitis vinifera); with 2.3% of PKL genes found within the top 50 InterPro hits in the filtered gene set. 1,312 PKLs were predicted to contain TPK and 1,271 to have PSTK activity which could be interpreted as a plant-specific, very broad functional assignment as DSKs (89). Remarkably, the rice kinome, for example, contains – depending on the reference source – 31 to 47% more kinases than Arabidopsis and is three times larger than the human kinome (Fig. 4, Table 5; (70–72, 90–92)). It is important to note that all of the numbers quoted above are approximate because of the presence of genes encoding atypical kinases and the frequent inclusion of catalytically inactive members where usually highly conserved core residues got substituted. Because kinase family structures are not well defined in plants, kinases are assigned to subfamilies based on putative function. 2.1. Kinome Differences Between Animals and Plants

After the completion of sequencing of the Arabidopsis genome (70), it became apparent that plant genomes, e.g. Arabidopsis (~4%), rice (~6%), and maize (~12%), encode higher percentages of PK-coding genes than yeast (~2%), Caenorhabditis elegans (~2%), Drosophila (~3%), and humans (~2%; Tables 1 and 5; Fig. 4). Comparative analyses suggest that plants have evolved both their own signalling molecules and signal transduction pathways. One supported idea is evolutionary combination or shuffling of novel sequences; however, conserved motifs are apparent in the

2  The Age of Protein Kinases

27

Fig. 4. Pie chart of human, rice, and Arabidopsis kinases. Distribution of kinases within the eight main kinase groups: AGC, CaMK, CMGC, CK1, STE, TK, TKL, and others according to Table 5. (a) Human, (b) rice, and (c) Arabidopsis kinomes. (d) Absolute numbers of aforementioned major kinase groups per kinome; the number of genes is shown on the y axis, subfamilies are listed along the x axis. Remarkably, the TK group (arrowhead in (a) and (d)) is missing entirely in both plant species (b, c). However, the TKL family (asterisk ) is highly overrepresented in plants (a–d). Data from KinBase, The Arabidopsis Information Resource (TAIR), and Rice Kinase Database (RKD).

high number of plant paralogues of PSTKs as a result of gene duplications. Furthermore, plant-specific modules of ligand reception and signal transduction cascades have developed. A good example is the machinery involved in ethylene reception, which perceives the gaseous phytohormone by a two-component His kinase and further transmits the signal by MAPK cascade elements, see also step 1 of Subheading 1.3. Thus, gene duplication has radically

28

N. Dissmeyer and A. Schnittger

Table 5 List of human, rice, and Arabidopsis kinases by groupa Human

Rice

Arabidopsis

AGC

69

35

39

CaMK

88

100

83

CMGC

63

85

50

CK1

12

15

10

STE

49

49

100

TK

94

0

0

TKL

43

1,104

600

Other

82

23

79

Graphical illustration in Fig. 4

a 

influenced the structure, organization, and function of plant PK genes and cascades leading to novel properties (93). Genomics has also revealed that animal genomes contain PSTKs, PTKs, and His PKs, whereas in plants, PSTKs and His PKs are present exclusively. In Arabidopsis, most PKs are PSTKs. Plants share histidine kinases with prokaryotes and yeast (94). A couple of PK families are specific to plants, for example, the family of RLKs, absent in yeast, which play a very important role in intercellular signalling in plants. In Arabidopsis, the 4% of PSTKs are split up into 2.6% RLKs, 1.2% non-RLKs, and 0.2% Rafs. Although plant genomes encode many of the animal-type kinases and hundreds of RLKs, they lack classical PTKs. The Arabidopsis genome encodes more than 200 leucine-rich repeat (LRR) RLKs with an organization of functional domain organization similar to that of animal receptor kinases and more than 600 RLKs, which is the largest kinase superfamily in plants and a major part of the PSTKs (90). Thus, they do not possess the typical genes encoding components similar to those of the major animal signalling pathways, which interact with ligands at the plasma membrane and subsequently mediate the extensive cascade of downstream Tyr phosphorylations. Receptor PTKs (RTKs), epidermal growth factor receptor (EGFR), Hedgehog, Jak/STAT, Notch, Wingless, and also transmembrane receptor-like PTKs from RTK-Ras pathways are lacking in plants. In contrast, signalling in Arabidopsis involves a huge number of protein serine/threonine receptor kinases, i.e. RLKs that were first discovered in the plant kingdom, and two-component histidine kinases present in both bacteria and plants. The Ser/Thr RLKs make up roughly one-third of all PSTKs. This composition of kinase specificity seems to be a characteristic feature of higher

2  The Age of Protein Kinases

29

plants and it is speculated that signalling mechanisms have diverged considerably in plants compared to other phyla due to the vast number of environmental and intracellular signals to be integrated by plants, which mirrors the same vague theory provided to explain extensive gene duplication and redundancy in plants (76). The presence of a large number of PSTKs has lead to the opinion that plant Tyr phosphorylation might be less frequent than in animals (17, 95). However, bioinformatics helped to identify putative DSKs and also candidates for PTKs (96–98). This might hint towards a situation similar to that of Saccharomyces cerevisiae, which also lacks PTKs but harbours a battery of DSKs. On the contrary, only recently, mass spectrometry indicated that Tyr phosphorylation is as extensive in plants as it is in animals (17). Nevertheless, a significant difference is noted between animals and plants regarding the function of protein phosphorylation in signal transduction (19).

3. Biological Roles of Kinases Almost every aspect of cellular life relies on kinase function. A paradigm is signalling networks that enable a cell to quickly respond to environmental stimuli and internal cues such as in nutrient and hormone reception and stress sensing. Besides being fast and reversible, protein phosphorylation is tightly regulated, highly specific, and allows signals to be sustained or attenuated via amplification, feedback, and crosstalk. Target protein phosphorylation often results in the modification of its activities that in turn might serve as another downstream signal for further changes in a cascade of protein activities. In this context, protein phosphorylation and dephosphorylation reactions play a pivotal role (99). In addition to that, also protein stability is often regulated by the state of phosphorylation. Target proteins may contain phosphoacceptor sites that function as so-called “phosphodegron motifs.” These in turn can be recognized by 14-3-3 proteins and/ or SCF (S-phase kinase-associated protein (Skp)-Cullin-F-box containing complex), a E3 ubiquitin ligase of the ubiquitin proteasome system (UPS). This ubiquitin ligase catalyzes target protein ubiquitination, ultimately leading to its degradation by the proteasome, a way of rapid depletion (100). The COP9 signalosome (CSN) regulates, for example, the ubiquitin-dependent degradation of transcription factors via phosphorylation (101–103) and phosphodegron-containing cyclins (104, 105), and CDKinhibitors (106) can be destructed in a similar way. On the other hand, phosphorylation events can also increase the stability of a protein such as for transcription factors which are substrates of c-Jun (102, 107).

30

N. Dissmeyer and A. Schnittger

The specificity in signalling is, in part, achieved by two means. Catalytic specificity of protein kinases and phosphatases provides the basis for site-specific phosphorylation and dephosphorylation, respectively (34). Specific tyrosine and serine/threonine phosphorylation sites and their surrounding sequences, in turn, provide selective binding sites for conserved protein modules found in most cytoplasmic signalling molecules (8, 33). Identifying the sites of protein phosphorylation and the nature of the phosphorylated residue is therefore crucial in the study of signal transduction. Phosphorylation and dephosphorylation of a protein often serves as an “ON/OFF” switch in the regulation of cellular activities, and protein phosphorylation appears to be involved in almost all signalling pathways throughout the kingdoms. For optimal function within the phosphorylation network, kinases and phosphatases must strike a balance in any given cell. However, only a very small fraction of the thousands of protein kinases and phosphatases in plants have yet been studied experimentally, but critical functions for these enzymes have been demonstrated many times in growth and development. 3.1. Examples

This section and the kinases mentioned hereafter represent a couple of examples related to this book and are referenced with those chapters presenting technologies for their study.

3.1.1. CDKs

Similar to the highly expanded families of RLKs and the MAPK cascade members, the number of putative CDKs and CKL/CLK/ LAMMERs is also increased in plants (82). Arabidopsis has one central CDK, namely CDKA;1 (108, 109). The main CDKs such as human Cdk1, yeast Cdc2+/Cdc28p, and also Arabidopsis CDKA;1, contain the archetypically conserved PSTAIRE hallmark in the C-helix of the N-terminal cyclin-binding domain (residues 42–57 in human Cdk2; (110)). However, so-called non-PSTAIRECdks with different functions also exist. Harashima et al. present detailed procedures both on expression of Arabidopsis CDKA;1 in insect cells and tobacco cell suspension cultures in Chapter 4. Furthermore, they describe immunoprecipitation-coupled and affinity purification-based kinase assays on purified CDK/Cyclin complexes. In Chapter 14, Pusch et al. give a detailed view of BiFC assays on CDKA;1 phospho-site mutants, and Dissmeyer and Schnittger highlight a complete procedure on phospho-site substitution, mutant transformation and in  vitro kinase assays of Arabidopsis CDKA;1 in Chapter 6 of this book.

3.1.2. MAPK

MAPK cascades are highly conserved modules in all eukaryotes. In plants, these participate in hormonal responses (auxin, abscissic acid (ABA), and possibly ethylene and cytokinins), cell cycle regulation, pathogen defence (by pathogens themselves or pathogen-derived elicitors), wounding response, hypersensitive

2  The Age of Protein Kinases

31

response (HR)-like programmed cell death (PCD), and mediate external stresses (111, 112). In addition, MAPK cascades are also involved in responses to a diversity of physical environmental stimuli and abiotic stresses including cold, heat, high UV, salinity, drought, and reactive oxygen species (ROS) (reviewed in refs. 113, 114) and function in interplay with CDPKs (reviewed in ref. 115). Arabidopsis MAPK 6 (MPK6) can regulate signalling of the gaseous phytohormone ethylene via phosphorylation of an in vivo substrate transcription factor (116) and control ethylene synthesis via phosphorylation of ethylene biosynthetic enzymes (117, 118). Chapters 3 and 5 by Sonkoly et al. and Dóczi et al. focus on the purification of Arabidopsis MAP kinase 9 (MPK9) and on general MAPK activity and reporter gene assays. In Chapter 9, Li et  al. describe MAPK inhibitor studies to investigate their role in PCD in pollen, and Salomon et al. write about chemical genetics approaches for the study of tomato MPK3 in Chapter 10. Umbrasaite et al. give a detailed protocol for inhibition of Arabidopsis PP2C-type protein phosphatase which counteracts MPK6 activity in order to regulate developmental and stress signalling pathways in Chapter 8. In addition, in Chapter 15, Böhmer et al. present the generation of Arabidopsis plants overexpressing inhibitor-sensitive CALCIUMDEPENDENT PROTEIN KINASE 1 (CPK1). 3.1.3. RLKs

Genetic and biochemical studies indicate specific functions for plant PSTKs in development and in sensing of environmental stimuli. The LRR-RLKs ERECTA, CLAVATA 1 (CLV1), TOUSLED, and HAESA are required to establish important developmental processes such as apical meristem identity and organ morphology (119–123). Proteomic approaches complemented genetical studies and this interplay lead to a breakthrough in the identification of members of the signal transduction cascade of growth-promoting brassinosteroid (BR) hormones in plants. This includes BR perception by the putative receptor of BR, BRASSINOSTEROID INSENSITIVE 1 (BRI1) receptor kinase at the cell surface (reviewed in refs. 4, 76, 124). Chapters 11 (Hink et  al.), 12 (Geldner et al.), and 13 (Kwaaitaal et al.) describe spectroscopical and microscopical techniques used to study some of these RLKs, e.g. by addressing receptor kinase dimerization kinetics, stability, and localization. Genetic evidence has identified the Brassica napus (rape seed) S-receptor-like kinase (SRK) as the female determinant of the self-incompatibility (SI) recognition response (reviewed in refs. 125–127). The SI recognition response in pollen–pistil interactions in the pollination process of plant sexual reproduction is based on secreted S-locus glycoprotein (SLG) and a transmembrane SRK (reviewed in refs. 123, 126). Inhibitor studies on the SI response are described in Chapter 9 by Li et al.

32

N. Dissmeyer and A. Schnittger

3.1.4. His Kinases

Ethylene is perceived through a two-component His kinase receptor (128) which interacts physically with CONSTITUTIVE TRIPLE RESPONSE 1 (CTR1) kinase, a Raf MAP3K/MEKK, the upstream element of a MAPK module. The three Arabidopsis cytokinin receptors ARABIDOPSIS HISTIDINE KINASE 2 and 3 (AHK2 and 3) as well as CYTOKININ RESPONSE 1 (CRE1; (129)) are His kinases like the five ethylene receptors ETHYLENE RESPONSE 1 and 2 (ETR1/2), ETHYLENE SENSOR 1 and 2 (ERS1/2), and ETHYLENE INSENSITIVE 4 (EIN4; (130–132)). These kinases are altogether vital for proper plant development. The Arabidopsis histidine kinase CYTOKININ-INSENSITIVE 1 (CKI1) was recently shown to be required for female gametophyte and vegetative growth (133), and a bacterial assay to study plant sensor histidine kinases is presented in Chapter 7 by Spíchal et al.

4. Databases and Webtools See Table 6

5. Note 1. According to Champion et  al., a new nomenclature for the plant MAPK cascade was suggested (81): MAPK is now MPK, MEK is MAPKK/MAP2K, and MEKK is MAPKKK/MAP3K. Moreover, for Arabidopsis, MKK for MEK/MAP2K and MPK for MAPK were introduced.

Acknowledgments We thank Karsten Niefind, Emily Mc Callum, and Anna Richter for critical reading and helpful comments on the manuscript. This work was supported by an Action Thématique et Incitative sur Programme (ATIP) grant from the Centre National de la Recherche Scientifique to A.S.

2  The Age of Protein Kinases

33

Table 6 List of useful online databases and tools Name

Description

Availability

BrachyBase

Displays the JGI 8× Brachypodium distachyon genome assemblies with MIPS/JGI gene predictions, Brachypodium EST alignments, Illumina-based RNAseq data, and empirical TAU gene model predictions

http://www. brachybase.org/

BRACHYPODIUM. ORG

http://www. The Brachypodium distachyon brachypodium. Information Resource. Genetic org/ stocks, tools, search, brachy sequence resource

Brachypodium genome database

Genome view, comparative map viewer, http://mips. data overview, search and search for helmholtzmuenchen. protein domains de/plant/ brachypodium/ index.jsp

Lotus japonicus genome database

Genome view, comparative map viewer, http://mips. data overview, search, and search for helmholtzmuenchen. protein domains de/plant/lotus/ index.jsp

MAtD

The MIPS Arabidopsis thaliana genome http://mips. helmholtzmuenchen. database. Genome view, comparative de/plant/athal/ map viewer, data overview, search index.jsp and search for protein domains, and chromosomal heatmaps

References

Plant sequence databases

Medicago MT3 genome UMN Medicago resources. Information http://www. medicago.org database about the genome sequencing project (MT3.0 assembly release) Medicago and other legume resources and links MaizeGDB

Maize genetics and genomics database

http://www. maizegdb.org/

MaizeSequence

Maize genome browser

http://maizesequence. org/

MGSP

The maize genome database. Genome view, comparative map viewer, data overview, search and search for protein domains

http://mips. helmholtz-muenchen. de/plant/maize/ index.jsp

modelcrop.org

The Brachypodium distachyon compara- http://www. tive genomics resource. Comparative modelcrop.org/ genomics tools and resources

(147)

(continued)

34

N. Dissmeyer and A. Schnittger

Table 6 (continued) Name

Description

Availability

MOsDB

The rice genome database. Genome view, comparative map viewer, data overview, search and search for protein domains, and comparative map viewer

http://mips. helmholtzmuenchen. de/plant/rice/ index.jsp

PlantsDB

http://mips. MIPS plant database for monocots helmholtzmuenchen. (maize, rice, Sorghum, Brachypodium) de/plant/ and dicots (Arabidopsis, Medicago, Lotus, tomato)

PoplarDB

Poplar functional genomics database http://mycor.nancy. with search, BLAST, and DB browser inra.fr/poplardb/

PopulusDB

Resource for tree genomics, including Populus DNA microarray database

Sorghum genome database

Genome view, comparative map viewer, http://mips. helmholtzmuenchen. data overview, search and search for de/plant/sorghum/ protein domains, and comparative index.jsp map viewer

TAIR

The Arabidopsis Information Resource. http://www. Arabidopsis.org/ The world’s leading database of genetic and molecular biology data for the model higher plant Arabidopsis thaliana and important resources. Complete genome sequence, gene structure, gene product information, metabolism, gene expression, DNA and seed stocks of mutants, genome maps, genetic and physical markers, publications, and information about the Arabidopsis research community

Tomato genome database

Genome view, comparative map viewer, http://mips. helmholtzmuenchen. data overview, search and search for de/plant/tomato/ protein domains, and comparative index.jsp map viewer

UrMeLDB

The Medicago MT3 genome database. http://mips. helmholtzmuenchen. Genome view, comparative map de/plant/medi3/ viewer, data overview, search and index.jsp search for protein domains

UK CropNet Databases Combination of six UK CropNet databases as CropSeqDB with data on crop plants and grasses (Arabidopsis Genome Resource, BarleyDB, BrassicaDB, FoggDB, MilletGenes)

http://www.populus. db.umu.se/

References

(86)

http://ukcrop.net/ db.html

(continued)

2  The Age of Protein Kinases

35

Table 6 (continued) Name

Description

Availability

References

Plant phosphorylation PepBase

http://pepbase.iab. A peptide database with MS/MS keio.ac.jp/phospho/ spectra, consists of experimental data msb/ focused on phosphoproteomics and membrane proteomics. PepBase is divided into two tools: PhosphoPepBase and MembranePepbase

PhosPhAt 3.0

PlantsP

http://phosphat. mpimp-golm.mpg. de/ Functional genomics database for plant http://plantsp.sdsc. edu/ phosphorylation, comprises information from all plant species (i.e. kingdom viridiplantae). PlantsP provides a resource for information on a collection of T-DNA insertion mutants (knockouts) in each kinase and phosphatase, primarily in Arabidopsis thaliana

(150, 151)

(74, 75)

Plant tools ABRC

Arabidopsis Biological Research Centre. http://Arabidopsis. org Resource centre at the Ohio State University which collects, reproduces, preserves, and distributes seed and DNA resources of Arabidopsis thaliana and related species. Stock information and ordering for the ABRC are fully integrated into TAIR

Arabidopsis eFP Browser

“Electronic Fluorescent Pictograph” browser for exploring and analyzing large-scale biological data sets

Genevestigator

https://www. Database of gene expression and genevestigator.com/ regulation in a broad variety of contexts summarizing and interpreting microarray data

KOME

http://cdna01.dna. (153) Knowledge-based Oryza molecular affrc.go.jp/cDNA/ biological encyclopaedia full-length cDNA database; full-length cDNA clones from rice (Oryza sativa L. ssp. japonica cv. Nipponbare)

NASC

Nottingham Arabidopsis Stock Centre

SIGNAL

Genomic DNA flanking sequences of http://signal.salk.edu/ (154) the T-DNA insertion for most of cgi-bin/tdnaexpress these populations are searchable here

http://www.bar. utoronto.ca/efp/

(152)

http://Arabidopsis.info

(continued)

36

N. Dissmeyer and A. Schnittger

Table 6 (continued) Name

Description

Availability

References

TIGR

The Institute of Genomic Research

ftp://ftp.tigr.org/ pub/data/ Eukaryotic_ Projects/o_sativa/

TILLING

Targeting Induced Local Lesions in Genomes; Arabidopsis TILLING Project (ATP)/Seattle TILLING Project (STP)

http://tilling. fhcrc.org/

kinase.com

Genomics, evolution, and function of protein kinases

http://kinase.com/

KinBase

The kinase database at Sugen/Salk

http://kinase.com/ kinbase/

KinG

Database of protein kinases in genomes, http://hodgkin.mbu. iisc.ernet.in/king/ kinase domains identified. Comprehensive collection of serine/ threonine/tyrosine-specific kinases and their homologues identified in various completed genomes using sequence and profile search methods. Catalytic domain search tool

(158)

Kinomer

Characterized Kinomes. Protein kinase http://www.compbio. dundee.ac.uk/ classifcation HMM library and kinomer/kinomes. database. Multilevel HMM library html that models these protein kinase groups. It allows accurate identification of protein kinases and classification to the appropriate kinase group

(98, 159)

Kinomer Search Tool

Precalculated Kinome Search

(98, 159)

KSD

Kinase Sequence Database. Collection http://sequoia.ucsf. edu/ksd/ of protein kinase sequences grouped into families by homology of their catalytic domains

MOLBINFO

Molecular Biology and Bioinformatics Unit

PhosphoBase

See Phospho.ELM

Phospho.ELM

Formerly PhosphoBase; a database of phosphorylation sites includes the Phospho.ELM BLAST Search tool

(155–157)

Kinase databases and tools

http://www.compbio. dundee.ac.uk/ kinomer/bin/ kinomes.pl

(67)

http://www.bio.unipd. it/molbinfo/ PTKtable.html

http://phospho.elm. eu.org/

(160)

(continued)

2  The Age of Protein Kinases

37

Table 6 (continued) Name

Description

Protein Kinase Resource Collection of services, tools, and information about kinases RKD

Availability

References

http://pkr.sdsc.edu/ html/index.shtml

(161)

Rice Kinase Database. Platform to http://rkd.ucdavis.edu (78) display user selected functional genomic data on a phylogenetic tree

Protein and proteomics Brenda

Enzyme Information System

http://www. brendaenzymes.org/

ConSurf

Server for the Identification of Functional Regions in Proteins by Surface-Mapping of Phylogenetic Information

http://consurf.tau.ac.il/

EBI

Analysis Tools at European Bioinformatics Institute

http://www.ebi.ac.uk/ Tools/index.html

ExPASy

Proteomic tools

http://www.expasy.ch/ tools/

Search tools BLAST

Basic Local Alignment Search Tool of http://www.ncbi.nlm. nih.gov/ the National Center for Biotechnology Information; finds regions of similarity between biological sequences

BLAST2

Advanced BLAST2 Search Server

http://dove. embl-heidelberg. de/Blast2/

BLASTP

Protein BLAST to search protein databases using a protein query

http://www.ncbi.nlm. nih.gov/

PatScan

Pattern scan of proteins or nucleotides

http://www-unix.mcs. anl.gov/compbio/ PatScan/HTML/ patscan.html

Peptide Search

Protein identification by peptide mapping or peptide sequencing

http://www.mann. embl-heidelberg.de/ GroupPages/ PageLink/ peptidesearchpage. html

PROPSEARCH

Compositional search using a sequence http://www.infobiosud. univ-montp1.fr/ SERVEUR/ PROPSEARCH/ propsearch.html (continued)

38

N. Dissmeyer and A. Schnittger

Table 6 (continued) Name

Description

Availability

References

PSI-BLAST

Position Specific Iterative BLAST, identification of protein kinases

(162)

RPS-BLAST

Reverse position specific BLAST; identification of protein kinases

(162)

Databases of structural protein properties (163)

CDD

Conserved Domain Database: a curated Entrez database of conserved domain alignments

Consensus sites

ScanProsite

http://www.expasy. org/tools/ scanprosite/

DOMO

Database of homologous protein domains

http://www. infobiogen.fr/srs6bin/ cgi-bin/wgetz?page+LibInfo+lib+DOMO+-newId

PDB

The Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank. Obtain PDB structure

http://www.pdb.org/

PFAM

Protein families database of alignments http://bioinformatics. (164) and HMMs (hidden Markov models) weizmann.ac.il/ Pfam/

PRODOM

The protein domain database

http://www.toulouse. inra.fr/prodom.html

PROSITE

Database of protein families and domains

http://www.expasy.ch/ prosite/

SCOP

Structural classification of proteins

http://scop.mrc-lmb. cam.ac.uk/scop/

Matrix Science Mascot

(Searches based on mass spectrometry data, generally very fast!)

http://www. matrixscience.com/ search_form_select. html

MOWSE

At the HGMP-RC, searches based on peptide masses

http://srs.hgmp.mrc. ac.uk/cgi-bin/ mowse

Peptide Mass

Calculates mass from a sequence

http://us.expasy.org/ tools/peptide-mass. html

Proteomics databases

(continued)

2  The Age of Protein Kinases

39

Table 6 (continued) Name

Description

Availability

ProFound

Searches based on mass spectrometry data

http://129.85.19.192/ profound_bin/ WebProFound.exe

ProteinProspector

Searches based on mass proteometry data

http://prospector.ucsf. edu/

SWISS-2DPAGE

Human 2-D PAGE databases for proteome analysis in health and disease

http://www.expasy.ch/ ch2d/

References

General sequence databases Animal Genome Size Database

Collection of services, tools, and information

http://www. genomesize.com/

dictyBase

Central resource for Dictyostelid genomics

http://dictybase.org/

DOGS

Database of Genome Sizes

http://www.cbs.dtu. dk/databases/ DOGS/

Uniprot

Universal Protein Resource

http://www.uniprot. org/

Interpro

Integrated database of predictive protein http://www.ebi.ac.uk/ interpro/ “signatures” used for the classification and automatic annotation of proteins and genomes, i.e. IPR011009 Protein kinase-like, IPR000719 Protein kinase, IPR001245 Tyrosine protein kinase, and IPR002290 Serine/ threonine protein kinase

EBI

European Bioinformatics Institute

http://www.ebi.ac.uk/

EMBL

European Molecular Biology Laboratory, service and tools Web pages

http://www. emblheidelberg.de/ Services/index.html

KEGG

Kyoto Encyclopaedia of Genomes and Genes

http://www.genome.jp

Kimball’s Biology Pages Collection of services, tools, and information MIPS

(165)

http://users.rcn.com/ jkimball.ma.ultranet/ BiologyPages/

Munich Information Center for Protein http://mips. helmholtzmuenchen. Sequences hosted by The Institute of de/ Bioinformatics and Systems Biology (IBIS) of the Helmholtz Zentrum München (continued)

40

N. Dissmeyer and A. Schnittger

Table 6 (continued) Name

Description

Availability

NCBI

National Center for Biotechnology Information

http://www.ncbi.nlm. nih.gov/

Royal Botanic Gardens

Kew Plant DNA C-values database

http://data.kew.org/ cvalues/

SWISS-PROT

Collection of services, tools, and information

http://www.expasy. org/sprot/

References

Appendix A Abbreviations and Synonyms ABA Abscissic acid AGC Group consisting of the cyclic nucleotide-dependent family (PKA, PKG), the PKC family and the ribosomal S6 kinase family AHK2/3 ARABIDOPSIS HISTIDINE KINASE 2/3 APC/C Anaphase-promoting complex/cyclosome APK Atypical PK bARK G-protein-coupled b-adrenergic RK ATM Ataxia telangiectasia mutated kinase ATR Ataxia telangiectasia and Rad3-related kinase BiFC Bimolecular fluorescence complementation BR Brassinosteroid BRI1 BRASSINOSTEROID INSENSITIVE 1 receptor kinase Cak Cdk-activating kinase CAKAK Cak-activating kinase CaM Calmodulin CaMII Ca2+/CaM-dependent kinase II CaMK Ca2+/CaM-regulated kinase CaMK Group consisting of CaMK interacting proteins and SNF1 proteins CaMKK CAMK kinase cAMP Cyclic adenosine monophosphate cAPK cAMP-dependent PK Cdc Cell division control Cdk Cyclin-dependent (protein) kinase CDPK Ca2+-dependent PK/CaM-like domain PK cGMP Cyclic guanosine monophosphate CK1/2 Protein kinase 1/2, name derived from Casein Kinase 1/2

2  The Age of Protein Kinases

41

CKI1 CYTOKININ-INSENSITIVE 1 CKL/CLK Cdk-like kinases CLV1 CLAVATA 1 CPK1 Arabidopsis CALCIUM-DEPENDENT PROTEIN KINASE 1 CRE1 CYTOKININ RESPONSE 1 CTR1 CONSTITUTIVE TRIPLE RESPONSE 1 DNA-PK DNA-dependent protein kinase DSK Dual-specificity kinase DYRK Dual-specificity Tyr-regulated kinase EEF2K Elongation factor-2 (eEF-2) kinase EF Elongation factor EGFR Epidermal growth factor receptor EIN4 ETHYLENE INSENSITIVE 4 EPK Eukaryotic PK ERK Extracellular signal-regulated kinase (MAPK) ERS1/2 ETHYLENE SENSOR 1/2 ETR1/2 ETHYLENE RESPONSE 1/2 GSK Glycogen synthase kinase IRAK Interleukin-1 receptor associated kinase JAK/STAT Janus family of TK/signal transducer and activator of transcription LAMMER Subfamily of kinases possessing a LAMMER (or related) amino acid sequence LCK Lymphocyte-specific PTK LRR Leucine-rich repeat MAP2K MAPK kinase, MAP kinase kinase, MAPKK, now MEK in plants and MKK in Arabidopsis* MAP3K MAP2K kinase, MAP kinase kinase kinase, MAPKKK, also known as MEKK* MAP4K MAP3K kinase, MAP kinase kinase kinase kinase, MAPKKKK* MAPK Mitogen-activated PK; now MPK in plants* MAPKK MAPK kinase* MAPKKK MAPKK kinase* MEK MAP/ERK kinase, MAPKK, also known as MKK/ MAP2K* MEKK MEK kinase, MAPKKK, canonical MAP3K* MHCK Myosin heavy chain kinase Mik1 Schizosaccharomyces pombe mitotic inhibitor kinase 1 MKK New name for Arabidopsis MEK/MAP2K/ MAPKK* MKK New name for Arabidopsis MAP2K* MLK Mixed lineage kinase MLK Mixed lineage kinase MPK New name for Arabidopsis MAPK* mTOR Molecular target of rapamycin

42

N. Dissmeyer and A. Schnittger

Myt1 Membrane-associated Tyr/Thr PK 1 NEK NIMA/NIM-A related kinase (NRK) NIMA “Never in mitosis A” (NIM-A) PDGFR Platelet-derived growth factor receptor PDHK Pyruvate dehydrogenase (acetyl-transferring) kinase PEPRK PPCK-related kinases PhK Phosphorylase kinase PIKK Phosphatidyl inositol 3¢ kinase-related kinase PK Protein kinase PKA, C, G Cyclic nucleotide-regulated protein kinase A, C, or G PKA/B/C Protein kinase A/B/C PKACa PKA catalytic subunit a PKAK1 Pyruvate dehydrogenase kinase PKL Protein kinase-like PPCK Phosphoenolpyruvate carboxylase kinase PPK1 Phosphatidylinositol-4-phosphate 5¢ kinase Prk Phosphoribulokinase PRKIN Protein kinase also called MHK PSTK Protein serine/threonine kinase Pti1 Pto-interacting 1 PTK Protein–tyrosine kinases Raf “Rapidly growing fibrosarcoma or rat fibrosarcoma,” cellular homolog of oncogene products from murine sarcoma virus, or cellular homolog of v-raf, the transforming gene from an avian retrovirus (MAP3K) Rb Retinoblastoma protein RD Kinase kinase containing invariant Asp residue as catalytic base preceded by an Arg RGC Receptor guanylate cyclase RIO Right open reading frame RK Receptor kinase RLK Receptor-like kinase (protein Ser/Thr RLK) ROS Reactive oxygen species RTK Receptor Tyr kinase SH Hydrosulphide or sulfhydryl group (in Cys) SHAGGY GSK from Drosophila SI Self-incompatibility SILAC Stable isotope labelling SLG S-locus glycoprotein SMG-1 Suppressor of morphogenesis in genitalia-1 SNF1 Sucrose non-fermenting 1 SnRK SNF1-related kinase SRK S-receptor-like kinase STE Family including MAP2K, MAP4K, CDCs, MEKK, and related sequences; kinase group consisting of Sterile 20 and p21Ras-activated PK (MAP4K) TGFb Transforming growth factor-b

2  The Age of Protein Kinases

43

TGFbR1 Transforming growth factor-b receptor kinase 1 (TGFBR1) TK Tyr kinase TKL Tyr kinase-like TRPM Transient receptor potential ion channel melastatin VEGFR Vascular endothelial growth factor receptor WAK Cell wall-associated kinase *New MAPK cascade nomenclature after (81) References 1. Boyer, P.D., and Krebs, E.G. (1986) The enzymes. Vol. XVII, Control by phosphorylation, part A: general features, specific enzymes (I), Academic Press, Orlando, Fla. 2. IUPAC-IUB Commission on Biochemical Nomenclature (CBN), T. (1977) Nomenclature of phosphorus-containing compounds of biochemical importance. (Recommendations 1976) IUPAC-IUB Commission on Biochemical Nomenclature. Hoppe Seylers Z Physiol Chem 358, 599–616. 3. Manning, G., Plowman, G. D., Hunter, T., and Sudarsanam, S. (2002) Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci 27, 514–20. 4. Chevalier, D., and Walker, J. C. (2005) Functional genomics of protein kinases in plants. Brief Funct Genomic Proteomic 3, 362–71. 5. Hubbard, M. J., and Cohen, P. (1993) On target with a new mechanism for the regulation of protein phosphorylation. Trends Biochem Sci 18, 172–7. 6. Ahn, N. G., and Resing, K. A. (2001) Toward the phosphoproteome. Nat Biotechnol 19, 317–8. 7. Duclos, B., Marcandier, S., and Cozzone, A. J. (1991) Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis. Methods Enzymol 201, 10–21. 8. Hunter, T. (1996) Tyrosine phosphorylation: past, present and future. Biochem Soc Trans 24, 307–27. 9. Ding, S.J., Qian, W. J., and Smith, R. D. (2007) Quantitative proteomic approaches for studying phosphotyrosine signaling. Expert Rev Proteomics 4, 13–23. 10. Zhang, Y., Wolf-Yadlin, A., and White, F.M. (2007) Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks. Methods Mol Biol 359, 203–12. 11. Seet, B.T., Dikic, I., Zhou, M. M., and Pawson, T. (2006) Reading protein modifications

with interaction domains. Nat Rev Mol Cell Biol 7, 473–83. 12. Sugiyama, N., Nakagami, H., Mochida, K., Daudi, A., Tomita, M., Shirasu, K., and Ishihama, Y. (2008) Large-scale phosphorylation mapping reveals the extent of tyrosine phosphorylation in Arabidopsis. Mol Syst Biol 4. 13. Riano-Pachon, D. M., Kleessen, S., Neigenfind, J., Durek, P., Weber, E., Engelsberger, W. R., Walther, D., Selbig, J., Schulze, W. X., and Kersten, B. (2010) Proteome-wide survey of phosphorylation patterns affected by nuclear DNA polymorphisms in Arabidopsis thaliana. BMC Genomics 11, 411. 14. Nakagami, H., Sugiyama, N., Mochida, K., Daudi, A., Yoshida, Y., Toyoda, T., Tomita, M., Ishihama, Y., and Shirasu, K. (2010) Large-scale comparative phosphoproteomics identifies conserved phosphorylation sites in plants. Plant Physiol 153, 1161–74. 15. Sugiyama, N., Masuda, T., Shinoda, K., Nakamura, A., Tomita, M., and Ishihama, Y. (2007) Phosphopeptide enrichment by aliphatic hydroxy acid-modified metal oxide chromatography for nano-LC-MS/MS in proteomics applications. Mol Cell Proteomics 6, 1103–9. 16. Molina, H., Horn, D. M., Tang, N., Mathivanan, S., and Pandey, A. (2007) Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci USA 104, 2199–204. 17. de la Fuente van Bentem, S., and Hirt, H. (2009) Protein tyrosine phosphorylation in plants: More abundant than expected? Trends Plant Sci 14, 71–6. 18. Smith, R. D., and Walker, J. C. (1996) Plant Protein Phosphatases. Annu Rev Plant Physiol Plant Mol Biol 47, 101–125. 19. Luan, S. (2003) Protein phosphatases in plants. Annu Rev Plant Biol 54, 63–92.

44

N. Dissmeyer and A. Schnittger

20. Wei, Y. F., and Matthews, H. R. (1991) Identification of phosphohistidine in proteins and purification of protein-histidine kinases. Methods Enzymol 200, 388–414. 21. Serber, Z., and Ferrell, J. E., Jr. (2007) Tuning bulk electrostatics to regulate protein function. Cell 128, 441–4. 22. Strickfaden, S. C., Winters, M. J., Ben-Ari, G., Lamson, R. E., Tyers, M., and Pryciak, P. M. (2007) A mechanism for cell-cycle regulation of MAP kinase signaling in a yeast differentiation pathway. Cell 128, 519–31. 23. Johnson, L. N., and Barford, D. (1993) The effects of phosphorylation on the structure and function of proteins. Annu Rev Biophys Biomol Struct 22, 199–232. 24. Groban, E. S., Narayanan, A., and Jacobson, M. P. (2006) Conformational changes in protein loops and helices induced by posttranslational phosphorylation. PLoS Comput Biol 2, e32. 25. Mandell, D. J., Chorny, I., Groban, E. S., Wong, S. E., Levine, E., Rapp, C. S., and Jacobson, M. P. (2007) Strengths of hydrogen bonds involving phosphorylated amino acid side chains. J Am Chem Soc 129, 820–7. 26. Lu, P. J., Zhou, X. Z., Shen, M., and Lu, K. P. (1999) Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283, 1325–8. 27. Rubin, S. M., Gall, A. L., Zheng, N., and Pavletich, N. P. (2005) Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 123, 1093–106. 28. Russo, A. A., Jeffrey, P. D., and Pavletich, N. P. (1996) Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat Struct Biol 3, 696–700. 29. Johnson, L. N., and O’Reilly, M. (1996) Control by phosphorylation. Curr Opin Struct Biol 6, 762–9. 30. Welburn, J. P., Tucker, J. A., Johnson, T., Lindert, L., Morgan, M., Willis, A., Noble, M. E., and Endicott, J. A. (2007) How tyrosine 15 phosphorylation inhibits the activity of cyclin-dependent kinase 2-cyclin A. J Biol Chem 282, 3173–81. 31. Hurley, J. H., Dean, A. M., Thorsness, P. E., Koshland, D. E., Jr., and Stroud, R. M. (1990) Regulation of isocitrate dehydrogenase by phosphorylation involves no longrange conformational change in the free enzyme. J Biol Chem 265, 3599–602. 32. Pawson, T., and Gish, G. D. (1992) SH2 and SH3 domains: from structure to function. Cell 71, 359–62.

33. Pawson, T. (1995) Protein modules and signalling networks. Nature 373, 573–80. 34. Hunter, T. (1995) Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225–36. 35. Johnson, L. N., Noble, M. E., and Owen, D. J. (1996) Active and inactive protein kinases: structural basis for regulation. Cell 85, 149–58. 36. Olah, G. A., Mitchell, R. D., Sosnick, T. R., Walsh, D. A., and Trewhella, J. (1993) Solution structure of the cAMP-dependent protein kinase catalytic subunit and its contraction upon binding the protein kinase inhibitor peptide. Biochemistry 32, 3649–57. 37. Liao, J. J. (2007) Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. J Med Chem 50, 409–24. 38. Liu, Y., and Gray, N. S. (2006) Rational design of inhibitors that bind to inactive kinase conformations. Nat Chem Biol 2, 358–64. 39. Johnson, L. N. (2009) The regulation of protein phosphorylation. Biochem Soc Trans 37, 627–41. 40. Huse, M., and Kuriyan, J. (2002) The conformational plasticity of protein kinases. Cell 109, 275–82. 41. Nolen, B., Taylor, S., and Ghosh, G. (2004) Regulation of protein kinases; controlling activity through activation segment conformation. Mol Cell 15, 661–75. 42. Kannan, N., and Neuwald, A. F. (2004) Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha. Protein Sci 13, 2059–77. 43. Hanks, S. K., and Hunter, T. (1995) Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. Faseb J 9, 576–96. 44. Taylor, S. S., Radzio-Andzelm, E., and Hunter, T. (1995) How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase. Faseb J 9, 1255–66. 45. Johnson, L. N., Lowe, E. D., Noble, M. E., and Owen, D. J. (1998) The Eleventh Datta Lecture. The structural basis for substrate recognition and control by protein kinases. FEBS Lett 430, 1–11. 46. Morgan, D. O. (2007) The cell cycle: principles of control, New Science Press Ltd in association with Oxford University Press, London.

2  The Age of Protein Kinases 47. Hanks, S. K., Quinn, A. M., and Hunter, T. (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42–52. 48. Niefind, K., Yde, C. W., Ermakova, I., and Issinger, O. G. (2007) Evolved to be active: sulfate ions define substrate recognition sites of CK2alpha and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases. J Mol Biol 370, 427–38. 49. Schulze-Gahmen, U., De Bondt, H. L., and Kim, S. H. (1996) High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design. J Med Chem 39, 4540–6. 50. Adams, J. A. (2001) Kinetic and catalytic mechanisms of protein kinases. Chem Rev 101, 2271–90. 51. Hanks, S. K., and Quinn, A. M. (1991) Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol 200, 38–62. 52. Nigg, E. A. (1993) Targets of cyclin-dependent protein kinases. Curr Opin Cell Biol 5, 187–93. 53. Songyang, Z., Blechner, S., Hoagland, N., Hoekstra, M. F., Piwnica-Worms, H., and Cantley, L. C. (1994) Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol 4, 973–82. 54. Bardwell, L., and Thorner, J. (1996) A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAPKs. Trends Biochem Sci 21, 373–4. 55. Jeffrey, P. D., Russo, A. A., Polyak, K., Gibbs, E., Hurwitz, J., Massague, J., and Pavletich, N. P. (1995) Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376, 313–20. 56. Brown, N. R., Noble, M. E., Endicott, J. A., and Johnson, L. N. (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol 1, 438–43. 57. De Bondt, H. L., Rosenblatt, J., Jancarik, J., Jones, H. D., Morgan, D. O., and Kim, S. H. (1993) Crystal structure of cyclin-dependent kinase 2. Nature 363, 595–602. 58. Zhang, F., Strand, A., Robbins, D., Cobb, M. H., and Goldsmith, E. J. (1994) Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Nature 367, 704–11. 59. Adams, J. A., McGlone, M. L., Gibson, R., and Taylor, S. S. (1995) Phosphorylation

45

modulates catalytic function and regulation in the cAMP-dependent protein kinase. Biochemistry 34, 2447–54. 60. Dissmeyer, N., Nowack, M. K., Pusch, S., Stals, H., Inze, D., Grini, P. E., and Schnittger, A. (2007) T-loop phosphorylation of Arabidopsis CDKA;1 is required for its function and can be partially substituted by an aspartate residue. Plant Cell 19, 972–85. 61. Pusch, S., Harashima, H., and Schnittger, A. (submitted) Identification and in vivo characterization of enzyme-substrate interactions by bimolecular fluorescence complementation assays. 62. Morgan, D. O., and De Bondt, H. L. (1994) Protein kinase regulation: insights from crystal structure analysis. Curr Opin Cell Biol 6, 239–46. 63. Macdonald, N., Welburn, J. P., Noble, M. E., Nguyen, A., Yaffe, M. B., Clynes, D., Moggs, J. G., Orphanides, G., Thomson, S., Edmunds, J. W., Clayton, A. L., Endicott, J. A., and Mahadevan, L. C. (2005) Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol Cell 20, 199–211. 64. Filippakopoulos, P., Kofler, M., Hantschel, O., Gish, G. D., Grebien, F., Salah, E., Neudecker, P., Kay, L. E., Turk, B. E., SupertiFurga, G., Pawson, T., and Knapp, S. (2008) Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 134, 793–803. 65. Ubersax, J. A., and Ferrell, J. E., Jr. (2007) Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol 8, 530–41. 66. Cheek, S., Zhang, H., and Grishin, N. V. (2002) Sequence and structure classification of kinases. J Mol Biol 320, 855–81. 67. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912–34. 68. Caenepeel, S., Charydczak, G., Sudarsanam, S., Hunter, T., and Manning, G. (2004) The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc Natl Acad Sci USA 101, 11707–12. 69. Ptacek, J., and Snyder, M. (2006) Charging it up: global analysis of protein phosphorylation. Trends Genet 22, 545–54. 70. The Arabidopsis Genome Initiative. (2000) Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408, 796–815. 71. International Rice Genome Sequencing Project. (2005) The map-based sequence of the rice genome. Nature 436, 793–800.

46

N. Dissmeyer and A. Schnittger

72. Krupa, A., Anamika, K., and Srinivasan, N. (2006) Genome-wide comparative analyses of domain organisation of repertoires of protein kinases of Arabidopsis thaliana and Oryza sativa. Gene 380, 1–13. 73. Ouyang, S., Zhu, W., Hamilton, J., Lin, H., Campbell, M., Childs, K., Thibaud-Nissen, F., Malek, R. L., Lee, Y., Zheng, L., Orvis, J., Haas, B., Wortman, J., and Buell, C. R. (2007) The TIGR Rice Genome Annotation Resource: improvements and new features. Nucleic Acids Res 35, D883–7. 74. Gribskov, M., Fana, F., Harper, J., Hope, D. A., Harmon, A. C., Smith, D. W., Tax, F. E., and Zhang, G. (2001) PlantsP: a functional genomics database for plant phosphorylation. Nucleic Acids Res 29, 111–3. 75. Tchieu, J. H., Fana, F., Fink, J. L., Harper, J., Nair, T. M., Niedner, R. H., Smith, D. W., Steube, K., Tam, T. M., Veretnik, S., Wang, D., and Gribskov, M. (2003) The PlantsP and PlantsT Functional Genomics Databases. Nucleic Acids Res 31, 342–4. 76. Champion, A., Kreis, M., Mockaitis, K., Picaud, A., and Henry, Y. (2004) Arabidopsis kinome: after the casting. Funct Integr Genomics 4, 163–87. 77. Hunter, T., and Plowman, G. D. (1997) The protein kinases of budding yeast: six score and more. Trends Biochem Sci 22, 18–22. 78. Dardick, C., Chen, J., Richter, T., Ouyang, S., and Ronald, P. (2007) The rice kinase database. A phylogenomic database for the rice kinome. Plant Physiol 143, 579–86. 79. Atkinson, H. J., Morris, J. H., Ferrin, T. E., and Babbitt, P. C. (2009) Using sequence similarity networks for visualization of relationships across diverse protein superfamilies. PLoS One 4, e4345. 80. Hardie, D. G. (1999) PLANT PROTEIN SERINE/THREONINE KINASES: Classification and Functions. Annu Rev Plant Physiol Plant Mol Biol 50, 97–131. 81. Champion, A., Picaud, A., and Henry, Y. (2004) Reassessing the MAP3K and MAP4K relationships. Trends Plant Sci 9, 123–9. 82. Menges, M., de Jager, S. M., Gruissem, W., and Murray, J. A. (2005) Global analysis of the core cell cycle regulators of Arabidopsis identifies novel genes, reveals multiple and highly specific profiles of expression and provides a coherent model for plant cell cycle control. Plant J 41, 546–66. 83. Pitzschke, A., Schikora, A., and Hirt, H. (2009) MAPK cascade signalling networks in plant defence. Curr Opin Plant Biol 12, 421–6. 84. Fiil, B. K., Petersen, K., Petersen, M., and Mundy, J. (2009) Gene regulation by MAP

kinase cascades. Curr Opin Plant Biol 12, 615–21. 85. Andreasson, E., and Ellis, B. (2010) Convergence and specificity in the Arabidopsis MAPK nexus. Trends Plant Sci 15, 106–113. 86. Sterky, F., Bhalerao, R. R., Unneberg, P., Segerman, B., Nilsson, P., Brunner, A. M., Charbonnel-Campaa, L., Lindvall, J. J., Tandre, K., Strauss, S. H., Sundberg, B., Gustafsson, P., Uhlen, M., Bhalerao, R. P., Nilsson, O., Sandberg, G., Karlsson, J., Lundeberg, J., and Jansson, S. (2004) A Populus EST resource for plant functional genomics. Proc Natl Acad Sci USA 101, 13951–6. 87. Tuskan, G. A., Difazio, S., Jansson, S., Bohlmann, J., Grigoriev, I., Hellsten, U., Putnam, N., Ralph, S., Rombauts, S., Salamov, A., Schein, J., Sterck, L., Aerts, A., Bhalerao, R. R., Bhalerao, R. P., Blaudez, D., Boerjan, W., Brun, A., Brunner, A., Busov, V., Campbell, M., Carlson, J., Chalot, M., Chapman, J., Chen, G. L., Cooper, D., Coutinho, P. M., Couturier, J., Covert, S., Cronk, Q., Cunningham, R., Davis, J., Degroeve, S., Dejardin, A., Depamphilis, C., Detter, J., Dirks, B., Dubchak, I., Duplessis, S., Ehlting, J., Ellis, B., Gendler, K., Goodstein, D., Gribskov, M., Grimwood, J., Groover, A., Gunter, L., Hamberger, B., Heinze, B., Helariutta, Y., Henrissat, B., Holligan, D., Holt, R., Huang, W., IslamFaridi, N., Jones, S., Jones-Rhoades, M., Jorgensen, R., Joshi, C., Kangasjarvi, J., Karlsson, J., Kelleher, C., Kirkpatrick, R., Kirst, M., Kohler, A., Kalluri, U., Larimer, F., Leebens-Mack, J., Leple, J. C., Locascio, P., Lou, Y., Lucas, S., Martin, F., Montanini, B., Napoli, C., Nelson, D. R., Nelson, C., Nieminen, K., Nilsson, O., Pereda, V., Peter, G., Philippe, R., Pilate, G., Poliakov, A., Razumovskaya, J., Richardson, P., Rinaldi, C., Ritland, K., Rouze, P., Ryaboy, D., Schmutz, J., Schrader, J., Segerman, B., Shin, H., Siddiqui, A., Sterky, F., Terry, A., Tsai, C. J., Uberbacher, E., Unneberg, P., et al. (2006) The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science 313, 1596–604. 88. International Brachypodium Initiative, T. (2010) Genome sequencing and analysis of the model grass Brachypodium distachyon. Nature 463, 763–8. 89. The French-Italian Public Consortium for Grapevine Genome Characterization. (2007) The grapevine genome sequence suggests ancestral hexaploidization in major angiosperm phyla. Nature 449, 463–467. 90. Shiu, S. H., and Bleecker, A. B. (2001) Receptor-like kinases from Arabidopsis form a

2  The Age of Protein Kinases monophyletic gene family related to animal receptor kinases. Proc Natl Acad Sci USA 98, 10763–8. 91. Shiu, S. H., Karlowski, W. M., Pan, R., Tzeng, Y. H., Mayer, K. F., and Li, W. H. (2004) Comparative analysis of the receptor-like kinase family in Arabidopsis and rice. Plant Cell 16, 1220–34. 92. Dardick, C., and Ronald, P. (2006) Plant and animal pathogen recognition receptors signal through non-RD kinases. PLoS Pathog 2, e2. 93. McCarty, D. R., and Chory, J. (2000) Conservation and innovation in plant signaling pathways. Cell 103, 201–9. 94. Wang, D., Harper, J. F., and Gribskov, M. (2003) Systematic trans-genomic comparison of protein kinases between Arabidopsis and Saccharomyces cerevisiae. Plant Physiol 132, 2152–65. 95. Luan, S. (2002) Tyrosine phosphorylation in plant cell signaling. Proc Natl Acad Sci USA 99, 11567–9. 96. Carpi, A., Di Maira, G., Vedovato, M., Rossi, V., Naccari, T., Floriduz, M., Terzi, M., and Filippini, F. (2002) Comparative proteome bioinformatics: identification of a whole complement of putative protein tyrosine kinases in the model flowering plant Arabidopsis thaliana. Proteomics 2, 1494–503. 97. Rudrabhatla, P., Reddy, M. M., and Rajasekharan, R. (2006) Genome-wide analysis and experimentation of plant serine/threonine/tyrosine-specific protein kinases. Plant Mol Biol 60, 293–319. 98. Miranda-Saavedra, D., and Barton, G. J. (2007) Classification and functional annotation of eukaryotic protein kinases. Proteins 68, 893–914. 99. Pawson, T., and Scott, J. D. (2005) Protein phosphorylation in signaling – 50 years and counting. Trends Biochem Sci 30, 286–90. 100. Deshaies, R. J. (1999) SCF and Cullin/Ring H2-based ubiquitin ligases. Annu Rev Cell Dev Biol 15, 435–67. 101. Seeger, M., Kraft, R., Ferrell, K., BechOtschir, D., Dumdey, R., Schade, R., Gordon, C., Naumann, M., and Dubiel, W. (1998) A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. Faseb J 12, 469–78. 102. Naumann, M., Bech-Otschir, D., Huang, X., Ferrell, K., and Dubiel, W. (1999) COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem 274, 35297–300. 103. Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C., and

47

Dubiel, W. (2001) COP9 signalosomespecific phosphorylation targets p53 to degradation by the ubiquitin system. Embo J 20, 1630–9. 104. Willems, A. R., Lanker, S., Patton, E. E., Craig, K. L., Nason, T. F., Mathias, N., Kobayashi, R., Wittenberg, C., and Tyers, M. (1996) Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway. Cell 86, 453–63. 105. Lanker, S., Valdivieso, M. H., and Wittenberg, C. (1996) Rapid degradation of the G1 cyclin Cln2 induced by CDK-dependent phosphorylation. Science 271, 1597–601. 106. Vlach, J., Hennecke, S., and Amati, B. (1997) Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. Embo J 16, 5334–44. 107. Uhle, S., Medalia, O., Waldron, R., Dumdey, R., Henklein, P., Bech-Otschir, D., Huang, X., Berse, M., Sperling, J., Schade, R., and Dubiel, W. (2003) Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. Embo J 22, 1302–12. 108. Nowack, M. K., Grini, P. E., Jakoby, M. J., Lafos, M., Koncz, C., and Schnittger, A. (2006) A positive signal from the fertilization of the egg cell sets off endosperm proliferation in angiosperm embryogenesis. Nat Genet 38, 63–7. 109. Iwakawa, H., Shinmyo, A., and Sekine, M. (2006) Arabidopsis CDKA;1, a cdc2 homologue, controls proliferation of generative cells in male gametogenesis. Plant J 45, 819–31. 110. Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., and Tsai, L. H. (1992) A family of human cdc2related protein kinases. Embo J 11, 2909–17. 111. Wang, H., Ngwenyama, N., Liu, Y., Walker, J. C., and Zhang, S. (2007) Stomatal development and patterning are regulated by environmentally responsive mitogen-activated protein kinases in Arabidopsis. Plant Cell 19, 63–73. 112. Lampard, G. R., Macalister, C. A., and Bergmann, D. C. (2008) Arabidopsis stomatal initiation is controlled by MAPKmediated regulation of the bHLH SPEECHLESS. Science 322, 1113–6. 113. Zhang, S., and Klessig, D. F. (2001) MAPK cascades in plant defense signaling. Trends Plant Sci 6, 520–7. 114. Jonak, C., Okresz, L., Bogre, L., and Hirt, H. (2002) Complexity, cross talk and integration of plant MAP kinase signalling. Curr Opin Plant Biol 5, 415–24.

48

N. Dissmeyer and A. Schnittger

115. Romeis, T. (2001) Protein kinases in the plant defence response. Curr Opin Plant Biol 4, 407–14. 116. Bethke, G., Unthan, T., Uhrig, J. F., Poschl, Y., Gust, A. A., Scheel, D., and Lee, J. (2009) Flg22 regulates the release of an ethylene response factor substrate from MAP kinase 6 in Arabidopsis thaliana via ethylene signaling. Proc Natl Acad Sci USA 106, 8067–72. 117. Joo, S., Liu, Y., Lueth, A., and Zhang, S. (2008) MAPK phosphorylation-induced stabilization of ACS6 protein is mediated by the non-catalytic C-terminal domain, which also contains the cis-determinant for rapid degradation by the 26S proteasome pathway. Plant J 54, 129–40. 118. Yoo, S. D., Cho, Y. H., Tena, G., Xiong, Y., and Sheen, J. (2008) Dual control of nuclear EIN3 by bifurcate MAPK cascades in C2H4 signalling. Nature 451, 789–95. 119. Torii, K. U., Mitsukawa, N., Oosumi, T., Matsuura, Y., Yokoyama, R., Whittier, R. F., and Komeda, Y. (1996) The Arabidopsis ERECTA gene encodes a putative receptor protein kinase with extracellular leucine-rich repeats. Plant Cell 8, 735–46. 120. Clark, S. E., Williams, R. W., and Meyerowitz, E. M. (1997) The CLAVATA1 gene encodes a putative receptor kinase that controls shoot and floral meristem size in Arabidopsis. Cell 89, 575–85. 121. Roe, J. L., Rivin, C. J., Sessions, R. A., Feldmann, K. A., and Zambryski, P. C. (1993) The Tousled gene in A. thaliana encodes a protein kinase homolog that is required for leaf and flower development. Cell 75, 939–50. 122. Jinn, T. L., Stone, J. M., and Walker, J. C. (2000) HAESA, an Arabidopsis leucine-rich repeat receptor kinase, controls floral organ abscission. Genes Dev 14, 108–17. 123. Torii, K. U. (2000) Receptor kinase activation and signal transduction in plants: an emerging picture. Curr Opin Plant Biol 3, 361–7. 124. Kim, T. W., and Wang, Z. Y. (2010) Brassinosteroid Signal Transduction from Receptor Kinases to Transcription Factors. Annu Rev Plant Biol 61, 1–23.24. 125. Nasrallah, J. B. (2000) Cell-cell signaling in the self-incompatibility response. Curr Opin Plant Biol 3, 368–73. 126. Becraft, P. W. (2002) Receptor kinase signaling in plant development. Annu Rev Cell Dev Biol 18, 163–92. 127. Hematy, K., and Hofte, H. (2008) Novel receptor kinases involved in growth regulation. Curr Opin Plant Biol 11, 321–8.

128. Chang, C., Kwok, S. F., Bleecker, A. B., and Meyerowitz, E. M. (1993) Arabidopsis ethylene-response gene ETR1: similarity of product to two-component regulators. Science 262, 539–44. 129. Higuchi, M., Pischke, M. S., Mahonen, A. P., Miyawaki, K., Hashimoto, Y., Seki, M., Kobayashi, M., Shinozaki, K., Kato, T., Tabata, S., Helariutta, Y., Sussman, M. R., and Kakimoto, T. (2004) In planta functions of the Arabidopsis cytokinin receptor family. Proc Natl Acad Sci USA 101, 8821–6. 130. Hua, J., and Meyerowitz, E. M. (1998) Ethylene responses are negatively regulated by a receptor gene family in Arabidopsis thaliana. Cell 94, 261–71. 131. Zhao, X. C., Qu, X., Mathews, D. E., and Schaller, G. E. (2002) Effect of ethylene pathway mutations upon expression of the ethylene receptor ETR1 from Arabidopsis. Plant Physiol 130, 1983–91. 132. Wang, W., Hall, A. E., O’Malley, R., and Bleecker, A. B. (2003) Canonical histidine kinase activity of the transmitter domain of the ETR1 ethylene receptor from Arabidopsis is not required for signal transmission. Proc Natl Acad Sci USA 100, 352–7. 133. Deng, Y., Dong, H., Mu, J., Ren, B., Zheng, B., Ji, Z., Yang, W.-C., Liang, Y., and Zuo, J. (2010) Arabidopsis Histidine Kinase CKI1 Acts Upstream of HISTIDINE PHOSPHOTRANSFER PROTEINS to Regulate Female Gametophyte Development and Vegetative Growth. Plant Cell, tpc.108.065128. 134. Hunter, T. (2000) Signaling – 2000 and beyond. Cell 100, 113–27. 135. Goffeau, A., Barrell, B. G., Bussey, H., Davis, R. W., Dujon, B., Feldmann, H., Galibert, F., Hoheisel, J. D., Jacq, C., Johnston, M., Louis, E. J., Mewes, H. W., Murakami, Y., Philippsen, P., Tettelin, H., and Oliver, S. G. (1996) Life with 6000 genes. Science 274, 546, 563–7. 136. King, N., Westbrook, M. J., Young, S. L., Kuo, A., Abedin, M., Chapman, J., Fairclough, S., Hellsten, U., Isogai, Y., Letunic, I., Marr, M., Pincus, D., Putnam, N., Rokas, A., Wright, K. J., Zuzow, R., Dirks, W., Good, M., Goodstein, D., Lemons, D., Li, W., Lyons, J. B., Morris, A., Nichols, S., Richter, D. J., Salamov, A., Sequencing, J. G., Bork, P., Lim, W. A., Manning, G., Miller, W. T., McGinnis, W., Shapiro, H., Tjian, R., Grigoriev, I. V., and Rokhsar, D. (2008) The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans. Nature 451, 783–8. 137. Goldberg, J. M., Manning, G., Liu, A., Fey, P., Pilcher, K. E., Xu, Y., and Smith, J. L.

2  The Age of Protein Kinases (2006) The dictyostelium kinome – analysis of the protein kinases from a simple model organism. PLoS Genet 2, e38. 138. Bradham, C. A., Foltz, K. R., Beane, W. S., Arnone, M. I., Rizzo, F., Coffman, J. A., Mushegian, A., Goel, M., Morales, J., Geneviere, A. M., Lapraz, F., Robertson, A. J., Kelkar, H., Loza-Coll, M., Townley, I. K., Raisch, M., Roux, M. M., Lepage, T., Gache, C., McClay, D. R., and Manning, G. (2006) The sea urchin kinome: a first look. Dev Biol 300, 180–93. 139. Plowman, G. D., Sudarsanam, S., Bingham, J., Whyte, D., and Hunter, T. (1999) The protein kinases of Caenorhabditis elegans: a model for signal transduction in multicellular organisms. Proc Natl Acad Sci USA 96, 13603–10. 140. Manning, G. (2005) Genomic overview of protein kinases. WormBook, 1–19. 141. C. elegans Sequencing Consortium, T. (1998) Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282, 2012–8. 142. Adams, M. D., Celniker, S. E., Holt, R. A., Evans, C. A., Gocayne, J. D., Amanatides, P. G., Scherer, S. E., Li, P. W., Hoskins, R. A., Galle, R. F., George, R. A., Lewis, S. E., Richards, S., Ashburner, M., Henderson, S. N., Sutton, G. G., Wortman, J. R., Yandell, M. D., Zhang, Q., Chen, L. X., Brandon, R. C., Rogers, Y. H., Blazej, R. G., Champe, M., Pfeiffer, B. D., Wan, K. H., Doyle, C., Baxter, E. G., Helt, G., Nelson, C. R., Gabor, G. L., Abril, J. F., Agbayani, A., An, H. J., AndrewsPfannkoch, C., Baldwin, D., Ballew, R. M., Basu, A., Baxendale, J., Bayraktaroglu, L., Beasley, E. M., Beeson, K. Y., Benos, P. V., Berman, B. P., Bhandari, D., Bolshakov, S., Borkova, D., Botchan, M. R., Bouck, J., Brokstein, P., Brottier, P., Burtis, K. C., Busam, D. A., Butler, H., Cadieu, E., Center, A., Chandra, I., Cherry, J. M., Cawley, S., Dahlke, C., Davenport, L. B., Davies, P., de Pablos, B., Delcher, A., Deng, Z., Mays, A. D., Dew, I., Dietz, S. M., Dodson, K., Doup, L. E., Downes, M., Dugan-Rocha, S., Dunkov, B. C., Dunn, P., Durbin, K. J., Evangelista, C. C., Ferraz, C., Ferriera, S., Fleischmann, W., Fosler, C., Gabrielian, A. E., Garg, N. S., Gelbart, W. M., Glasser, K., Glodek, A., Gong, F., Gorrell, J. H., Gu, Z., Guan, P., Harris, M., Harris, N. L., Harvey, D., Heiman, T. J., Hernandez, J. R., Houck, J., Hostin, D., Houston, K. A., Howland, T. J., Wei, M. H., Ibegwam, C., et al. (2000) The genome sequence of Drosophila melanogaster. Science 287, 2185–95.

49

143. Mouse Genome Sequencing Consortium, T., Waterston, R. H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J. F., Agarwal, P., Agarwala, R., Ainscough, R., Alexandersson, M., An, P., Antonarakis, S. E., Attwood, J., Baertsch, R., Bailey, J., Barlow, K., Beck, S., Berry, E., Birren, B., Bloom, T., Bork, P., Botcherby, M., Bray, N., Brent, M. R., Brown, D. G., Brown, S. D., Bult, C., Burton, J., Butler, J., Campbell, R. D., Carninci, P., Cawley, S., Chiaromonte, F., Chinwalla, A. T., Church, D. M., Clamp, M., Clee, C., Collins, F. S., Cook, L. L., Copley, R. R., Coulson, A., Couronne, O., Cuff, J., Curwen, V., Cutts, T., Daly, M., David, R., Davies, J., Delehaunty, K. D., Deri, J., Dermitzakis, E. T., Dewey, C., Dickens, N. J., Diekhans, M., Dodge, S., Dubchak, I., Dunn, D. M., Eddy, S. R., Elnitski, L., Emes, R. D., Eswara, P., Eyras, E., Felsenfeld, A., Fewell, G. A., Flicek, P., Foley, K., Frankel, W. N., Fulton, L. A., Fulton, R. S., Furey, T. S., Gage, D., Gibbs, R. A., Glusman, G., Gnerre, S., Goldman, N., Goodstadt, L., Grafham, D., Graves, T. A., Green, E. D., Gregory, S., Guigo, R., Guyer, M., Hardison, R. C., Haussler, D., Hayashizaki, Y., Hillier, L. W., Hinrichs, A., Hlavina, W., Holzer, T., Hsu, F., Hua, A., Hubbard, T., Hunt, A., Jackson, I., Jaffe, D. B., Johnson, L. S., Jones, M., Jones, T. A., Joy, A., Kamal, M., et  al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520–62. 144. Rat Genome Sequencing Project Consortium, T., Gibbs, R. A., Weinstock, G. M., Metzker, M. L., Muzny, D. M., Sodergren, E. J., Scherer, S., Scott, G., Steffen, D., Worley, K. C., Burch, P. E., Okwuonu, G., Hines, S., Lewis, L., DeRamo, C., Delgado, O., Dugan-Rocha, S., Miner, G., Morgan, M., Hawes, A., Gill, R., Celera, Holt, R. A., Adams, M. D., Amanatides, P. G., Baden-Tillson, H., Barnstead, M., Chin, S., Evans, C. A., Ferriera, S., Fosler, C., Glodek, A., Gu, Z., Jennings, D., Kraft, C. L., Nguyen, T., Pfannkoch, C. M., Sitter, C., Sutton, G. G., Venter, J. C., Woodage, T., Smith, D., Lee, H. M., Gustafson, E., Cahill, P., Kana, A., DoucetteStamm, L., Weinstock, K., Fechtel, K., Weiss, R. B., Dunn, D. M., Green, E. D., Blakesley, R. W., Bouffard, G. G., De Jong, P. J., Osoegawa, K., Zhu, B., Marra, M., Schein, J., Bosdet, I., Fjell, C., Jones, S., Krzywinski, M., Mathewson, C., Siddiqui, A., Wye, N., McPherson, J., Zhao, S., Fraser, C. M., Shetty, J., Shatsman, S., Geer, K., Chen, Y., Abramzon, S., Nierman, W. C., Havlak, P. H., Chen, R., Durbin, K. J., Egan, A., Ren, Y., Song, X. Z., Li, B., Liu, Y., Qin, X., Cawley,

50

N. Dissmeyer and A. Schnittger

S., Worley, K. C., Cooney, A. J., D’Souza, L. M., Martin, K., Wu, J. Q., Gonzalez-Garay, M. L., Jackson, A. R., Kalafus, K. J., McLeod, M. P., Milosavljevic, A., Virk, D., Volkov, A., Wheeler, D. A., Zhang, Z., Bailey, J. A., et al. (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428, 493–521. 145. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., Gocayne, J. D., Amanatides, P., Ballew, R. M., Huson, D. H., Wortman, J. R., Zhang, Q., Kodira, C. D., Zheng, X. H., Chen, L., Skupski, M., Subramanian, G., Thomas, P. D., Zhang, J., Gabor Miklos, G. L., Nelson, C., Broder, S., Clark, A. G., Nadeau, J., McKusick, V. A., Zinder, N., Levine, A. J., Roberts, R. J., Simon, M., Slayman, C., Hunkapiller, M., Bolanos, R., Delcher, A., Dew, I., Fasulo, D., Flanigan, M., Florea, L., Halpern, A., Hannenhalli, S., Kravitz, S., Levy, S., Mobarry, C., Reinert, K., Remington, K., AbuThreideh, J., Beasley, E., Biddick, K., Bonazzi, V., Brandon, R., Cargill, M., Chandramouliswaran, I., Charlab, R., Chaturvedi, K., Deng, Z., Di Francesco, V., Dunn, P., Eilbeck, K., Evangelista, C., Gabrielian, A. E., Gan, W., Ge, W., Gong, F., Gu, Z., Guan, P., Heiman, T. J., Higgins, M. E., Ji, R. R., Ke, Z., Ketchum, K. A., Lai, Z., Lei, Y., Li, Z., Li, J., Liang, Y., Lin, X., Lu, F., Merkulov, G. V., Milshina, N., Moore, H. M., Naik, A. K., Narayan, V. A., Neelam, B., Nusskern, D., Rusch, D. B., Salzberg, S., Shao, W., Shue, B., Sun, J., Wang, Z., Wang, A., Wang, X., Wang, J., Wei, M., Wides, R., Xiao, C., Yan, C., et al. (2001) The sequence of the human genome. Science 291, 1304–51. 146. Nuhse, T. S., Stensballe, A., Jensen, O. N., and Peck, S. C. (2004) Phosphoproteomics of the Arabidopsis plasma membrane and a new phosphorylation site database. Plant Cell 16, 2394–405. 147. Schnable, P. S., Ware, D., Fulton, R. S., Stein, J. C., Wei, F., Pasternak, S., Liang, C., Zhang, J., Fulton, L., Graves, T. A., Minx, P., Reily, A. D., Courtney, L., Kruchowski, S. S., Tomlinson, C., Strong, C., Delehaunty, K., Fronick, C., Courtney, B., Rock, S. M., Belter, E., Du, F., Kim, K., Abbott, R. M., Cotton, M., Levy, A., Marchetto, P., Ochoa, K., Jackson, S. M., Gillam, B., Chen, W., Yan, L., Higginbotham, J., Cardenas, M., Waligorski, J., Applebaum, E., Phelps, L., Falcone, J., Kanchi, K., Thane, T., Scimone, A., Thane, N., Henke, J., Wang, T., Ruppert, J., Shah, N.,

Rotter, K., Hodges, J., Ingenthron, E., Cordes, M., Kohlberg, S., Sgro, J., Delgado, B., Mead, K., Chinwalla, A., Leonard, S., Crouse, K., Collura, K., Kudrna, D., Currie, J., He, R., Angelova, A., Rajasekar, S., Mueller, T., Lomeli, R., Scara, G., Ko, A., Delaney, K., Wissotski, M., Lopez, G., Campos, D., Braidotti, M., Ashley, E., Golser, W., Kim, H., Lee, S., Lin, J., Dujmic, Z., Kim, W., Talag, J., Zuccolo, A., Fan, C., Sebastian, A., Kramer, M., Spiegel, L., Nascimento, L., Zutavern, T., Miller, B., Ambroise, C., Muller, S., Spooner, W., Narechania, A., Ren, L., Wei, S., Kumari, S., Faga, B., Levy, M. J., McMahan, L., Van Buren, P., Vaughn, M. W., et al. (2009) The B73 maize genome: complexity, diversity, and dynamics. Science 326, 1112–5. 148. Hardie, R. E. G., and Hanks, S. (1995) The Protein Kinase Factsbook. Protein-Serine Kinases, Academic Press, London. 149. Bartova, I., Koca, J., and Otyepka, M. (2008) Functional flexibility of human cyclindependent kinase-2 and its evolutionary conservation. Protein Sci 17, 22–33. 150. Heazlewood, J. L., Durek, P., Hummel, J., Selbig, J., Weckwerth, W., Walther, D., and Schulze, W. X. (2008) PhosPhAt: a database of phosphorylation sites in Arabidopsis thaliana and a plant-specific phosphorylation site predictor. Nucleic Acids Res 36, D1015–21. 151. Durek, P., Schmidt, R., Heazlewood, J. L., Jones, A., MacLean, D., Nagel, A., Kersten, B., and Schulze, W. X. (2009) PhosPhAt: the Arabidopsis thaliana phosphorylation site database. An update. Nucleic Acids Res 38, D828–34. 152. Winter, D., Vinegar, B., Nahal, H., Ammar, R., Wilson, G. V., and Provart, N. J. (2007) An “Electronic Fluorescent Pictograph” browser for exploring and analyzing largescale biological data sets. PLoS One 2, e718. 153. Kikuchi, S., Satoh, K., Nagata, T., Kawagashira, N., Doi, K., Kishimoto, N., Yazaki, J., Ishikawa, M., Yamada, H., Ooka, H., Hotta, I., Kojima, K., Namiki, T., Ohneda, E., Yahagi, W., Suzuki, K., Li, C. J., Ohtsuki, K., Shishiki, T., Otomo, Y., Murakami, K., Iida, Y., Sugano, S., Fujimura, T., Suzuki, Y., Tsunoda, Y., Kurosaki, T., Kodama, T., Masuda, H., Kobayashi, M., Xie, Q., Lu, M., Narikawa, R., Sugiyama, A., Mizuno, K., Yokomizo, S., Niikura, J., Ikeda, R., Ishibiki, J., Kawamata, M., Yoshimura, A., Miura, J., Kusumegi, T., Oka, M., Ryu, R., Ueda, M., Matsubara, K., Kawai, J., Carninci, P., Adachi, J., Aizawa, K., Arakawa, T., Fukuda, S., Hara, A., Hashizume, W., Hayatsu, N., Imotani, K., Ishii, Y., Itoh, M., Kagawa, I., Kondo, S.,

2  The Age of Protein Kinases Konno, H., Miyazaki, A., Osato, N., Ota, Y., Saito, R., Sasaki, D., Sato, K., Shibata, K., Shinagawa, A., Shiraki, T., Yoshino, M., Hayashizaki, Y., and Yasunishi, A. (2003) Collection, mapping, and annotation of over 28,000 cDNA clones from japonica rice. Science 301, 376–9. 154. Alonso, J. M., Stepanova, A. N., Leisse, T. J., Kim, C. J., Chen, H., Shinn, P., Stevenson, D. K., Zimmerman, J., Barajas, P., Cheuk, R., Gadrinab, C., Heller, C., Jeske, A., Koesema, E., Meyers, C. C., Parker, H., Prednis, L., Ansari, Y., Choy, N., Deen, H., Geralt, M., Hazari, N., Hom, E., Karnes, M., Mulholland, C., Ndubaku, R., Schmidt, I., Guzman, P., Aguilar-Henonin, L., Schmid, M., Weigel, D., Carter, D. E., Marchand, T., Risseeuw, E., Brogden, D., Zeko, A., Crosby, W. L., Berry, C. C., and Ecker, J. R. (2003) Genomewide insertional mutagenesis of Arabidopsis thaliana. Science 301, 653–7. 155. Till, B. J., Reynolds, S. H., Greene, E. A., Codomo, C. A., Enns, L. C., Johnson, J. E., Burtner, C., Odden, A. R., Young, K., Taylor, N. E., Henikoff, J. G., Comai, L., and Henikoff, S. (2003) Large-scale discovery of induced point mutations with high-throughput TILLING. Genome Res 13, 524–30. 156. Till, B. J., Colbert, T., Tompa, R., Enns, L. C., Codomo, C. A., Johnson, J. E., Reynolds, S. H., Henikoff, J. G., Greene, E. A., Steine, M. N., Comai, L., and Henikoff, S. (2003) High-throughput TILLING for functional genomics. Methods Mol Biol 236, 205–20. 157. Henikoff, S., Till, B. J., and Comai, L. (2004) TILLING. Traditional mutagenesis meets functional genomics. Plant Physiol 135, 630–6. 158. Krupa, A., Abhinandan, K. R., and Srinivasan, N. (2004) KinG: a database of protein kinases in genomes. Nucleic Acids Res 32, D153–5. 159. Martin, D. M., Miranda-Saavedra, D., and Barton, G. J. (2009) Kinomer v. 1.0: a database of systematically classified eukaryotic protein kinases. Nucleic Acids Res 37, D244–50. 160. Diella, F., Cameron, S., Gemund, C., Linding, R., Via, A., Kuster, B., Sicheritz-Ponten, T., Blom, N., and Gibson, T. J. (2004) Phospho. ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinformatics 5, 79. 161. Smith, C. M., Shindyalov, I. N., Veretnik, S., Gribskov, M., Taylor, S. S., Ten Eyck, L. F., and Bourne, P. E. (1997) The protein kinase resource. Trends Biochem Sci 22, 444–6. 162. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman,

51

D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25, 3389–402. 163. Marchler-Bauer, A., Anderson, J. B., DeWeese-Scott, C., Fedorova, N. D., Geer, L. Y., He, S., Hurwitz, D. I., Jackson, J. D., Jacobs, A. R., Lanczycki, C. J., Liebert, C. A., Liu, C., Madej, T., Marchler, G. H., Mazumder, R., Nikolskaya, A. N., Panchenko, A. R., Rao, B. S., Shoemaker, B. A., Simonyan, V., Song, J. S., Thiessen, P. A., Vasudevan, S., Wang, Y., Yamashita, R. A., Yin, J. J., and Bryant, S. H. (2003) CDD: a curated Entrez database of conserved domain alignments. Nucleic Acids Res 31, 383–7. 164. Bateman, A., Birney, E., Cerruti, L., Durbin, R., Etwiller, L., Eddy, S. R., Griffiths-Jones, S., Howe, K. L., Marshall, M., and Sonnhammer, E. L. (2002) The Pfam protein families database. Nucleic Acids Res 30, 276–80. 165. Bairoch, A., Apweiler, R., Wu, C. H., Barker, W. C., Boeckmann, B., Ferro, S., Gasteiger, E., Huang, H., Lopez, R., Magrane, M., Martin, M. J., Natale, D. A., O’Donovan, C., Redaschi, N., and Yeh, L. S. (2005) The Universal Protein Resource (UniProt). Nucleic Acids Res 33, D154–9. 166. Admiraal, S. J., and Herschlag, D. (1995) Mapping the transition state for ATP hydrolysis: implications for enzymatic catalysis. Chem Biol 2, 729–39. 167. Lindqvist, Y., Schneider, G., and Vihko, P. (1994) Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism. Eur J Biochem 221, 139–42. 168. Xu, W., Harrison, S. C., and Eck, M. J. (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595–602. 169. Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., Sproesser, K., Li, L., Smalley, K. S., Fong, D., Zhu, Y. L., Marimuthu, A., Nguyen, H., Lam, B., Liu, J., Cheung, I., Rice, J., Suzuki, Y., Luu, C., Settachatgul, C., Shellooe, R., Cantwell, J., Kim, S. H., Schlessinger, J., Zhang, K. Y., West, B. L., Powell, B., Habets, G., Zhang, C., Ibrahim, P. N., Hirth, P., Artis, D. R., Herlyn, M., and Bollag, G. (2008) Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci USA 105, 3041–6. 170. Zheng, J., Trafny, E. A., Knighton, D. R., Xuong, N. H., Taylor, S. S., Ten Eyck, L. F., and Sowadski, J. M. (1993) 2.2 A refined

52

N. Dissmeyer and A. Schnittger

crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor. Acta Crystallogr D Biol Crystallogr 49, 362–5. 171. Chen, P., Luo, C., Deng, Y., Ryan, K., Register, J., Margosiak, S., Tempczyk-Russell, A., Nguyen, B., Myers, P., Lundgren, K., Kan, C. C., and O’Connor, P. M. (2000) The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell 100, 681–92. 172. Chandran, V., Stollar, E. J., Lindorff-Larsen, K., Harper, J. F., Chazin, W. J., Dobson, C. M., Luisi, B. F., and Christodoulou, J. (2006) Structure of the regulatory apparatus of a calcium-dependent protein kinase (CDPK): a novel mode of calmodulin-target recognition. J Mol Biol 357, 400–10. 173. Yde, C. W., Ermakova, I., Issinger, O. G., and Niefind, K. (2005) Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate. J Mol Biol 347, 399–414.

174. Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H., and Goldsmith, E. J. (1997) Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90, 859–69. 175. Bellon, S., Fitzgibbon, M. J., Fox, T., Hsiao, H. M., and Wilson, K. P. (1999) The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation. Structure 7, 1057–65. 176. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., and Pearl, L. H. (2001) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721–32. 177. Squire, C. J., Dickson, J. M., Ivanovic, I., and Baker, E. N. (2005) Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation. Structure 13, 541–50. 178. DeLano, W. L. (2005), DeLano Scientific LLC, San Carlos, CA, USA.

Part II Kinase Expression, Purification and Activity Assays

wwwwwwwwwwwwwwwww

Chapter 3 Expression and Purification of Active Protein Kinases from Wheat Germ Extracts Boglárka Sonkoly, Viola Bardóczy, and Tamás Mészáros Abstract In vitro functional studies of eukaryotic kinases are often constrained by the availability of pure and ­enzymatically active kinase of interest. Though numerous proteins have been synthesized by cell-based systems, in vivo production of properly folded, eukaryotic proteins remains a challenging task. Current wheat-germ-based cell-free in vitro translation systems present a plausible alternative for protein synthesis since majority of eukaryotic proteins could be obtained in their native folded form with general protocols. The use of special in vitro translation vectors with ligation-independent cloning sites and cleavable affinity tags eliminates further bottlenecks of the protein producing procedure and makes this system a reasonable method for simultaneous generation of active kinases. Key words: Active kinase, In vitro translation, Wheat germ, Ligation-independent cloning, Affinity purification, TEV protease

1. Introduction Escherichia coli-based protein overexpression systems are the ­traditional method of choice for targeted protein synthesis; however, application of these systems is severely limited by the fact that ­multidomain eukaryotic proteins tend to form aggregates in prokaryotic cells. Various alterations have been made to the E. coli system to alleviate this inherent limitation, but there are no general methods for successful protein production in prokaryotic cells, which makes the procedure laborious (1). The eukaryotic cell-based expression systems offer advantage over the bacterial systems in terms of protein

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_3, © Springer Science+Business Media, LLC 2011

55

56

B. Sonkoly et al.

folding and posttranslational modifying capacity, but often require laboratories with dedicated instrumentation and are not suitable for parallel production of a panel of proteins. The robustness of the translation apparatus is known since the 1950s, but only the latest technical improvements made the ­cell-free translation a reasonable alternative of cell-based protein synthesis (2). Various sources of translation machinery could be used in cell-free in  vitro translation systems, but – due to the prokaryotic nature of protein translation and folding – E. coli extract is not optimal for the production of eukaryotic proteins. Cell-free systems originated from reticulocytes, yeast, and insect cells provide eukaryotic proteins in their native folded form but all suffer from low productivity. Presently, wheat-germ-derived extract seems the most promising choice for preparative protein in vitro translation for these systems cost-effectively synthesize properly folded eukaryotic proteins at mg/ml scale (3).

2. Materials 2.1. Cloning and Purification of In Vitro Translation Vectors

1. High-fidelity DNA polymerase. 2. PCR cleaning-up buffer: 26.2% (w/v) PEG 8000, 6.6  mM MgCl2, 0.6 M NaOAc, pH 5.2 (4). 3. SspI restriction endonuclease, T4 DNA polymerase, 10  mM dNTP mix, and 100 mM dCTP and dGTP stock solutions. 4. TAE buffer: 40 mM Tris–acetate, 1 mM EDTA, pH 8.0. 5. 5 mM EDTA. 6. 0.8% (w/v) agarose gel in TAE buffer. 7. Agarose gel staining solution: 2× GelGreen (Biotium) in H2O with 100 mM NaCl. 8. Commercial agarose gel extraction kit. 9. SOC medium: 0.5% (w/v) yeast extract, 2% (w/v) tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose. 10. Standard competent cells. 11. LB agar plates containing 100 mg/ml carbenicillin. 12. PureYield Plasmid Miniprep System (Promega). 13. RNase-free water, barrier tips. 14. pEU vector specific primers: pEUE01 forward: CGATTTA GGTGACACTATAGAACTC pEU3-NII forward: CACTATAGGGTACACGGAATTCGC pEU reverse: TATAGGAAGGCCGGATAAGACG. 15. FastDigest NotI (Fermentas).

3  Expression and Purification of Active Protein Kinases from Wheat Germ Extracts

2.2. In Vitro Translation and Purification of Proteins

57

1. Wheat germ in vitro protein translation kit: RTS 100 Wheat Germ CECF Kit (5 Prime) and ENDEXT Wheat Germ Expression H or ENDEXT Wheat Germ Expression G Kit (CellFree Sciences) for bilayer translation. 2. MagneHis or MagneGST Protein Purification System (Promega) with an appropriate magnetic separation device. 3. PBS buffer: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4 , 1.47 mM KH2PO4 , pH 7.4. 4. Modified PBS buffer for His-tagged proteins: add 10  mM ­imidazole, 500 mM NaCl, and 0.2% (v/v) Triton X-100 final concentration to standard PBS. 5. 100 mM Imidazole, 5 M NaCl, and 2% (v/v) Triton X-100 to adjust concentrations in translation mixture. 6. Modified PBS buffer for GST-tagged proteins: add 0.2% (v/v) Triton X-100 to standard PBS. 7. Standard SDS-PAGE solutions and instrumentation. 8. Fast Coomassie Brilliant Blue staining solution: Paper filtered 0.2% (w/v) Coomassie R 250 and 0.2 M citric acid solution. 9. TEV protease (5). 10. TEV protease buffer: standard PBS containing 2 mM DTT. 11. 96-Well titer plates for ENDEXT Wheat Germ Expression Kits.

3. Methods Protein synthesis by in  vitro translation could be carried out by technically different approaches. The batch translation takes place in a homogenous solution, and the protein synthesis ceases in approximately 3–4  h when one of the substrates is used up or byproducts cause translation inhibition. Although, this mode of translation is convenient for rapid checking of protein function and interaction, its productivity does not meet the protein needs of biochemical studies. Much higher protein yields could be ensured by constant replenishment of substrates and removal of byproducts. The continuous-exchange cell-free (CECF) protein synthesis system tackles this technical difficulty with application of dialysis membranes. The membrane permits passive exchange of small molecular weight compounds between the reaction chamber containing the translation machinery and the feeding chamber containing the consumable substrates; thus extends the lifetime and, consequently,

58

B. Sonkoly et al.

productivity of in vitro translation. The invention of CECF resulted in systems that could work efficiently for days, and synthesize ­exogenous proteins up to several mg/ml (6). In order to meet the demands of whole-proteome scale ­functional studies, a technically more simple wheat germ in vitro translation system – bilayer cell-free protein synthesis – has been devised. The bilayer reaction circumvents application of dialysis membrane by simply overlaying the substrate providing solution onto the batch translation reaction. This arrangement allows ­constant exchange of byproducts and substrates by diffusion via the border layer between the translation and substrate mixtures resulting in at least ten times higher productivity in comparison to batch translation (7). Although production of wheat germ protein extract is ­theoretically simple, the quality of in  vitro translation mixture is greatly determined in practice by the primary wheat germ source. Thus, the application of commercial translation systems is the rational decision for general biochemical laboratories. The yields of commercially available CECF and bilayer systems are comparable; both are expected to produce proteins at 0.2–1  mg/ml scale, an ample amount for in vitro kinase activity studies. 3.1. Insertion of Kinases of Interest into Translation Vectors

1. Ligation-independent cloning (LIC) ready translation vectors are made by SspI digestion and T4 DNA polymerase treatment of relevant pEU-LIC vectors (see Note 1). The vectors are hydrolyzed with a tenfold excess of SspI for 2  h at 37°C, ­separated on 0.8% agarose gel, and purified with a gel extraction kit (see Note 2). 2. To generate the cohesive ends, 1  mg linearized vector is ­incubated for 10 min at 37°C with 1 U T4 DNA polymerase in presence of the provided buffer and 1  mM dGTP. The reaction is stopped by heat inactivation for 20 min at 75°C. The treated vector can be further stored at −20°C for ­subsequent use. 3. Primers for LIC should be designed with the following appended sequences: Forward 5¢-TACTTCCAATCCAAT GCAATG-15-20N-3¢ and reverse 5¢-TTATCCACTTCCA ATGTCA-15-20N-3¢ (in italics: nucleotides of the gene ­specific sequence). 4. The coding sequence is amplified with a standard 50 ml PCR (see Note 3). 5. The PCR product is precipitated by the addition of an equal volume of PCR clean-up buffer and thorough mixing. After 10 min at room temperature, the sample is spun at full speed in a microcentrifuge for 10 min, and then the supernatant is

3  Expression and Purification of Active Protein Kinases from Wheat Germ Extracts

59

carefully removed. The pellet is washed once with ethanol, air dried, then dissolved in 20 ml water. 6. After checking the PCR efficiency and specificity on a 0.8% agarose gel, 10 ml of purified PCR product is treated for 10 min at 37°C with 1 U T4 DNA polymerase in presence of the provided buffer and 1 mM dCTP. The reaction is terminated by heat inactivation for 20 min at 75°C. 7. 60  ng Vector and 30  ng PCR fragment resulting from T4 DNA polymerase treatment are mixed and adjusted to 12.5 ml final volume with 5 mM EDTA. This annealing reaction is incubated at room temperature for 20 min, and then competent cells are transformed with 6 ml of the annealing reaction. The transformed cells are incubated in 500 ml SOC solution for 30 min at 37°C, and then 200 ml is plated onto LB agar plates containing 100  mg/ml carbenicillin for selection. 8. Although LIC produces very few background clones lacking an inserted fragment, colonies should be tested by colony PCR using primers that anneal to the vector sequences. 9. Plasmids of positive colonies are then isolated by PureYield Plasmid Miniprep System (see Note 4). 10. The purified plasmids are linearized by 30 min incubation at 37°C with FastDigest NotI enzyme at 1 mg/10 U concentration in 1× FasDigest buffer (see Note 5). The treated plasmids can be directly applied in the next step without any further processing. 3.2. Protein Translation with CECF System

1. The lyophilisates of the CECF Kit are reconstituted with the provided buffers and kept on ice until setting up the reaction (see Note 6). In order to alleviate the nonspecific binding of wheat germ proteins to affinity matrices, the reconstituted wheat germ lysate can be preincubated for 30 min at 4°C with 2  ml beads of the respective MagneHis or GST Protein Purification System. 2. The solutions are prepared according to the manufacturer’s instructions and 1 ml of feeding and 50 ml reaction mix completed with 2 mg T7 promoter-driven plasmid is added into the lower, feeding and upper, reaction chambers of the translation system, respectively (see Notes 7 and 8). Further explanations for feeding and reaction chambers can be found in the introduction of the methods part. 3. The module is carefully closed with adhesive film and fastened onto a regular orbital shaker and incubated at 250  rpm and 24°C for 24 h.

60

B. Sonkoly et al.

Fig.  1. SDS-PAGE analysis of in  vitro translated protein kinase. His-tagged Arabidopsis MAP kinase 9 (MPK9) has been produced by continuous-exchange cell-free (CECF) in vitro translation and total translation mixture has been separated on a 10% SDS-PAGE. Following Coomassie staining, the translated exogenous protein (indicated by the dot) is clearly visible at the expected size.

4. The efficiency of translation is checked by separating 1 ml of reaction mix on SDS-PAGE. The in  vitro translated ­exogenous protein is generally clearly visible following Coomassie staining. Example of successful translation is shown in Fig. 1. The protein solution is stored on ice until further processing. 3.3. Protein Translation with Bilayer System

1. In vitro transcription is set up with 2 mg SP6 promoter-driven plasmid in 20 ml reaction volume according to the manufacturer’s instructions and incubated for 6 h at 37°C. 2. The quantity and quality of transcribed mRNA is checked by separating 1 ml of transcription reaction on a 0.8% agarose gel. The produced mRNA generally forms a smear-like pattern but small molecular weight products below 1 kb are indicative of RNA degradation. A preparation containing these should not be used for further in vitro translation. Results of in vitro transcription are presented in Fig. 2. 3. The translation mixture is prepared by using half of the transcription reaction (10–20 mg mRNA) following the manufacturer’s instructions. 4. The feeding solution is transferred into a well of a 96-well titer plate. The translation mixture is carefully pipetted into the bottom of the well to form the two layers. 5. The plate is sealed and incubated at 24°C for 16 h, and then stored on ice until further processing. 6. The productivity of translation is analyzed by separating 3 ml of the reaction solution via SDS-PAGE.

3  Expression and Purification of Active Protein Kinases from Wheat Germ Extracts

61

Fig. 2. Agarose gel analysis of translation ready mRNA. pEU-E01-HLIC vectors with 1.5 (lane 1) and 1.7  kb (lane 2), exogenous protein coding insertion has been in  vitro ­transcribed, and checked on a 0.8% agarose gel.

3.4. Purification of Affinity-Labeled Proteins

1. The reaction mix of CECF is diluted five times with the ­modified PBS buffer for His-tagged proteins (completed with imidazole, NaCl, and Triton X-100) and added to 15  ml MagneHis (see Note 9) particles pre-equilibrated in the same buffer. The translation mixture of the bilayer system is complemented with 100  mM imidazole, 5  M NaCl, and 2% Triton X-100 to achieve the concentrations of the modified PBS, and then applied to the same volume of MagneHis particles. 2. In case of GST-tagged proteins, the reaction solution of CECF is mixed with five times modified PBS buffer for GST-tagged proteins and added to 7 ml pre-equilibrated MagneGST beads. The translation solution accompanying the bilayer system kit is completed with Triton X-100 before addition to the MagneGST beads. 3. After 1 h incubation with rotation at 4°C, the affinity purification matrix is washed three times with 200 ml of modified PBS buffer for GST-tagged proteins. 4. The tagged proteins are cleaved from the particles by TEV protease treatment in 20 ml TEV protease buffer at 4°C for 16 h. 5. In order to expel the TEV protease, supernatant of TEV protease-treated GST-labeled proteins is incubated with 1  ml MagneHis particles at room temperature for 15 min. 6. 1 ml of supernatants are separated by SDS-PAGE, and stained with Coomassie solutions to check efficacy of purification. 7. Activity of purified kinase is determined by using 10–100 ng of protein in an appropriate in vitro kinase assay (see Note 10).

62

B. Sonkoly et al.

4. Notes 1. pEU3-NII-GLIC, pEU-E01-GLIC for N-terminal GSTtagging and pEU3-NII-HLIC, pEU-E01-HLIC for N-terminal His-tagging. pEU3-NII and pEU-E01 vectors are suitable for T7 and SP6 promoter-driven in  vitro transcription, respectively (8). 2. Careful separation of linearized vector from uncut vector is critical to produce high-quality LIC vectors. The separation time should be approximately 4 h at 100 V. 3. Due to the nature of applied template, the actual PCR conditions and protocols may differ, thus have to be optimized case by case. 4. Special attention should be paid to keep the plasmid preparation free of RNase since its contamination severely decreases the transcription, and thus the translation productivity. If the RNase contamination persists, standard phenol/chloroform purification of isolated plasmids can be applied. 5. Linearization of plasmids is generally not required, but it could significantly increase the transcription efficiency with certain plasmids constructs. 6. Wheat germ lysates can loose their activities upon thawing more than three times. It has to be aliquoted according to your needs and thaw under running tap water without vigorous shaking. The reaction devices are stored at room temperature for at least one day before starting the translation. 7. In CECF system, in vitro transcription and translation can be coupled in space and time; hence template DNA is directly added to the reaction solution. 8. The majority of plant kinases produced by wheat germ in vitro translations possess high kinase activity, but it can be increased further by co-translation with the relevant activators. In cases when the kinase of interest is activated by phosphorylation, the template plasmids should be added in a 10:1 kinase:activator ratio. If the kinase activity depends on complex formation, the ratio of kinase and regulatory subunit coding vectors should be kept at 1:1. 9. Considering the expected yield of the described in vitro translation reactions, the target proteins can be efficiently purified by few micro liter of beads, and addition of affinity matrix in surplus increases binding of nonspecific proteins deteriorating the efficiency of purification. Working with such volumes is an arduous task with traditional affinity matrixes, therefore application of magnetic particles is recommended.

3  Expression and Purification of Active Protein Kinases from Wheat Germ Extracts

63

10. Most of the kinases could be stored in the TEV protease buffer with 50% glycerol at −20°C for up to a few months. However, certain kinases tend to loose their activity upon long-term storage and freeze/thaw cycles, and should be kept on ice and not used over multiple days.

Acknowledgments This work was supported by Hungarian Scientific Research Fund and National Office for Research and Technology grant K69187 and K68160. References 1. Sorensen, H. P., and Mortensen, K. K. (2005) Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 115, 113–28. 2. Spirin, A. S. (2004) High-throughput cell-free systems for synthesis of functionally active proteins. Trends Biotechnol 22, 538–45. 3. Endo, Y., and Sawasaki, T. (2006) Cell-free expression systems for eukaryotic protein production. Curr Opin Biotechnol 17, 373–80. 4. Rosenthal, A., Coutelle, O., and Craxton, M. (1993) Large-scale production of DNA sequencing templates by microtitre format PCR. Nucleic Acids Res 21, 173–4. 5. van den Berg, S., Lofdahl, P. A., Hard, T., and Berglund, H. (2006) Improved solubility of

TEV protease by directed evolution. J Biotechnol 121, 291–8. 6. Shirokov, V. A., Kommer, A., Kolb, V. A., and Spirin, A. S. (2007) Continuous-exchange protein-synthesizing systems. Methods Mol Biol 375, 19–55. 7. Sawasaki, T., Hasegawa, Y., Tsuchimochi, M., Kamura, N., Ogasawara, T., Kuroita, T., and Endo, Y. (2002) A bilayer cell-free protein synthesis system for high-throughput screening of gene products. FEBS Lett 514, 102–5. 8. Bardoczy, V., Geczi, V., Sawasaki, T., Endo, Y., and Meszaros, T. (2008) A set of ligationindependent in  vitro translation vectors for eukaryotic protein production. BMC Biotechnol 8, 32.

wwwwwwwwwwwwwwwww

Chapter 4 Measurement of Plant Cyclin-Dependent Kinase Activity Using Immunoprecipitation-Coupled and Affinity Purification-Based Kinase Assays and the Baculovirus Expression System Hirofumi Harashima and Masami Sekine Abstract Orderly progression of the eukaryotic cell cycle is governed by a coordinated response to intrinsic and extracellular cues through activation of cyclin-dependent kinases (CDKs). It is therefore important to verify the kinase activity of distinct types of CDKs during the cell cycle. The immunoprecipitation-coupled kinase assay is a useful procedure to evaluate CDK activity in vivo. Although a specific antibody is usually required for immunoprecipitation, transgenic plant cells expressing tag- or marker protein-fused CDKs are also suitable for this purpose. In addition, the baculovirus expression system is a valuable tool for analyzing CDK activity in vitro, because activation of CDKs is regulated by posttranscriptional modification systems that are active in the insect host cells. Key words: CDKA, Kinase activity, BY-2, Baculovirus, Sf 9, Immunoprecipitation, Affinity purification, p13suc1

1. Introduction Cyclin-dependent kinases (CDKs) are a family of serine/threonine protein kinases that play important roles in cell-cycle progression in plants as well as yeasts and vertebrates (1, 2). Activation of CDKs requires the binding of a regulatory cyclin subunit and phosphorylation of a conserved threonine residue in the T-loop by CDKactivating kinase (CAK). The activity of CDKs is also regulated by inhibitory phosphorylation and activating dephosphorylation at the ATP-binding sites, threonine 14 and tyrosine 15 (3). Plants have several types of CDKs, two of which, A-type (CDKA) and B-type CDK (CDKB), are principally responsible for cell-cycle N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_4, © Springer Science+Business Media, LLC 2011

65

66

H. Harashima and M. Sekine

control (4). CDKA, which includes the canonical PSTAIRE motif, has been implicated in the control of both the G1/S and G2/M transitions (1, 2). CDKB is a plant-specific CDK which shows cell cycle-regulated expression and is mostly active during G2 phase (1, 2). A T-DNA insertional mutant of the single Arabidopsis CDKA gene (CDKA;1) is homozygous lethal because proliferation of ­generative cells during male gametogenesis is blocked (5, 6). We have used tobacco Bright Yellow-2 (BY-2) cells to evaluate the kinase activities of various types of CDK/cyclin complexes (7–11). BY-2 cells have been extensively studied as a model ­suspension culture cell, because they are highly homogeneous and their cell cycle can be synchronized up to a high degree with a combination of aphidicolin and propyzamide (12). In addition, the production of recombinant proteins by the baculovirus expression system provides several advantages. First, insect cells have the capability of proteolytic processing such as disulfide bond formation, glycosylation, and phosphorylation of the recombinant protein. Second, multiple proteins can be expressed in this system. Thus, these advantages are useful to analyze which pair of cyclins and CDKs possesses kinase activity in vitro. In this chapter, we describe the method for an immunoprecipitationcoupled kinase assay using suspension culture cells (BY-2) expressing GFP-fused tobacco CDKA and insect cells expressing FLAG-tagged tobacco CDKA.

2. Materials 2.1. Preparation of p13 suc1 Beads

1. Glycerol stock of Escherichia coli expressing p13suc1 protein such as E. coli BL21 (DE3); pET-Suc1. 2. 2× YT medium: Bacto-tryptone 16  g/L, Bacto-yeast extract 10 g/L, NaCl 5 g/L. 3. 3-L Baffled flasks. 4. Isopropyl-b-d-thiogalactopyronoside (IPTG, Nacalai tesque): prepare 1 M stock. Store in aliquots at −20°C. 5. Buffer 1: 20 mM Tris–HCl, 2 mM EDTA, pH 8.0. 6. Buffer 2: buffer 1 containing 1 M NaCl. 7. 50-mL Tubes. 8. Sonicator (such as Astrason XL2020 Ultrasonic Processor using a microtip probe set at 3). 9. 10% (w/v) Polyethylene glycol mono-p-isooctylphenyl ether (Triton X-100). 10. Water bath. 11. FPLC system (GE Healthcare). 12. HiTrap DEAE FF 5-mL column (GE Healthcare).

4  Measurement of Plant Cyclin-Dependent Kinase Activity…

67

13. Superose 12 HR 10/30 column (GE Healthcare). 14. Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-10 membrane (Millipore). 15. CNBr-activated Sepharose 4B (Amersham). 16. Econopack column (Bio-Rad). 17. Coupling buffer: 0.2 M NaHCO3, 0.5 M NaCl, pH 8.0. 18. Blocking buffer: 0.1 M Tris–HCl, pH 8.0. 19. Wash buffer: 0.1 M sodium acetate, 0.5 M NaCl, pH 4.0. 20. Phosphate-buffered saline (PBS): 140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4 (see Note 1). 21. PBS containing 0.05% NaN3. 2.2. Plant Suspension Cell Culture and Subculture

1. Modified Linsmaier and Skoog (LS) medium (12) (see Note 2). 2. 300-mL Erlenmeyer flasks (Iwaki). 3. Silicon caps. 4. 10-mL Komagome pipette (Iwaki) and nipple. 5. Shaker (such as BR-3000LF, Taitec). 6. BY-2 cells expressing GFP-fused tobacco CDKA proteins.

2.3. Preparation of Plant Suspension Cell Extracts

1. IP buffer: 25  mM Tris–HCl, 75  mM NaCl, 15  mM MgCl2, 15 mM EGTA, 0.1% NP-40 (Nonidet P-40), pH 7.5. 2. Complete EDTA-free protease inhibitor cocktail tablets (Roche): prepare 25× solution by dissolving one tablet in 2 mL of water. Store in aliquots at −20°C. 3. Phosphatase inhibitors: 100 mM NaF, 50 mM b-glycerophosphate and 100 mM sodium orthovanadate. Store in aliquots at −20°C. 4. Handy Sonic model UR-10P (Tomy Seiko): adjust power ­output to 8. 5. nProtein A Sepharose 4 Fast Flow (GE Healthcare). 6. Ultrafree-MC, HV, 0.45 mm (Millipore). 7. Anti-GFP antibody (Roche): dissolve the lyophilizate in ­ distilled water and prepare a 0.4  mg/mL stock. Store in ­aliquots at −20°C. 8. Kinase buffer: 50 mM Tris–HCl, 10 mM MgCl2, 1 mM EGTA, pH 7.5.

2.4. Preparation of Insect Cell Culture and Recombinant Baculovirus

1. Grace’s insect cell culture medium (GIM) (Invitrogen) and GIM supplemented with 10% fetal bovine serum (FBS) (Japan Bioserum) and 50 mg/mL gentamicin (Sigma) (see Note 3). 2. Sf 9 insect cells (Invitrogen). 3. TE buffer: 10 mM Tris–HCl, pH 7.0, 1 mM EDTA. 4. 125-mL Spinner flasks (Wheaton Science Products).

68

H. Harashima and M. Sekine

5. Magnetic stirrer (MCS-101, EYLA). 6. Incubator (MIR-153, Sanyo) set at 27°C. 7. 35- and 60-mm dishes (Corning). 8. Cell scrapers (Iwaki). 9. Purified recombinant bacmid DNA in the appropriate ­pFastBac (Invitrogen) construct in TE buffer. 10. Cellfectin Transfection Reagent (Invitrogen). 2.5. Preparation of Insect Cell Extracts

1. TBS: 50 mM Tris–HCl, 150 mM NaCl, pH 7.5. 2. Complete EDTA-free (Roche), prepare working solution as above. 3. Phosphatase inhibitors: prepare working solution as above. 4. Handy Sonic model UR-10P (Tomy Seiko). 5. Anti-FLAG M2 beads (Sigma): prepare 50% slurry. 6. Kinase buffer: 50 mM Tris–HCl, 10 mM MgCl2, 1 mM EGTA, pH 7.5. 7. Liquid nitrogen.

2.6. Kinase Assay

1. [g-32P]-ATP (9.25 MBq, GE Healthcare). 2. Histone H1 (Calbiochem): prepare a 10 mg/mL solution in PBS. Store in aliquots at −80°C. 3. Block incubator (Astec). 4. SDS-PAGE sample buffer (4×): 250 mM Tris–HCl, 40% (v/v) glycerol, 8% SDS, 20% (v/v) 2-mercaptoethanol, 0.1% (w/v) bromophenol blue. Store in aliquots at −80°C.

2.7. SDSPolyacrylamide Gel Electrophoresis

1. Separating buffer (8×): 3 M Tris–HCl, pH 8.8. 2. Stacking buffer (4×): 0.5 M Tris–HCl, pH 6.8. 3. Thirty percent acrylamide/bis solution (37.5:1, 2.6% C) and N,N,N ¢,N ¢-Tetramethyl-ethylenediamine (TEMED, Nacalai tesque). Store at 4°C. 4. 10% SDS. 5. 10% Ammonium persulfate (APS, Nacalai tesque) in water. Store in aliquots at −20°C. 6. Running buffer (10×): 250 mM Tris–HCl, 1.92 M glycine, 1% (w/v) SDS. Store at room temperature. 7. Prestained molecular weight markers (Bio-Rad). 8. CBB staining solution: stir 1 g Coomassie Brilliant Blue R-250 (CBR-250) in 500  mL methanol, 100  mL acetic acid, and 400  mL H2O overnight to dissolve the Coomassie powder. Filter the solution through a filter paper (No. 2, Advantec). Store at room temperature.

4  Measurement of Plant Cyclin-Dependent Kinase Activity…

69

9. Destaining solution: 12% methanol, 7% acetic acid. Store at room temperature. 10. Mini slab gel electrophoresis unit (NA-1012, Nihon-Eido) and power supply (NC-1017, Nihon-Eido). 11. 1-mL syringe with 23-Gauge needle. 12. Kimwipe tissue. 13. 3MM Chr paper (Whatman). 14. DE81 paper (Whatman). 15. Saran Wrap (Asahikasei). 16. HydroTech Gel Drying System (Bio-Rad) set to 80°C.

3. Methods Because CDK activity is regulated by phosphorylation of a specific amino acid residue, the active phosphorylated CDKs tend to be labile owing to protein phosphatase activities within the cell. To obtain reliable and reproducible results, therefore, phosphatase inhibitors must be added to the extraction buffer to inhibit protein phosphatase activities during the preparation of cell extracts. It is also important to check whether the antibody can be used for immunoprecipitation of active CDK/cyclin complexes: in particular, when the antibody is prepared against a catalytic subunit, it is necessary to check whether the antibody masks the activity, since antibody binding can affect the conformation of the catalytic site. Although p13suc1-beads have been used widely for detecting histone H1 kinase activity in plants, p13suc1-beads can bind to CDKA and, to a lesser extent, CDKB in Arabidopsis (13). In addition, we found that p13suc1-beads can bind to both CDKA and CDKB in BY-2 cells, with a higher affinity for CDKA than for CDKB (7). Therefore, it is necessary to identify the extent of CDK binding in your samples. 3.1. Preparation of p13 suc1 Beads

1. Inoculate a 10-mL overnight culture of E. coli BL21 (DE3) cells transformed with the plasmid pET-Suc1, which produces p13suc1 under control of the T7 promoter, into 1  L 2× YT medium containing 100  mg/mL ampicillin in a 3-L Baffled flask and grow at 37°C to an OD600 of 0.6. 2. Add 300 mL of 1 M IPTG to induce p13suc1 production and cultivate for a further 6 h at 37°C. 3. After cooling the culture on ice for 10 min, harvest the cells by centrifugation at 4,000 × g for 15  min at 4°C. Discard the supernatant.

70

H. Harashima and M. Sekine

4. Wash the cells once with 100  mL buffer 1. Centrifuge at 4,000 × g for 15 min at 4°C. Discard the supernatant. 5. Resuspend the cells in 50 mL buffer 1, and dispense into two 50-mL tubes. Freeze at −20°C overnight. 6. Thaw the cell suspension in an ice water bath, and disrupt the cells by sonication by applying ten pulses of 10 s at 10-s ­intervals on ice. 7. Add one-fiftieth volume of 10% (w/v) Triton X-100 to the lysate and incubate at 4°C for 20 min with gentle agitation. 8. Centrifuge at 10,000 × g for 40 min at 4°C, and incubate the supernatant in a water bath at 70°C for 3  min. Centrifuge again at 10,000 × g for 20 min at 4°C. 9. Apply the supernatant to a HiTrap DEAE FF column and pool the eluate fractions containing p13suc1 (flow rate: 2.5 mL/min; gradient: 0–100% buffer 2 in 20 column volumes). 10. Apply the elution pool to a Superose 12 HR 10/30 column equilibrated with coupling buffer (flow rate: 0.5 mL/min) and concentrate the p13suc1 protein with an Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-10 membrane. 11. Suspend 0.3 g CNBr-activated Sepharose 4B in 10 mL 1 mM HCl and pour the slurry into an empty Econopack column. Wash the medium with 60 mL 1 mM HCl. 12. Cap the bottom, add p13suc1 protein suspended in coupling buffer, and cap the top. Incubate for 1 h at room temperature with gentle agitation. 13. Remove both caps to permit flow of coupling buffer. 14. Replace the bottom cap, add 5  mL of blocking buffer, and then replace the top cap. Leave the column for 2 h at room temperature. 15. Remove both caps to start blocking buffer flow. Load 5  mL wash buffer followed by 5  mL coupling buffer. Repeat this wash step twice. 16. Equilibrate the beads with PBS, and then suspend them in the same volume of PBS containing 0.05% (w/v) NaN3 to obtain a 50% slurry of p13suc1 beads. This stock is stable at 4°C for 1 year. 3.2. Preparation of Cyclin/CDK Complexes from BY-2 Cell Extracts 3.2.1. Suspension Cell Culture

1. Culture tobacco BY-2 cells in a 300-mL Erlenmeyer flask ­containing 95  mL modified LS medium with shaking at 130 rpm in the dark at 27°C. 2. Every 7 days, subculture 2  mL aliquots of stationary-phase ­culture into 95 mL fresh medium with a 10-mL Komagome pipette (see Note 4).

4  Measurement of Plant Cyclin-Dependent Kinase Activity… 3.2.2. Preparation of Cell Extracts from Plant Cell

71

1. Stand the flask for 7 min. Transfer 1.4 mL of the BY-2 cells from the bottom to a 1.5-mL microtube with a tip-cut 1-mL microtip. 2. Centrifuge the microtube at 500 × g for 1  min at room ­temperature. Remove the supernatant. 3. Freeze samples in liquid nitrogen, and store at −80°C. 4. Add 700 mL of IP buffer containing protease and phosphatase inhibitors to each sample. Lyse the BY-2 cells by sonication by applying ten pulses of 10 s at 5-s intervals on ice. 5. Centrifuge the microtube at 10,000 × g for 30  min at 4°C. Transfer the supernatant to a new 1.5-mL microtube, and ­centrifuge at 100,000 × g for 1 h at 4°C. 6. Determine protein concentration by the Bradford method (14) using BSA as a standard. 7. Dispense the sample into a new 1.5-mL microtube at a ­concentration of 300 mg overall protein in 150 mL IP buffer.

3.2.3. Affinity Purification from Plant Suspension Cell Extracts Using p13 suc1 Beads

1. Add 20 mL of a 50% slurry of p13suc1-conjugated Sepharose 4B to each sample, and incubate at 4°C for 1 h with rotation. 2. Centrifuge the microtube at 10,000 × g for 30 s, and remove the supernatant. 3. Add 300 mL of IP buffer, centrifuge at 10,000 × g for 30 s, and remove the supernatant. Repeat this step twice to wash the beads. 4. Add 300 mL of kinase buffer, centrifuge at 10,000 × g for 30 s, and remove the supernatant. Repeat this step twice to ­equilibrate the beads. 5. Add 10 mL of kinase buffer, and suspend with a tip-cut 200-mL microtip. Transfer 15 mL of the resultant 50% slurry of p13suc1conjugated Sepharose 4B to a new microtube.

3.2.4. Immunoprecipitation from Plant Suspension Cell Extracts

1. Add 20 mL of a 50% slurry of nProtein A Sepharose 4 Fast Flow to each sample, and incubate at 4°C for 1 h with rotation. 2. Centrifuge the microtube at 10,000 × g for 30 s, and transfer the suspension to a filter unit. 3. Centrifuge the filter device at 10,000 × g for 30 s, and transfer the flow through to a new 1.5-mL microtube. 4. Add 4 mg of monoclonal anti-GFP antibody, and incubate at 4°C for 1  h with rotation. Centrifuge the microtube at 10,000 × g for 30 s. 5. Add 20  mL of a 50% slurry of nProtein A Sepharose 4 Fast Flow, and incubate at 4°C for 1 h with rotation. Centrifuge the microtube at 10,000 × g for 30 s, and remove the supernatant.

72

H. Harashima and M. Sekine

6. Add 300 mL of IP buffer, centrifuge the microtube at 10,000 × g for 30 s, and remove the supernatant. Repeat this step twice to wash the beads. 7. Add 300  mL of kinase buffer, centrifuge the microtube at 10,000 × g for 30 s, and remove the supernatant. Repeat this step twice to equilibrate the beads. 8. Add 10 mL of kinase buffer, and suspend with a tip-cut 200-mL microtip. Transfer 15 mL of the 50% slurry of anti-GFP beads to a new microtube. 3.3. Preparation of Cyclin/CDK Complexes Using Baculovirus Expression System 3.3.1. Insect Cell Culture

3.3.2. Preparation of Recombinant Baculovirus

1. When the cells in the Spinner flask reach a density of 1 × 106 cells/mL, dilute to one-fourth (remove the cell culture down to 30 mL then add fresh GIM supplemented with 10% (v/v) FBS and 50 mg/mL gentamicin up to 125 mL). 2. Loosen the side arm caps and incubate the Spinner flask at 27°C with constant stirring at 60 rpm in the dark for 3 or 4 days (see Note 5). 1. Seed a 35-mm dish with 106 Sf9 cells. Allow the cells to attach to the surface of the dish for 40 min at room temperature (see Note 6). 2. Prepare bacmid DNA: Cellfectin Reagent complexes as follows in a 1.5-mL sterile microtube. (a) Dilute 1 mg purified bacmid DNA in 100 mL GIM. (b) Mix Cellfectin Reagent thoroughly before use by inverting the tube five to ten times. Add 6  mL of Cellfectin Reagent to 100 mL GIM. (c) Combine the diluted bacmid DNA with the diluted Cellfectin Reagent. Mix gently and incubate for 20 min at room temperature. 3. While the DNA:lipid complexes are incubating, remove the medium from the cells and wash once with 2 mL GIM. Remove the wash medium. 4. Add 0.8 mL of GIM to each tube containing the DNA:lipid complexes. Mix gently and transfer to the cells. 5. Incubate the cells for 5 h at 27°C. 6. Remove the DNA:lipid complexes and add 2 mL of complete growth medium to the cells. 7. Incubate the cells for 3 days at 27°C. 8. Collect the medium containing baculovirus from each dish and transfer to sterile 15-mL snap-cap tubes. Centrifuge the tubes at 500 × g for 5 min. 9. Transfer the supernatant (P1 viral stock) to fresh 15-mL ­snap-cap tubes wrapped with aluminum foil to protect from light. Store at 4°C.

4  Measurement of Plant Cyclin-Dependent Kinase Activity… 3.3.3. Baculovirus Amplification

73

1. Plate Sf 9 cells at 3 × 106 cells per 60-mm dish. Incubate cells for 40 min at room temperature. 2. Discard the medium and add 5 mL of GIM supplemented with 10% (v/v) FBS and 50 mg/mL gentamicin. 3. Add 0.5 mL of P1 viral stock to the dish and incubate the cells for 3 days at 27°C. 4. Collect the medium containing baculovirus and transfer to a sterile 15-mL snap-cap tube. Centrifuge the tube at 500 × g for 5 min. 5. Transfer the clarified supernatant (P2 viral stock) to a new 15-mL snap-cap tube wrapped with aluminum foil to protect from light. Store at 4°C (see Note 7).

3.3.4. Preparation of Cell Extracts from Insect Cell

1. Seed a 60-mm dish with 3 × 106 Sf 9 cells. Let the cells attach for 40 min at room temperature. 2. Remove the medium and replace with 5  mL GIM supplemented with 10% (v/v) FBS and 50 mg/mL gentamicin. Add 100 mL of P2 baculoviral stock. Seal the dish with Parafilm and incubate the cells at 27°C. 3. Collect Sf9 cells expressing FLAG-CDKA and/or CYCD3 using a cell scraper, 60 h after infection, and transfer to a sterile 15  mL snap-cap tube. Centrifuge the tube at 1,000 × g for 5 min at 4°C. Discard the supernatant and resuspend the cells in 1 mL TBS. Transfer the suspension to a new 1.5-mL microtube. Centrifuge the tube at 10,000 × g for 1  min at 4°C. Remove the supernatant. 4. Freeze samples in liquid nitrogen, and store at −80°C. 5. Add 1 mL of TBS containing protease and phosphatase inhibitors. Disrupt the Sf 9 cells by sonication by applying ten pulses of 10 s at 5-s intervals on ice. 6. Centrifuge the tube at 10,000 × g for 30 min at 4°C. Transfer the supernatant to a new 1.5-mL microtube, and centrifuge at 100,000 × g for 1 h at 4°C. 7. Divide the sample into 90-mL aliquots, and add 60  mL of TBS to each. Freeze samples in liquid nitrogen, and store at −80°C.

3.3.5. Immunoprecipitation from Insect Cell Extracts

1. Thaw the frozen lysate on ice. Add 20 mL of a 50% slurry of anti-FLAG M2 beads. Incubate for 1 h at 4°C. 2. Centrifuge at 10,000 × g for 30  s at 4°C, and remove the ­supernatant. Add 300 mL of TBS, centrifuge again at 10,000 × g for 30 s at 4°C, and then remove the supernatant. Repeat this step twice. 3. Add 300 mL of kinase buffer, centrifuge at 10,000 × g for 30 s at 4°C, and then remove the supernatant. Repeat this step two more times.

74

H. Harashima and M. Sekine

4. Add 10 mL of kinase buffer, and suspend with a tip-cut 200-mL microtip. Transfer 15 mL of the resultant 50% slurry of antiFLAG M2 beads to a new microtube. 3.4. Kinase Assay

1. Mix 4.5  mL kinase buffer, 0.25  mL 10  mg/mL histone H1 stock solution and 0.25 mL [g-32P]ATP (see Notes 8 and 9). 2. Incubate at 30°C for 30 min and then chill on ice. 3. Add 5 mL of 4× SDS-PAGE sample buffer. Mix by tapping and centrifuge the microtube at 10,000 × g for 1 min. 4. Incubate at 95°C for 3  min. Centrifuge the microtube at 10,000 × g for 1 min.

3.5. SDS-PAGE

1. Prepare a 1-mm thick, 12.5% separating gel by mixing 0.83 mL 8× separating buffer with 2.75  mL acrylamide/bis solution, 2.95 mL water, 66 mL 10% (w/v) SDS, 7 mL TEMED, and 66 mL 10% (w/v) APS. Cast the gel, leaving space for a stacking gel, and overlay with isopropanol. The gel should polymerize in about 30 min. 2. Pour off the isopropanol and rinse the top of the gel twice with distilled water. 3. Prepare the stacking gel by mixing 0.5 mL 4× stacking buffer with 1.23  mL distilled water, 0.25  mL acrylamide/bis solution, 20 mL 10% (w/v) SDS, 2 mL TEMED, and 20 mL APS. 4. Remove the comb carefully and rinse the gel unit briefly with distilled water. 5. Add 1× running buffer to the lower chamber, insert the gel unit and then add running buffer to the upper chamber. Wash the wells using a 1-mL syringe fitted with a 23-Gauge needle. 6. Load 15 mL of sample prepared in Subheading 3.4 per well, leaving one well for prestained molecular weight marker. 7. Connect to a power supply and run at 25 mA constant current. Run until the dye front has almost moved through the entire gel. In case the dye fronts run off the gel, the buffer will contain most of the unincorporated radiolabel.

3.6. Staining and Autoradiography

1. Add the CBB staining solution to a suitable container and soak the gel for 20 min at room temperature with gentle agitation. 2. Discard the CBB staining solution and rinse the gel briefly with 50 mL destaining solution. 3. Add 100 mL destaining solution and two sheets of Kimwipe, which accelerate the destaining, and incubate overnight at room temperature with gentle agitation.

4  Measurement of Plant Cyclin-Dependent Kinase Activity…

75

4. Transfer the gel onto a wet 3MM paper, and put it on DH81 paper. After wrap with Saran Wrap, set these sheets in the gel dryer. Dry the gel for 25 min. 5. Detect phosphorylated histone H1 by autoradiography. Alternatively, place the dry gel in contact with an IP plate for 25 min and scan with an imaging system (e.g., BAS, Fujifilm) (see Note 10). Examples of signals for active CDKA are shown in Figs. 1 and 2.

Fig. 1. Immunoprecipitation-coupled kinase assay using BY-2 cells expressing GFP-fused tobacco CDKA. (a) Fluorescence microscopic images showing BY-2 cells at 3 days after induction with estrogen. One day after induction with 4 mM b-estradiol, (b) crude extracts and immunoprecipitates were prepared from BY-2 cells expressing GFP (lane 1), CDKA(WT)-GFP (lane 2), CDKA(D146N)-GFP (lane 3), and CDKA(T161A)-GFP (lane 4). WT: wild type CDKA, D146N is a dominant-negative variant, and T161A lacks the Thr161 that is activatorily phosphorylated by CAKs in the T-loop of CDKA. Crude extracts were subjected to western blotting with a GFP antibody. Immunoprecipitates were prepared with a GFP antibody from BY-2 cells expressing the GFP-fusions of the CDKA variants and used for western blots with a GFP antibody to detect the fusion proteins. (c) Immunoprecipitates were also used for in vitro histone H1 kinase assays. The samples were separated by 12.5% SDS-PAGE and a CBB stain of the gel is shown (CBB, lower panel ). (d) Total kinase activity was evaluated by measurement as p13suc1-associated histone H1 kinase activity. Samples were prepared from BY-2 cells expressing CDKA(WT)-GFP (lane 1), CDKA(D146N)-GFP (lane 2), and CDKA(T161A)-GFP (lane 3) and separated by 12.5% SDS-PAGE, followed by CBB staining (lower panel ). (Reproduced from ref. 7 with permission from Blackwell Publishing).

76

H. Harashima and M. Sekine

Fig. 2. Kinase assay using insect cells expressing FLAG-tagged CDKA. His-tagged tobacco cyclin (CYCD3) and FLAG-tagged tobacco CDKA and its mutants were expressed individually or co-expressed in insect cells as indicated. Cell lysates from the insect cells were immunoprecipitated with anti-FLAG M2 beads and the immunoprecipitates were tested in in vitro histone H1 kinase assays. Cell lysates were used for western blots with anti-CYCD3 antibody and anti-FLAG M2 antibody. The same membrane was probed sequentially with each antibody. The asterisk at the right in the top panel marks bands cross-reacting nonspecifically with the antibody. The 12.5% SDS-PAGE gel used for histone H1 kinase assays was stained with CBB (bottom panel ). (Reproduced from ref. 7 with permission from Blackwell Publishing).

4. Notes 1. Unless otherwise stated, all solutions should be prepared in distilled water or water purified using a Milli-Q system (Millipore). 2. LS medium can be made by preparing stock solutions or by using appropriate reagents which are available from commercial sources (e.g., Murashige and Skoog (MS) Basal Salt Mixture, Sigma). 3. FBS is available from other commercial sources. Lot checking of FBS should be undertaken for insect cells under the conditions you use. 4. The cell material will be very viscous at stationary phase and thus hard to pipette. The easiest is to use the Komagome pipette or, if not available, a wide-mouthed pipette to transfer the cell suspension to fresh medium. Other valuable technical notes for maintaining BY-2 cells can be found in (15). 5. This protocol is based on the instruction manual of the Bac-toBac® baculovirus expression system (Invitrogen). 6. It is necessary to verify, using an inverted microscope, that insect cells are attached to the surface of the culture dish. Viable cells usually attach within 5 min.

4  Measurement of Plant Cyclin-Dependent Kinase Activity…

77

7. We did not check baculovirus titer or multiplicity of infection, but two rounds of amplification are usually sufficient to obtain baculovirus which can be used to produce enough target proteins in the subsequent steps. 8. For convenience, we routinely prepare a mixture (the total volume is 5 mL × sample number) containing kinase buffer, histone H1 stock solution, and [g-32P]ATP in the ratio of 18:1:1. 9. Other than histone H1, retinoblastoma-related protein (RBR) is one of the most important CDK substrates in plants. Since the molecular weight of RBR protein is more than 110 kDa, it is difficult to obtain sufficient amounts of purified full-length RBR from E. coli. Therefore, we usually use glutathione S-transferase (GST)-fused C-terminal domain of RBR as a substrate (7, 9). GST fusion proteins are purified using glutathione Sepharose 4B beads according to the manufacturer’s instructions. 10. Quantification of data may be desirable, and this can be done by scanning and densitometry of the films. Care should be taken to ensure that the signal has not saturated. Alternatively, chemiluminescent signals can be captured digitally with an instrument such as a BAS-2500 (Fujifilm).

Acknowledgments The authors wish to thank Drs. Ko Kato, Kazuya Yoshida, and Atsuhiko Shinmyo for their helpful discussions and suggestions. The authors also wish to thank Dr. Ian Smith for critical reading of the manuscript. This research was supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology and by a Grant-in-Aid for Creative Scientific Research. References 1. Gutierrez, C. (2005) Coupling cell proliferation and development in plants. Nat.Cell Biol. 7, 535–541. 2. Oakenfull, E.A., Riou-Khamlichi, C., and Murray, J.A. (2002) Plant D-type cyclins and the control of G1 progression. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 357, 749–760. 3. Pines, J. (1995) Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J. 308, 697–711. 4. Joubes, J., Chevalier, C., Dudits, D., HeberleBors, E., Inze, D., Umeda, M., and Renaudi, J.P. (2000) CDK-related protein kinases in plants. Plant Mol. Biol. 43, 607–620.

5. Iwakawa, H., Shinmyo, A., and Sekine, M. (2006) Arabidopsis CDKA;1, a cdc2 homologue, controls proliferation of generative cells in male gametogenesis. Plant J. 45, 819–831. 6. Nowack, M.K., Grini, P.E., Jakoby, M.J., Lafos, M., Koncz, C., and Schnittger, A. (2006) A positive signal from the fertilization of the egg cell sets off endosperm proliferation in angiosperm embryogenesis. Nat. Genet. 38, 63–67. 7. Harashima, H., Shinmyo, A., and Sekine, M. (2007) Phosphorylation of threonine 161 in plant cyclin-dependent kinase A is required for cell division by activation of its associated kinase. Plant J. 52, 435–448.

78

H. Harashima and M. Sekine

8. Harashima, H., Kato, K., Shinmyo, A., and Sekine, M. (2007) Auxin is required for the assembly of A-type cyclin-dependent kinase complexes in tobacco cell suspension culture. J. Plant Physiol. 164, 1103–1112. 9. Nakagami, H., Kawamura, K., Sugisaka, K., Sekine, M., and Shinmyo, A. (2002) Phosphorylation of retinoblastoma-related protein by the cyclin D/cyclin-dependent kinase complex is activated at the G1/S-phase transition in tobacco. Plant Cell. 14, 1847–1857. 10. Nakagami, H., Sekine, M., Murakami, H., and Shinmyo, A. (1999) Tobacco retinoblastomarelated protein phosphorylated by a distinct cyclin-dependent kinase complex with Cdc2/ cyclin D in vitro. Plant J. 18, 243–252. 11. Sorrell, D.A., Menges, M., Healy, J.M., Deveaux, Y., Amano, C., Su, Y., Nakagami, H., Shinmyo, A., Doonan, J.H., Sekine, M., and Murray, J.A. (2001) Cell cycle regulation of

cyclin-dependent kinases in tobacco cultivar Bright Yellow-2 cells. Plant Physiol. 126, 1214–1223. 12. Nagata, T., Nemoto, Y., and Hasezawa, S. (1992) Tobacco BY-2 cell-line as the Hela-Cell in the cell biology of higher-plants. Int. Rev. Cytol. 132, 1–30. 13. De Veylder, L., Segers, G., Glab, N., Casteels, P., Van Montagu, M., and Inze, D. (1997) The Arabidopsis Cks1At protein binds the cyclindependent kinases Cdc2aAt and Cdc2bAt. FEBS Lett. 412, 446–452. 14. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254. 15. Nagata, T., and Kumagai, F. (1999) Plant cell biology through the window of the highly synchronized tobacco BY-2 cell line. Meth. Cell Sci. 21, 123–127.

Chapter 5 Mitogen-Activated Protein Kinase Activity and Reporter Gene Assays in Plants Róbert Dóczi, Elizabeth Hatzimasoura, and László Bögre Abstract Mitogen-activated protein (MAP) kinase pathways are conserved in eukaryotes and transmit a plethora of stimuli. MAP kinases (MAPKs) are part of signalling modules that consist of three to four tiers of protein kinases in a phosphorylation cascade. MAPKs are known to phosphorylate specific substrates at specific sites at a ­threonine or serine residue followed by proline, but the surrounding amino acids of the phosphorylation site and docking interactions are also important for substrate recognition. MAPK activity can be assayed by detecting their phosphotransferase activity, their activation state, or detecting the switching on or off reaction of specific genes, or cellular responses. Prior to the kinase assay, specific MAPK proteins can be immunoprecipitated either by MAPK-specific antibodies or by the introduction of C-terminal epitope tags and expression of the fusion proteins in planta or transiently in protoplasts. Protoplasts derived from Arabidopsis thaliana cell cultures or leaves provide a valuable tool to co-express multiple gene constructs, thus in this system MAPKs can be co-expressed with upstream regulatory components or downstream targets. In protoplasts, the signalling activity through MAPK pathways can also be monitored by ­co-transforming reporter genes fused to target promoters. Furthermore, components of the MAPK ­signalling pathways can be silenced by co-transformation of RNAi or amiRNA constructs, and the impact of silencing on MAPK activation or gene expression can thus be determined. Key words: Mitogen-activated protein kinase, MAP kinase, MAPK, Protoplast, Immunoprecipitation, Phosphotransferase activity, Myelin basic protein, MBP, Promoter activity, Arabidopsis cell suspension culture

1. Introduction Mitogen-activated protein (MAP) kinase signal transduction modules mediate the transfer of information from extracellular ­signals to cellular responses. These signalling pathways are ubiquitously found from yeast to animal and plant cells throughout eukaryotes.

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_5, © Springer Science+Business Media, LLC 2011

79

80

R. Dóczi et al.

MAP kinases (MAPK) cascades are composed of distinct combinations of three to four families of protein kinases: MAP kinase kinase kinase kinase (MAP4K), MAP kinase kinase kinase (MAP3K/MEKK), MAP kinase kinase (MAP2K/MEK/MKK), and MAP kinase (MAPK/MPK), which are activated in a sequential ­phosphorylation cascade (1, 2). The activated MAPK then phosphorylates ­various downstream components, including ­transcription factors and other kinases thereby modulating their activity, stability, or localisation. In Arabidopsis thaliana, genes encoding 20 MPKs, 10 MKKs, and 60–80 MAP3Ks and 10 MAP4Ks were identified based on the annotation of the genome sequence (3, 4). In plants, MAPK signalling pathways play important ­regulatory roles in several processes such as biotic and abiotic stress, as well as hormone and developmental signalling (1, 5). MAPK activities are rapidly and in most cases transiently switched on in response to specific signals, and therefore appropriate time-course experiments that typically span 0, 1, 2, 5, 10, 20, 30, and 60 min are used. Detection of MAPK activity status under various conditions is an important part of functional MAPK analysis. MAPK activity in plants is most commonly determined by measuring the phosphotransferase activity by use of radiolabelled ATP and measuring the amount of incorporated 32PO43− into a MAPK artificial substrate such as myelin basic protein (MBP) (e.g. (6–8)). To this end, MAPKs can be immunoprecipitated from crude protein extracts (immunocomplex kinase assay) or the reaction can be performed after separation of protein samples by polyacrylamide gel electrophoresis (PAGE) where the MBP substrate is incorporated into the gel (in gel kinase assay) (7). The third approach to detect MAPK activities is the use of antibodies specific to the phosphorylated form of MAPKs (9). Currently, only antibodies against the ­phosphorylated form of animal MAPKs are commercially available. The threonin, glutamate, tyrosine (TEY) motif that gets phosphorylated during the activation of MAPKs by MEKs is conserved and present in a number of plant MAPKs, but the surrounding amino acids are not fully conserved. Therefore, the phospho-ERK ­(animal extracellular (signal-)regulated kinase; one of the prominent ­models for MAPKs) antibodies, which are widely used against phospho-MAPKs, only weakly recognise plant MAPKs, and thus can only be used with variable success. Protoplasts are plant cells of which cell walls have been enzymatically removed. Protoplasts are responsive to external stimuli such as hormones, stresses, and microbial elicitors (10). What is more, protoplasts can be transformed with multiple gene constructs for transient expression, thus providing a system to study their interactions. To this end, a variety of biochemical experiments can be applied such as co-immunoprecipitation, GFP localisation, bimolecular fluorescence complementation (BiFC), and promoter analysis with reporter genes (11), kinase, and phosphatase assays. Further important application of the protoplast system is the ­possibility to

5  Mitogen-Activated Protein Kinase Activity and Reporter Gene Assays in Plants

81

silence genes specifically using RNAi or amiRNA constructs. It is important to note that the transformation ­efficiency is only around 20–40%, but the co-transformation efficiency with another construct is close to 100%. Therefore, it is possible to develop readouts for the effect of silencing a gene by co-transfection of downstream components of the regulatory pathway. For example one can silence receptors and search for downstream ­signalling components by detecting their activity after co-transformation. Similarly, one can silence signalling components and determine their effects on the expression of target genes using promoter-reporter constructs. Here, we describe methods to test MAPK activities based either on testing their phosphotransferase activity to substrate ­proteins or detecting reporter gene induction based on their ­transcriptional regulatory roles. We provide a detailed protocol to prepare and transform Arabidopsis thaliana cell culture-derived protoplasts; however, protoplasts from leaf mesophyll cells can also be used to carry out the same techniques (12).

2. Materials 2.1. Protoplast Isolation from Arabidopsis Suspension Culture Cells 2.1.1. Maintaining Arabidopsis Cultured Cells

1. Arabidopsis medium: 4.414 g/l MS (Murashige and Skoog) + B5 vitamins (Duchefa), 30 g/l sucrose, and 1 mg/l 2,4-dichlorophenoxyacetic acid (2,4-D), adjust pH to 5.7 with 0.1  M KOH, and autoclave.

2.1.2. Protoplasting the Cells

1. 50 and 15 ml Falcon tubes. 2. Eppendorf 5810 R or similar centrifuge that fits 50- and 15-ml Falcon tubes. 3. Large Petri dishes. 4. Sterile plastic Pasteur pipettes (~2–3 ml). 5. Fuchs–Rosenthal counting chamber. 6. Inverted microscope. 7. B5 0.34 M glucose-mannitol medium (B5-GM): 3163.98 mg/l B5 powder (Duchefa), 0.34 M glucose, and 0.34 M mannitol, adjust pH to 5.5 with 0.1 M KOH, autoclave. 8. B5 0.28  M sucrose medium (B5-SM): 3163.98  mg/l B5 ­powder (Duchefa) and 0.28 M sucrose, adjust pH to 5.5 with 0.1 M KOH, autoclave.

82

R. Dóczi et al.

9. Enzyme solution: 1% cellulase (Yakult or Serva), 0.2% macerozyme (Yakult or Serva) in B5-GM. Stir for 30 min and filter through Whatman paper or centrifuge at 3200 rcf 10 min. Filter sterilise. Prepare freshly before use. 2.2. Protoplast Transformation and Treatments 2.2.1. Protoplast Transformation

1. Plasmid(s) to be transformed. 2. Salmon sperm DNA (10 mg/ml). 3. PEG solution: 25% PEG 6000, 0.45 M mannitol, and 0.1 M Ca(NO3)2 (see Note 1). 4. 0.275 M Ca(NO3)2, pH 5.6 (with 0.1 M KOH). 5. Vacuum pump. 6. 24-Well plates.

2.2.2. Protoplast Treatments

1. Liquid nitrogen.

2.3. MAPK Activity Assays

1. TissueLyser (Qiagen) or quartz sand and grinder, vortexer.

2.3.1. Total Protein Extraction

3. Bradford protein assay kit (BioRad).

2. Cooled microcentrifuge (such as from Eppendorf). 4. Spectrophotometer. 5. Lacus buffer: 25  mM Tris–HCl, 10  mM MgCl2, 15  mM EGTA, 75  mM NaCl, 1  mM DTT, 1  mM NaF, 0.5  mM Na3VO4, 15  mM b-glycerolphosphate, 15  mM p-nitrophenylphosphate, 0.1% Tween 20, 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 5 mg/ml leupeptine, and 5 mg/ml aprotinin. Store at −20°C.

2.3.2. Protein Immunoprecipitation from Total Protein Extracts

1. Rolling incubator. 2. Insulin syringe and needles. 3. Protein A or G Sepharose (GE Healthcare). 4. Anti-HA or anti-c-myc monoclonal antibodies (Roche). 5. Anti-Arabidopsis MAPK antibodies (a-AtMPK3, a-AtMPK4, and a-AtMPK6; Sigma). 6. SUC1 buffer: 50 mM Tris–HCl, 250 mM NaCl, 5 mM EGTA, 5  mM EDTA, 0.1% Tween 20, 5  mM NaF, 0.1% Nonidet P-40, and 0.5 mM PMSF. Store at −20°C (see Note 2). 7. Kinase buffer: 20 mM HEPES, pH 7.5, 15 mM MgCl2, 5 mM EGTA, and 1  mM DTT. Prepare a 10× stock solution and store at −20°C.

5  Mitogen-Activated Protein Kinase Activity and Reporter Gene Assays in Plants 2.3.3. Protein Kinase Activity Assay of Immunoprecipitated MAPKs (Immunocomplex Kinase Assay)

83

1. SDS-PAGE equipment. 2. Vacuum gel-dryer and heating block. 3. Phosphorimager or autoradiography film. 4. Whatman 3MM paper. 5. Coomassie Brilliant Blue G 250 (CBB-G) staining solution: 0.12 w/v % Coomassie Blue R250, 0.03 w/v %g Comassie Blue G250, 45 v/v % methanol, and 10 v/v % acetic acid. 6. Coomassie Brilliant Blue G 250 (CBB-G) destaining solution: 45 v/v % methanol and 10 v/v % acetic acid. 7. 10 mg/ml MBP (myelin basic protein) (see Note 7). 8. 1 M DTT. 9. 10 mM ATP. 10. [g-32P]-ATP (3,000 Ci/mmol). 11. 5× SDS loading buffer: 1M TRIS, pH 6.8, 500 mM DTT, 10% SDS, 0.5% bromophenol blue, and 62.5% glycerol. 12. Kinase assay buffer: 50  mM Hepes-HCl, pH 8.0, 2.0  mM DTT, 0.1 mM EGTA, and 20 mM MgCl2.

2.3.4. Phosphotransferase Activity Assay of MAPKs in SDS-PAGE (In-Gel Kinase Assay)

1. 12.5% SDS-PAGE gel containing 0.5 mg/ml of MBP. 2. 20% 2-propanol in 50 mM Tris–HCl, pH 8.0. 3. Buffer A: 50 mM Tris–HCl, pH 8.0, 5 mM DTT. 4. Denaturation buffer: 6  M guanidine-HCl (Ultrapure, ICN), 20 mM DTT, 2 mM EDTA, and 50 mM Tris–HCl, pH 8.0. 5. 10% Trichloroacetic acid. 6. 1% Sodium pyrophosphate. 7. Tween-40. 8. ATP 9. [g-32P]-ATP (3,000 Ci/mmol).

2.4. Detection of MAPK Activity by Using Reporter Gene Constructs 2.4.1. Protein Extraction for MUG Assay

1. 1.5-ml microcentrifuge tubes. 2. Bradford protein assay kit (BioRad). 3. GUS extraction buffer (EB): 50 mM Na phosphate pH 7.0, 1 mM Na2EDTA, 5 mM DTT, and 0.1% Triton-X 100, aliquot and store at 4°C for up to 1 month.

2.4.2. MUG Assay Using a Microtitre Plate-Reader Fluorimeter

1. Titre plates. 2. Plate-reader fluorimeter.

84

R. Dóczi et al.

3. 1  mM 4-methyl-umbelliferyl-ß-glucuron (MUG) in EB. Prepare 1 ml aliquots, store at −20°C. 4. 10 mM 4-methyl-umbelliferyl (MU) in H2O. 5. Stop reagent: 0.2 M Na2CO3.

3. Methods 3.1. Protoplast Isolation from Arabidopsis Suspension Culture Cells 3.1.1. Maintaining Arabidopsis Cultured Cells

The most important factor in protoplast transformation is the ­starting material: the Arabidopsis cell culture. Every cell culture responds differently to the protoplasting, protoplast isolation, and transformation protocols. Our protocol has been developed for the cell culture initiated from Arabidopsis Col-0 (ecotype Columbia-0) roots in Csaba Koncz’s laboratory (Max-Planck-Institut für Pflanzenzüchtungsforschung, Köln, Germany) (13, 14). To maintain the culture, dilute cells weekly 1:5 in Arabidopsis medium (10 ml cells with 40 ml fresh medium). The growth of the culture should be regularly checked, if the culture has not reached the stationary phase, adopt a lower dilution, e.g. 1:4. The culture fails to grow at low density.

3.1.2. Protoplasting the Cells

This protocol is intended to prepare protoplasts from 50  ml culture. 1. Collect 3–4-day-old Arabidopsis cells by centrifuging them in a 50-ml Falcon tube for 5 min at 290 rcf (i.e. 1,500 rpm in an Eppendorf 5810 centrifuge with rotor no. F34-6-38) (see Note 3). 2. Discard supernatant by decanting. There should be approximately 10–15 ml of pelleted cells left. 3. Mix cells with 25 ml of enzyme solution and fill up to 50 ml with B5-GM (B5 0.34 M glucose-mannitol medium). 4. Split the content into two large Petri plates, and add 25 ml of B5-GM to both plates. 5. Shake carefully and slowly at 30–40  rpm/min for approximately 3  h and check protoplasts in an inverted microscope every 30  min to decide on the timing for harvesting. When about 80% of the cells start to look spherical (indicating that they are fully protoplasted), allow to shake a further 20–30 min and then start the protoplast isolation by transferring the contents of the dish to two 50-ml Falcon tubes.

5  Mitogen-Activated Protein Kinase Activity and Reporter Gene Assays in Plants

85

6. Centrifuge for 5 min at 290 rcf. 7. Discard supernatant by carefully decanting. Resuspend pellets in 25 ml B5-GM. 8. Centrifuge for 5 min at 130 rcf (1,000 rpm in an Eppendorf 5810 with rotor no. F34-6-38). 9. Discard supernatant and resuspend pellets in 5  ml B5-SM (B5 0.28 M sucrose medium) and then transfer to 15-ml Falcon tubes. 10. Centrifuge for 7  min at 130 rcf (800  rpm in an Eppendorf 5810, rotor no. A-4-62). Cells should float, if not increase spinning time. Failure to float prevents protoplast isolation and is a typical symptom of a change in cell culture growth. 11. Transfer floating cells with sterile wide-mouthed plastic Pasteur pipettes to a new 15-ml Falcon tube. 12. Determine the number of cells/ml: dilute 1:50 in B5-SM, fill an aliquot into a Fuchs–Rosenthal counting chamber, count the number of protoplasts in 3–4 large squares, and calculate the average number. Concentration of the protoplasts is ­determined by the following formula:

average number × dilution factor × 5, 000 = protoplasts per ml

13. Dilute the protoplasts with B5-SM to a final concentration of 6 × 106/ml. 14. Use the protoplasts for transformation immediately or store them at 4°C for up to 24 h. 3.2. Protoplast Transformation and Treatments 3.2.1. Protoplast Transformation

1. Use 1–5  mg of each plasmid per transformation. Several ­constructs can be combined for co-transformation. To increase transformation efficiency, 10 mg of salmon sperm DNA can be added here (see Note 4). 2. Add 1–3 × 105 protoplasts in 50 ml per tube and mix by ­carefully flicking the tube for a few times (see Note 5). 3. Immediately add 150  ml of PEG solution by using widemouthed pipette tips (e.g. cut off the tip) and mix by flicking. 4. Incubate for 10–15 min at room temperature in the dark. 5. Add 1 ml of 0.275 M Ca(NO3)2 and mix by inverting the tubes a couple of times. Make sure all the viscous PEG on the ­bottom of tubes are mixed into the Ca(NO3)2 solution. 6. Centrifuge for 5 min at 130 rcf. 7. Aspirate off the supernatant with a vacuum pump. 8. Add 0.5 ml of B5 GM. Place the tubes in the dark in a vertical position for cultivation. Alternatively, protoplasts can be

86

R. Dóczi et al.

transferred to a 24-well plate. Add sterile water in between the wells on the plate to prevent the cells from drying out. Incubation can be for 4 h up to 3–4 days, as necessary for your experiment. Transient expression starts at around 4–6 h (see Note 6). 3.2.2. Protoplast Treatments

For convenience, protoplasts are often cultivated overnight after transformation. Samples transformed with the same plasmid(s) can be pooled to reduce variations between independent transformations and have identical samples for treatments. Pooled protoplasts can then be re-aliquoted as required, but have to be rested for at least 2 h to avoid possible activation of signalling pathways due to mechanical stress caused by pooling. Protoplasts then can be subjected to various treatments (e.g. temperature, osmotic stress, and pathogenic elicitors) and collected by a brief centrifugation (30 s at 290 rcf). Aspirate off the medium with a vacuum pump and freeze protoplasts in liquid nitrogen. Store at −80°C.

3.3. MAPK Activity Assays

Total protein extract, e.g. from Arabidopsis protoplasts, cells, or from seedlings can be used.

3.3.1. Total Protein Extraction

1. Frozen Arabidopsis tissue can be broken up either by using a TissueLyser or by homogenising with quartz sand and a grinder. Add 100–200 ml of Lacus buffer. Thaw frozen protoplasts on ice and add 100–200 ml of Lacus buffer. No homogenisation is required for protoplasts cultured overnight. 2. Centrifuge at 15,400 rcf for 40  min at 4°C in a cooled Eppendorf microcentrifuge. 3. Transfer the supernatant into fresh tubes. 4. Total protein concentration can be determined by the Bradford protein assay kit: 800 ml of H2O + 200 ml of assay reagent + 2–4 ml of total protein extract. Vortex and incubate at room temperature for 5 min. Measure the A595 and the protein concentration is determined against a calibration curve.

3.3.2. Protein Immunoprecipitation from Total Protein Extracts

1. Add 30  ml of Protein A or G Sepharose and the appropriate antibody to 100–150 mg protein extract (adjust to equal final volumes by Lacus buffer). For immunoprecipitation of HA- or myc-tagged MPKs and MKKs, typically 0.8 mg of anti-HA or anti-c-myc monoclonal antibodies are used, or comparable amount of specific MAPK antibodies. Specific antibodies against Arabidopsis MAP kinases (a-AtMPK3, a-AtMPK4, and a-AtMPK6) are commercially available. Incubate at 4°C for at least 3 h or overnight with constant rolling. 2. Centrifuge at 290 rcf for 1 min at 4°C. 3. Wash the beads 3× with 1 ml SUC1 buffer. Centrifuge at 290 rcf for 1  min at 4°C and aspirate off the supernatant with a vacuum pump, care should be taken not to remove the beads.

5  Mitogen-Activated Protein Kinase Activity and Reporter Gene Assays in Plants

87

4. Wash the beads with 1 ml kinase buffer. Centrifuge at 290 rcf for 1  min at 4°C and aspirate off the supernatant with the vacuum pump. Remove the residual buffer with a thin needle, e.g. 27 Gauge, connected to an insulin syringe. 3.3.3. Protein Kinase Activity Assay of Immunoprecipitated MAPKs (Immunocomplex Kinase Assay)

1. Prepare the kinase buffer master mix and add per sample: 14 ml of kinase buffer, 0.01 ml of 1 M DTT, 0.1 ml of 10 mM ATP, and 1  ml of 10  mg/ml MBP (see Note 7). Finally, add the radioisotope to the master mix: 0.2 ml of [g-32P]-ATP (2 mCi). 2. Add 15 ml of master mix to the immunoprecipitate prepared as described in Subheading  3.3.2, mix, and incubate at room temperature for 30 min. 3. Terminate the reaction by adding 4  ml of 5 × SDS loading ­buffer, mix, and heat at 95°C for 3 min. Collect contents by a brief spin. 4. Load 8 ml of the kinase reaction onto a 15% SDS-polyacrylamide gel. The rest of the reaction can be kept at −20°C for maximum of 2 weeks. Run at 15 mA per gel. Phosphorylated MBP migrates as a 20-kDa protein in a 15% SDS-polyacrylamide gel (see Note 8). 5. Stain gels with Coomassie brilliant blue G 250 (CBB-G) and destain with at least five changes of destaining solution 30 min each, the last destaining should last overnight. 6. Place gels on Whatman 3MM paper for drying on a vacuum gel-dryer. 7. For quantification use a phosphorimager or expose dry gels to autoradiography film and scan these (see Note 9).

3.3.4. Phosphotransferase Activity Assay of MAPKs in SDS-PAGE (In-Gel Kinase Assay)

It has been shown that certain monomeric protein kinases can be renatured after SDS-PAGE, and retain their protein kinase activities. Based on this, the in-gel kinase assay has been developed, where the activity of the protein kinase is measured after separation in SDS-PAGE (15). The advantage of using in-gel kinase assay to immunocomplex kinase assay is that this approach does not require specific antibodies and multiple MAPK activities can be monitored in parallel for each sample. The identity of the protein kinase must not necessarily be known, only its (theoretically calculated) mobility in the SDS gel. By using knockout mutants for the most commonly observed MAPKs that have prominent activities in plant extracts, such as MPK3, MPK4, and MPK6, the identity can be determined by comparison. This method requires large amount of radiolabelled nucleotides and the described protocol is based on (15). 1. Prepare a 12.5% SDS-PAGE gel (8 × 12 × 1  mm) containing 0.5  mg/ml of MBP in the resolving gel. The stacking gel is prepared without the substrate. Load 25 mg protein and run at

88

R. Dóczi et al.

110 V, 12 mA for about 3–4 h, run until the dye front and also the 25 kDa marker band runs out of the gel. 2. After electrophoresis, wash the gel with 100 ml 20% 2-propanol in 50 mM Tris–HCl (pH 8.0) for 1 h at room temperature with continuous agitation and change the wash buffer at least twice to remove most of the SDS. Incubate the gel for 1 h in 150 ml buffer A with continuous agitation. 3. Incubate the gel in 50 ml denaturation buffer for 30 min at room temperature with continuous agitation. Repeat this step once. 4. Renaturation is normally performed overnight by incubating the gel without agitation in buffer A containing 0.04% Tween 40 for 12–18  h at 4°C with at least five buffer changes of 200 ml each (e.g. 3 × 1 h, 1 × 10 h, and 3 × 1 h). 5. Prior to the kinase assay pre-incubate the gel in 10 ml kinase assay buffer at room temperature with continuous agitation for 30 min. 6. For the kinase assay, incubate the gel for 1 h at room temperature in kinase assay buffer containing 30 mM ATP and 50 mCi [g-32P]-ATP (3,000 Ci/mmol) (see Note 10). 7. Wash the gel at least five times for 15  min with 10% (w/v) trichloroacetic acid and 1% sodium pyrophosphate. The washes should be performed repeatedly for about 1.5 h to reduce the background. 8. Place the gel on Whatman 3MM paper for drying on a vacuum gel-dryer. 9. For quantification, use a phosphorimager or expose the dry gel to autoradiography film and scan. MAPK activity is indicated by the phosphorylation of MBP adjacent to the MAPKs of molecular weight of 42–44 kDa. 3.4. Detection of MAPK Activity by Using Reporter Gene Constructs

In many cases, MAPKs regulate gene expression by modifying transcription factors. Thus, a MAPK activity can also be monitored by detecting target promoter activities using reporter genes (e.g. (8)). Here, we describe the use of promoter:GUS fusions, which can be co-transformed into protoplasts with combinations of overexpression or RNAi constructs to MAP kinases, MAPK kinases, or any other putative upstream signalling components and may also be subjected to different treatments. This assay is used to quantify the activity of the ß-glucuronidase (GUS) enzyme that cleaves 4-methyl-umbelliferyl-ß-glucuron (MUG) substrate into 4-methyl-umbelliferyl (MU) that can be quantified fluorimetrically. Protoplast transformation, cultivation, collection, and storage are carried out as described in Subheadings 3.1–3.2.

5  Mitogen-Activated Protein Kinase Activity and Reporter Gene Assays in Plants

89

Fig. 1. Schematic representation of practical sample arrangement in a microtitre plate for MUG assay. Rows and columns are indicated by letters and numbers respectively. Loading wells at the edges of the plate should be avoided (indicated by asterisks). Serial dilutions of MU for calibration curve are placed in one row (row B), MU concentration values are given in mM. The remaining wells are used for sample measurements, according to reaction time points.

3.4.1. Protein Extraction for MUG Assay

1. Thaw the frozen protoplasts on ice and add 300  ml of GUS extraction buffer (EB). Vortex for resuspension and cell break-up. 2. Centrifuge for 10 min at 15,400 rcf at 4°C. 3. Remove supernatant and transfer into new tubes. Use 200 ml for the GUS assay and 100 ml to measure protein concentration (Bradford reaction).

3.4.2. MUG Assay Using a Microtitre Plate-Reader Fluorimeter

1. Add 225 ml of stop reagent per well and cover. Best is to load the standard curve in one row, i.e. B2-B9 and the time points for each reaction consecutively. This will give immediate impression of linearity for each reaction. Avoid loading at the edges of the plate, indicated by the asterisk in Fig.  1 (see Note 11). 2. Prepare serial dilutions of MU for calibration curve: standards of MU serially diluted in EB are freshly used to produce a calibration curve. Prepare serial dilutions starting from a 10 mM MU stock. 3. Prepare serial dilutions for 100, 40, 20, 10, 5, 2.5, 1.25, and 0.625 mM in EB. Add 25 ml of the standards into 225 ml stop reagent per well. Use a blank with 25 ml EB added into 225 ml of stop reagent. 4. Add 200 ml of 1 mM MUG into 200 ml protein extract in a microcentrifuge tube. Mix and immediately transfer 25 ml of

90

R. Dóczi et al.

the reaction mixture into one well with stop reagent. This is time point t0. 5. Incubate the reaction mixture at 37°C and collect time points for 5, 10, and 20 min by repeating the process as for t0 min: incubate at 37°C, remove 25 ml, and add it into one well for t5, t10, t20, etc. Do not touch the stop reagent with the pipette tip. When the GUS activities are low, use more crude extract and measure at 1 and 2 h. Measure MU contents according to the guidelines of the particular fluorimeter available in your laboratory. GUS activity is expressed as pmol MU·mg−1·protein·min−1, subtract the value obtained with untransformed protoplasts.

4. Notes 1. PEG is very viscous, stir and let it fully dissolve for 1–2 h. Set pH to 9.0 with 0.1 M KOH drop by drop, check the pH 3–4 times at 1-h intervals. Leave stirring overnight, re-adjust the pH, and store as 15 mL aliquots at −20°C. Do not re-freeze after use. 2. A commercially available protease inhibitor cocktail is also suitable for Lacus and SUC1 buffer preparation. We have used Complete EDTA-free protease inhibitor tablets (Roche). 3. For all centrifuging steps of protoplasts, reduce brake intensity: e.g. brake level 5–6 in an Eppendorf 5810 R centrifuge, or omit braking. 4. Carry out at least two independent transformations per experimental sample to increase protein yield and reduce variations. Optimal plasmid size is 4–6 kb (e.g. pRT100 derivatives); large binary vectors have lower transformation efficiency, in that case use higher amounts of plasmids. Set the volume to 15  ml in microcentrifuge tubes. Up to 10 mg carrier DNA (e.g. salmon sperm DNA from a 10 mg/ml stock) may be used to increase transformation efficiency, but it can lead to arrest of cell ­division in long-term cultures, probably by activating a DNA damage checkpoint signalling. 5. For all pipetting steps involving protoplasts or the viscous PEG solution, use wide-mouthed pipette tips that were opened by cutting off the tip. 6. Always check transformation efficiency by transfecting a control sample with a Pro35S:GFP construct (Pro35S: strong almost ubiquitously active promoter derived from cauliflower mosaic virus). 20–50% transformation efficiency is required for further experiments.

5  Mitogen-Activated Protein Kinase Activity and Reporter Gene Assays in Plants

91

7. MBP is an artificial phosphorylation substrate, which is a ­suitable tool to assay MAPK activity status. On the contrary, the above method can also be used to test whether specific proteins are substrates of specific MAPKs. To this end, use 1 mg purified recombinant proteins instead of MBP. Several protein expression systems are available for optimal expression of your protein of interest. MAPKs may be activated either by treating protoplasts by activating stimuli, or by coexpression of MAP kinase kinases. Constitutively active mutant MKK variants are generated by replacing the serine/ threonine residues of their phosphorylation sites by aspartate or glutamate. Recently, intrinsically active yeast and animal MPK mutant forms have also been reported (yeast MPK1-R68S, mammalian ERK1-R84S, ERK2-R65S) (16). Although the activity of such plant MPK variants has not yet been demonstrated, the corresponding motif is also conserved in Arabidopsis MPKs (Arg106 in AtMPK6). Similarly, immunoprecipitated MAP kinase kinases can be assayed for their ability to phosphorylate recombinant MAP kinases. In order to prevent MAPK ­autophosphorylation, kinase inactive MPK versions have to be generated by exchanging the conserved lysine residues in the MPK ATP-binding domains to methionine and arginine (e.g. K66M and K67R for MPK3; K72M and K73R for MPK4; and K92M and K93R for MPK6). 8. The migration contains the majority of unincorporated radioactive nucleotides, which contaminates the running buffer. Care should be taken to collect and appropriately discard the running buffer as radioactive liquid waste. Stain/destain gels with Coomassie brilliant blue G 250 (CBB-G) for determination of equal loading of MBP and immunoglobulins. 9. A portion of the same protein samples is subjected to immunoblotting with MAPK-specific or epitope-specific (if epitope tag fusion constructs are used) antibodies to test MAPK protein levels in the samples. Equal protein loading is tested by Ponceau S staining of the membranes prior to antibody reaction. 10. Make sure the entire gel is covered with the reaction mixture, which usually requires 15–20  ml for a 14-cm gel. Prepare a small container from Parafilm within a box to reduce the ­volume, and facilitate the safe disposal of radioactivity. This volume can be further reduced if the reaction is carried out in a plastic bag (10 ml). 11. The reaction may also be carried out in tubes, using a ­traditional fluorimeter without plate-reading function.

92

R. Dóczi et al.

References 1. Colcombet, J., and Hirt, H. (2008) Arabidopsis MAPKs: a complex signalling network involved in multiple biological processes. Biochem J 413, 217–26. 2. Chang, L., and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37–40. 3. Jonak, C., Okresz, L., Bogre, L., and Hirt, H. (2002) Complexity, cross talk and integration of plant MAP kinase signalling. Curr Opin Plant Biol 5, 415–24. 4. MAP Kinase Group (2002) Mitogen-activated protein kinase ­cascades in plants: a new nomenclature. Trends Plant Sci 7, 301–8. 5. Nakagami, H., Pitzschke, A., and Hirt, H. (2005) Emerging MAP kinase pathways in plant stress signalling. Trends Plant Sci 10, 339–46. 6. Teige, M., Scheikl, E., Eulgem, T., Doczi, R., Ichimura, K., Shinozaki, K., Dangl, J. L., and Hirt, H. (2004) The MKK2 pathway mediates cold and salt stress signaling in Arabidopsis. Mol Cell 15, 141–52. 7. Meszaros, T., Helfer, A., Hatzimasoura, E., Magyar, Z., Serazetdinova, L., Rios, G., Bardoczy, V., Teige, M., Koncz, C., Peck, S., and Bogre, L. (2006) The Arabidopsis MAP kinase kinase MKK1 participates in defence responses to the bacterial elicitor flagellin. Plant J 48, 485–98. 8. Doczi, R., Brader, G., Pettko-Szandtner, A., Rajh, I., Djamei, A., Pitzschke, A., Teige, M., and Hirt, H. (2007) The Arabidopsis mitogenactivated protein kinase kinase MKK3 is upstream of group C mitogen-activated ­protein

kinases and participates in pathogen signaling. Plant Cell 19, 3266–79. 9. Peck, S. C. (2006) Analysis of protein phosphorylation: methods and strategies for studying kinases and substrates. Plant J 45, 512–22. 10. Yoo, S. D., Cho, Y. H., and Sheen, J. (2007) Arabidopsis mesophyll protoplasts: a versatile cell system for transient gene expression analysis. Nat Protoc 2, 1565–72. 11. De Sutter, V., Vanderhaeghen, R., Tilleman, S., Lammertyn, F., Vanhoutte, I., Karimi, M., Inze, D., Goossens, A., and Hilson, P. (2005) Exploration of jasmonate signalling via automated and standardized transient expression assays in tobacco cells. Plant J 44, 1065–76. 12. Sheen, J. (2001) Signal transduction in maize and Arabidopsis mesophyll protoplasts. Plant Physiol 127, 1466–75. 13. Mathur, J., and Koncz, C. (1998) Establishment and maintenance of cell suspension cultures. Methods Mol Biol 82, 27–30. 14. Mathur, J., and Koncz, C. (1998) PEGmediated protoplast transformation with naked DNA. Methods Mol Biol 82, 267–76. 15. Shibuya, E. K., Boulton, T. G., Cobb, M. H., and Ruderman, J. V. (1992) Activation of p42 MAP kinase and the release of oocytes from cell cycle arrest. Embo J 11, 3963–75. 16. Levin-Salomon, V., Kogan, K., Ahn, N. G., Livnah, O., and Engelberg, D. (2008) Isolation of intrinsically active (MEK-independent) variants of the ERK family of mitogen-activated protein (MAP) kinases. J Biol Chem 283, 34500–10.

Chapter 6 Use of Phospho-Site Substitutions to Analyze the Biological Relevance of Phosphorylation Events in Regulatory Networks Nico Dissmeyer and Arp Schnittger Abstract Biological information is often transmitted by phosphorylation cascades. However, the biological relevance of specific phosphorylation events is often difficult to determine. An invaluable tool to study the effect of kinases and/or phosphatases is the use of phospho- and dephospho-mimetic substitutions in the respective target proteins. Here, we present a generally applicable procedure of how to design, set-up, and carry out phosphorylation modulation experiments and subsequent monitoring of protein activities, taking ­cyclin-dependent kinases (CDKs) as a case study. CDKs are key regulators of cell cycle progression in all eukaryotic cells. Consequently, CDKs are controlled at many levels and phosphorylation of CDKs ­themselves is used to regulate their kinase activity. We describe in detail complementation experiments of a mutant in CDKA;1, the major cell cycle kinase in Arabidopsis, with phosphorylation-site variants of CDKA;1. CDKA;1 versions were generated either by mimicking a phosphorylated amino acid by replacing the respective residue with a negatively charged amino acid, e.g., aspartate or glutamate, or by mutating it to a non-phoshorylatable amino acid, such as alanine, valine, or phenylalanine. The genetic complementation studies were accompanied by the isolation of these kinase variants from plant extract and subsequent kinase assays to determine changes in their activity levels. This work allowed us to judge the importance of ­posttranslational regulation of CDKA;1 in plants and has shown that the molecular mechanistics of CDK function are apparently conserved across the kingdoms. However, the regulatory wiring of CDKs is ­strikingly different between plants, animals, and yeast. Key words: Cyclin-dependent kinase, CDKA;1, Cdk1, Suc1, Cks, Plant cell cycle, Kinase assay, Phosphorylation, Phospho-mimicry, Phospho-mimetic, Phospho-site, Substitution

1. Introduction Modulation of protein activities through phosphorylation and de-phosphorylation is a recurrent theme in most if not all regulatory cascades. Typically, this modulation is repeated such as protein

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_6, © Springer Science+Business Media, LLC 2011

93

94

N. Dissmeyer and A. Schnittger

A phosphorylates protein B, which becomes activated by this and subsequently phosphorylates protein C (a well-studied example are MAP kinase cascades, see also Chapters 2, 4, 7, 8, 9, and 14). The consecutive change in protein activities serves many purposes. Among others, it allows information to be transmitted from one compartment, e.g., from the cell membrane to the nucleus. In addition, the initial information becomes amplified since one upstream kinase might activate several downstream kinases. Moreover, especially long cascades allow the integration of several information pathways and different inputs can be compared with each other, resulting in a fine-tuned response. These cascades in turn might be coupled to threshold levels of protein activities, resulting in very sensitive biological switches. A paradigm for such a wiring of phosphorylation cascades is cell cycle regulation in which extrinsic (environmental) cues such as temperature or light are integrated with intrinsic (developmental) information such as tissue or organ cues. 1.1. Regulation of CDK Activity During Cell Cycle Progression by Phosphorylation

The prototypical mitotic cell cycle in plants and in other eukaryotes is composed of four phases: DNA synthesis or S phase when replication events take place, M phase or mitosis when chromosomes are separated and cells subsequently divide, and gap phases G1 (after M) and G2 (after S), in which most of the cell-physiological processes take place. The progression through the mitotic cell cycle is regulated by the protein kinase activity of a heterodimeric complex formed by a substrate-specific cyclin protein and a catalytically active cyclin-dependent kinase (Cdk) subunit. The small 34-kDa serine/threonine protein kinase in yeast designated p34, Cdc2+ (Schizosaccharomyces pombe), and CDC28p (Saccharomyces cerevisiae), or the homologous cyclin-dependent kinase 1 (Cdk1) in humans is a key regulator of the eukaryotic cell cycle, and controls entry into S- and M-phase (for a general review, see (1)). Similarly, the Arabidopsis homolog of Cdk1, designated CDKA;1, was found to be involved in the regulation of both cell cycle checkpoints (2, 3). Studies in yeast and human cell cultures have demonstrated that monomeric CDKs have no detectable activity and need to bind their cyclin cofactors (1). Different cyclins can form ­complexes with CDKs that are implicated at specific cell cycle phases such as, for instance, B-type cyclins for mitosis. CDK activity is also negatively regulated by cofactors, called CDK inhibitors (CKIs) that are – like cyclins – themselves under strict transcriptional and proteolytic control. Similar to cyclin families, there exist especially in plants large families of CKIs (4). Besides the binding of positive or negative cofactors, CDKcyclin activity has been found to be strongly modulated by phosphorylation at two different sites in the protein, the so-called T- and P-loop (1). Phosphorylation in the T-loop at a highly

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

95

c­ onserved threonine residue around position 160 (depending on the homolog, for instance in Arabidopsis position 161) is required for kinase activity and was recently shown to be essential in Arabidopsis, too (5, 6). T-loop phosphorylation is catalyzed by CDK-activating kinases (CAKs) (7). In Arabidopsis, at least four putative CAKs can be found, called CDKD1-D3 and CDKF, that can all phosphorylate CDKA;1 in  vitro (8). However, which kinase(s) are functioning as CAKs in vivo is not clear yet. In contrast to T-loop phosphorylation, phosphorylation of the conserved residues Thr14 and/or Tyr15 (or the homologous ­position) in the P-loop inhibits CDK activity in animals and yeast. Phosphorylation of the P-loop is executed by WEE1-, MYT1-, or MIK1-like tyrosine or dual-specificity kinases in animals and yeast. Phosphorylation of the P-loop is reverted by CDC25-like phosphatases and the wiring of positive (CDC25) with negative (WEE1, MYT1, and MIK1) regulators gives rise to oscillating levels of CDK activity that drive cell cycle progression (9). In addition, negative phosphorylation is crucial for cell cycle arrest upon DNA damage to allow sufficient time for repair. Whether Arabidopsis CDKA;1 is also subject to P-loop ­phosphorylation control was not clear since the identified CDC25 candidate gene from Arabidopsis does not contain the hallmark of CDC25 phosphatases, i.e., a very large N-terminal regulatory region (10, 11). Moreover, the CDC25 candidate was found to have arsenate reductase activity, questioning further an involvement in cell cycle regulation (10, 12, 13). A straight-forward approach was, therefore, to test the importance of phospho- and dephosphorylation events in the P-loop of CDKA;1 by phosphomimetic mutants. 1.2. Application of Phospho-Site Mutations

As phospho-site mutations, the charged residues aspartate and ­glutamate are used to mimic phosphorylation, whereas a ­constitutive dephosphorylation is mimicked by Ala, Val, or Phe substitutions. To pay attention to overall sterical considerations and to reduce the effect of unspecific effects, one might consider replacing Ser with Ala and Asp, Thr with the slightly larger Val and Glu, and the much larger phospho-acceptor Tyr with Phe. However, there are also cases where substitution of any hydroxy group-containing amino acid with any charged amino acid or any small non-phosphorylatable amino acid was conclusive. Examples of the use of phosphorylation-site mutants in the cell cycle field are listed in Table 1. Examples of phospho-site substitutions in Arabidopsis outside the cell cycle field are experiments on nitrate reductase, transcription factors, oxidases, receptors, and kinases. A selection is listed in Table 2.

96

N. Dissmeyer and A. Schnittger

Table 1 Effects of phospho-site mutations in CDK homologs Homolog

Mutationa

Substitutions of the P-loop SpCDC2 T14F15 GgCDC2 A14 GgCDC2 F15 GgCDC2 A14F15 GgCDC2 GgCDC2 GgCDC2 GgCDC2

GgCDC2

T14E15 or E14Y15 D14F15 or A14D15 A14Y15 or T14F15 A14F15

A14T15 or T15

Substitutions of the T-loop HsCDC2 V161 HsCDC2

E161

GgCDC2

A161 or D161

GgCDC2

E161

SpCDC2

A167

AtCDKA;1

D161

AtCDKA;1

V161

Effect

References

Advances cells prematurely into mitosis No significant changes No significant changes Much higher in vitro kinase activity than in wild-type; premature entry into mitosis in transfected HeLa cells Dominant negative cell cycle arrest when overexpressed

[14] [15] [15] [15] [16]

Dominant negative

[16]

Rescue of temperature-sensitive cdc mutant

[16]

Rescue of temperature-sensitive cdc mutant; advanced and premature mitosis; loss of coordination between cell cycle events; cells fail to respond normally to checkpoint controls at S-phase and mitosis; increased levels of histone H1 kinase activity Dominant negative cell cycle arrest; possibly production of nonfunctional kinase

[16]

Inhibits association with A- and B-type cyclins; causes a lethal phenotype in the S. pombe Potentially mimicking phosphorylation, causes loss of coordination of mitosis and multiple cytokinesis Nonfunctional; dominant cell cycle arrest Nonfunctional; gave rise to slowly growing cells showing abnormalities in septation and cell separation; might retain partially active No in vitro kinase activity

[16]

[17] [17] [16] [16] [18]

Generation of a weak allele that can partially rescue [5, 6] cdka;1 mutant plant. The same construct is dominantly negative in S. Pombe Nonfunctional; construct behaves dominantly negative [5, 6] in S. pombe

Triple mutants of both the P- and T-loop GgCDC2 A14F15D161 Dominant cell cycle arrest

[16]

The wild-type residues of the phosphor-acceptor sites are Thr14; Tyr15; Thr161 (Hs and Gg)/Thr167 (Sp). Sp Schizosaccharomyces pombe (fission yeast), Gg Gallus gallus (chicken), Hs Homo sapiens (human), At Arabidopsis thaliana a 

T872A

BRASSINOSTEROID INSENSITIVE 1 (BRI1; JM and CT domains) S286D S838D T842D T846D S858D

S11A/D S15A/D S19A/E

BASIC LEUCINE ZIPPER 63 (BZIP63)

D85E/N

D80E

S534D/A

ARABIDOPSIS NITRATE REDUCTASE 2 (NR2) ARABIDOPSIS RESPONSE REGULATOR 2 (ARR2) ARABIDOPSIS RESPONSE REGULATOR 7 (ARR7)

ARABIDOPSIS K TRANSPORTER 2 (AKT2)

S26A T31A S86A S94A T135A S210A/E/N S329A/E/N

Substitution

ABSCISIC ACID RESPONSIVE ELEMENTS BINDING FACTOR/ PROTERN 2 (AREB1)

In plantsa

Gene

Increases its kinase activity by over tenfold, due to an increased Vmax and reduced Km Abolishes BAK1 activity in vitro and in vivo, although S286A has little effect Enhances the phosphorylation of a BRI1 synthetic peptide substrate in the absence of BRI1-associated kinase 1 (BAK1)

Creates a dominant-active form of ARR2 that causes plants to become partially independent of the exogenously applied phytohormones ethylene Mutant ARR7 alleles mimicking the active, phosphorylated form, cause the formation of aberrant shoot apical meristems. Ubiquitous overexpression of the dominant-negative form D85N did not cause any morphological defects Phosphomimetic substitutions of some of these serines strongly interfere with the DNA binding of the prototypical transcription factor bZIP63. Decreases binding to the corresponding promoter elements. Double and triple mutants tested

These substitutions in the K+-channel interfere both with function and gating modes of channel. S-to-N substitution mimics a phosphorylated serine in a mutant of AKT2 Block both 14-3-3-inhibitory interactions

Results in an autophosphorylated, transcriptionally active form of the bZIPtype transcription factor

Effect

Table 2 Examples for phospho-site substitutions in the plant field

(continued)

[26] [26]

[25]

[24]

[23]

[22]

[21]

[20]

[19]

References 6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance… 97

TRANSLOCON AT THE OUTER ENVELOPE MEMBRANE OF CHLOROPLASTS 33 (TOC33)

TOBACCO MOSAIC VIRUS RESISTANCE GENE N (N)

ROOT HAIR DEFECTIVE 2 (RHD2)

RESPIRATORY BURST OXIDASE HOMOLOG F (RBOHF)

3-PHOSPHOINOSITIDEDEPENDENT PROTEIN KINASE-1 (PDK1)

T223R/N S181A/D/E

S318A S322A Y12F

T176A T211A S288E S290E S174A

Results in an approximately 40% reduction of the phosphorylation of the NADPH oxidase by the ABA-activated SnRK2 protein kinase open stomata 1 (OST1) Causes more than 50% reduction in ROS production of the NADPH oxidase The tobacco protein “N” alters its hypersensitive response (HR)-inducing activity of the plant resistance® gene (Toll interleukin-1 receptor homology region (TIR)-nucleotide-binding site-LRR). Y12S alters the activity but to a lesser extent compared to the Y12F substitution Results in a dominant inhibitory function All transgenes were able to complement mutants for the GTPase transit peptide receptor of the chloroplast outer envelope membrane efficiently. S181A lacks phosphorylation

Partial loss of autophosphorylation and downstream phosphorylation activity Results in an increase in the basal autophosphorylation level

Modulation of suspected CKll site leads to stronger interaction with target promoters of this bZIP transcription factor Aspartate substitutions strongly interfere with the DNA binding of the prototypical bZIP HY5. Results in a considerable decrease in binding to the promoter elements

S36A S15A/D

Phosphorylation at this site is required for kinase activity

Y200F

BRASSINOSTEROID INSENSITIVE 2 (BIN2) ELONGATED HYPOCOTYL 5 (HY5)

Effect

Substitution

Gene

Table 2 (continued)

[34–36] [37–39]

[33]

[32]

[31]

[30]

[29]

[24]

[28]

[27]

References

98 N. Dissmeyer and A. Schnittger

S66A/D S68A/D S72A/D S212A T214A S218G S226G S227G S231G S247G S258A/D T261A/D S265A/D S267A

S258A

S149A

Substitution

Changes in single-strand nucleic acid-binding activity, correct protein folding, and cell wall anchoring of the tobacco mosaic virus (TMV) nucleic acid-binding protein

No phosphorylation of the Pseudomonas syringae pv tomato protein by Arabidopsis leaf protein extracts. Multiple Ser substitutions (S147, S149, and S153) generate a phosphorylation-null protein Loss of virulence and the diminution of avirulence activity. S258D has activities like wild type Delays symptom development and affects the infectivity of the Cauliflower mosaic virus (CaMV)

Effect

a 

if not stated otherwise, the plant species is Arabidopsis thaliana Arabidopsis thaliana

P30

coat protein precursor (pre-CP)

AvrPto

Plant pathogens

Gene

[43]

[42]

[41]

[40]

References 6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance… 99

100

N. Dissmeyer and A. Schnittger

1.3. Generation of Phospho-Site Mutations in CDKA;1 and Analysis

To test the importance of CDKA;1 phosphorylation, the following mutants were generated: Thr14, Tyr15 ® Asp14, Glu 15 (short DE) and Thr14, Tyr15 ® Val14, Phe15 (short VF). The so-modified cDNAs were cloned behind a promoter fragment of CDKA;1 that was known to fully complement cdka;1 mutants when driving the unmodified CDKA;1 cDNA. Heterozygous cdka;1 mutants were transformed with the individual constructs, and the T2 generation was screened for the appearance of homozygous cdka;1 mutants that harbored the phospho-mutant construct. A morphological analysis of these isolated plants revealed that DE could not fully rescue cdka;1 mutants and only small and sterile plants were recovered (5, 10). Subsequent kinase assays showed that DE plants indeed displayed very little kinase activity in comparison to wild-type plants. These results were consistent with an inhibitory function of P-loop phosphorylation on CDK activity. In contrast, the dephosphomutant VF could fully rescue cdka;1 mutants and in contrast to studies in animals and yeast, VF plants neither proceed faster through mitosis nor display hypersensitivity against genotoxic stress. Together with the observation that ­neither mutants in the CDC25 candidate gene in Arabidopsis displayed any alteration of the cell cycle nor plants overexpressing the CDC25 candidate showed any enhancement of cell proliferation, we conclude that phosphorylation of CDKA;1 does not play such a major role as CDK phosphorylation does in animals or yeast. Many studies in the animal and yeast fields investigating CDK activities have employed a cell lysate system to produce active ­complexes in  vitro mostly using bacterial, insect cell, or cell-free (rabbit reticulocyte or wheat germ lysate) expression systems. One advantage of using E. coli or cell-free expression systems besides simplicity is that far fewer contaminating protein kinases might be present than in eukaryotic cells. However, especially when it comes to multicompound protein kinase complexes that must be formed from individual binding partners and – like in the case of CDK/ cyclin complexes – even activated by further cofactors, one might desire to use in vivo expression systems as far as possible to reduce contamination or unwanted protein modifications by the host organism. Although the recent literature reports in vivo and in vitro binding partners of Arabidopsis CDKA;1 in detail (44–47), the actual requirements of these protein complexes to promote cell cycle ­progression, e.g., the G2-M transition, are still unclear. Thus, one possibility was to try to complement the cdka;1 mutant with the CDKA;1 variants and to pull down active complexes in their in vivo composition to further study them in kinase activity assays.

1.4. Purification via CKS-Affinity Binding

The core part of the protocol describes the purification and kinase assay of CDKA;1 variants complexed with their in vivo subunits. Different approaches can be followed in order to purify the desired CDK/cyclin complexes. For example, immunoprecipitation (IP)

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

101

is widely used to co-precipitate active complexes, but some domains of both the CDK and cyclin can be masked in active complexes and are, therefore, not accessible by the antibody. The powerful antiPSTAIRE antibodies raised against the conserved PSTAIRE motif in the cyclin-binding domain can only recognize the unbound and inactive CDK subunit. Thus, they are solely useful for immunoblotting but cannot be used for co-IPs of active kinase complexes since they would precipitate monomeric CDK (48). We use a p13Suc1-affinity matrix for CDK/cyclin purification (see also Chapter 4). Suc1 stands for “suppressor of cdc2” from S. pombe and is a member of the so-called CKS (CDK subunit) subfamily of CDK adaptor proteins, see Fig. 1. The matrix is comprised of Suc1 protein (MW 13 kDa) that is either covalently cross-linked to or noncovalently associated with the agarose bead material and represents the method of choice for obtaining semi-purified mitotic CDK activity in a quantitative scale (52–54) (see Note 1). Suc1 and its Cks1 homologs from S. cerevisiae, human, or Xenopus, and CKS1 in Arabidopsis have all been found to bind to CDK complexes. These can be specifically precipitated with these beads and it was shown that CKS directly binds to the CDK polypeptide chain (Fig. 1; (49)). Also, other proteins of the CKS family can be used as an affinity matrix. Besides S. pombe p13Suc1, these include p9Cks1 from Xenopus and humans as well as Arabidopsis p10CKS1 and bind a number of CDK/cyclin complexes in cell lysates – notably CDK/ cyclin B that is present at the G2/M transition – with high affinity. De Veylder et al. describe a method to precipitate different plantspecific CDKs selectively by using subsequent purification steps of

Fig. 1. Cks1 binds to the C-terminal part of Cdk2. A and B crystal structures of human Cdk2 bound to either the cell cycle regulatory protein Cks1 (a) or human Cyclin A (b) in a similar orientation. For better orientation, the subunits are separated by a dashed line and the N- and C-terminals of Cdk2 are indicated by letters (N, C). (a) Side view of the crystal structure of a human Cdk2-Cks1 kinase complex (PDB ID: 1BUH; [49]). Cks1 binds via four beta strands to the Cdk2 C-terminal lobe. The mode of binding suggests that Cks1 may target Cdk2 to other proteins during the cell cycle. (b) Structure of a complex of human Cdk2-Cyclin A (PDB ID: 1QMZ; [50]) to illustrate the site of Cks1-binding in a possible multimeric complex (close to the C-terminal (C) and below the Cdk2-Cyclin A complex in the figure). There is no crystallographic data available for a Cdk-Cyclin-Cks complex up to now. Visualized with PyMOL [51].

102

N. Dissmeyer and A. Schnittger

either p9 (human Cks1) or p10 (Arabidopsis CKS1) beads (55). Human p9Cks1 binds selectively to CDKA;1, whereas Arabidopsis p10CKS1 and S. pombe p13Suc1 bind to both A- and B1-type CDKs (5, 55, 56). The preparation of a CKS affinity medium is, besides the laborious protein expression and purification steps, quite straight forward (57) (see also Chapter 4 and Note 2). In order to obtain highest saturation of the beads with mitotic CDK/cyclin complex, yeast or human cell cultures can be arrested in mitosis with nocodazole for maximum activity. Since this is impossible in our case where in planta material is to be assayed, we depend on the use of proliferative material with a high mitotic index. The optimal material is the shoot apical meristem including flower buds with its rapidly dividing tissues. The methodology of affinity binding to directly agarose- or sepharose-coupled bait proteins can be transferred to other proteins by adapting the actual coupling (not described here) and assay protocols. However, most commonly, baits are either fused to entire helper proteins or parts such as glutathione S-transferase (GST), maltose-binding protein (MBP), avidin, calmodulin, thioredoxine, ubiquitin-binding domains, and lectins, or to small peptide tags such as Strep, tandem-affinity purification (TAP), hemagglutinin (HA), myc, FLAG, or His that indirectly lead to binding of the target protein to the bait bound to the matrix via these tags. In this chapter, we describe an integrated series of subsequent protocols to test the activity of different CDKA;1 phospho-site variants isolated from the cdka;1 mutant background. These kinases are purified using CKS beads and subjected to a phosphorylation reaction involving bovine histone H1 as an in  vitro substrate together with radioactively labeled g-ATP (see Note 3).

2. Materials Most of the experiments do not necessitate special infrastructure. However, the plant cultivation and transformation steps have to be prepared and completed in either greenhouses or – better – climate chambers in a highly controllable environment. For the key part of the kinase assay, the phosphorylation reaction, a distinct laboratory is required where radioisotopes can be used under authorized conditions. 2.1. General Equipment and Infrastructure

Climatized greenhouse or growth chambers. Fridge or cold room with tumbler. Cooling microcentrifuge or regular microcentrifuge in cold room.

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

103

Gloves (due to the use of carcinogenic acrylamide and radioisotopes). Safety goggles (due to the use of b-irradiating radioisotopes). Radiation safety equipment (for further details, see Subheading 2.6). 1.5-mL microcentrifuge tubes, prechilled to 4°C. Forceps, tweezers, and scissor (used for sample collection, radioisotope handling, or Western blotting). Dewar container with swimmer, liquid nitrogen. Clean, ethanol-rinsed plastic pistils (Roth or Eppendorf) or clean porcelain pestle and mortar (autoclave and bake, for example). Ice bucket and wet ice. Vortex mixer. Graduated cylinders and containers for reagent preparation and storage. Pipets accurately delivering 2.5, 20, 200, and 1,000 mL. Soil mixture for Arabidopsis cultivation, selection, and propagation: mix, e.g., 8 bags of MiniTray® (70  L/bag, Balster Einheitserdewerk) and add 50  L water containing 800  mL Osmocote® Start (Scotts International BV) and 250  g BioMükk® (Sautter & Stepper, see Note 4). 2.2. Generation of Transgenic Plant Material 2.2.1. Cloning of the Expression Constructs

cDNA from Arabidopsis thaliana (L.) Heynh., ecotype Columbia-0 (Col-0). Standard cloning equipment. Site-specific oligonucleotides (see Table 3). Proofreading polymerase such as Pfu (Fermentas). ExoSAP-IT® (usb/Affymetrix). Gateway® BP and LR kits (Invitrogen). Gateway®-compatible (Invitrogen).

Entry

vector

such

as

pDONR201

DH5a® or equivalent cloning hosts (Invitrogen). Binary Gateway®-compatible Destination vector such as pAMPAT-ProCDKA;1 containing the endogenous promoter of CDKA;1 (3). 2.2.2. Plant Transformation and Selection of Transformants

Agrobacterium tumefaciens strain GV3101-pMP90RK, which is compatible with pAM-PAT binary Destination vector (58, 59), store in 25 mL aliquots at −80°C. Luria–Bertani (LB) medium for E. coli.

104

N. Dissmeyer and A. Schnittger

Table 3 Examples for cloning and mutagenesis oligonucleotides used in CDKA;1 studies (5) Name

5¢-Sequence-3¢

attB1 fwd

GGGGACAAGTTTGTACAAAAAAGCAGGCTTCAACAATGGATCAGTA CGAGAAAG

attB2 rev

GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAAGGCATGCCTCCAAG

T161D fwd

GTCAGGACATTTGATCATGAGGTTGTTACT

T161D rev

AGTAACAACCTCATGATCAAATGTCCTGAC

T14D/Y15E fwd

ATTGGTGAAGGAGATGAGGGTGTGGTTTAT

T14D/Y15E rev

ATAAACCACACCCTCATCTCCTTCACCAAT

T14V/Y15F fwd 1 ATTGGTGAAGGAGTTTTCGGTGTGGTTTAT T14V/Y15F rev 1

ATAAACCACACCGAAAACTCCTTCACCAAT

T14V/Y15F fwd 2 TGAGAAGATTGGTGAAGGAGTCTTCGGTGTGGTTTATAAGGCACG T14V/Y15F rev 2

CGTGCCTTATAAACCACACCGAAGACTCCTTCACCAATCTTCTCA

YEB medium for Agrobacterium; for 1 L: each 5 g meat extract, tryptone/peptone, and sucrose; 1  g yeast extract; and 2  mL MgSO4 1 M; sterilize by autoclaving. Carbenicillin 50 mg/mL, this semi-synthetic analog was replaced by ampicillin in our laboratory due to its increased thermoand pH stability and resistance in the presence of ß-lactamase; store at −20°C. Kanamycin 25 mg/mL, store at −20°C. Rifampicin 50 mg/mL in DMSO, dissolves only if warmed up to 30–40°C; store at −20°C. Sucrose (saccharose/household sugar works great). Arabidopsis thaliana cdka;1 mutant seeds, line SALK_106809 (Nottingham Arabidopsis Stock Center, Nottingham, UK, cat. no. N606809). Silvet L–77® surfactant (“Vac-In-Stuff”; OSi Specialties Inc. or GE Silicones, see Note 5). Dismozon® pur (oxygen-active broad-spectrum disinfectant, Bode Chemie). BASTA® (alternative names: phosphinothricin (PPT), glufosinate ammonium, 2-amino-4-(hydroxy-methyl-phosphinyl)-butanoic acid; Bayer Group, see Note 6). Pressure sprayer to spread BASTA® solution (standard gardening quality, capacity of 10 L, e.g., from GLORIA or Birchmeier).

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance… 2.2.3. Genotyping

105

1.2 mL 96-well storage plates, polypropylene (“collection blocks”, alphanumeric grid-referenced, U-shaped bottom; Thermo Scientific/ABgene, cat. no. AB-0564). Do not use polystyrene blocks, they break or burst easily. Stainless steel beads (e.g., Brammer 3.5 mm, cat. no. KU.4 G28, or Mühlmeier 3.175 mm, cat. no. 75306). Bead dispenser, 96-well, fits one 3.00–3.5-mm bead per well adapted to the collection blocks, can be made from Plexiglas®/ Perspex® by drilling 96 holes. Collection microtube caps (polypropylene, 960 in strips of 8, perfectly matching onto the collection blocks, Qiagen, cat. no. 19566). Sealing mats, 96-well, round (silicon, Thermo Scientific/ABgene, cat. no. AB-0674). Bead mixer mill (Retsch MM 200 or Qiagen TissueLyser, cat. no. 69984). Adapter set plates 2 × 96 for use with Qiagen collection microtubes, racked, matches perfectly with ABgene storage plates (Qiagen, cat. no. 69984). 45° Long-nosed pliers (from crafting or hardware store). PCR plates, 96-well, cheapest quality. Long pipette tips for up to 10 mL (e.g., Starlab TipOne pipette tip, 0.1–10 mL, extended length, cat. no. S1110–3000). Multichannel pipette (Eppendorf or Thermo Labsystems). Home-made Taq polymerase. Allele-specific oligonucleotides (see Table 4). Laboratory detergent. Rubbing alcohol. Eau de Javel (household bleach, e.g., from FLOREAL Haagen). Extraction buffer for genomic plant DNA (“sucrose solution/ buffer” or “Magic buffer”). For 1 L: 50 mL 1 M Tris–Cl, pH 7.5 (for 50 mM), 60 mL 5 M NaCl (for 300 mM), and 100 g sucrose (for 300 mM), adjust to 1 L; sterilize by autoclaving. 10× PCR buffer (“Direct buffer” with gel-tracking dyes). For 1 L: 24.23 g Tris (for 200 mM), 37.275 g KCl (for 500 mM), and 4.07 g MgCl2 hexahydrate (for 20 mM) to pH 8.7 with ~5 mL HCl. Add 1.5 g/L xylene cyanol FF (a blue, strongly quenching band runs at about 5  kb; Sigma cat. no. 95600) and 1.5 g/L Orange G (a yellow, weakly quenching band runs at approximately 100 b and an additional blue band that is only visible under UV runs directly at the migration border; Sigma cat. no. O3756); sterilize by autoclaving.

106

N. Dissmeyer and A. Schnittger

Table 4 Allele-specific genotyping oligonucleotides Name

Target

5¢-Sequence-3¢

N034

CDKA;1 exon

CCAGATTCTCCGTGGAATTGCG

N048

CDKA;1 intron

CAGATCTCTTCCTGGTTATTCACA

N049

CDKA;1 intron

TGTACAAGCGAATAAAGACATTTGA

SALK-LB

Salk T-DNA, left border

GCGTGGACCGCTTGCTGCAACTCTCTCAGG

2.3. Phosphoprotein Extraction

Chemicals and reagents to be used in the following procedures should be of the best grade commercially available and all solutions prepared with sterile Milli-Q ultrapure water. All temperaturelabile compounds must be added immediately before use and the completed buffer has to be kept on ice. Individual buffers and solutions should be autoclaved beforehand whenever possible. Most prepared solutions of the fine chemicals (such as inhibitors) used in this protocol should be stored in small aliquots at −20°C, unless otherwise indicated. Under these conditions, they are usually stable for at least a couple of months. All assay buffers should be prepared fresh on the day of assay and stored on ice. Storage of the completed solutions containing sensitive reagents and fine chemicals overnight at 4°C can lead to a significant loss of measurable kinase activity in the assay (60). Add the protease inhibitors immediately before use to prevent their degradation and avoid freeze–thawing of aliquoted stocks. In some cases, a 1:100 dilution of commercially available protease inhibitor cocktail (Sigma or Roche) is advisable. The mixtures include inhibitors of serine and cysteine proteases, which are the most prevalent protease classes in plant extracts (see Note 7).

2.3.1. Stock Solutions

500 mM tris(hydroxymethyl)aminomethane (Tris–Cl) at both pH 7.8 and pH 7.6. 150 mM magnesium chloride (MgCl2). 2.5 M sodium chloride (NaCl). 50 mM ethylenediaminetetraacetic acid disodium salt (Na2-EDTA, pH 8.0, see Note 8). 50 and 150  mM ethylene glycol-bis(2-aminoethylether)N,N,N¢,N¢-tetraacetic acid disodium salt (Na2-EGTA), pH 8.0. 5 and 50 mM dithiothreitol (DTT).

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

107

10% Igepal CA-630 or Nonidet P-40 (Sigma, the latter is not longer commercially available). 10% Tween 20. 2.3.2. Inhibitors

Use of inhibitors, see also Note 9. 50 mM sodium fluoride (NaF, Fluka; toxic). 10  mM sodium orthovanadate (Na3VO4, Sigma; toxic, must be activated, see Note 10). 150  mM p-nitrophenylphosphate (p-NO2PhePO4Na2).

disodium

salt

500 mM b-glycerophosphate disodium salt. 100  mM phenylmethanesulfonyl fluoride (PMSF, Fluka, see Note 11). 100 mM benzamidine hydrochloride (Sigma). 1 mg/mL antipain dihyrochloride (Sigma). 1 mg/mL aprotinin from bovine lung (Fluka, store at −80°C). 1 mg/mL soybean trypsin inhibitor (STI, Fluka). Extraction buffer: 25 mM Tris–Cl, pH 7.6, 85 mM NaCl, 15 mM MgCl2, 2.5 mM NaF, 15 mM EGTA, 1 mM Na3VO4, 15 mM p-NO2PhePO4, 60  mM b-glycerophosphate, 5  mM DTT, 0.1% Tween 20, 0.1% Igepal, and a protease inhibitor cocktail composed of 1 mM PMSF or 10 mg/mL AEBSF, 10 mg/mL antipain, 10 mg/mL aprotinin, 10 mg/mL STI, and 0.1 mM benzamidine. Optional protease inhibitors, to achieve a broader range of protease inhibition (see Note 9): 1 mg/mL chymostatin (Sigma, in DMSO). 1 mg/mL leupeptin hemisulfate (Fluka, store at −80°C). 1 mg/mL pepstatin A (Fluka, store at −80°C). 1  mg/mL 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF, Sigma; store at −80°C). Some of these inhibitors can also be purchased in a mixture as follows: Protease inhibitor cocktail (Sigma cat. no. P8340, or Roche Applied Science cat. no. 1836153). 2.4. Protein Concentration Determination

Protein Assay Dye Reagent Concentrate (Bio-Rad). 1 mg/mL bovine serum albumin (BSA). Cuvettes with 1-cm path length matched to laboratory spectrophotometer. Spectrophotometer set to 595 nm.

108

N. Dissmeyer and A. Schnittger

2.5. p13Suc1-Sepharose Affinity Binding and Pull-Down

p13Suc1 agarose conjugate (GST-Suc1 fusion protein, non-covalently bound to agarose, do not freeze or vortex, store at 4°C; Upstate/Millipore, cat. no. 14–122). 1-mL syringes and 21-G needles, prechilled to 4°C. End-over-end rotator or rotating wheel. Bead or wash buffer: 2,000 mL/sample is required. Add 50 mM Tris–Cl, pH 7.6, 250 mM NaCl, 5 mM NaF, 5 mM EDTA, 5  mM EGTA, 1  mM Na3VO4, 10  mM b-glycerophosphate, 1  mM DTT, 0.1% Tween 20, 0.1% Igepal, 1  mM PMSF or 10 mg/mL AEBSF, 10 mg/mL antipain, 10 mg/mL aprotinin, 10 mg/mL STI, and 0.1 mM benzamidine. Store on ice. Pre-kinase buffer: 500  mL/sample is required. Add 50  mM Tris–Cl, pH 7.8, 15 mM MgCl2, 5 mM EGTA, 2 mM DTT, 1  mM PMSF or 10  mg/mL AEBSF, 10  mg/mL antipain, 10 mg/mL aprotinin, 10 mg/mL STI, and 0.1 mM benzamidine. Store on ice.

2.6. Phosphorylation Reaction

Heating block or thermo shaker that rises up to 95°C (see Note 12). Needle to eventually punch holes into tube lids. Screw-cap microcentrifuge tubes (optional). Histone H1 (10  mg/mL in water, store aliquots at −80°C, Millipore/Upstate, cat. no. 14–155). 10  mM adenosine-5¢-triphosphate, lithium salt (Li-ATP, store in small aliquots at −20°C, Roche Applied Science cat. no. 11140965001, see Note 13). 1 mM Li-ATP. [g-33P]-ATP (or [g-32P]-ATP both at 10 mCi/mL, >6,000 Ci/mmol (220 TBq/mmol, see Note 14), Hartmann Analytic or Amersham), both stabilized and conveniently delivered and stored at +4°C instead of −20°C, preferentially colored (in red) for convenient monitoring of the radionuclide during the pipetting steps. Kinase buffer: 31 mL/sample is required. Add per sample 11.75 mL water, 3.5 mL each of 500 mM Tris–Cl, pH 7.8 (for 50 mM), 150  mM MgCl2 (for 15  mM), 50  mM EGTA (for 5  mM), 10 mM DTT (for 1 mM), and complement with 1.75 mL histone H1 (stock 10 mg/mL). Store on ice. ATP mix: 5 mL/sample is required. Add per sample 4.1 mL water, 0.3 mL 1 mM Li-ATP (here 60 mM), and 0.6 mL = 6 mCi [g-33P]ATP (here 200 nM, calculated from a fresh stock of 10 mCi/mL; if 32P is preferred as tracer, use same volumes/amounts/activities of [g-32P]-ATP). The overall specific activity of both cold and

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

109

hot ATP in this mixture is 20 mCi/mmol with 0.3 nmol ATP or 6  mCi per 5  mL. Store on ice behind b-shielding in a Plexiglas®/Perspex® block in an ice bucket. 2.7. SDSPolyacrylamide Gel Electrophoresis

SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) equipment and power supply, we preferentially use large gel systems such as a PerfectBlue® Twin M (PeqLab). Magnetic stirrer. 30% Acrylamide mix (30% acrylamide/N,N¢-methylenebisacrylamide solution, ratio 37.5:1 in water, see Note 15). 1.5 M Tris–Cl, pH 8.8 (for separating gel). 1 M Tris–Cl, pH 6.8 (for stacking gel). 10% Ammonium persulfate (APS, immediately freeze upon ­preparation in single-use aliquots, store at −20°C). 10% Sodium dodecyl sulfate (SDS, sodium lauryl sulfate). N,N,N¢,N¢-tetramethylethylenediamine (TEMED, see Note 16). Isopropanol (see Note 17). Gel loading tips, extended length. Protein gel running buffer 10×; for 1 L: 30.2 g Tris–HCl, 144.2 g ­glycine, and 10 g SDS in water. Pre-stained molecular weight markers such as Precision Plus Protein Standard All Blue (Bio-Rad). 5× SDS sample buffer: 0.225  M Tris–Cl, pH 6.8, 50% glycerol, 5% SDS, 0.05% bromophenol blue, and 0.25 M DTT. Laemmli sample buffer 2×: 4% SDS, 20% glycerol, 200  mM DTT, 120  mM Tris–Cl, pH 6.8, and 0.02% bromophenol blue (61). Prepare gel volumes according to the sizes of your gel system, all percentages in (v/v), modified from ref. 62: For a 12% separating gel, add 33% water, 40% acrylamide mix (30%), 25% 1.5  M Tris–Cl, pH 8.8, 1% SDS (10%) and APS (10%), and 0.04% TEMED. For a 5% stacking gel, add 68% water, 17% acrylamide mix (30%), 12.5% 1.5 M Tris–Cl, pH 8.8, 1% SDS (10%) and APS (10%), and 0.1% TEMED.

2.8. Western Transfer of Radioactive Proteins

Tank blot apparatus (such as Tankblot SCIE-PLAS EB10). Magnetic stirrer. Power supply. Filter paper (Whatman®). Nitrocellulose membrane (Amersham).

110

N. Dissmeyer and A. Schnittger

Ice bucket and wet ice. Rabbit anti-Cdc2 antibody (polyclonal a-PSTAIRE; Santa Cruz cat. no. sc-53). Goat anti-rabbit HRP-conjugated antibody ImmunoPure peroxidase (Pierce, included in cat. no. 1858415). Saran wrap or plastic disposal bags. Enhanced chemiluminescent reagents for chemiluminescent imaging (ECL, SuperSignal West Femto, Pierce, cat. no. 1858415). BioMax Light film for chemiluminescent imaging (Kodak). Tris-buffered saline (TBS) 10×; for 1 L, solve 87.66 g NaCl and 12.11 g Tris–Cl in water; adjust to pH 7.5. TBST; for 1  L, add 100  mL 10× TBS (for 150  mM NaCl and 10  mM Tris, pH 8.0) and 10  mL 10% Tween 20 (for 0.1% v/v) to water. Towbin wet blot transfer buffer 10×; for 1 L, add 30.3 g Tris (for 25 mM), 144 g glycine (for 192 mM), and 100 mL 10% SDS (for 1%). For 1×, add 100 mL 10× buffer and 200 mL methanol to 1 L. Use ice cold. 2.9. Autoradiography

Autoradiography cassette. Autoradiography film (GE Healthcare Hyperfilm MP or Kodak Bio-Max MR). Film developing unit. PhosphorImager scanner with screen (MolecularDynamics or Amersham).

3. Methods The methods described below outline (1) the construction and transformation of expression plasmids harboring phospho-site variants of CDKA;1, (2) the extraction and purification of the CDK/ cyclin complex from proliferating plant material, and (3) the phosphorylation reaction. The following procedure is a modification of the methods of De Veylder et al. (55) and Bögre et al. (63) and has been used successfully in our laboratory (5, 10). Here, we also highlight several references presenting a wide variety of protocols for analyzing the cell cycle (64–66), giving more details for analyzing CDK activity (67, 68), and presenting excellent information on handling radioisotopes and safety precautions (69–71).

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

111

3.1. Overview

In our case of assaying for mutant variants of Arabidopsis CDKA;1, we prefer to run a procedure that includes a transfer of the radioactively labeled substrate protein onto nitrocellulose membrane via Western blotting before autoradiography (see Note 18). To obtain reliable results, the samples of choice must be prepared and lysed under the same conditions. It is always preferable to process the samples to be compared simultaneously and run with one assay master mix on one SDS-PAGE gel. Thus, all samples must be subjected to one and the same blotting and evaluation procedure. Otherwise, it will be difficult or even impossible to determine whether a change in radiolabel incorporation is due to the amino acid substitution or treatment, or if that came along with running on and blotting from a different gel, for example.

3.1.1. Time Considerations

If you are planning to run the experiment, especially the kinase assay, for the first time, it is highly recommended to start with a practice run and process no more than a small number of samples at a time. For example, wild-type Arabidopsis and one phosphomutant could be harvested and processed simultaneously in order to test the degree of reproducibility of the approach and, more importantly, to allow the experimenter to get used to the methodology. A typical time frame from start to finish for the whole protein procedure is approximately 5 days. It includes approximately 8–12 h for the main assay part, depending not only on the number of samples, but also on the skill level of the researcher and optional preparation that might speed up the entire procedure. Thus, it might be more convenient to harvest and deep-freeze the flowers 1 day before the actual kinase assay experiment and get an early start the next day. The main assay day should end right after stopping the kinase assay, by loading the samples onto the gel and running the gel overnight or best already by overnight Western blotting. The next days have little hands-on work and require antibody incubation and autoradiography steps.

3.2. Generation of Transgenic Plant Material

We applied classical PCR cloning strategies to obtain the mutant alleles of Arabidopsis CDKA;1. This protocol was based on subsequent two-step fusion PCR steps and is explained in the following (see Note 19).

3.2.1. Cloning of the Expression Constructs

In brief, primers containing the Gateway® attB1 and attB2 sites (Table 5) were used for flanking the 5¢- and 3¢-ends of each final fusion construct. The substitution was introduced according to the Arabidopsis codon usage (see Note 20) and a silent restriction site was incorporated to later on allow tracking of the mutated version in planta (see Note 21). First, the separate 5¢- and 3¢-parts of the overall construct containing the attB sites were amplified, and the PCR product cleaned from the remaining oligonucleotides by treating with ExoSAP-IT® (usb/Affymetrix) and fused in a second

112

N. Dissmeyer and A. Schnittger

Table 5 Gateway® attB-recombination recognition sites for BP cloning of PCR fragments Name

5¢-Sequence-3¢

attB1

ggggACAAGTTTGTACAAAAAAGCAGGCTtc

attB2

ggggACCACTTTGTACAAGAAAGCTGGGTc

SelA

TCGCGTTAACGCTAGCATGGATCTC

SelB

GTAACATCAGAGATTTTGAGACAC

gggg extra base pairs; tc and c spacer base pairs; SelA and SelB are standard sequencing primers annealing at either the 5¢- or 3¢-attB-sites, respectively

round of PCR. The obtained fragments were cloned into pDONR201 vector using Gateway® BP clonase enzyme mix (Invitrogen) and the obtained plasmids analyzed via restriction digest and sequencing. A list of cloning and sequencing primers can be found in Table  5. Thereafter, the insert of the resulting entry vector was recombined into the respective plant transformation destination vector (in this case, pAM-PAT-ProCDKA;1; (3)) using Gateway® LR clonase enzyme mix (Invitrogen), giving rise to the binary plant expression vector. For further details on the procedures, see ref. 72. The isolated expression vector was transformed into Agrobacterium tumefaciens GV3101-pMP90RK (59). Be aware of the high transformation efficiency of this strain and streak out the transformed clones thoroughly. We typically transform 25  mL of thawed Agrobacterium suspension with 0.2 mL vector (that can also just be “a little remainder” in a crystal tip), incubate it for 45 min at 28°C, plate 400 mL of YEB onto the selective plates, and inoculate this puddle with 1 or 2.5 mL of the actual transformation reaction. Before plant transformation, the presence of the constructs in the Agrobacterium strain was verified by plasmid isolation and subsequent restriction digestion. Since often the expression vectors can only be isolated in low concentrations or purity, a clearer result can be obtained by back-transforming the plasmid isolated from Agrobacterium in E. coli followed by plasmid isolation and a repetition of the digests. Unless stated otherwise, all manipulations were performed using standard molecular methods (73). 3.2.2. Plant Transformation and Selection of Transformants

Heterozygous cdka;1 mutant plants were transformed according to a modified “floral dip” method (74). In our hands, the best transformation results were obtained with healthy plants that are in full blossom, e.g., grown at 18°C until the first filled siliques appeared. Four days before plant transformation, 50 mL Agrobacterium preculture was inoculated in selective YEB medium (50 mg/mL each

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

113

of rifampicin/kanamycin/carbenicillin) by a single Agrobacterium colony and incubated for approximately 2 days at 28°C and 250 rpm in the shaking incubator until opaque. This pre-culture was used to inoculate the final 500 mL culture, which was then incubated again for approximately 2 days with shaking under the same conditions. Before transformation, 5% sucrose and 0.05% Silvett L-77 surfactant were added to the culture. Flowering parts of the plants were immersed in this solution as long as properly wetted, laid down in a plastic tray, and afterward covered with a lid to keep moist. The lid was removed on the following day and all contaminated waste was autoclaved or decontaminated according to good microbiological practice, for instance with Dismozon® pur (Bode Chemie). Typically, 4  weeks after transformation, the seeds are ripe and can be collected. The T1 generation was then sowed on large trays containing soil, stratified at 4°C in the dark for 4–5 days, and transferred to the greenhouse. To identify the transformants, plants were grown on soil for 10–15  days until the cotyledons have formed and then sprayed with a 0.001% BASTA® solution. The spraying was repeated twice in an interval of 2–4 days to select for the plants carrying the construct. 3.2.3. Genotyping

Allele-specific PCRs were carried out to determine the T-DNA insertion and for isolating hetero- and homozygous cdka;1 transgenics using the primers SALK-LB (left border T-DNA primer for the cdka;1 SALK line) and N034 or N049 (anneals within genomic wild-type CDKA;1). To identify homozygous knockout plants rescued by a ProCDKA;1:CDKA;1 construct, the primers N048 and N049 were used. The latter two are intron specific to avoid binding with the transgenes. Plant DNA material was prepared in a modified protocol according to ref. 75. Prepare bead dispenser with 96 stainless steel beads. Transfer beads into 96-well polypropylene collection block by turning the dispenser/collection block setup overhead. Label blocks with water-proof marker for permanent identification. Before starting to twitch leaves, check for the correct orientation (A to H and 1 to 12) of the collection blocks! Use a 96-formatted collection plan referring to the sample setup in the block itself. With fine forceps, collect one or more samples per individual plant and add to the bead in the tube. Try to restrict yourself to collect leaf material of an approximate maximum size of the larger upper diameter of a 1,000  mL pipet tip and use young, still dividing tissue only. Take a small leaf rather than parts of a bigger and older one. Complement samples to be genotyped with controls (e.g., Col-0 and/or water).

114

N. Dissmeyer and A. Schnittger

After collection, close blocks with 96-well sealing mat and – if samples cannot be processed the same day – deep-freeze and store at −80°C. Add 500 mL of extraction buffer for genomic plant DNA preparation (“sucrose solution/buffer” or “Magic buffer”) and seal the wells with polypropylene collection microtube caps. If less material was collected, downscale the buffer accordingly. Make sure that all the sample tubes are equally filled with sucrose buffer. Shake blocks in the mixer mill at a frequency of about 25 Hz for 2  min in one orientation of the collection block. Make sure that the leaf suspensions are greenish and that there is only little unsmashed plant material left in the tubes. If necessary, spin down, open strips and push unsmashed leaves back into the tube, close lids, and shake again for 1–2 min. Briefly spin down collection blocks at 1,500 RCF to avoid crosscontamination via sample splashing during the opening procedure of the caps. Grip blocks properly and carefully, rip off 8-well strips with pliers and discard. Samples in the closed collection blocks (use silicone sealing mats) can be stored at −20°C for many months. The crude suspension can be kept at 4°C for about 1 week without any remarkable loss in sample quality. Caution: Do not invert collection blocks closed with the silicon mats because they do not completely seal the tubes. For PCR, prepare a master mix with some volumes in excess (e.g., prepare for 25 mL but pipet just 23 mL into the PCR plates). For 25 mL PCR setup, we use 18.8 mL water, 2.5 mL 10× PCR buffer (“Direct buffer ” ), 0.45 mL 10 mM dNTP, 1 mL of each primer, and 0.5 mL Taq polymerase. Check for equal filling of PCR plate tubes with master mix; adjust if necessary. Use clear pipet tips and a multichannel pipet (8- or 12-channel) for transferring 1.5  mL of the cleared template suspension directly from the spinned plant sucrose buffer preparation. In case only small volumes such as 100 mL have been used for tissue lysis, only extended tips that reach the bottom of the U-shaped bottom can be used. Always check for equal filling of the tips. If unsure, repeat transfer with fresh tips. You can leave the filled sample tips in the PCR wells for the purpose of overview. In addition, after having transferred all DNA samples, this will help to pipet up and down once with a volume of 10 mL into the PCR plate. Discard tips. If necessary, briefly spin down PCR plates at 1,500 RCF.

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

115

Use a hot-start PCR setup with, for example, 35 cycles for genotyping such as the following: 95°C for 5:00 min 95°C for 0:30 min 58°C for 1:00 min × 35 72°C for 2:00 min 72°C for 10:00 min 15°C forever Underlined temperatures should be cycled about 35×. After the PCR, check for possible evaporated PCR product and repeat reaction for eligible sample(s). To clean the steel beads, do not acid-wash beads. Used beads can be cleaned by soaking them for a couple of hours or overnight in a solution of laboratory detergent in warm water. Rinse several times with warm tap water, then deionized water, and optionally with rubbing alcohol. Dry the beads in an open tray at 40–70°C or fill them in bottles for autoclaving (see Note 22). 3.3. Phosphoprotein Extraction

In cells, CDKs exist as phosphoproteins themselves and the maintenance of their phosphorylation state is crucial for their kinase activity. Thus, it is essential to attempt to preserve the phosphate groups linked to a particular threonine in the activation loop by inhibiting protein phosphatases, and appropriate inhibitors must be added to the extraction buffer immediately before use. For our experiments, we use flowering, approximately 4–6 weeks old transgenic Arabidopsis thaliana plants (see Note 23). Most experiments require that exactly the same growth conditions are used for all tests done. In addition, the material should be frozen only once since multiple cycles of freezing and unfreezing tissue lower the quality of the material and it starts to degrade. The plant protein extracts should be used immediately for the assays until proper storage conditions (e.g., −70°C and liquid nitrogen) have been determined. It may not be possible to store the extract to be used for activity measurements at all. Ideally, samples should be assayed in multiple replicates and it is recommended to always load those samples on one single gel which should be actually compared because only in this case, all samples will be treated identically. The lysed plant material should not be frozen and stored for another round of kinase assays; all CDKs of interest have to be analyzed in parallel on the same day. Storing the supernatant for further use as normal protein extract, for experiments other than those relying on the presence of phosphoproteins, is usually not a problem. All protein manipulation steps are carried out on either wet ice or at 4°C; this is to preserve the activity of the kinase as close as possible to its original state. Therefore, always use prechilled microcentrifuge tubes for extract and bead handling.

116

N. Dissmeyer and A. Schnittger

Harvest plant flower material (see Note 24) and either snap-freeze in liquid nitrogen and store at −80°C, or immediately grind with a plastic pistil first and then in ice-cold extraction buffer on ice. Larger amounts can be ground in a mortar that is deepfrozen with liquid nitrogen. Use 2  mL buffer per g fresh weight. 100 mg fresh weight will give about 2 mg overall protein; thus, if 100 mg tissue is taken up in 200 mL buffer, one will end up with about 10 mg/mL overall protein. Continue immediately with processing the suspension for the next steps and finally the in vitro kinase reaction (see Note 25). Pellet the debris by centrifugation. Spin down the crude extract in a precooled microcentrifuge at maximum speed for 10–20 min at 4°C. Transfer the supernatant containing the proteins to a fresh tube and re-spin for another 10 min. Transfer the supernatant to a new chilled microcentrifuge tube on ice. Be careful not to include any of the pellet. Discard the pellet and proceed with the supernatant. 3.4. Protein Concentration Determination

Use your favorite method to determine the overall protein content of the cleared supernatant and follow the manufacturer’s instructions (see Note 26). A decent BSA calibration curve is received when a protein standard such as BSA (stock is 1 mg/mL) is added in steps of 0, 2, 4, 6, 8, 10, 12, 16, 20, 24 mL + 2 mL extraction buffer to each tube. The concentrations usually represent the concentrations present in the supernatants to be tested. The linear range of the assay for BSA is 0.2–0.9 mg/mL. Prepare as many cuvettes as needed with protein assay components (800 mL water and 200 mL Bio-Rad Protein Assay solution). Add 2 mL of each sample to the sample cuvettes. Invert the cuvettes wearing gloves, make sure not to carry over any protein from one assay to the other by wiping the gloves with paper towels. Incubate at room temperature for at least 5 min. Absorbance will increase over time; samples should be incubated at room temperature for no more than 1 h. Measure the absorbance at 595 nm. Plot the standard and the sample values to extrapolate the protein concentrations. Adjust protein concentrations either to 1 mg/mL or to the lowest concentration within the sample series with extraction or bead buffer. Use the supernatants to purify the CDK/cyclin complex using p13Suc1-conjugated agarose beads (see Note 27).

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

3.5. p13 Suc1-Sepharose Affinity Binding and Pull-Down

117

Throughout this step, use prechilled microcentrifuge tubes and perform the actual pull-down incubation at 4°C either in a cold room or a fridge. Two problems occur when using commercially available affinity matrix. First, the bead material is expensive and second, it is very difficult to aliquot. The matrix sediments quickly and will cover the surface of all used pipet tips, soon coming along with a partial loss of material. We found that the best way is to take approximately 30 mL of the 50% (v/v) slurry per kinase reaction plus one backup volume extra that will be lost during the procedure. The amount contained in 30  mL pulls down enough complex material even from samples of poor concentration in larger volumes. Spin down the beads at 400 RCF for 2 min at 4°C and wash two times with 500 mL ice-cold bead buffer. Now, it is crucial to survey the applied volumes of actual bead material and those of added wash buffer. According to the protocol below, 15 mL of the actual solid agarose conjugate remaining per reaction that have to be taken up by 500 mL buffer overall. Thoroughly aspirate the washes from the beads with a syringe equipped with a 27-G needle. Always keep the pellet on ice (see Note 28). After the first two washes, the beads must be distributed evenly into the fresh and prechilled assay tubes. It might be appropriate to use either screw-cap microcentrifuge tube or safe-lock microcentrifuge tubes at this point because they will be used all the way until loading the SDS-PAGE gel. The use of these tubes can prevent further radioactive contamination; see Subheading 3.6. Thus, take the respective volume of a well-mixed but not vortexed (!) bead suspension to each tube:



(30µL bead slurry )×(no. of assays)×0.5 + 500µL bead buffer no. of assays = volume to be aliquoted into each tube Make sure to flip the tube before every pipetting procedure. The beads precipitate fast and it is of utmost importance to have the same amount of beads in each and every assay tube. Different bead loading gives rise to incomparable results after the actual kinase assay due to different amounts of bound CDK/cyclin complex. Per desired kinase reaction, equal amounts of total protein (we use roughly 150 mg total protein per assay) were added to the pellet of initially 30 mL of p13Suc1-agarose 50% (v/v) bead slurry in a prechilled 1.5-mL microcentrifuge tube on ice (see Note 29). Spin down the mixture at 400 RCF for 2 min at 4°C.

118

N. Dissmeyer and A. Schnittger

Wash the beads three times with 500 mL ice-cold bead buffer until the yellow-greenish color of the p-NO2PhePO4 and/or the chlorophyll has almost disappeared. Wash once with 500 mL pre-kinase buffer (see Note 30). After the final wash, thoroughly aspirate the buffer from the beads. Take care neither to aspirate the beads nor to dry out the pellet (see Note 28). Keep the pellets permanently on ice. 3.6. Phosphorylation Reaction

At this point, the pellet consists of the purified CDK/cyclin complex non-covalently bound to the p13Suc1 affinity matrix and is ready for the in vitro kinase reaction. The following steps involve radioisotopes and must be carried out behind a b-shield to protect the experimenter from the emitted radiation. 32P was formerly the label of choice but nowadays it gets often substituted by 33P, which has a lower emission energy and therefore displays a lower radiation hazard (69). Always wear safely goggles and the follow the safely rules for working with radioisotopes. Especially the hard b-irradiation of the 32P isotope is known to harm both the cornea and the eye lens strongly (see Note 31). In this part of the experiment, hot g-ATP, histone H1, and the desired concentration of unlabeled ATP are subsequently added to the beads. Within the reaction, about 1  mM ATP is required to enhance phosphorylation of co-precipitated substrates and up to 100 mM to favor linearity of the kinase reaction and histone H1 phosphorylation. The overall kinase reaction takes place in a volume of 36 mL (including g-ATP-labeling mix, see Note 32). If the SDS-PAGE should be run at the same day as the kinase assay, prepare the acrylamide mixes and cast the gels during the incubation time. Prepare the assay reaction by adding to each pellet 31 mL of the kinase buffer. Start the reactions by adding 5 mL of the ATP mix. From now on, the samples are radioactive and have to be treated with proper caution. Keep the tubes in a b-shielded container. Make sure that the reaction mix is properly mixed. If 32P is used, according to our experiences, the best way to achieve this is to use a pair of tweezers with a solid grip to take out the sample tubes from the Plexiglas®/Perspex® rack at the cylindrical part and mix the content by carefully flipping the reagent-containing bottom with a glass rod or a similar tool to avoid any unnecessary radiation exposure of the finger tips. However, it is important to manipulate the tube both safely and quickly when handling outside the shielding, so use tools that you are familiar with rather than risk a possible accident by losing control.

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

119

Incubating for 45 min at room temperature or 30°C (see Note 33). Flip the tubes once in a while, e.g., every 10–15 min. Vortex the samples briefly and then spin the tubes for 1 s to collect the mix at the bottom of the tube. Terminate the reactions by adding 7.5 mL 6× SDS sample buffer and boiling for 5 min at 95°C or heating for 10 min at 85°C in a heating block. Heat the samples either in screw-cap microcentrifuge tubes or in regular safe-lock microcentrifuge tubes under a radionuclide fume hood to reduce the risk of contamination by vaporizing radioisotope. Centrifuge at maximum speed for about 1 min. The samples are now ready for immediate loading onto the SDS-PAGE gel. Either keep the tubes on ice until ready to run the gel or alternatively, the samples can be frozen and stored overnight at −20°C. 3.7. SDSPolyacrylamide Gel Electrophoresis

The SDS-PAGE also needs to be run behind a b-shield. We recommend the use of large gel sizes (16 or 20  cm width, such as PerfectBlue® Twin M, PeqLab) for optimal separation of the protein bands and a possible resolution of hypo- or hyperphosphorylated substrates. Employ neither thin nor small mini-gels. The large gel size conveniently accommodates the sample volume and at a thickness of 1.5 mm, the gel is also relatively robust for the subsequent handling. Phosphorylation or phospho-mimetic substitutions of CDK (e.g., on Thr161) may lead to an increased or reduced mobility of the protein on SDS-PAGE that can be detected as a band-shift on regular immunoblots. Place the fully assembled SDS-PAGE gel apparatus onto the bench and rinse carefully all the gel pockets that should be used. It helps to run some 2× sample buffer on top of the pockets to visualize where improperly polymerized or clogging polyacrylamide is remaining. Purge the pockets with a 1,000-mL or 200-mL tip full of running buffer and straighten the pockets with a needle or fine gel loading tip if necessary. Load the molecular weight marker on both sides of the samples. Also load the wells that remain empty and are directly adjacent to the sample wells with SDS-PAGE sample buffer. We use 200-mL gel-loading pipet tips with extended length to load the samples onto a gel. This helps to avoid spillover but the thin lumen tends to get clogged easily from the agarose bead matrix or the gel itself. Mount the b-shielding.

120

N. Dissmeyer and A. Schnittger

Load the samples very carefully into the gel since even a small spill into the upper buffer chamber can make the whole gel radioactive. Make sure that they have been centrifuged at full speed to pellet the agarose beads that otherwise will clog the pipet tips. Load only the supernatant, which contains the CDK variants, cyclins, histone H1 substrate, recombinant p13Suc1:GST, and other soluble proteins precipitated on the beads. Importantly, the supernatant also contains the non-incorporated g-ATP that represents the majority of the radioactivity actually involved in the entire experiment. Carefully close the SDS-PAGE tank behind the b-screen. Run the gel according to the manufacturer’s instructions. For example, set the power supply initially to 100  V and then, after 15 min or entry of the dye front into the separating gel, increase the voltage to 150 V. Use cooling devices if possible (see Note 34). Make sure that the clearly visible running front is kept inside and does not run out of the gel into the bottom reservoir because it contains almost all of the non-incorporated radioisotope. Thus, stop the run with the running front at least 1 cm away from the end of the gel. It will require much more effort to dispose the radioactive waste properly and to take care of the additional and stronger contamination. In a well-run experiment, the bottom reservoir will contain almost no measurable radioactivity. Completely disconnect the gel unit from the power supply, disassemble the apparatus, quickly measure the activity of the ­buffers to obtain an estimate of it’s radioactivity, and keep the glass plates containing the gel behind a b-shield. Cut off the very radioactive dye front and the separating gel below and dispose it as soon as possible into the solid radioactive waste to clear your working area from the bulk of the radioisotope. If this procedure has not been accomplished properly, there will still be some non-incorporated radioisotope present in the gel, and the free g-ATP can diffuse within the gel and cause a significant increase in the general background of the whole gel. Cut between the stacking and the separating gel to remove and discard the stacking gel and cut the remaining part vertically if not all the pockets of the gel have been loaded to remove and discard the empty lanes. Cut off a small piece from a corner to mark the orientation of the gel. All unnecessary gel goes directly into the solid radioactive waste. Rinse the gel briefly with water in a metal or glass tray and ­discard the wash into the radioactive waste, if necessary (see Note 35).

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

3.8. Western Transfer of Radioactive Proteins

121

In the following part, the proteins contained in the kinase reactions are blotted to nitrocellulose, probed with a Cdc2 antibody (a-PSTAIRE), and detected via chemoluminescence. This allows the proper correlation of CDKA;1 abundance with incorporation of the label and thus to estimate the ratio of mutant CDKA;1 variant to its activity toward histone H1. These directions assume the use of a tank blot transfer system that can be cooled and gently run overnight. For each blot, prepare six sheets of Whatman® filter paper and one sheet of nitrocellulose membrane of the appropriate size, slightly larger than the gel. Fill the transfer tank three-fourth with ice-cold transfer buffer and add a stir bar. In a clean, fat-free glass or metal tray, allow the foam sheets and filter papers to wet by capillary action and equilibrate the membrane (see Note 36). Assemble the lower part of the blotting sandwich: start with the bottom of gel cassette that will face the anode (red, +), foam sheet, three filter papers, and membrane. Make sure to keep all the layers moist and take precautions not to include air bubbles in the setup. Roll out the air in all the layers using a rinsed test tube or glass rod. Carefully lay the separating gel on top of the nitrocellulose membrane. Douse with transfer buffer repeatedly. Add remaining three sheets of filter paper and the foam, ensuring that no bubbles are trapped in the resulting sandwich. Close transfer cassette and assemble transfer unit. Place the cassette into the transfer tank so that the nitrocellulose membrane is enclosed between the gel and the anode (red, +). It is vitally important to ensure that this orientation or the proteins will be lost! This procedure is preferentially continued in the cold room at 4°C. If done at room temperature, flood the cooling water system of the tank blot and start circulation to maintain the temperature between 10 and 15°C. Start stirring regardless of how you decided to blot. Activate the power supply and transfer at roughly 0.65 mA/cm2 gel size (height × width × 0.65 = mA/gel). The transfer can be accomplished at either 80 mA overnight or 400 mA for 1–2 h at 4°C. Once the transfer is complete, take the cassette out of the tank and disassemble carefully. Monitor the radioactivity of the transfer buffer and proceed accordingly. Leave the gel in place on top of the membrane and mark the shape of the gel. The remaining radioactivity can now be found on

122

N. Dissmeyer and A. Schnittger

the membrane. However, both the gel and excess nitrocellulose are to be discarded in the solid radioactive waste. Label the membrane at the rims with a pencil or water-proof pen: marker and other important positions and, optionally, also the description of the antibody to be used. The success of transfer can be estimated by the appearance of the pre-stained molecular weight marker, and phosphorylated histone H1 can usually be detected on the dried membrane with a hand-held b-counter (see Note 37). Rinse the membrane briefly twice in TBST. Incubate the nitrocellulose in 10  mL blocking buffer (3% BSA/ TBST) for 1 h at room temperature on a rocking platform. Discard the buffer and rinse the membrane quickly in TBST prior to addition of the primary antibody dilution of rabbit a-PSTAIRE 1:1,000 in 3% BSA/TBST (Santa Cruz). Incubate with primary antibody overnight at 4°C while rocking. Remove the primary antibody and wash the membrane three times for 5 min each with 50 mL TBST (see Note 38). Freshly prepare the secondary horseradish-conjugated antibody dilution of goat a-rabbit 1:5,000 in 3% BSA/TBST (Pierce) and add to the membrane for 1 h at room temperature on a rocking platform. Discard the secondary antibody and wash the membrane three times for 10 min each with TBST. After the final wash, briefly dry the membrane on filter paper and label if not done previously. Line the X-ray film cassette with Saran wrap or a plastic bag and position the blot into a wrap or plastic pocket to separate the membrane to be soaked from the film. Mix the ECL reagents (SuperSignal West Femto, Pierce) in a ratio of 1:1, immediately spread it over the membrane, rotate it by hand, and incubate at room temperature for 1 min to ensure even coverage. Squeeze out excess liquid, blot with tissue paper, and move toward the dark room where the remaining steps are done under safe light conditions. Expose the first film for a suitable exposure time, typically a few minutes, and determine optimal exposure time later on. 3.9. Autoradiography

Phosphorylated histone is detected after Western blot and immunostaining via autoradiography or densitometry using PhosphorImager scanning. Typically, activity is high enough to have strong H1 bands in a 10–16-h exposure, see Fig. 2 (see Note 39).

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

123

Fig.  2. Comparison of the phosphorus isotopes used in in vitro kinase assays. Two protein samples each of Col-0 flower material were subjected to p13Suc1-mediated pull down and further assayed in in vitro histone H1 kinase assays. On the left hand, [g-32P]-ATP was used in the kinase reaction, on the right hand [g-33P]-ATP. Using 32P, both films and screens can easily be overexposed by the high energy emission of b-particles. This can be avoided by using 33P which – in the case of histone H1 as a substrate – gives the characteristic doublet band pattern of ohosphorylated H1. Equal loading was confirmed by immunoblotting of the same membrane used for kinase assay by a-PSTAIRE antibody.

Fig. 3. Flowchart of the analysis of kinase activity in variants of CDKA;1. The steps of the entire procedure described in this chapter are listed in the chart with focus on the kinase assay part. Steps assembled within one black box should be done within one working day. The dashed box indicates the involvement of radioisotopes.

124

N. Dissmeyer and A. Schnittger

Put the sealed membrane into a film cassette with intensifying screen, assemble the film between gel and screen and transfer the entire cassette to a −80°C freezer during exposure of the film. Alternatively, measure the amount of incorporated label using a PhosphorImager (see Note 40). 3.10. Troubleshooting

If the assay does not work, confirm that both the g-ATP and the substrate protein have been added at the correct concentrations. It is also crucial to keep the phosphoprotein extract as source of the active kinase complex on ice before use and to always keep it on ice between experimental steps. The problem might be due to a poor storage of the labile enzyme, for example. It will always be better to use freshly harvested flower material. Further on, experimental errors can occur if a proper Western transfer failed. This can easily be checked by using the transfer efficiency of pre-stained markers or via the reversible Ponceau S staining.

4. Notes 1. Cyanogen bromide-activated agarose or sepharose matrix can be cross-linked with recombinant Suc1 in the laboratory or can be purchased (Millipore/Upstate). The matrix is simply used by incubating it in a cell or tissue extract, much as an IP would be done. If necessary, the activity can also be eluted from the beads using excess soluble Suc1 competitor. A Suc1 bead assay is much more sensitive and specific than an assay based on crude extract, but a disadvantage is that the definite composition of the CDK/cyclin complexes bound to it is not clear. Thus, there might be certain CDK/cyclin complex that fails to bind to the beads. In addition, there might be also kinases bound such as MAP kinases, possibly leading to a high background in the activity assay. 2. The binding capability of CDK catalytic-site mutants such as R126A, D127A/E, or R150A (all residues according to human Cdk2) to an affinity resin with a broader specificity such as ATP-agarose can be tremendously impaired, presumably due to alterations in the ATP-binding site (76). CKS affinity is not affected and can easily be double checked via Western blotting for CDK, which is also to be considered as mandatory to exclude unequal CDK loading. 3. One disadvantage of the kinase assay protocol included in this chapter is that it requires the use of a radioactive tracer isotope, either 33P or 32P, with the latter being a high-energy b-emitter. There are a few examples of kinase assays that do not require [g-32P]-ATP, but they tend to be more specialized

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

125

and generally not as widely applicable. However, we present here the use of 33P as a safer alternative with reduced irradiation energy coming along with the very positive side effect of producing much sharper bands on the films of the final assay blots or gels. Furthermore, nonradioactive kinase assays could provide decent alternatives to the use of radioisotopes (KinaseGlo® and ProFluor®, Promega, or PolarScreenT CDK Assay Kit®, Invitrogen). 4. This is the soil composition commonly used at our plant facilities. BioMükk® is a non-poisonous, high-potency biological larvicide that selectively acts against mosquitoes (Culicidae), blackflies (Simuliidae), and fungus gnats (Sciaridae). It contains main protein compounds of Bacillus thuringiensis var. israelensis (Bti, 3,000  international units (ITU)/mg). BioMükk® can be replaced by 14 g Confidor® WG 70, which is a systemical insecticide and molluscicide and contains 700  g/kg Imidacloprid (Bayer CropScience). 5. Silvet L-77® is a silicone-polyether copolymer and a mixture of polyalkyleneoxide-modified heptamethyltrisiloxane (84%) and allyloxypolyethyleneglycol methyl ether (16%). It is an essential infiltration media ingredient for all Agrobacterium-based transformations of Arabidopsis and other plants. 1 mL is sufficient quantity to prepare 3.3 L of vacuum infiltration medium when used at the recommended rate of 0.033% (v/v). We use it, however, at a low concentration as 0.0002%, i.e., 200 ppm. 6. Phosphinothricin-N-acetyltransferase (PAT, from Streptomyces viridochromogenes) is a gene that confers resistance against the herbicide PPT, the active ingredient in the herbicides Basta, Rely, Finale, and Liberty. It is widely used as a selection marker enabling identification of transformed plant cells and as a source of resistance to the herbicide phosphinothricin for transgenic plants. This is especially due to its easy application, i.e., spraying of the small 1- to 3-week-old plantlets. PPT acts by inhibiting the plant glutamine synthetase, the only enzyme in plants that detoxifies ammonia by incorporating it into glutamine. Inhibition of this enzyme leads to an accumulation of ammonia in the plant tissues, which kills the plant within hours of application. PAT catalyzes the acetylation of the herbicide and thus detoxifies the chemical into an inactive compound. 7. Another well-intentioned advice is to always prepare sufficient amounts of “master mixes” of the reaction buffers, for example, the volume for one reaction in excess, also of the hot ATP mix. Prepare the mixes in a single Falcon or microcentrifuge tube for samples by multiplying the quantities for a single reaction by the total number of reactions plus 1 or 2. Then, the total volume of each reaction mixture can be added to each sample or tube, very conveniently reducing the risk of pipetting errors.

126

N. Dissmeyer and A. Schnittger

8. The chelators EDTA (Ca2+, Zn2+, Mg2+) and EGTA (Ca2+, Zn2+) strongly inhibit metalloproteases and also both act as potent inhibitors of kinases that require divalent metal ions to be activated. 9. The Na3VO4 is both a potent and nonselective tyrosine phosphatase and kinase inhibitor. The inclusion of NaF (and optionally tetra-sodium pyrophosphate, Na4P2O7) should effectively inhibit most serine/threonine phosphatases. NaF inhibits both the pyrimidine nucleoside monophosphate kinase and the protein phosphatase 2A (PP2A). To generally inhibit proteases, a cocktail of benzamidine, PMSF, pepstatin A, antipain, leupeptin, EDTA, and EGTA is found to be most effective. Benzamidine hydrochloride inhibits peptidases, Pepstatin A (Isovaleryl-LVal-L-Val-statinyl-L-Ala-statin) specifically inhibits aspartic proteases and might precipitate from solutions. Aprotinin is also known as bovine pancreatic trypsin inhibitor (BPTI), trypsin kallikrein inhibitor (TKI), or Trasylol® (Bayer). Leupeptin (Ac-Leu-Leu-argininal) was isolated as a peptide antibiotic from Streptomyces and reversibly inhibits serine and cysteine proteases. Soybean trypsin inhibitor (STI) is a protein and thus cannot be dissolved in organic solvents and is heat sensitive. Both b-glycerophosphate and p-nitrophenylate (p-NO2PhePO4) compete as phosphatase substrates. Acting as potent inhibitors, they strongly stabilize the H1 kinase activity. The latter hydrolyzes to yellow p-nitrophenylate in basic pH ranges that absorbs at 405 nm and might interfere with certain spectrophotometric measurements. Sometimes we include 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF) (to replace the highly toxic PMSF), leupeptin, pepstatin, and/or chymostatin in the extraction buffer, although this will greatly increase the cost of the solution with relatively little gain in quality of the data. 10. Orthovanadate VO43− is an analog of the phosphate ion PO43−. Activation depolymerizes the vanadate, converting it to a more potent inhibitor of protein phosphotyrosyl phosphatases (77). Activation protocol: Prepare 200  mM sodium orthovanadate (MW 183.9, e.g. ,0.37 g to 10 mL solution) in water. Adjust pH to 10.0 with either 1 M NaOH or 1 M HCl, depending on the lot supplied by the manufacturer. At pH 10.0, the solution turns yellow. Boil the solution until it turns colorless, this might take up to 15 min. Allow the solution to cool to room temperature. Readjust pH to 10.0 and repeat the steps until the solution remains colorless and the pH stabilizes at 10.0. Store in aliquots at −20°C. Caution: adding DTT rapidly inactivates sodium orthovanadate and the inhibition of cystein proteases can also be reversed by reduced thioles such as DTT. Vanadate influences certain standard methods used for protein concentration

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

127

determination. Coomassie brilliant blue will be negatively affected, but Lowry, BCA, or Bradford still can be used (78, 79). Vanadate polymers that reform in aqueous solution turn the buffers used here into a yellowish color (see Note 22). 11. PMSF is highly toxic for mucous membranes, eyes, and skin. Every exposure has to be avoided. It is recommended to be replaced by the equally effective, less harmful but more expensive AEBSF. PMSF is a serine protease inhibitor and inhibits ATPase, alkaline, protein phosphotyrosyl, and other dual-specific phosphatases. It is soluble in water-free DMSO, methanol, ethanol, or best in isopropanol. Can be stored at 4°C or is even stable for months at room temperature. At −20°C, PMSF precipitates from isopropanol. PMSF is poorly soluble in water and since it has a short half-life in aqueous solutions, PMSF should be made fresh and added to all buffers shortly before they are used, and they should be used within 1 or 2 h. The concentrated PMSF should be added to a vigorously stirred solution to prevent the PMSF from precipitating. 12. Either use screw-cap microcentrifuge tubes when boiling the samples to reduce the risk of vaporizing radioisotope or work under a radionuclide fume hood, and punch holes into the lids to prevent that they open during heating and deliver droplets of their radioactive content in the working area. 13. Usually, ATP is purchased as a disodium salt (Na2-ATP); however, most kinases require it to be complexed with Mg2+ (or Mn2+) for being an efficient kinase substrate. If no Li-ATP, as suggested in this chapter, is available, a Mg2+-ATP solution can easily be prepared from 20 mM MgCl2 (or MgSO4) and 20 mM Na2A-TP stock solutions by mixing of equal volumes and adjusting the pH to 7.4 with 100 mM HCl or 100 mM NaOH. Mg2+ATP solution can be stored in small single-use aliquots at −20°C. Precipitation might occur if the pH is not properly adjusted. 14. g-ATP is usually available at a variety of specific activities. A good specific activity to use is >3,000 Ci/mmol or even the highest one at approximately the double activity as mentioned in this protocol. The activity is normally provided at a concentration of 10  mCi/mL, ready to use. Here, we recommend using high specific activity to reduce the impact of “contamination” of cold ATP within the isotope lot itself. 15. Acrylamide is a neurotoxin and carcinogenic in the unpolymerized form (of which even the polymerized gel contains still traces of ) and thus, has to be handled very carefully. Any waste has to be disposed off accordingly. 16. TEMED is best stored at room temperature in a desiccator. Buy small bottles as it may decline in quality after opening and thus, gels will take longer to polymerize.

128

N. Dissmeyer and A. Schnittger

17. To prevent bubbles at the border of the separating gel, it is overlaid with either isopropanol or water-saturated isobutanol. For the latter, shake equal volumes of water and isobutanol in a glass bottle and allow separation. Use the top layer. Store at room temperature. 18. If the experimenter desires the protocol to be altered from the way presented here in terms of including a cold Western blot for determining the amount of CDK in the samples, the pulldown material has to be split in two for Western blotting pull-down control and actual kinase assay reaction. We recommend to subject 150 mg total protein to the kinase assay and pull-down control if done as described in the main protocol, or if a separate cold blot is desired, then one could use 30 mg of extra total protein for this purpose. 19. Alternatively, site-directed or megaprime mutagenesis can be applied to receive the desired mutant variants. In our case, we tried the QuikChange Site-Directed Mutagenesis Kit, PfuTurbo and PfuUltra proofreading polymerases (all from Stratagene). These polymerases have sixfold or even a higher fidelity in DNA synthesis than regular Taq or Pfu enzymes. The error rate is also drastically reduced. The procedure utilizes a supercoiled donor vector with the insert of interest and two synthetic oligonucleotide primers containing the desired mutation(s) which were designed according to the manufacturer’s instructions and had a minimal overlap of 15 base pairs from the actual site of mutagenesis. A small amount of starting template plasmid, the high fidelity of the DNA polymerase, and the low number of thermal cycles contribute to the high mutation efficiency and decreased potential for generating random mutations during the reaction. The method used here allowed using miniprep double-stranded DNA plasmids and this template can be directly subjected to the mutagenesis procedure. The procedure was used to generate single or multiple point mutations and multiple base pair exchanges both to switch amino acids and to introduce unique restriction sites for screening purposes. For single point mutations, 12 cycles were used and for single amino acid changes, 16 cycles. Proper amplification was verified by electrophoresis of several microliters of the PCR product on a 1% agarose gel. Following temperature cycling, the parental DNA template has to be removed of the PCR product by treatment with DpnI endonuclease (Fermentas). A prerequisite for the use of DpnI is that the template DNA must be isolated from E. coli strains such as DH5a that dam methylates its DNA. After digestion, the remaining nicked vector DNA containing the desired mutations was directly transformed into DH5a electrocompetent cells. It is not uncommon to observe very low numbers of

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

129

colonies, especially when generating large mutations. Most of the colonies that do appear will contain mutagenized plasmid. Due to the sometimes occurring leakiness of the DpnI digestions, the use of fusion PCRs instead of the site-directed method was often more efficient in our hands. 20. The Arabidopsis relative synonymous codon usage (RSCU) is the observed frequency divided by the expected frequency assuming random codon usage in the respective organism. Tables can be accessed at http://www.nal.usda.gov/pgdic/ Probe/v4n1_2/table1a.html or http://www.kazusa.or.jp. 21. The silent mutation restriction enzyme scan (SILENT) is available at the Mobyle portal at http://bioweb.pasteur.fr/seqanal/interfaces/silent.html. 22. If nucleic acids are isolated from disrupted tissue as in our case, beads can also be soaked in a 1:10 dilution of Eau de Javel (store-bought household bleach, FLOREAL Haagen) for 5 min. This both cleans and sterilizes the beads and completely destroys contaminating nucleic acids (80). 23. The beginning of flowering strongly depends on the growth conditions applied in the greenhouse or the phytochambers and it is strongly recommended to always grow the different genotypes to be compared in their kinase activity at the same time under exactly the same conditions and to treat the crude material all the way equally. Besides that, when Agrobacterium transfer DNA (T-DNA) is transformed into Arabidopsis, it is randomly integrated into the genome. Thus, insertions occur by chance in hetero- or euchromatic regions, in single or multiple copies, in tandem, inverted repeats or truncated ­versions which can explain the consequent variability of expression. It is, therefore, recommended to test the expression level of several individual transgenic lines of the same construct, preferably by Western blotting, as it is necessary to both have high and comparable amounts of kinase to perform the activity assay. The binary vectors that we use for Agrobacterium-mediated transformation carry several selection markers, e.g., nptII/neo (neomycin phosphotransferase II gene from transposon Tn5, against Neomycin/Kanamycin), hph (Hygromycinphosphotransferase from E. coli, destroys Hygromycin), sul2 (dihydropteroate synthase, degrades the sulfonamide antibiotic Sulfadiazine), or most conveniently, PAT (resistance against BASTA®). It is highly advisable to not treat differentially with these agents, e.g., spray a construct carrying thus resistant subpopulation of the individuals to be tested with the selective agents and keep other lines, e.g., the wild-type control or mutants without the specific transgene conferring the

130

N. Dissmeyer and A. Schnittger

resistance, only untreated (because they are sensitive). Different treatments of subpopulations will invariably result in differences in growth and development, and at least retard the treated population in terms of flowering start compared to the nontreated plants. This would give rise to a difference in harvesting date and quality of the flower material to be assayed. 24. Flower buds contain meristematic and thus highly dividing tissues, with high levels of CDK expression. Try to collect only closed flower buds using fine forceps. We found CDK/cyclin activity from flower material to be stable at −80°C and reliable assays were possible even up to 1 year after harvest. 25. Once the flower buds have been lysed by the addition of extraction buffer and grinding, the proteins will have to be processed all the way to the step where the kinase reaction products are loaded onto the SDS-PAGE gel. Flower buds can be preserved quite easily at −80°C and the next “storage format” or possibility to end the working day is only the radioactive kinase assay products from the stopped reaction. Before this, the experimenter has to deal with unstable complexed subunits and activatory phosphorylations that have to be preserved and must not be frozen in order to give reliable results. Thus, once the lysate is produced, it should not be stored but used immediately. Freezing and storing the cells in lysis buffer even for just 1 day can result in marked loss of kinase activity (81). 26. For the determination of the overall protein concentration in each sample, we routinely use the Protein Assay Kit from BioRad that is based on the method of Bradford. Vanadate influences certain standard methods used for protein concentration determination (see Note 6). We usually add 800 mL water with 200  mL protein assay solution to each cuvette, add 2  mL of supernatant, and incubate for 5 min at room temperature. In case we expect unusually low yield (<1 mg/mL), we scale up the assay conditions in terms of transferred supernatant volume. The standard curve is established by using different amounts of BSA. To each BSA sample, we also add the same volume of extraction buffer (2  mL) that is contained in the unknowns; this compensates for the slight coloring from the inhibitors. 27. Preservation of CDK activity seems to be a very sensitive issue as often mentioned in animal or yeast protocols. Brooks et al. postulate that CDK activities in frozen lysates could remain measurable for 2–3 days after extraction when stored in liquid nitrogen. However, the degree of measurable activity deteriorates rapidly such that only 50–75% of original activity in freshly prepared lysates remains after 1 day of storage and 25–50% after 2 days (60).

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

131

28. During the wash steps of the bead material and the pull downs, it is crucial to not lose any of the pellet, but at the same time to wash it most efficiently. In order to remove the supernatant as completely as possible after each centrifugation step, we use syringe and fine needle (27 gauge/“27 G” or 0.4 mm in diameter and ¾ in. or 2 cm in length, gray color code; the higher the G or gauge number, the smaller the lumen of the needle) to aspirate the supernatant. The lumen of the needle tip is kept toward the wall of the tube and it must be prevented to insert the needle right into the pellet, because this will soon clog the very fine needles, whereas with needles of larger diameters, this procedure will lead to some loss of pellet and irreproducible results. 29. We routinely use this commercially available liquid suspension of recombinant p13Suc1:GST fusion protein (source of Suc1 is S. pombe, MW of fusion protein is 39 kDa) that is non-covalently bound to glutathione-agarose. In these lots, 2.5 mg p13Suc1:GST is bound to 250 mL of agarose beads provided as a 50% (v/v) gel slurry in PBS containing 50% glycerol and 0.05% sodium azide. Given the MW of 13 kDa of Suc1, 26 kDa of GST, and the stoicheometric binding of CKS to CDK/cyclin complex at a ratio of 1:1 (49), the content of one tube with its 2.5 mg binding partner could theoretically precipitate about 1.6  mg CDK. Since the association of the glutathione and the GST is not cross-linked and the bead material is quite sensitive per se, the material must not be vortexed. 30. If a separate pull-down control is desired, the pellet can now be splitted in two for Western blotting. At the same time, an optional additional pull-down step can be included: after centrifugation, fresh beads can be added to the supernatant and incubated for an additional time to increase the amount of extracted CDK/cyclin complex. 31. Working with 33P and 32P requires caution. This assay uses radioactively labeled g-ATP that contains a covalently linked 32 P-orthophosphate group at the g-position of the triphosphate. This phosphate is – in the case of 32P – a strong emitter of b-particles of high energy which should be handled and ­disposed off according to the federal and institutional radiation protection procedures applicable to work with the respective radioactive isotope. Contact your institutional radiation safety representative for proper handling and disposal procedures. Some standard protocols about good laboratory practice with regard to working with 33P and 32P can be found in the appendix (literature: Radiation safety, (69–71)). Make sure to use Plexiglas®/Perspex® shields while in the vicinity of radiation and also take precaution for proper shielding for your lab mates. Never use plain lead with its high atom weight to

132

N. Dissmeyer and A. Schnittger

­ protect” against b-irradiation emitted from 32P because the “ high energy will be transferred further to Bremsstrahlung, which is as difficult to shield as g-irradiation or X-rays and multiplies the risk of radiation exposure. Just use Plexiglas®/ Perspex®, glass, or water, which are materials with a low atom weight and high shielding capacity toward b-particles. In this experiment, either 33P- or 32P-labeled g-ATP can be used. Most protocols rely on 32P, maybe because “it has always been that way” and the use of 32P is well established in the laboratory due to the lower cost compared to that of 33P. However, we strongly recommend the use of 33P for several reasons such as remarkably better experimental performance and radiation safety. 33P offers clear advantages over 32P with respect to the ease of handling because the maximum energy of the emitted b-radiation is between that one of 35  S (0.17  MeV) and 32P (1.71  MeV) and does not require as much shielding as is needed for 32P. The effects of the use of a “safer radionuclide” must not be underestimated because the experimenter will have less trouble with, e.g., handling and this can easily advantageously result in a higher confidence throughout performing the experiment. Thus, the replacement might turn out to be conductive for a more coolheaded working. The range of 32P-b in air is up to 790 cm, and in water and Plexiglas® about 0.8 cm. 33P-b reaches only 49 cm in air and shielding is not necessarily needed for activity amounts typically used in the laboratory (71). In fact, the b-radiation emitted from 33P (Emax = 0.25  MeV) can barely penetrate through two pairs of gloves and the outer dead layer of skin, so the external exposure hazard associated with even mCi amounts of 33P is minimal. 33P preparations are accordingly only delivered in plain plastic containers instead of in the heavily lead-shielded ones for the transport of 32P products. The best way to determine whether additional shielding is needed when using this isotope is to monitor the source using a b-sensitive radiation meter. If counts can be detected, add a layer of Plexiglas® as described for 32P. Another great advantage of using 33P is that gel bands visualized on autoradiographs of 33P-labeled compounds are much sharper than bands labeled with 32P because the low-energy b-radiation does not scatter as the high-energy b-radiation of 32P. For 33P, a much higher specific activity can be achieved due to the longer half-life of 33P (25 days compared to 14 days for 32P), which also allows a broader time frame for experimental planning. Despite the slightly higher cost of 33P, these distinct features make 33P-labeled nucleotides very interesting for use in experiments where discrimination of closely spaced gel bands is important.

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

133

Good ranges for the final overall ATP concentration is up to 100 mM (including negligible amounts of the g-ATP and at a specific activity of approximately. 1 mCi/mL reaction volume). 32. Controls are important to evaluate the results of your experiments. You should always include a no-substrate control, a noenzyme source control, and a heat-denatured enzyme control in your assays. As a further test for the specificity of the kinase assay, a parallel set of controls can be inhibited with chemical inhibitors of the CDK/cyclin complex. Two of the most specific inhibitors are probably roscovitine (5 mM) and olomoucine (10  mM). They can be added to a separate reaction to indicate whether the bulk of the kinase activity is due to a CDK/cyclin complex. 33. The enzymatic activity assayed is the initial rate of the reaction when the substrates are not limiting. The number of moles of reaction product formed after a certain time (number of moles of phosphate transferred to H1 histone) is a measure of the initial reaction rate if the reaction is still linear at this time. The assay described here fulfils these conditions: neither ATP nor histone is limiting and the reaction is still linear even toward the end of the incubation time. It is often advantageous to perform kinase assays at 30°C rather than 37°C because the lower temperature makes it easier to stay within the linear range of the phosphotransfer reaction catalyzed by the kinase, thus providing more control over the assay. Most kinases have a Km for ATP of 1–100 mM and if there is too much ATP in the reaction mixture, it will be difficult to measure phosphotransfer. An ATP concentration of 50–100 mM tends to work well; at this concentration, the enzyme should be working in the range of 50% of maximum, depending on its apparent Km for ATP. Usually, the substrate concentration is high so that the enzyme is working at or close to Vmax. The concentration of radioactive g-ATP is negligible compared to the added cold ATP. 34. Some instruments allow cooling via water tubes, which might help to chill down the buffer tank and the gels during a long run. One can also run the gel overnight, e.g., at 35–50  V according to the apparatus of choice. In this case, in the next morning, the voltage can be increased again to complete the run, if required. 35. At this point, the SDS-PAGE gel can be processed in two different ways. We prefer the hot Western blot to correlate the histone H1 kinase activity directly with the abundance of – desirably equal – CDKA;1 loading monitored by immunoprobing with a-PSTAIRE antibody. However, if the experimenter decides to just check overall protein abundance and/or only incorporation of radiolabel, the gel can

134

N. Dissmeyer and A. Schnittger

be optionally stained with Coomassie Brilliant Blue (CBB). CBB staining solution is 50% methanol, 10% glacial acetic acid, and 0.12–0.25% Coomassie blue R-250 in water; destaining solution is 10–50% methanol and 10% glacial acetic acid in water. After staining, the gel can be fixed with fixing solution (25–50% methanol and 7–10% acetic acid) for 45 min to 1 h and then soaked in anti-cracking solution (7% methanol, 7% glacial acetic acid, and 1% glycerol) for 5  min. Place the gel on a sheet of Whatman® 3MM filter paper and cover with cellophane paper or plastic wrap and dry at 80°C for 30–120 min under a vacuum using a conventional gel dryer with safety Woulff bottle and (oil) vacuum pump; dry completely. The solutions must be disposed into the radioactive waste, if necessary. Photo- and autoradiograph. In general, a Coomassie stain could be used to check for equal amounts of substrate in each samples. In our special case, however, where not only a doublet of histone H1 runs at about 30–34 kDa but also multiple variants of CDKA;1 at 34 kDa, that might be difficult. The same is true for Ponceau S staining of blotted Western membranes. 36. Equilibration of different membranes: nitrocellulose is briefly immersed in water and then in transfer buffer. Immobilon (Millipore) is briefly wetted in methanol, then kept for 2 min in water, and moved for 5–10 min into transfer buffer; PVDF should be wetted briefly in 60% methanol and then in transfer buffer, and assembled with the glossy side toward the gel. 37. The membrane can be dried between Whatman® filter paper and optionally stained with Ponceau S red dye (either 0.1–0.22% Ponceau S in 1–3% acetic acid or 2% Ponceau S in 30% trichloroacetic acid (TCA) and 30% sulfosalicyclic acid, can be re-used multiple times). Immerse membrane in stain, shake for 10 min, and destain by rinsing with water. In general, a Ponceau S stain could be used to check for equal amounts of substrate in each samples. The same is true for Coomassie staining, see also Fig. 2 and Note 31. 38. The primary antibody can be saved for subsequent experiments in the presence of 0.02% sodium azide (NaN3, stock 10%, store at room temperature) and stored at 4°C. NaN3 is very toxic and must be strictly kept away from heavy metal salts under all circumstances because explosive azides can form that are highly sensitive to touch and warmth. Primary antibodies conserved like this can be used for many blots over several months; however, the length of exposure to film upon ECL treatment might have to be adjusted. 39. On a 12% SDS-PAGE, the labeled histone H1 will appear as a doublet of two distinct bands running at ~32 and 34  kDa, compare to Fig. 2.

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance…

135

40. Given the limited linear response of X-ray film, densitometry is an inaccurate way to measure the incorporation of label. It will provide only a rough guide to the relative amount of kinase activity in each sample. A much better way to quantify the kinase activities would be to use liquid scintillation counting for either 33P or 32P.

Acknowledgments The authors thank Annika Weimer for critical reading and helpful comments on the manuscript. Frank Sprenger and Vimal Ramachandran helped with running the first kinase assays of Drosophila Cdc2 in  vitro translations and shared materials at the old Institute for Genetics of the University of Cologne. We thank Aurine Verkest, Max Bush, Lazlo Bögre, and Mihály Horváth for helpful communication and assistance on the experimental ­procedures. N.D. was a fellow of the International Max Planck Research School and funded by the Max Planck Society, work in the laboratory of A.S. is supported through an ATIP grant from the Centre National de la Recherche Scientifique (CNRS) and an ERC starting grant from the European Union. References 1. Morgan, D. O. (2007) The cell cycle: ­principles of control, New Science Press Ltd in association with Oxford University Press, London. 2. Iwakawa, H., Shinmyo, A., and Sekine, M. (2006) Arabidopsis CDKA;1, a cdc2 homologue, controls proliferation of generative cells in male gametogenesis. Plant J 45, 819–31. 3. Nowack, M. K., Grini, P. E., Jakoby, M. J., Lafos, M., Koncz, C., and Schnittger, A. (2006) A positive signal from the fertilization of the egg cell sets off endosperm proliferation in angiosperm embryogenesis. Nat Genet 38, 63–7. 4. Inze, D. (2007) Cell Cycle Control and Plant Development, Vol. 32, Wiley-Blackwell, Oxford. 5. Dissmeyer, N., Nowack, M. K., Pusch, S., Stals, H., Inze, D., Grini, P. E., and Schnittger, A. (2007) T-loop phosphorylation of Arabidopsis CDKA;1 is required for its function and can be partially substituted by an aspartate residue. Plant Cell 19, 972–85. 6. Harashima, H., Shinmyo, A., and Sekine, M. (2007) Phosphorylation of threonine 161 in plant cyclin-dependent kinase A is required for

cell division by activation of its associated kinase. Plant J 52, 435–48. 7. Kaldis, P. (2006) Cell cycle regulation, Springer, Berlin; London. 8. Shimotohno, A., and Umeda, M. (2007) CDK phosphorylation, in The cell cycle control and plant development; Annual plant reviews, 32 (Inze, D., Ed.), Blackwell Publ., Oxford [u.a.]. 9. Morgan, D. O. (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13, 261–91. 10. Dissmeyer, N., Weimer, A. K., Pusch, S., De Schutter, K., Kamei, C. L., Nowack, M. K., Novak, B., Duan, G. L., Zhu, Y. G., De Veylder, L., and Schnittger, A. (2009) Control of cell proliferation, organ growth, and DNA damage response operate independently of dephosphorylation of the Arabidopsis Cdk1 homolog CDKA;1. Plant Cell 21, 3641–54. 11. Dissmeyer, N., Weimer, A. K., De Veylder, L., Novak, B., and Schnittger, A. (2010) The regulatory network of cell-cycle progression is fundamentally different in plants versus yeast or metazoans. Plant Signal Behav 5, 1613–8.

136

N. Dissmeyer and A. Schnittger

12. Bleeker, P. M., Hakvoort, H. W., Bliek, M., Souer, E., and Schat, H. (2006) Enhanced arsenate reduction by a CDC25-like tyrosine phosphatase explains increased phytochelatin accumulation in arsenate-tolerant Holcus lanatus. Plant J 45, 917–29. 13. Ellis, D. R., Gumaelius, L., Indriolo, E., Pickering, I. J., Banks, J. A., and Salt, D. E. (2006) A novel arsenate reductase from the arsenic hyperaccumulating fern Pteris vittata. Plant Physiol 141, 1544–54. 14. Gould, K. L., and Nurse, P. (1989) Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 342, 39–45. 15. Krek, W., and Nigg, E. A. (1991) Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. Embo J 10, 3331–41. 16. Krek, W., Marks, J., Schmitz, N., Nigg, E. A., and Simanis, V. (1992) Vertebrate p34cdc2 phosphorylation site mutants: effects upon cell cycle progression in the fission yeast Schizosaccharomyces pombe. J Cell Sci 102 (Pt 1), 43–53. 17. Ducommun, B., Brambilla, P., Felix, M. A., Franza, B. R., Jr., Karsenti, E., and Draetta, G. (1991) cdc2 phosphorylation is required for its interaction with cyclin. Embo J 10, 3311–9. 18. Atherton-Fessler, S., Parker, L. L., Geahlen, R. L., and Piwnica-Worms, H. (1993) Mechanisms of p34cdc2 regulation. Mol Cell Biol 13, 1675–85. 19. Furihata, T., Maruyama, K., Fujita, Y., Umezawa, T., Yoshida, R., Shinozaki, K., and Yamaguchi-Shinozaki, K. (2006) Abscisic acid-dependent multisite phosphorylation regulates the activity of a transcription activator AREB1. Proc Natl Acad Sci USA 103, 1988–93. 20. Michard, E., Dreyer, I., Lacombe, B., Sentenac, H., and Thibaud, J. B. (2005) Inward rectification of the AKT2 channel abolished by voltagedependent phosphorylation. Plant J 44, 783–97. 21. Kanamaru, K., Wang, R., Su, W., and Crawford, N. M. (1999) Ser-534 in the hinge 1 region of Arabidopsis nitrate reductase is conditionally required for binding of 14-3-3 proteins and in vitro inhibition. J Biol Chem 274, 4160–5. 22. Hass, C., Lohrmann, J., Albrecht, V., Sweere, U., Hummel, F., Yoo, S. D., Hwang, I., Zhu, T., Schafer, E., Kudla, J., and Harter, K. (2004) The response regulator 2 mediates ethylene signalling and hormone signal integration in Arabidopsis. Embo J 23, 3290–302.

23. Leibfried, A., To, J. P., Busch, W., Stehling, S., Kehle, A., Demar, M., Kieber, J. J., and Lohmann, J. U. (2005) WUSCHEL controls meristem function by direct regulation of cytokinin-inducible response regulators. Nature 438, 1172–5. 24. Kirchler, T., Briesemeister, S., Singer, M., Schutze, K., Keinath, M., Kohlbacher, O., Vicente-Carbajosa, J., Teige, M., Harter, K., and Chaban, C. (2010) The role of phosphorylatable serine residues in the DNA-binding domain of Arabidopsis bZIP transcription factors. Eur J Cell Biol 89, 175–83. 25. Wang, X., Goshe, M. B., Soderblom, E. J., Phinney, B. S., Kuchar, J. A., Li, J., Asami, T., Yoshida, S., Huber, S. C., and Clouse, S. D. (2005) Identification and functional analysis of in vivo phosphorylation sites of the Arabidopsis BRASSINOSTEROID-INSENSITIVE1 receptor kinase. Plant Cell 17, 1685–703. 26. Wang, X., Kota, U., He, K., Blackburn, K., Li, J., Goshe, M. B., Huber, S. C., and Clouse, S. D. (2008) Sequential transphosphorylation of the BRI1/BAK1 receptor kinase complex impacts early events in brassinosteroid signaling. Dev Cell 15, 220–35. 27. Kim, T. W., Guan, S., Sun, Y., Deng, Z., Tang, W., Shang, J. X., Sun, Y., Burlingame, A. L., and Wang, Z. Y. (2009) Brassinosteroid signal transduction from cell-surface receptor kinases to nuclear transcription factors. Nat Cell Biol 11, 1254–60. 28. Hardtke, C. S., Gohda, K., Osterlund, M. T., Oyama, T., Okada, K., and Deng, X. W. (2000) HY5 stability and activity in Arabidopsis is regulated by phosphorylation in its COP1 binding domain. Embo J 19, 4997–5006. 29. Otterhag, L., Gustavsson, N., Alsterfjord, M., Pical, C., Lehrach, H., Gobom, J., and Sommarin, M. (2006) Arabidopsis PDK1: identification of sites important for activity and downstream phosphorylation of S6 kinase. Biochimie 88, 11–21. 30. Zegzouti, H., Anthony, R. G., Jahchan, N., Bogre, L., and Christensen, S. K. (2006) Phosphorylation and activation of PINOID by the phospholipid signaling kinase 3-phosphoinositide-dependent protein kinase 1 (PDK1) in Arabidopsis. Proc Natl Acad Sci USA 103, 6404–9. 31. Sirichandra, C., Gu, D., Hu, H. C., Davanture, M., Lee, S., Djaoui, M., Valot, B., Zivy, M., Leung, J., Merlot, S., and Kwak, J. M. (2009) Phosphorylation of the Arabidopsis AtrbohF NADPH oxidase by OST1 protein kinase. FEBS Lett 583, 2982–6. 32. Takeda, S., Gapper, C., Kaya, H., Bell, E., Kuchitsu, K., and Dolan, L. (2008) Local positive

6  Use of Phospho-Site Substitutions to Analyze the Biological Relevance… feedback regulation determines cell shape in root hair cells. Science 319, 1241–4. 33. Dinesh-Kumar, S. P., Tham, W. H., and Baker, B. J. (2000) Structure-function analysis of the tobacco mosaic virus resistance gene N. Proc Natl Acad Sci USA 97, 14789–94. 34. Hildebrandt, J. D., Day, R., Farnsworth, C. L., and Feig, L. A. (1991) A mutation in the putative Mg(2+)-binding site of Gs alpha prevents its activation by receptors. Mol Cell Biol 11, 4830–8. 35. Chen, S. Y., Huff, S. Y., Lai, C. C., Der, C. J., and Powers, S. (1994) Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guaninenucleotide resistant complex with CDC25 exchange factor. Oncogene 9, 2691–8. 36. Wu, T. H., and Marinus, M. G. (1994) Dominant negative mutator mutations in the mutS gene of Escherichia coli. J Bacteriol 176, 5393–400. 37. Jelic, M., Soll, J., and Schleiff, E. (2003) Two Toc34 homologues with different properties. Biochemistry 42, 5906–16. 38. Aronsson, H., Combe, J., Patel, R., and Jarvis, P. (2006) In vivo assessment of the significance of phosphorylation of the Arabidopsis chloroplast protein import receptor, atToc33. FEBS Lett 580, 649–55. 39. Oreb, M., Zoryan, M., Vojta, A., Maier, U. G., Eichacker, L. A., and Schleiff, E. (2007) Phospho-mimicry mutant of atToc33 affects early development of Arabidopsis thaliana. FEBS Lett 581, 5945–51. 40. Anderson, J. C., Pascuzzi, P. E., Xiao, F., Sessa, G., and Martin, G. B. (2006) Host-mediated phosphorylation of type III effector AvrPto promotes Pseudomonas virulence and avirulence in tomato. Plant Cell 18, 502–14. 41. Xiao, F., Giavalisco, P., and Martin, G. B. (2007) Pseudomonas syringae type III effector AvrPtoB is phosphorylated in plant cells on serine 258, promoting its virulence activity. J Biol Chem 282, 30737–44. 42. Champagne, J., Laliberte-Gagne, M. E., and Leclerc, D. (2007) Phosphorylation of the termini of Cauliflower mosaic virus precapsid protein is important for productive infection. Mol Plant Microbe Interact 20, 648–58. 43. Citovsky, V., McLean, B. G., Zupan, J. R., and Zambryski, P. (1993) Phosphorylation of tobacco mosaic virus cell-to-cell movement protein by a developmentally regulated plant cell wall-associated protein kinase. Genes Dev 7, 904–10. 44. Van Leene, J., Stals, H., Eeckhout, D., Persiau, G., Van De Slijke, E., Van Isterdael, G., De Clercq, A., Bonnet, E., Laukens, K., Remmerie, N.,

137

Henderickx, K., De Vijlder, T., Abdelkrim, A., Pharazyn, A., Van Onckelen, H., Inze, D., Witters, E., and De Jaeger, G. (2007) A tandem affinity purification-based technology platform to study the cell cycle interactome in Arabidopsis thaliana. Mol Cell Proteomics 6, 1226–38. 45. Nieuwland, J., Menges, M., and Murray, J. A. (2007) The plant cyclins, in Cell Cycle Control and Plant Development (Inze, D., Ed.), John Wiley & Sons Inc. 46. Boruc, J., Van den Daele, H., Hollunder, J., Rombauts, S., Mylle, E., Hilson, P., Inze, D., De Veylder, L., and Russinova, E. (2010) Functional modules in the Arabidopsis core cell cycle binary protein-protein interaction network. Plant Cell 22, 1264–80. 47. Van Leene, J., Hollunder, J., Eeckhout, D., Persiau, G., Van De Slijke, E., Stals, H., Van Isterdael, G., Verkest, A., Neirynck, S., Buffel, Y., De Bodt, S., Maere, S., Laukens, K., Pharazyn, A., Ferreira, P. C., Eloy, N., Renne, C., Meyer, C., Faure, J. D., Steinbrenner, J., Beynon, J., Larkin, J. C., Van de Peer, Y., Hilson, P., Kuiper, M., De Veylder, L., Van Onckelen, H., Inze, D., Witters, E., and De Jaeger, G. (2010) Targeted interactomics reveals a complex core cell cycle machinery in Arabidopsis thaliana. Mol Syst Biol 6, 397. 48. Lorca, T., Labbe, J. C., Devault, A., Fesquet, D., Capony, J. P., Cavadore, J. C., Le Bouffant, F., and Doree, M. (1992) Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. Embo J 11, 2381–90. 49. Bourne, Y., Watson, M. H., Hickey, M. J., Holmes, W., Rocque, W., Reed, S. I., and Tainer, J. A. (1996) Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1. Cell 84, 863–74. 50. Brown, N. R., Noble, M. E., Endicott, J. A., and Johnson, L. N. (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol 1, 438–43. 51. DeLano, W. L. (2005), DeLano Scientific LLC, San Carlos, CA, USA. 52. Brizuela, L., Draetta, G., and Beach, D. (1987) p13suc1 acts in the fission yeast cell division cycle as a component of the p34cdc2 protein kinase. Embo J 6, 3507–14. 53. Arion, D., Meijer, L., Brizuela, L., and Beach, D. (1988) cdc2 is a component of the M phasespecific histone H1 kinase: evidence for identity with MPF. Cell 55, 371–8. 54. Azzi, L., Meijer, L., Reed, S. I., Pidikiti, R., and Tung, H. Y. (1992) Interaction between the cell-cycle-control proteins p34cdc2 and

138

N. Dissmeyer and A. Schnittger

p9CKShs2. Evidence for two cooperative binding domains in p9CKShs2. Eur J Biochem 203, 353–60. 55. De Veylder, L., Segers, G., Glab, N., Casteels, P., Van Montagu, M., and Inze, D. (1997) The Arabidopsis Cks1At protein binds the cyclindependent kinases Cdc2aAt and Cdc2bAt. FEBS Lett 412, 446–52. 56. Stals, H., Casteels, P., Van Montagu, M., and Inze, D. (2000) Regulation of cyclin-dependent kinases in Arabidopsis thaliana. Plant Mol Biol 43, 583–93. 57. Landrieu, I., Casteels, P., Odaert, B., De Veylder, L., Portetelle, D., Lippens, G., Van Montagu, M., and Inze, D. (1999) Recombinant production of the p10CKS1At protein from Arabidopsis thaliana and 13C and 15N doubleisotopic enrichment for NMR studies. Protein Expr Purif 16, 144–51. 58. Weinl, C., Marquardt, S., Kuijt, S. J., Nowack, M. K., Jakoby, M. J., Hülskamp, M., and Schnittger, A. (2005) Novel Functions of Plant Cyclin-Dependent Kinase Inhibitors, ICK1/KRP1, Can Act Non-CellAutonomously and Inhibit Entry into Mitosis. Plant Cell. 59. Koncz, C., and Schell, J. (1986) The promoter of TL-DNA gene 5 controls the tissue-specific expression of chimaeric genes carried by a novel type of Agrobacterium binary vector. Mol Gen Genet 204, 383–396. 60. Brooks, G. (2005) Cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors: detection methods and activity measurements. Methods Mol Biol 296, 291–8. 61. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–5. 62. Harlow, E., and Lane, D. (1988) Antibodies: a laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 63. Bögre, L., Zwerger, K., Meskiene, I., Binarova, P., Csizmadia, V., Planck, C., Wagner, E., Hirt, H., and Heberle-Bors, E. (1997) The cdc2Ms Kinase Is Differently Regulated in the Cytoplasm and in the Nucleus. Plant Physiol 113, 841–852. 64. Fantes, P., and Brooks, R. (1993) The Cell cycle: a practical approach, IRL Press at Oxford University Press, Oxford; New York. 65. Pagano, M. (1996) Cell cycle: materials and methods, Berlin: Springer, c1996. 66. Dunphy, W. G. (1997) Cell cycle control, Vol. 283, Academic Press, San Diego. 67. Pines, J., Jackman, M., and Simpson, K. (2001) Assays for CDK activity and DNA replication in the cell cycle. Curr Protoc Cell Biol Chapter 8, Unit 8 2.

68. Carter, A. N. (2001) Assays of protein kinases using exogenous substrates. Curr Protoc Mol Biol Chapter 18, Unit 18 7. 69. Slater, R. J. (2002) Radioisotopes in biology: a practical approach, Oxford University Press, Oxford; New York. 70. Ballance, P. E., Day, L. R., Morgan, J., and Association of University Radiation Protection, O. (1992) Phosphorus-32: practical radiation protection, H and H Scientific Consultants, Leeds. 71. Meisenhelder, J., and Bursik, S. (2007) Safe use of radioisotopes. Curr Protoc Mol Biol Appendix 1, Appendix 1F. 72. Karimi, M., Inze, D., and Depicker, A. (2002) GATEWAY vectors for Agrobacterium-mediated plant transformation. Trends Plant Sci 7, 193–5. 73. Sambrook, J., and Russell, D. W. (2001) Molecular cloning: a laboratory manual, 3rd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 74. Clough, S. J., and Bent, A. F. (1998) Floral dip: a simplified method for Agrobacteriummediated transformation of Arabidopsis thaliana. Plant J 16, 735–43. 75. Berendzen, K., Searle, I., Ravenscroft, D., Koncz, C., Batschauer, A., Coupland, G., Somssich, I. E., and Ulker, B. (2005) A rapid and versatile combined DNA/RNA extraction protocol and its application to the analysis of a novel DNA marker set polymorphic between Arabidopsis thaliana ecotypes Col-0 and Landsberg erecta. Plant Methods 1, 4. 76. Connell-Crowley, L., and Harper, J. W. (1995) Bacterial expression and in  vitro assay of cell cycle kinases, in Cell Cycle – Materials and Methods (Pagano, M., Ed.) pp 157–168, Springer, Berlin; New York. 77. Gordon, J. A. (1991) Use of vanadate as proteinphosphotyrosine phosphatase inhibitor. Methods Enzymol 201, 477–82. 78. Matejovicova, M., Mubagwa, K., and Flameng, W. (1997) Effect of vanadate on protein determination by the coomassie brilliant blue microassay procedure. Anal Biochem 245, 252–4. 79. Shareef, M. M., and Shetty, K. T. (1998) Effect of vanadate on different forms of Coomassie brilliant blue and protein assay. Anal Biochem 258, 143–6. 80. Prince, A. M., and Andrus, L. (1992) PCR: how to kill unwanted DNA. Biotechniques 12, 358–60. 81. Schönthal, A. H. (2004) Measuring cyclindependent kinase activity. Methods Mol Biol 281, 105–24.

Chapter 7 Bacterial Assay to Study Plant Sensor Histidine Kinases Lukáš Spíchal Abstract Cytokinins, like other phytohormones, act in plants as signaling molecules at very low concentrations. The system that mediates between their chemical recognition and the responses that they induce requires a hormone receptor that, together with down-stream located elements, forms a signaling network, converting the signal into a specific response. Identification of the cytokinin-binding histidine kinases CRE1/AHK4, AHK3, and AHK2 as cytokinin receptors in Arabidopsis was an important milestone in the elucidation of cytokinin signal transduction pathways. Their molecular characterization through the use of transgenic E. coli strains revealed that a variety of cytokinin compounds may have signaling functions, but only with specific receptors. This indicates that differential ligand specificities of the receptors may be a mechanism to fine-tune the various cytokinin responses. This chapter describes the detailed protocol of a method employing transgenic E. coli which substantially contributes to our understanding of cytokinin perception, a crucial step in the cytokinin regulation of diverse plant growth and development processes. Key words: Sensor histidine kinase, AHK3, CRE1/AHK4, Hormone receptor, Cytokinin, Transgenic Escherichia coli, Arabidopsis thaliana

1. Introduction In 2001 receptors of cytokinins (an important group of plant hormones) were identified as members of the family of histidine kinases (1, 2). Histidine kinases form the sensor part of two-component signal transduction pathways that are known to respond to various external stimuli in prokaryotes and lower eukaryotes. Their function in perception of cytokinins in higher plants was confirmed using heterologous complementation of yeast and bacterial twocomponent regulatory pathways ((1, 2), reviewed in ref. 3). In the latter case, expression of histidine kinases CRE1/AHK4 and AHK3 in the eubacterium E. coli resulted in the first demonstration of

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_7, © Springer Science+Business Media, LLC 2011

139

140

L. Spíchal

functional complementation of an E. coli sensor mutant by a plant receptor gene (2, 4). AHK histidine kinases share some structural features with the RcsC receptor, the part of the two-component signaling pathway that leads to activation of the cps (capsular polysaccharide synthesis) operon through phosphorylation of the Hpt element YojN and the response regulator RscB (5). When CRE1/ AHK4 or AHK3 are expressed in the DrcsC and cps::lacZ mutant strain, b-galactosidase, which can easily be determined quantitatively, is produced in the presence of cytokinin (Fig. 1). This bacterial assay has been used to confirm the ability of cytokinin receptors

Fig. 1. Bacterial assay based on expression of histidine kinases CRE1/AHK4 and/or AHK3 in E. coli sensor mutant. AHK histidine kinases share some structural features with the RcsC receptor, the part of the two-component signaling pathway leading to activation of the cps operon through the phosphorylation of the Hpt element YojN and the response regulator RscB (5). Activation of the cytokinin receptor in the DrcsC and cps::lacZ mutant strain can easily be scored by quantitative fluorometric assay using the fluorogenic substrate of b-galactosidase, MUG and/or by the formation of blue colonies on X-Gal-containing medium. Abbreviations: D receiver domain, Da and Db receiver domains of a and b, respectively, H histidine kinase, MUG 4-methyl umbelliferyl galactoside, X-Gal 5-bromo-4-chloro-3-indolyl-b-d-galactoside. This figure is displayed in greyscale in the print edition but available in color in the electronic version.

7  Bacterial Assay to Study Plant Sensor Histidine Kinases

141

of Arabidopsis thaliana and Zea mays to perceive cytokinins in vitro and for their molecular and biochemical characterization (1–3, 6, 7). This works revealed that the receptors recognize naturally occurring isoprenoid and aromatic cytokinins and also, albeit to varying extents, synthetic cytokinins derived from phenylurea. Furthermore, they allowed the demonstration that individual receptors of Arabidopsis and maize differ in ligand specificity, being most sensitive to the bases of the isoprenoid-type cytokinins trans-zeatin and isopentenyladenine but differing significantly in the recognition of cytokinin ribosides and ribotides. Using this assay cis-zeatin, which was generally believed to be an inactive or only weakly active cytokinin, was shown to activate some of the Arabidopsis and maize cytokinin receptors. Doležal et al. have used the assay to study the biological activity of aromatic cytokinins. Whereas the majority of synthetic derivatives of N6-benzyladenine prepared in this work exhibited high activity in classical cytokinin bioassays (the tobacco callus growth, wheat leaf senescence, and Amaranthus bioassays), surprisingly all were recognized with much lower sensitivity than trans-zeatin in both the A. thaliana AHK3 and AHK4 receptor assays (8). Together the results obtained employing the bacterial receptor assay indicated that differences in the ligand specificities of the receptors may be a way of fine-tuning the various cytokinin responses and that diverse cytokinin compounds might have specific functions which depended on the different receptors for them and the associated signaling pathways. Romanov et al. used the approach described above to characterize the interaction of the receptor with cognate ligand, employing intact transgenic bacteria expressing a functionally active eukaryotic receptor protein CRE1/AHK4 and AHK3 in binding assays and comparing the binding data with results obtained from isolated membranes (9, 10). They showed that these strains can be used in a live cell hormone-binding assay to determine the most important characteristics of the hormone–receptor interaction. The detailed protocol is described by Romanov in ref. 11. The assay described here in this chapter can be used as rapid and sensitive cytokinin bioassay. The short incubation time (up to a few hours) reduces metabolic conversion of the tested compounds and the breakdown that usually occurs in plant tissues during the long-term incubation necessary in classical cytokinin bioassays. The assay also offers the advantages of allowing the use of 96-well plates to both culture the bacteria and subsequently to determine marker enzyme activity. This makes the assay a highthroughput procedure allowing different concentrations of a number of compounds to be tested with a high degree of replication in one run. In comparison to published alternative yeast assays (1, 2), the bacterial assay is more convenient because of the antibiotic resistance of receptor-expressing bacteria, obviating the need for strictly sterile conditions during performance of the test. Using

142

L. Spíchal

this method, activation of cytokinin receptors can easily be scored by the formation of blue colonies on X-Gal-containing media and/ or by quantitative fluorometric assay using the fluorogenic substrate of b-galactosidase MUG.

2. Materials 2.1. Control of AHK-Expressing Strain Identity

1. Solid M9 minimal medium: 47.76 mM Na2HPO4, 22.2 mM KH2PO4, 8.6 mM NaCl, 18.7 mM NH4Cl, 2.0 mM MgSO4, 22.2 mM glucose, 0.1 mM CaCl2; for right procedure of media preparation follow detailed protocol (12). 2. M9 minimal medium supplemented with 0.1% (w/v) casamino acids (casein hydrolysate, acid hydrolyzed; Merck): first dissolve agar in water (at 15 g/L in the volume recommended in the standard protocol for liquid media) and sterilize by autoclaving. To sterile agar solution, cooled to approximately 50°C, add salts following the standard protocol for liquid media and supplement with 0.1% (v/v) casamino acids (20% stock solution in water sterilized by passing through a 0.22-mm filter, store at 4°C). Add antibiotics before filling the plates. Solid M9 medium (without antibiotics) is stored at room temperature. 3. Antibiotics: ampicilin/carbenicilin for culturing of CRE1/ AHK4 and chloramphenicol for culturing of AHK3-expressing bacteria (see Note 1). 4. Control cytokinins: 10 mM stock solutions of trans-zeatin or N 6-benzyladenine in 100% DMSO, store at −20°C. Working solutions are prepared by dilution in sterile water to 100 mM (final concentration of DMSO is 1%). 5. 20 mg/mL 5-bromo-4-chloro-3-indolyl-b-d-galactoside (X-Gal; Sigma): dissolve in N,N-dimethylformamide, store in 0.5 mL aliquots at −20°C. 6. Standard sterile Petri dishes (10 cm).

2.2. Preparation of Preculture and Culture of Cells in a 96-Well Plate

1. E. coli strains KMI001 (DrcsC, cps::lacZ) carrying the vectors pINIIIDEH or pSTV28, which expresses the Arabidopsis histidine kinases CRE1/AHK4 and AHK3, respectively (2, 4). 2. Liquid M9 minimal medium (12) supplemented with 0.1% (w/v) casamino acids (casein hydrolysate, acid hydrolyzed; Merck) and antibiotics (ampicilin/carbenicilin, and chloramphenicol for culturing of CRE1/AHK4- and AHK3-expressing bacteria, respectively (see Note 1)). Complete liquid M9 medium is stored at 4°C. 3. Casamino acids are dissolved at 20% (w/v) in water, sterilized by passing through a 0.22-mm filter before adding to M9 diluted salts. The stock casamino acid solution is stored at 4°C.

7  Bacterial Assay to Study Plant Sensor Histidine Kinases

143

4. Sterile standard microtiter plates with six wells (for cultivation of preculture; for alternative see Note 2) and 96 wells (for bacterial assay). 5. Multichannel and multistep pipettes. 6. Thermomixer for incubation in microtiter plates (see Note 3). 2.3. Measurement of b-Galactosidase Activity in a 96-Well Microtiter Plate

1. 4-Methyl umbelliferyl galactoside (MUG, Sigma) is dissolved in dimethyl sulfoxide (DMSO) at 25 mM and stored in 0.5 mL aliquots at −20°C (see Note 4). 2. 4-Methyl umbelliferone (4MU) standard: 50  nM 4MU in glycine carbonate stop buffer, prepared just before use from 1 mM water stock (store at 4°C, away from light). 3. Glycine carbonate stop buffer: 133  mM glycine, 83  mM Na2CO3, pH 10.7 with concentrated NaOH. 4. Nonsterile standard microtiter 96-well plates (see Note 5). 5. Multichannel and multistep pipettes. 6. Spectrophotometer for measurement of absorbance/optical density in microtiter plates (see Note 6). 7. Fluorometer for measurement of fluorescence in microtiter plates (e.g., Fluoroscan Ascent, Labsystems), excitation and emission wavelengths of 365 and 460 nm, respectively.

3. Methods The assay consists of bacterial cultivation and measurement of b-galactosidase activity, both in 96-well microtiter plate. Before carrying out the assay the identity of stored bacterial strain should be checked. In the case of newly transformed bacteria, it is recommended that the kinetics of cytokinin-dependent induction of b-galactosidase (b-gal) activity is checked, using standard cytokinin (e.g., trans-zeatin or isopentenyladenine) so that the preculture dilution and time of culturing can be optimized. The assay should always include controls: a positive control with standard cytokinin, a negative control (e.g., adenine), a noninduced control and, importantly, a solvent control (solvents can increase background readings). Note that precise temperature control is very important to obtain reproducible results. 3.1. Control of AHK-Expressing Strain Identity

1. The Petri dishes are filled in a flow-box with solid M9 medium containing an appropriate antibiotic. 2. 20 mL of 100 mM cytokinin and 25 mL of X-Gal are applied on the surface of solid media and stirred till dry. Dishes without cytokinin are used as a control.

144

L. Spíchal

3. The bacteria are streaked from frozen culture (or culture freshly prepared by transformation) and cultivated 1–2 days at 25°C in the dark. Active colonies are stained blue compared to the white control. 3.2. Preparation of Preculture and Culture of Cells in a 96-Well Plate

1. The E. coli strains are grown overnight at 25°C (see Note 3) in liquid M9 media enriched with 0.1% casamino acids and antibiotics until the OD600 reaches approx. 1. Such precultures can be stored at 4°C up to 4 days. 2. The preculture is diluted 1:600 (see Note 7) in M9 medium (containing 0.1% casamino acids and antibiotics) to a volume that is sufficient to fill up every well of a 96-well plate with 200 mL of the diluted culture (minimum volume required is 20 mL). 3. 1 mL stock solution of either the tested compound or solvent control is added and cultures are further grown while shaking for 17 h at 25°C in a thermomixer (see Note 8).

3.3. Measuring of b-Galactosidase Activity in a 96-Well Microtiter Plate

1. 50  mL aliquots of the culture are transferred to a microtiter plate containing 2 mL of 25 mM MUG/well. The plate is subsequently incubated for 30  min at 37°C and the reaction is stopped by adding 100 mL glycine carbonate stop buffer. 2. During the incubation the OD600 of remaining culture is determined using a spectrophotometer designed to measure samples in microtiter plates (see Note 9). 3. Fluorescence is measured using a fluorometer for measuring in mictrotiter plates at the excitation and emission wavelengths of 365 and 460 nm, respectively. The 4MU standard is used to generate a calibration curve. 4. b-Galactosidase activity is calculated as nmol 4-methylumbelliferone × OD600−1 × h−1 (see Note 10).

4. Notes 1. Stocks of antibiotics are prepared, stored, and added to M9 media as recommended in standard laboratory manuals. We use a concentration of 50  mg/mL (w/v) for preparing the stock solution and add this to the working solution at 50 mg/ mL (w/v). We recommend the use of carbenicilin instead of ampicilin due to its better stability in the medium. 2. Alternatively, the preculture can be prepared in the standard way, e.g., in 10 mL glass tubes with a screw cap. However, the cultivation temperature is critical (as described in Note 3) and

7  Bacterial Assay to Study Plant Sensor Histidine Kinases

145

the use of a six-well plate for the preparation of precultures in a thermomixer designed for mixing microtiter plates gives the advantage of precisely controlled and reproducible conditions. 3. The temperature is very critical. Cultivation at temperatures higher than 25°C leads to the formation of inclusion bodies and decreases the proportion of functional cytokinin receptors bound to bacteria plasma membranes. Thus, the capacity of bacteria to perceive cytokinin is decreased. A thermomixer with a high level temperature stability thermoblock (with cooling), designed for incubating and mixing aqueous solutions in microtiter plates (e.g., Thermomixer comfort, Eppendorf) is highly recommended to increase reproducibility of the assay. The uniformity of heating allows the use of all wells of the 96-well microtiter plate. 4. Do not expose the solution to light during the assays; aluminum foil can be used to cover the tubes. 5. For the measurement of b-galactosidase activity, sterile conditions are not needed. The use of nonsterile standard microtiter plates thus decreases the expenses for the assay. 6. A spectrophotometer to measure the OD600 of the culture directly in the microtiter plates (e.g., Tecan Sunrise) is needed. 7. Dilution depends on the time adjustment of the cultivation. Growth curves of bacteria grown in wells of microtiter plate from different dilutions should be checked. It is better to avoid performing the assaying with the culture in its late stationary phase of growth, and thus two parameters – the time and dilution of the preculture – can be combined. One should also keep in mind the time course of the experiment; overnight (17 h) culturing with a starting dilution of 1:600 was appropriate. We suggest optimizing the conditions so that the standard cytokinin control reaches the receptor saturation at the highest concentration applied. An example of the kinetics of cytokinindependent induction of b-galactosidase activity in E. coli expressing CRE1/AHK4 and cultivated for different times with a starting dilution of 1:100 is shown in Fig. 2. 8. Especially when different concentrations of a compound are assayed, the tested compound can be predissolved separately in volumes sufficient for triplicate assays. After the wells of a 96-well plate have been filled, a multichannel pipette can be used to further dilute the culture containing the highest concentration of tested compound directly in the plate. This saves time and allows the testing of compounds in over a range of concentrations so that dose-dependent curves of cytokinin-like

146

L. Spíchal

Fig. 2. Kinetics of cytokinin-dependent induction of b-galactosidase activity in E. coli. CRE1/ AHK4-expressing E. coli were incubated with different concentrations of trans-zeatin for the indicated time. The preculture was diluted 1:100. The b-galactosidase activity in the noninduced strain (control) is indicated by the dotted line. Error bars show SD (n = 2).

activity can be constructed. Because the temperature is very critical, the use of a special incubator for microtiter plates with high temperature uniformity (see Note 3) is recommended, otherwise reproducibility of the test may be affected in different parts of the plate. 9. Alternatively, the cultures can be centrifuged using adapters for centrifugation of microtiter plates and 50  mL aliquots of the supernatant can then be used for measurements of enzyme activity. In this case, the OD600 of each culture has to be determined before centrifugation. 10. Specific activity of enzymes is usually expressed per unit of protein. The measurement of total protein content would involve cell lysis of 96 samples, which is time-consuming and can be problematic because of the volume and number of samples. To simplify the assay and avoid measurement of total protein content, the OD600 of each culture is used instead as the total amount of biomass reflects the total protein content.

Acknowledgments I thank Miroslav Strnad, Thomas Schmülling, and David Morris for their helpful suggestions and critical reading of the manuscript. This work was supported by the Grant Agency of the Czech Republic (522/07/P197) and the Czech Ministry of Education (MSM 6198959216 and LC06034).

7  Bacterial Assay to Study Plant Sensor Histidine Kinases

147

References 1. Inoue, T., Higuchi, M., Hashimoto, Y., Seki, M., Kobayashi, M., Kato, T., Tabata, S., Shinozaki, K., and Kakimoto,T. (2001) Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature 409, 1060–1063. 2. Suzuki, T., Miwa, K., Ishikawa, K., Yamada, H., Aiba, H., and Mizuno, T. (2001) The Arabidopsis sensor His-kinase, AHK4, can respond to cytokinins. Plant Cell Physiol. 42, 107–113. 3. Schmülling, T. (2001) CREam of cytokinin signalling: receptor identified. Trends Plant Sci. 6, 281–284. 4. Yamada, H., Suzuki, T., Terada, K., Takei, K., Ishikawa, K., Miwa, K., Yamashino, T., and Mizuno, T. (2001) The Arabidopsis AHK4 histidine kinase is a cytokinin-binding receptor that transduces cytokinin signals across the membrane. Plant Cell Physiol. 42, 1017–1023. 5. Takeda, S., Fujisawa, Y., Matsubara, M., Aiba, H., and Mizuno, T. (2001) A novel feature of the multistep phosphorelay in Escherichia coli: a revised model of the RcsC → YojN → RcsB signalling pathway implicated in capsular synthesis and swarming behaviour. Mol. Microbiol. 40, 440–450. 6. Spíchal, L., Rakova, N.Y., Riefler, M., Mizuno, T., Romanov, G.A., Strnad, M., and Schmülling, T. (2004) Two cytokinin receptors of Arabidopsis thaliana, CRE1/AHK4 and AHK3, differ in their ligand specificity in a bacterial assay. Plant Cell Physiol. 45, 1299–1305.

7. Yonekura-Sakakibara, K., Kojima, M., Yamaya, T., and Sakakibara, H. (2004) Molecular characterization of cytokinin-responsive histidine kinases in maize. Differential ligand preferences and response to cis-zeatin. Plant Physiol. 134, 1654–1661. 8. Doležal, K., Popa, I., Kryštof, V., Spíchal, L., Fojtíková, M., Holub, J., Lenobel, R., Schmülling, T., and Strnad, M. (2006) Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells. Bioorg. Med. Chem. 14, 875–884. 9. Romanov, G.A., Spíchal, L., Lomin, S.N., Strnad, M., and Schmülling, T. (2005) A live cell hormone-binding assay on transgenic bacteria expressing a eukaryotic receptor protein. Anal. Biochem. 347, 129–134. 10. Romanov, G.A., Lomin, S.N., and Schmülling, T. (2006) Biochemical characteristics and ligand-binding properties of Arabidopsis cytokinin receptor AHK3 compared to CRE1/ AHK4 as revealed by a direct binding assay. J.Exp.Bot. 57, 4051–4058. 11. Romanov G.A., Lomin S.N. Hormone-binding assay using living bacteria expressing eukaryotic receptors. In: Methods in Molecular Biology, Plant Hormone Protocols (2nd Ed.). Humana Press. 2007. 12. Sambrook, J., and Russell D.W. (2001) Molecular Cloning: A Laboratory Manual, third ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.

wwwwwwwwwwwwwwwww

Chapter 8 Substrate Analysis of Arabidopsis PP2C-Type Protein Phosphatases Julija Umbrasaite, Alois Schweighofer, and Irute Meskiene Abstract Protein phosphorylation by protein kinases can be reversed by the action of protein phosphatases. In plants, the Ser/Thr-specific phosphatases dominate among the protein phosphatase families with the type 2C protein phosphatases (PP2Cs) being the most abundant among them. PP2Cs are monomeric enzymes that require metal cations for their activity and are insensitive to known phosphatase inhibitors. PP2Cs were shown to counteract the mitogen-activated protein kinase (MAP kinase/MAPK) activities in plants and to regulate developmental and stress signaling pathways. Studies of PP2C activities can be performed in vitro using recombinant proteins. The potential substrates of PP2Cs can be tested for dephosphorylation by the phosphatase in vitro. We have found that the stress-induced PP2Cs from alfalfa and Arabidopsis interact with stress-activated MAPKs in yeast two-hybrid (Y2H) screens. Consequently, recombinant MAPKs were employed as substrates for dephosphorylation by selected PP2Cs from different family clusters. The members of the PP2C phosphatase family demonstrated specificity toward the substrate already in vitro, supporting the notion that protein phosphatases are specific enzymes. The PP2C from Arabidopsis thaliana cluster B, Arabidopsis PP2C-type phosphatase (AP2C1), and its homolog from Medicago sativa, Medicago PP2C-type phosphatase (MP2C), were able to dephosphorylate and inactivate MAPKs, whereas the ABSCISIC ACID (ABA)-INSENSITIVE 2 (ABI2) and HOMOLOGY TO ABI1 (HAB1) PP2Cs from the distinct Arabidopsis cluster A were not able to do so. The method described here can be used for the determination of PP2C protein activity and for studying the effect of mutations introduced into their catalytic domains. Key words: protein phosphatase, PP2C, specificity of protein phosphatases, specificity to substrate, selectivity of substrate, protein kinase, mitogen-activated protein kinase, MAPK, MPK6, AP2C1, HAB1, ABI2, in vitro dephosphorylation, Arabidopsis, loss-of-function phosphatase

1. Introduction Reversible protein phosphorylation, performed by protein kinases (PKs) and protein phosphatases (PPs), is one of the most common mechanisms to control protein function and thereby regulating N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_8, © Springer Science+Business Media, LLC 2011

149

150

J. Umbrasaite et al.

multiple processes in plants. Phosphorylation, performed by PKs, can be reversed by the action of PPs, leading to the dephosphorylation of substrate proteins. A variety of proteins can be targets for the reversible protein phosphorylation, including protein kinases themselves. PKs are represented by 1,126 members in Arabidopsis and 1,496 in rice (Oryza sativa) according to the Kinomer v. 1.0 database (http://www.compbio.dundee.ac.uk/kinomer/) (1) and the Rice Kinase Database (http://rkd.ucdavis.edu/) (2), respectively (see Note 1). Interestingly, PPs are represented only by 150 members in Arabidopsis (3, 4) and 194 phosphatase loci in rice (Rice Genome Annotation; see Note 1; (2, 5)). The discrepancy in gene numbers between kinases and phosphatases might create the impression that PPs are “pleiotropic” enzymes that would dephosphorylate protein substrates unspecifically. However, physiological studies have shown that different stimuli modulate a subset of phosphorylation events to regulate selected aspects of mammalian cell physiology (6) and plant PP2Cs show specificity in substrate recognition and dephosphorylation (7, 8). Our results demonstrate that even members from the same phosphatase family retain strict specificity toward the protein substrate in vivo and in vitro (7, 8), underlining the applicability for testing enzyme specificity already by in vitro assays. The specificity toward the protein substrate may be attained through gene expression, protein localization, regulatory proteins, and specific domains in protein structure. According to the structure and specificity to substrate phospho-amino acids (phosphoserine, phosphothreonine, and phosphotyrosine), eukaryotic PPs are classified into several families (9, 10). Protein tyrosine phosphatases (PTPs) dephosphorylate phosphotyrosine (tyrosine-specific PTPs) or all three amino acids (dual specificity protein phosphatases; DSPs), whereas phosphoprotein phosphatase (PPP), metallodependent protein phosphatase (PPM), and aspartate-based phosphatases (FCP-like and HAD-family phosphatases) dephosphorylate phosphoserine and phosphothreonine residues. PPP and PPM families represent the majority of eukaryotic serine/threonine phosphatases. They contain structurally similar protein catalytic sites, but the sequence divergence suggests that these families evolved independently (4). The PPM family is represented by the type 2C PPs (PP2Cs) that act as monomers, require Mn2+ or Mg2+ for their activity, and are insensitive to known phosphatase inhibitors, including okadaic acid (OA). Recently, compounds inhibiting the mammalian PP2Ca in  vitro at micromolar range have been identified (11). Among other regulators of PP2C activities, unsaturated fatty acids were observed to activate mammalian PP2Ca (12), but long-carbon-chain polyunsaturated fatty acids and a-linolenic acid inhibited MP2C, the PP2C from alfalfa (Medicago sativa; (13)). The identification of specific inhibitors would favor the analysis of numerous PP2C phosphatase groups in plants. In Arabidopsis, 76 members of the PP2C gene family (14) and four PP2C-like candidate genes (15) were identified by global

8  Substrate Analysis of Arabidopsis PP2C-Type Protein Phosphatases

151

Fig. 1. Scheme of action of plant PP2Cs. (a) Plant PP2C AP2C1/MP2C in the MAPK pathway and (b) the KIM-containing Arabidopsis PP2Cs of cluster B. This figure is displayed in greyscale in the print edition but available in color in the electronic version.

genome bioinformatics analysis. Only few of these phosphatases are characterized (10). The structural diversity of PP2Cs is attributed to N- or C-terminal extensions that harbor regulatory sequences. The N-terminal domain of several cluster B-PP2Cs from Arabidopsis contains a regulatory sequence, the MAPK-interacting motif (KIM) in the noncatalytic part of the protein (Fig. 1). MAPKs are known to mediate developmental and environmental signals from the cell membranes to the nucleus, where they regulate transcription factors and gene activities. The putative KIM motif [(K/R)3-4X1-6(L/I) X(L/I)] is identified in transcription factors, PKs (e.g., MAPK kinases/MAPKK/MAP2K/MEK/MKK), PPs, and other MAPKinteracting proteins in yeast, mammals, and plants (16, 17). The activities of MAPKs to perform their functions on substrate proteins depend on the phosphorylation of their activation loop. Plant PPs being able to dephosphorylate the MAPK-activation loop phosphoamino acids pTXpY are identified as MAPK phosphatases (MKPs). MKPs include enzymes from the DSP phosphatase subfamily (18–20) and from PP2Cs (7, 8). Both plant PTPs and PP2Cs that interact with and inactivate MAPKs contain the KIM motif (8, 21). PP2Cs are known as negative regulators of MAPKs in budding and fission yeasts (22–26), Drosophila (27, 28), and mammalian cells (29). In plants, stress-induced PP2Cs switch off MAPK signaling cascades (7, 8).

152

J. Umbrasaite et al.

Fig. 2. Y2H assays demonstrate MAPKs as potential substrates for AP2C1. (a) MAPK and AP2C1 interactions tested by yeast selection on SD media without adenine, (b) AP2C1 protein interactions tested with 18 Arabidopsis MAPKs. (c) Mutations in the phosphatase KIM motif consensus abolishes AP2C1 and MAPK interactions, (d) the alignment of KIM-motif found in Arabidopsis phosphatases MKP1, AP2C1, alfalfa MP2C, Arabidopsis MAPKK AtMKK4 with mouse and human transcription factor E-26-like protein (ELK)-KIM motif. Figure 2b,c is reproduced from Schweighofer et al. (8) http://www.plantcell.org, Copyright American Society of Plant Biologists. This figure is displayed in greyscale in the print edition but available in color in the electronic version.

Protein–protein interactions can be identified by Y2H assays or screens. The PP2C MP2C from Medicago suppresses the yeast pheromone-induced MAPK signaling pathway (26). MAPKs interacting with PP2C-type phosphatase MP2C and its Arabidopsis homolog PP2C-type phosphatase AP2C1 were identified in Y2H screens (7, 8). The specific interactions between AP2C1 and MPK4 or MPK6 were demonstrated by Y2H with 18 MAPKs (Fig. 2). To test whether the interacting proteins are the substrates for PP2Cs, the phosphatase activities toward the potential protein substrates were investigated in vitro. The activities of PP2Cs were tested on phosphocasein as a common substrate and recombinant MAPK proteins, phosphorylated in  vitro with 32P. AP2C1 recombinant protein dephosphorylated both substrates: phosphocasein and phospho-MPK6 (Fig. 3). Fig. 3. In vitro phosphatase assays. (a) Phosphatase activities of recombinant GST-fusions AP2C1, AP2C1lof, ABI2, and HAB1 proteins (0.1 mg used in each reaction) toward 32P-phosphocasein (12.5 mg used in each reaction) monitored by measuring the released free phosphate. (b and c) Phosphatase activities on [32P] phospho-GST-MPK6. (b) GST fusions of AP2C1, AP2C1lof, ABI2, and HAB1 proteins (0.5  mg per reaction) incubated with (~1  mg MPK6 per reaction), and the released free phosphate was measured by scintillation counter (c) kinetics of dephosphorylation reaction at 0, 30, and 60 min.

8  Substrate Analysis of Arabidopsis PP2C-Type Protein Phosphatases

153

154

J. Umbrasaite et al.

Thus, the analysis of phosphatase activities by recombinant protein approach provides the possibility to test if the phosphatase acts on the substrate kinase directly. To assess if the inactivation of MAPK by PP2Cs is specific, the activities of Arabidopsis PP2Cs, such as AP2C1 (14), HOMOLOGY TO ABI1 (HAB1; (30)) and ABSCISIC ACID (ABA)-INSENSITIVE 2 (ABI2; (31, 32)) were assayed on phospho-MPK6. AP2C1 is the closest homolog of Medicago MP2C and belongs to the cluster B of PP2Cs. ABI2 and HAB1 phosphatases belong to the cluster A of PP2Cs and are involved in abscisic acid (ABA)-signaling. All tested PP2Cs dephosphorylated the common substrate phosphocasein, but the specificity toward MAPKs was maintained in the PP2C cluster B as AP2C1 but not ABI2 and HAB1 was able to dephosphorylate MPK6. Both AP2C1 and MP2C, but not the PP2Cs from the A cluster, inactivated MAPKs also in isolated protoplasts (7, 8, 33). The identification of MAPKs as the substrates of PP2C phosphatase in vitro and the analysis of kinase activities in plants indicates the regulation of kinases by specific PP2Cs (7, 8). In contrast to AP2C1 wild-type recombinant protein, the AP2C1-G178D mutant (created based on the G180D loss-of-function mutation in the ABI1 phosphatase (abi1-1; (37))) of the AP2C1 phosphatase had low activity toward casein and MPK6 (Fig. 3). The phosphatase activity assay in vitro indicated that the point mutation in catalytic domain strongly reduces phosphatase activity of AP2C1 toward the casein and even stronger toward the substrate MAPK. The products of the dephosphorylation reaction in  vitro are measured in a scintillation counter as released inorganic phosphate (32Pi) during the dephosphorylation reaction, or they can be monitored by autoradiography after SDS-PAGE to visualize the phosphorylation of substrate proteins. The sets of experiments described above provide the tools to study PP2C phosphatase activities and investigate the potential substrates and inhibitors.

2. Materials 2.1. Isolation of Recombinant PP2C Proteins from E. coli

1. pGEX-4T-1 vector (GE Healthcare) containing the cDNA of PP2C. 2. E. coli strain BL21 (F-ompT hsdSB (rB- mB-) gal dcm). 3. LB media with 100 mg/mL ampicilin (LBAmp). 4. 1 M isopropyl-b-d-thiogalactopyranoside (IPTG; see Note 2). 5. Lysis buffer with and without protease inhibitors: 50  mM Tris–HCl (pH 8.0), 10 mM MgCl2, 150 mM NaCl, 1% (v/v) NP-40. Use 1 tablet of protease inhibitor cocktail (Roche) in 50 mL of lysis buffer, if required (see Note 3).

8  Substrate Analysis of Arabidopsis PP2C-Type Protein Phosphatases

155

6. GSH-sepharose 4B (GE Healthcare). 7. Elution buffer: 50  mM Tris–HCl (pH 8.0), 10  mM MgCl2, and 10 mM reduced GSH. 8. Coomassie Blue staining solution: 12.5% (v/v) glacial acetic acid, 50% (v/v) methanol, and 0.25% (w/v) Coomassie Briliant Blue R-250. 9. Destaining solution: 45% (v/v) methanol, 10% (v/v) acetic acid. 10. Polypropylene columns (Qiagen). 11. Bradford reagent (BioRad). 12. Sodium dodecyl sulfate (SDS) loading buffer (4×): 200 mM Tris–HCl (pH 6.8), 400 mM DTT, 8% (w/v) SDS, 40% (v/v) glycerol, and 0.1% (w/v) bromophenol blue. 13. 10–15% poly-acrylamide (PAA)/SDS gel. 14. SDS-running buffer: 0.025 M Tris base, 0.192 M glycine, and 0.1% (w/v) SDS. 15. Filter paper (3MM paper; Whatman). 16. 50 mL tubes (Falcon) and microcentrifuge tubes. 17. Vacuum dryer. 18. Optional: NanoDrop (Qiagen). 2.2. Phosphorylation of Substrate Casein by PKA

1. Partially dephosphorylated casein lysate (Sigma C-4765). 2. Bovine heart PK A catalytic subunit (PKA bovine heart A-kinase; Sigma P-2645). Reconstitute PKA catalytic subunit by adding 50 mM DTT to make 5 U/mL solution (see Note 4). 3. 10  mCi/mL [g-32P]-ATP, 6,000  Ci/mmol (Amersham Biosciences; see Note 5). 4. Kinase A buffer: 0.05 M Tris (pH 7.0), 5 mM MgCl2. 5. 20% (v/v) trichloroacetic acid (TCA) in 20 mM NaH2PO4. 6. Norit A solution: 0.9  M HCl, 90  mM Na4P2O7, 2  mM NaH2PO4, and 4% (w/v) Norit A (see Note 6). 7. Liquid scintillation counter. 8. 100 mM okadaic acid (from Prorocentrum concavum, Sigma) in DMSO. Aliquot and store in −20°C (see Note 7). 9. 0.2 M Tris (pH 8.0). Add okadaic acid to final concentration of 100 nM before use.

2.3. Phosphorylation of Substrate MAPK by MAPKK

1. 10 mCi/mL [g-32P]-ATP, 6,000 Ci/mmol. 2. Buffer I: 50  mM Tris–HCl (pH 8.0), 10  mM MgCl2, and 1 mM DTT. 3. PD-10 Desalting column (GE Healthcare).

156

J. Umbrasaite et al.

4. Norit A solution: 0.9  M HCl, 90  mM Na4P2O7, 2  mM NaH2PO4, and 4% (w/v) Norit A (see Note 6). 5. Liquid scintillation counter. 2.4. In Vitro Dephosphorylation of Substrates by PP2C

1. Phosphatase buffer: 50  mM Tris–HCl (pH 8.0), 10  mM MgCl2, 0.1 mM EGTA, and 1 mM DTT. Add okadaic acid to final concentration of 100 nM before use. 2. Norit A solution: 0.9  M HCl, 90  mM Na4P2O7, 2  mM NaH2PO4, and 4% (w/v) Norit A. 3. Liquid scintillation counter.

3. Methods 3.1. Isolation of Recombinant PP2C Proteins from E. coli

1. Inoculate E. coli strain BL21 containing GST-recombinant protein expression plasmid (pGEX-4T-1 containing the cDNA of PP2C) in 10  mL of LBAmp media and cultivate at 37°C overnight. 2. Dilute the overnight culture in 100 mL of LBAmp to OD600 of 0.1 and cultivate to OD600 of 0.8 at 37°C. 3. Save a 300-mL aliquot of the culture as a negative control before induction with IPTG. Centrifuge for 1  min at max speed in a microcentrifuge. Remove the supernatant and resuspend the pellet in 50 mL of running buffer and add SDS loading buffer (4×). Store at −20°C. 4. Add IPTG into the rest of the culture to a final concentration of 0.1–1 mM and cultivate at 28°C for 2 h (see Note 8). 5. For the control after the induction with IPTG, save a 300-mL aliquot of the culture. Centrifuge for 1  min at max speed. Remove the supernatant and resuspend in the pellet in 50 mL of running buffer and add SDS loading buffer (4×). Store at −20°C. 6. After 2 h of cultivation in the presence of IPTG, place the flask with the culture on ice for 2–3 min. 7. Aliquot the culture to two 50-mL tubes and centrifuge at 3,220 rcf (4,000 rpm Eppendorf 5810 R centrifuge) for 10 min at 4°C. 8. Discard the supernatant (see Note 9). 9. Resuspend the pellet in 20  mL of lysis buffer with protease inhibitors on ice. 10. Sonicate the suspension in the 50-mL tubes twice for 10 s with 1–2-min pause between the pulses. Keep the tube on ice all the time (see Note 10).

8  Substrate Analysis of Arabidopsis PP2C-Type Protein Phosphatases

157

11. Centrifuge at 23,400 rcf (14,000  rpm on Sorvall RC5C centrifuge) for 10 min at 4°C. 12. Transfer the supernatant to a new test tube and keep it on ice. 13. Add 150–200 mL of GSH-sepharose 4B and roll the mixture for 30 min at 4°C. Transfer the sepharose beads to the polypropylene column (see Note 11). 14. Wash the sepharose with 10 mL of lysis buffer containing protease inhibitors and three times (10 mL each) with lysis buffer without protease inhibitors. Let it flow through. 15. Elute GST-fused protein in five aliquots each with 100 mL of elution buffer. Collect the elution fractions into separate microcentrifuge tubes. 16. Measure protein concentration or by Bradford assay, if available with a NanoDrop. 17. For Bradford assay, mix in cuvettes 800 mL of water with 1 mL of protein aliquot from eluted fraction and 200 mL of Bradford reagent. Mix well by vortexing and measure with spectrophotometer at the wavelength of 595  nm and compare the data against the BSA calibration curve to calculate the values. 18. Mix 10 mL from each elution fraction with SDS loading buffer (4×), heat for 3 min at 95°C and run on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) together with 10 mL of each control. Control samples are taken before and after induction with IPTG. 19. Stain the PAA gel with Coomassie Blue solution to check protein size and evaluate relative amounts in eluted fractions. Place the PAA gel on filter paper and vacuum-dry at 80°C for 1 h. 20. Aliquot the protein elution fractions and store at −80°C. Avoid repeated thaw–freeze cycles (see Note 12). 3.2. The Phosphoryl­ ation of Substrate Casein by PKA

1. Add 100 mCi of [g-32P]-ATP to ~1 mg of casein and 25 U of PKA in 100 mL of kinase A buffer. 2. Incubate the reaction for 30 min at 30°C. 3. Stop the reaction by adding 500  mL of 20% (v/v) TCA (in 20 mM NaH2PO4) and keep the mixture for 20 min on ice. 4. Centrifuge the precipitates at max speed for 10 min at room temperature (RT). Discard the supernatant. 5. Wash the pellet with 0.7  mL of 20% (v/v) TCA in 20  mM NaH2PO4 and centrifuge at max speed for 1 min at RT. 6. Transfer 500  mL of the supernatant to new microcentrifuge tube. Measure the radioactivity of the supernatant in the scintillation counter. Repeat the washing until the radioactivity of the supernatant is less than 200 cpm (counts per minute). 7. Remove supernatant completely and resuspend the pellet in 400 mL of 0.2 M Tris pH (8.0) containing 100 nM okadaic acid.

158

J. Umbrasaite et al.

8. Measure the radioactivity of 5  mL of the labeled casein: mix 5  mL of labeled casein with 750  mL of Norit A solution. Incubate for 10 min at RT. Centrifuge for 5 min at max speed. Transfer 500  mL of the supernatant to new microcentrifuge tube. Place the tube into the scintillation vial and measure the radioactivity in the scintillation counter. The radioactivity of 5  mL of 32P-casein should be more than 200,000  cpm for a good dephosphorylation assay. 9. Aliquot the labeled casein and store at −20°C. Avoid repeated thawing and freezing; this preparation is stable up to 4 weeks. 3.3. The Phosphoryl­ ation of Substrate MAPK by MAPKK

The recombinant kinase-inactive MAPK (loss-of-function mutation in the ATP-binding site, such as K93R in Arabidopsis MPK6) and upstream activating MAPKK proteins are isolated from E. coli as described in Subheading 3.1. 1. Mix 25 mg of kinase-inactive MAPK with 1 mg of MAPKK and 50 mCi of [g-32P]-ATP in buffer I in 100-mL reaction volume. 2. Incubate the reaction for 1 h at 30°C. 3. Preequilibrate a PD-10 desalting column with buffer I according to the manufacturer’s recommendations. 4. Flow the solution through a PD-10 desalting column. 5. Elute proteins in 10 fractions of 500 mL each of buffer I, i.e., in overall 5 mL. 6. Measure the efficiency of the 32P-incorporation in each fraction: mix 5 mL of eluted fraction with 750 mL of Norit A solution. Incubate for 10 min at RT. Centrifuge for 5 min at max speed. Transfer 500 mL of the supernatant to a new microcentrifuge tube. Place the tube into the scintillation vial and measure the radioactivity in scintillation counter. Use only the fractions that give 15,000–75,000 cpm/5 mL.

3.4. In Vitro Dephosphorylation of Phosphocasein by PP2C

Mix 0.5–1 mg of isolated recombinant phosphatase with 5 mL of labeled casein in 50 mL of phosphatase buffer containing 100 nM okadaic acid. 1. Incubate the reaction for 30 min at 28°C. 2. Stop the reaction by adding 750 mL Norit A solution. Mix and incubate at RT for 10 min. 3. Centrifuge the mixture at max speed for 5 min. 4. Transfer 500 mL of supernatant to new microcentrifuge tube avoiding contamination of the sample with any charcoal particles (see Note 13). 5. Place the tube into the scintillation vial and measure the radioactivity of released 32P by scintillation counting.

8  Substrate Analysis of Arabidopsis PP2C-Type Protein Phosphatases

3.5. In Vitro Dephosphorylation of Phospho-MAPK by PP2C

159

1. Mix 0.5–1 mg of isolated recombinant phosphatase with 5 mL of labeled MAPK in 50 mL of phosphatase buffer containing 100 nM okadaic acid. 2. Incubate the reaction for 30 min at 28°C. 3. Stop the reaction by adding 750 mL of Norit A solution. Mix and incubate at RT for 10 min. 4. Centrifuge the mixture at max speed for 5 min. 5. Transfer 500 mL of supernatant to a new microcentrifuge tube avoiding contamination of the sample with any charcoal particles. 6. Place the tube into the scintillation vial and measure the radioactivity of released 32P by scintillation counting.

4. Notes 1. These databases can be accessed using the following Web addresses: Kinomer v. 1.0 database: http://www.compbio. dundee.ac.uk/kinomer/ (1) and Rice Kinase Database: http://rkd.ucdavis.edu/ (2). The Rice Genome Annotation: http://rice.plantbiology.msu.edu/ (2, 5). 2. Sterilize IPTG stock solution by filtration through a 0.2-mm filter. Aliquot and store at −20°C. 3. Add 1 tablet of protease inhibitor cocktail (Roche) in 50 mL of lysis buffer before use. 4. Use only freshly prepared PKA or store reconstituted PKA on ice for 2–3 days. Do not freeze-thaw the enzyme, as it will decrease its activity. 5. There are generally two products of [g-32P]-ATP of lower and higher specific activity (3,000 and 6,000 Ci/mmol) available. Use [g-32P]-ATP of the highest specific activity of 6,000 Ci/ mmol. 6. Mix well before use. Pipette with wide-open tip. 7. PP2C type phosphatases are insensitive to okadaic acid (34, 35) which specifically inhibits PP1 and PP2A PPs (36). 8. The concentration of IPTG may vary depending on the requirements for expressing the recombinant protein, i.e., on the nature of the vector and especially the E. coli strain used. Increase the concentration of IPTG, if needed, depending on the success and level of protein expression. 9. Completely remove the medium. At this point, the pellet can be stored in 50-mL tubes at −80°C.

160

J. Umbrasaite et al.

10. All the time during the protein extraction and purification, keep the proteins on ice and use prechilled, ice-cold solutions. 11. All the work of protein binding to sepharose, washing, and elution should be done in a cold room (4°C), using prechilled, ice-cold solutions. 12. Freezing–thawing of proteins will decrease enzyme activity. 13. Trapping charcoal particles in the supernatant might strongly affect the activity measurement; to reduce such a contamination, respin the sample, if necessary.

Acknowledgments We thank Haruo Saito, for providing us with the information on the method of yeast PP2C activity measurement. Our research is supported by grants from the Austrian Science Fund FWF (I255 L687), the Lithuanian Science Council, European Union COST action (FA0605), University of Vienna PhD Fellowship for J.U. and Marie Curie PostDoc Fellowship for A.S. References 1. Martin, D. M., Miranda-Saavedra, D. and Barton, G. J. (2009) Kinomer v. 1.0: a database of systematically classified eukaryotic protein kinases. Nucleic Acids Res 37, D244–50. 2. Dardick, C., Chen, J., Richter, T. et al. (2007) The rice kinase database. A phylogenomic database for the rice kinome. Plant Physiol 143, 579–86. 3. Kerk, D., Templeton, G. and Moorhead, G. B. (2008) Evolutionary radiation pattern of novel protein phosphatases revealed by analysis of protein data from the completely sequenced genomes of humans, green algae, and higher plants. Plant Physiol 146, 351–67. 4. Moorhead, G. B., De Wever, V., Templeton, G. et  al. (2009) Evolution of protein phosphatases in plants and animals. Biochem J 417, 401–9. 5. Yuan, Q., Ouyang, S., Wang, A. et al. (2005) The institute for genomic research Osa1 rice genome annotation database. Plant Physiol 138, 18–26. 6. Virshup, D. M. and Shenolikar, S. (2009) From promiscuity to precision: protein phosphatases get a makeover. Mol Cell 33, 537–45. 7. Meskiene, I., Baudouin, E., Schweighofer, A. et  al. (2003) The Stress-induced protein

phosphatase 2C is a negative regulator of a ­mitogen-activated protein kinase. J Biol Chem 278, 18945–18945. 8. Schweighofer, A., Kazanaviciute, V., Scheikl, E. et  al. (2007) The PP2C-type Phosphatase AP2C1, Which Negatively Regulates MPK4 and MPK6, Modulates Innate Immunity, Jasmonic Acid and Ethylene Levels in Arabidopsis. Plant Cell 19, 2213–24. 9. Cohen, P. T. (2004) in: Protein phosphatases, Vol. 5, pp. 1–20 (D. R. A. J. Arino, Ed.) Springer-Verlag, Berlin Heidelberg. 10. Schweighofer, A. and Meskiene, I. (2008) in: Plant Growth Signalling, Vol. 10, pp. 277–97 (L. Boegre, Ed.) Springer-Verlag, Heidelberg. 11. Rogers, J. P., Beuscher, A. E. t., Flajolet, M. et al. (2006) Discovery of protein phosphatase 2C inhibitors by virtual screening. J Med Chem 49, 1658–67. 12. Klumpp, S., Selke, D. and Hermesmeier, J. (1998) Protein phosphatase type 2C active at physiological Mg2+: stimulation by unsaturated fatty acids. FEBS Lett 437, 229–32. 13. Baudouin, E., Meskiene, I. and Hirt, H. (1999) Short Communication: Unsaturated fatty acids inhibit MP2C, a protein phosphatase 2C involved in the wound-induced

8  Substrate Analysis of Arabidopsis PP2C-Type Protein Phosphatases MAP kinase pathway regulation. Plant J 20, 343–348. 14. Schweighofer, A., Hirt, H. and Meskiene, I. (2004) Plant PP2C phosphatases: emerging functions in stress signaling. Trends Plant Sci 9, 236–43. 15. Kerk, D. (2006) Genome-Scale Discovery and Characterization of Class-Specific Protein Sequences: An Example Using the Protein Phosphatases of Arabidopsis thaliana. Methods Mol Biol 365, 347–70. 16. Ho, D. T., Bardwell, A. J., Abdollahi, M. et al. (2003) A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates. J Biol Chem 278, 32662–72. 17. Kiegerl, S., Cardinale, F., Siligan, C. et  al. (2000) SIMKK, a mitogen-activated protein kinase (MAPK) kinase, is a specific activator of the salt stress-induced MAPK, SIMK. Plant Cell 12, 2247–58. 18. Ulm, R., Ichimura, K., Mizoguchi, T. et  al. (2002) Distinct regulation of salinity and genotoxic stress responses by Arabidopsis MAP kinase phosphatase 1. EMBO J 21, 6483–93. 19. Lee, J. S. and Ellis, B. E. (2007) Arabidopsis MAPK phosphatase 2 (MKP2) positively regulates oxidative stress tolerance and inactivates the MPK3 and MPK6 MAPKs. J Biol Chem 282, 25020–9. 20. Lee, J. S., Wang, S., Sritubtim, S. et al. (2009) Arabidopsis mitogen-activated protein kinase MPK12 interacts with the MAPK phosphatase IBR5 and regulates auxin signaling. Plant J 57, 975–85. 21. Biondi, R. M. and Nebreda, A. R. (2003) Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem J 372, 1–13. 22. Warmka, J., Hanneman, J., Lee, J. et al. (2001) Ptc1, a type 2C Ser/Thr phosphatase, inactivates the HOG pathway by dephosphorylating the mitogen-activated protein kinase Hog1. Mol Cell Biol 21, 51–60. 23. Nguyen, A. N. and Shiozaki, K. (1999) Heatshock-induced activation of stress MAP kinase is regulated by threonine- and tyrosine-specific phosphatases. Genes-Dev. 1999 Jul 1; 13, 1653–63. 24. Takekawa, M., Maeda, T. and Saito, H. (1998) Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. Embo J 17, 4744–52. 25. Takekawa, M., Adachi, M., Nakahata, A. et al. (2000) p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38

161

MAPK-p53 signaling in response to UV radiation. Embo J 19, 6517–26. 26. Meskiene, I., Bogre, L., Glaser, W. et al. (1998) MP2C, a plant protein phosphatase 2C, functions as a negative regulator of mitogenactivated protein kinase pathways in yeast and plants. Proc Natl Acad Sci USA 95, 1938–43. 27. Baril, C., Sahmi, M., Ashton-Beaucage, D. et al. (2009) The PP2C Alphabet is a Negative Regulator of SAPK Signaling in Drosophila. Genetics 181, 567–79. 28. Baril, C. and Therrien, M. (2006) Alphabet, a Ser/Thr phosphatase of the protein phosphatase 2C family, negatively regulates RAS/ MAPK signaling in Drosophila. Dev Biol 294, 232–45. 29. Tamura, S., Toriumi, S., Saito, J. et al. (2006) PP2C family members play key roles in regulation of cell survival and apoptosis. Cancer Sci 97, 563–7. 30. Saez, A., Apostolova, N., Gonzalez-Guzman, M. et al. (2004) Gain-of-function and loss-offunction phenotypes of the protein phosphatase 2C HAB1 reveal its role as a negative regulator of abscisic acid signalling. Plant J 37, 354–69. 31. Leung, J., Merlot, S. and Giraudat, J. (1997) The Arabidopsis ABSCISIC ACIDINSENSITIVE2 (ABI2) and ABI1 genes encode homologous protein phosphatases 2C involved in abscisic acid signal transduction. Plant Cell 9, 759–71. 32. Rodriguez, P. L., Benning, G. and Grill, E. (1998) ABI2, a second protein phosphatase 2C involved in abscisic acid signal transduction in Arabidopsis. FEBS Lett 421, 185–90. 33. Schweighofer, A., Ayatollahi, Z. and Meskiene, I. (2009) Methods Mol Biol 479, 247–60. 34. Bialojan, C. and Takai, A. (1988) Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256, 283–90. 35. Barford, D., Das, A. K. and Egloff, M. P. (1998) The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27, 133–64. 36. Lawson, J. E., Niu, X. D., Browning, K. S. et al. (1993) Molecular cloning and expression of the catalytic subunit of bovine pyruvate dehydrogenase phosphatase and sequence similarity with protein phosphatase 2C. Biochemistry 32, 8987–93. 37. Bertauche, N., Leung, J., and Giraudat, J. (1996) Protein phosphatase activity of abscisic acid insensitive 1 (ABI1) protein from Arabidopsis thaliana. Eur J Biochem 241, 193–200.

wwwwwwwwwwwwwwwww

Part III Studying Kinase Function at the Cellular Level

wwwwwwwwwwwwwwwww

Chapter 9 Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen Shutian Li and Vernonica E. Franklin-Tong Abstract Signal transduction through mitogen-activated protein kinase (MAPK) cascades regulates many cellular responses. One example of a stimulus-mediated MAPK signaling network in plants is the self-incompatibility (SI) response in Papaver rhoeas, which represents an important mechanism to prevent self-fertilization. This involves interaction of pistil S-locus determinants with a pollen receptor in an incompatible interaction, resulting in a Ca2+-dependent signaling network involving activation of a MAPK, p56, and stimulation of several caspase-like activities, resulting in programmed cell death (PCD). MAPK inhibitors provide a useful tool to dissect these mechanisms and distinguish their regulation by different signaling pathways. U0126 is a potent, noncompetitive, and specific inhibitor of MAPK signaling pathways that result in the inhibition of MAPK activation. Here, we describe the use of this drug in combination with a TEY (threonine– glutamic acid–tyrosine) antibody to alter and monitor MAPK activation, together with a range of markers for PCD to implicate a role for MAPK activation in signaling to PCD in pollen tubes. These techniques may be potentially adapted for use in other plant tissues to investigate MAPK activation in other physiologically relevant systems. Key words: Self-incompatibility, U0126, MAPK, PCD, Caspase-3-like activity, Papaver rhoeas

1. Introduction Signal transduction through mitogen-activated protein kinase (MAPK) cascades regulates many cellular responses. MAPKs trigger diverse signaling cascades in response to a variety of signals and stimuli (1–6). Experimental evidence has demonstrated the involvement of MAPKs in activation of defense responses, resulting in programmed cell death (PCD) and resistance to pathogens (3–6). The challenge in this area is to assign these modules to specific signaling pathways with defined functions.

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_9, © Springer Science+Business Media, LLC 2011

165

166

S. Li and V.E. Franklin-Tong

One example of a stimulus-mediated MAPK signaling network in plants is the self-incompatibility (SI) response in the field poppy (Papaver rhoeas), which is an important mechanism to prevent inbreeding through specific recognition and rejection of incompatible (“self ”) pollen. SI in Papaver rhoeas can be induced by the addition of recombinant pistil S-proteins (PrsS, Papaver rhoeas stigma S-proteins) (7) to pollen tubes growing in vitro, allowing analysis of events triggered specifically in incompatible pollen. The SI interaction triggers a Ca2+-dependent signaling network, involving rapid increases in cytosolic free Ca2+ (8), depolymerization of F-actin and microtubules (9–11), Ca2+-dependent hyperphosphorylation of two soluble inorganic pyrophosphatases (12) and consequent rapid arrest of pollen tube growth, activation of a p56-MAPK (13, 14), cytochrome c leakage into the cytosol, activation of several caspase-like activities ultimately resulting in cellular dismantling and DNA fragmentation (15, 16). Activation of p56-MAPK was shown to peak at 10 min after SI induction (13), which is after initial arrest of pollen tube growth, indicating that it might be involved in later events triggered by SI. MAPK cascades consist of three kinase modules (MAP kinase kinase kinase: MAP3K/MEKK, MAP kinase kinase: MAPKK/ MAP2K/MEK/MKK, and MAP kinase: MAPK/MPK), which are linked to upstream receptors and downstream targets. MAPKs are highly conserved Ser/Thr kinases across eukaryotes that are activated by dual phosphorylation of Thr and Tyr residues in a TEY/ TDY (threonine–glutamic acid/aspartic acid–tyrosine) motif via specific upstream MAPK kinases (MAP2K/MAP3K). A commercially available, anti-active (-phosphorylated) MAPK pTEpY/ pTDpY antibody (p: pohosphorylated residue) recognizes dually phosphorylated MAPKs and hence allows monitoring of MAPK activity by Western blotting (17, 18). Cell-permeable MAPK pathway inhibitors serve as a powerful tool to dissect MAPK-mediated signaling pathways. U0126 is a chemically synthesized organic compound and a highly potent inhibitor of MAPK cascades (19, 20). Unlike PD098059 that only inhibits activation of inactive MAPKs, U0126 inhibits both active and inactive MAPKs (21, 22). U0126 has been widely used to block MAPK cascades and assign them to specific signaling pathways with known functions in both animal and plant cells (19, 20, 22). Here, we describe methods used to implicate a MAPK involvement in mediating PCD in incompatible pollen (14). Briefly, U0126 and its inactive and noninhibiting analog U0124 were used to prevent p56-MAPK activation. We use a pTEpY antibody, which cross-reacts specifically with activated MAPKs, to monitor MAPK activity in extracts from pollen tubes subjected to different treatments and thereby verify whether MAPK activity was effectively inhibited or not. This antibody is useful to investigate how many MAPKs are activated by the treatment, their relative activity, and

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen

167

their molecular weights. In parallel, we monitor samples for evidence of PCD, using DNA fragmentation, a PARP-cleavage assay, and a caspase-3 substrate as markers (14). These tools help to provide evidence for a link between MAPK activation and induction of PCD, as inhibition of MAPK activation alleviated the incidence of PCD. Pretreatment of growing pollen tubes with U0126 inhibits SI-mediated activation of p56-MAPK and also reduces DNA fragmentation, compromises PARP cleavage and caspase-3like/DEVDase activity, whereas pretreatment with its inactive analog U0124 does not. Together, these experiments implicate the involvement of p56-MAPK in signaling to SI-induced PCD (14).

2. Materials 2.1. Pollen Growth Medium and SI Induction

1. Germination medium (GM) salt stock solution: 2% (w/v) KNO3, 2% (w/v) H3BO3, 2% (w/v) Mg(NO3)2·6H2O, and 7.2% (w/v) CaCl2·2H2O in 100 mL H2O, sterilize by filtration and store at 4°C. 2. Liquid GM: 1.35 g sucrose in 10 mL H2O, add 50 mL of GM salt stock solution. 3. Solid GM: 13.5 g sucrose, 1.2 g agarose, and 500 mL of GM salt stock solution in 100 mL H2O; heat to dissolve all solutes, allow to cool down, and then make plates. Store plates at 4°C. 4. Pollen collected from S1S8 (incompatible) and S2S6 (compatible) plants of the field poppy (Papaver rhoeas), store at −20°C.

2.2. MAPK Inhibitor U0126

2.3. Protein Extraction from Plant Tissues

100 mM U0126 (1,4-diamino-2,3-dicyano-1,4-bis(2aminophenylthio)-butadiene; Calbiochem) and 100 mM U0124 (1,4-diamino-2,3-dicyano-1,4-bis(methylthio)-butadiene; Calbiochem) in dimethyl sulfoxide (DMSO), store at −20°C, tightly sealed and protected from light. 1. 2 M Tris–HCl (pH 7.8), autoclave. 2. 1 M NaCl, autoclave. 3. 1 M MgCl2, autoclave. 4. 1 M EGTA: adjust pH to 8.0 by adding NaOH pellets, sterilize by filtration and store at 4°C. 5. 1 M b-glycerophosphate. 6. 1 M DTT, sterilize by filtration, aliquot, and store at −20°C. 7. 1 M NaF, sterilize by filtration, aliquot, and store at −20°C. 8. 1 M Na3VO4, sterilize by filtration, aliquot, and store at −20°C. 9. 2 mg/mL leupeptin: sterilize by filtration, aliquot, and store at −20°C.

168

S. Li and V.E. Franklin-Tong

10. 2  mg/mL aprotinin: sterilize by filtration, aliquot, and store at −20°C. 11. 1 M 4-nitrophenyl phosphate: filter-sterilize, aliquot, and store at −20°C. 12. 100 mM phenylmethanesulfonyl fluoride (PMSF) in isopropanol or ethanol, aliquot and store at −20°C (see Note 1). 13. 5× Immunoprecipitation (IP) buffer: 125 mM Tris–HCl (pH 7.8), 375 mM NaCl, 75 mM EGTA, 75 mM b-glycerophosphate, 75 mM 4-nitrophenyl phosphate, 50 mM MgCl2, 5 mM dithiothreitol (DTT), 5 mM NaF, 2.5 mM Na3VO4, 2.5 mM PMSF, 50 mg/mL leupeptin, 50 mg/mL aprotinin, and 0.5% (v/v) Tween-20. Prepare fresh just before use and keep on ice until use. 14. Protein assay kit II (Bio-Rad). 2.4. SDSPolyacrylamide Gel Electrophoresis

1. 1 1.5 M Tris–HCl (pH 8.8), autoclave. 2. 1 M Tris–HCl (pH 6.8), autoclave. 3. 10% (w/v) sodium dodecyl sulfate (SDS). 4. 10% (w/v) ammonium persulfate (APS), store at −20°C. 5. N,N,N¢,N¢,-tetramethyl-ethylenediamine (TEMED), store at 4°C. 6. 30% (v/v) acrylamide/bis solution (29:1), store at 4°C (see Note 2). 7. Isobutanol. 8. 10× running buffer: 151.4 g Tris base, 720.7 g glycine, and 50 g SDS in 5 L H2O. If necessary, adjust pH to ca. 8.3. 9. 50% (v/v) glycerol: autoclave. 10. 1% (w/v) bromophenol blue in H2O, remove unsolved solid particles through filtration. 11. b-Mercaptoethanol, store at 4°C. 12. 5× loading buffer: 0.6 mL 1 M Tris–HCl (pH 6.8), 5 mL 50% (v/v) glycerol, 2  mL 10% (w/v) SDS, 1  mL 1% (w/v) bromophenol blue, and 0.5  mL b-mercaptoethanol, fill up to 10 mL. Aliquot and store at −20°C. 13. SeeBlue Plus2 Prestained Standard (Invitrogen).

2.5. Western Blotting for MAPKs

1. 10× blotting buffer: 30.3 g Tris base and 144 g glycine in 1 L H2O. If necessary, adjust pH to ca. 8.3. Autoclave. 2. 1× blotting buffer: 100  mL 10× blotting buffer, 200  mL methanol, and 700  mL H2O (see Note 3). Precool prior to use. Methanol is toxic; avoid eye and skin contact. 3. 10× Tris-buffered saline for Western blotting (TBS-P): 80  g NaCl, 2 g KCl, and 30 g Tris base in 800 mL H2O, adjust pH

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen

169

to 7.4 with HCl and fill up to 1 L. Autoclave. Dilute 100 mL with 900 mL H2O to prepare 1× TBS-P for use. 4. Tris-buffered saline Tween (TBS-T): 1× TBS-P, 0.1% (v/v) Tween-20. 5. Blocking buffer: 1× TBS-P, 0.1% (v/v) Tween-20, 5% milk powder (blotting grade). Prepare fresh just before use. 6. 10% (w/v) sodium azide (NaN3): 1  g NaN3 in 10  mL 20% (v/v) ethanol. Store at 4°C. Working concentration is 0.1%. NaN3 is toxic; wear gloves and avoid skin contact. 7. Hybond-ECL nitrocellulose membrane, Hyperfilm ECL membrane, Hypercassette Neutral, and ECL Western Blotting Detection Reagents (all from Amersham Biosciences). 8. Ponceau S solution for electrophoresis (Serva). 9. Whatman 3MM filter paper (Whatman). 2.6. Detection of p56-MAPK Activity Using pTEpY Antibody

1. Rabbit anti-active MAPK polyclonal antibody (pTEpY Ab; Cell Signaling Technology). This antibody is notoriously unstable, so store at −20°C and use within a few months. 2. Anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibody (Sigma). 3. X-ray film cassette (e.g., Hypercassette Neutral, Amersham Biosciences). 4. Autoradiography Biosciences).

2.7. DNA Fragmentation Assay

film

(Hyperfilm

ECL,

Amersham

1. 24% (w/v) sucrose. 2. 0.25 M piperazine-1,4-bis(2-ethanesulfonic acid (PIPES; pH 6.8)): predissolve 7.56 g PIPES in 60 mL H2O, add NaOH pellets while stirring until PIPES has dissolved, adjust pH with NaOH to 6.8 and then fill up to 100 mL. Store at 4°C. 3. 20% (w/v) paraformaldehyde: predissolve 2  g paraformaldehyde in 7 mL H2O and 0.2 mL 2.5% (w/v) NaOH, heat at 65°C with occasional shaking until paraformaldehyde has dissolved, fill up to 10 mL, and adjust pH to 7.0 with 0.25 M PIPES (pH 6.8); stable at 4°C for a week. 4. 4% (w/v) paraformaldehyde working solution: 2 mL 20% (w/v) paraformaldehyde, 8 mL 24% (w/v) sucrose. Final sucrose concentration is ca. 19% (w/v), stable at 4°C for a week. 5. 10× Tris-buffered saline for DNA fragmentation (TBS-D): predissolve 40.9 g NaCl, 12.11 g Tris base in 400 mL H2O, adjust pH to 7.6 with HCl, and fill up to 500 mL. Autoclave, dilute 100 mL with 900 mL H2O to prepare 1× TBS-D for use. 6. 20× SSC stock solution (pH 7.0): predissolve175.3  g NaCl, 88.2 g sodium citrate in 800 mL H2O, adjust pH to 7.0 with

170

S. Li and V.E. Franklin-Tong

10 M NaOH, fill up to 1 L, autoclave. Dilute 100 mL with 900 mL H2O to prepare 2× SSC for use. 7. DeadEnd Fluorometric TUNEL System (Promega). 8. Triton X-100 (Merck). 9. VECTASHIELD mounting medium with 6-diamidine2¢-phenylindole dihydrochloride (DAPI; Vector Laboratories). 10. Poly-l-lysine-coated glass slides. 11. Nail varnish. 12. Fluorescence microscope (e.g., Nikon T300) equipped with FITC and UV filters. 2.8. PARP Cleavage Assay

1. 0.5  M EDTA: predissolve 186.1  g Na2-EDTA·2H2O in 800 mL of H2O. Adjust pH to 8.0 with about 20 g of NaOH pellets. EDTA does not completely dissolve until pH is around 8. Autoclave. 2. 1  M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; pH 7.4): predissolve 238.3  g HEPES in 800  mL H2O, adjust pH to 7.4 with 40–45 mL of 10 M KOH, and fill up to 1 L. Sterilize by filtration and store at 4°C. 3. 10% (w/v) 3-[(3-Cholamidopropyl)dimethylammonio]-1propanesulfonate (CHAPS): 1  g CHAPS in 10  mL, aliquot and store at −20°C. 4. HEPES extraction buffer: 50 mM HEPES (pH 7.4), 10 mM NaCl, 0.1% (w/v) CHAPS, 10  mM DTT, 1  mM Na2·EDTA·2H2O, and 10% (v/v) glycerol. Store at −20°C. 5. Bovine poly-(ADP-ribose) BIOMOL).

polymerase

(bovine

PARP;

6. Anti-PARP (mouse monoclonal antibody; BIOMOL). 7. Anti-mouse horseradish peroxidase ­secondary antibody (BIOMOL). 2.9. Caspase-3-Like Activity Assay

(HRP)-conjugated

1. 3  M sodium acetate (NaAc; pH 6.0): predissolve 408.1  g NaAc·3H2O in 800  mL H2O, adjust pH to 6.0 with glacial acetic acid, fill up to 1 L. Autoclave. 2. 1  M l-cysteine: 1.2  g l-cysteine in 10  mL H2O, aliquot and store at −20°C. 3. 10  mM Ac-DEVD-AMC [N-acetyl-Asp-Glu-Val-Asp-AMC (7-amino-4-methylcoumarin)]: 5  mg fluorogenic caspase-3 substrate Ac-DEVD-AMC (Calbiochem) in 0.74 mL DMSO, aliquot and store at −20°C. Ac-DEVD-AMC is light sensitive, protect from light. 4. 10  mM Ac-YVAD-AMC [N-acetyl-Tyr-Val-Ala-Asp-AMC (7-amino-4-methylcoumarin)]: 5  mg fluorogenic caspase-1 substrate Ac-YVAD-AMC (Calbiochem) in 0.75 mL DMSO,

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen

171

aliquot and store at −20°C. Ac-YVAD-AMC is light sensitive, protect from light. 5. 10  mM Ac-DEVD-CHO [N-acetyl-Asp-Glu-Val-Aspaldehyde]: 5  mg caspase-3 inhibitor Ac-DEVD-CHO (Calbiochem) in 1 mL DMSO, aliquot and store at −20°C. 6. 10 mM Ac-YVAD-CHO [N-acetyl-Tyr-Val-Ala-Asp-aldehyde]: 5  mg caspase-1 inhibitor Ac-YVAD-CHO (Calbiochem) in 1 mL DMSO, aliquot and store at −20°C. 7. Caspase extraction buffer (pH 5.0): 50 mM NaAc·3H2O (pH 6.0), 10 mM l-cysteine, 10% (v/v) glycerol, and 0.1% (w/v) CHAPS. Adjust pH to 5.0 with glacial acetic acid, aliquot and store at −20°C. 8. 96-well ELISA plates. 9. Fluorescence plate-reader (e.g., a FLUOstar OPTIMA 413-1183; BMG Lab Technologies) with suitable filter sets (e.g., for FITC).

3. Methods 3.1. Preparation of Pollen Samples and Protein Extracts for p56-MAPK Activity Assay

1. Weigh out 4  mg pollen for each treatment and hydrate the grains for 30 min at 25°C in a plastic tray (see Note 4). For SI experiments, pollen of specific S-haplotypes must be used to match S-protein alleles (e.g., carrying S1 to match S1 recombinant pistil protein) to achieve SI response. Alternatively, any pollen could be used for other experiments to test for induction of MAPKs in response to other treatments (e.g., stress, drugs, etc.). 2. Transfer pollen to a 1.5-mL microcentrifuge tube, add 1 mL liquid germination medium (GM), vigorously shake and resuspend pollen, transfer pollen onto Petri dishes containing solid GM and allow to grow for 1 h at 25°C. 3. Then, treat pollen to stimulate MAPK activity via SI induction, e.g., by adding recombinant stigmatic S-proteins S1e and S8e (both at 10 mg/mL) to S1S8 (incompatible) and S2S6 (compatible) pollen. The production of recombinant S-proteins, S1e and S8e, is performed as described previously (23, 24). Heatdenatured S-proteins boiled for 30 min prior to use are applied as additional controls. Gently swirl Petri dishes containing pollen and S-proteins and incubate for further 10 min. Alternative treatments (e.g., drug application such as A23187 or mastoparan to stimulate Ca2+ increase) can be included with any pollen. These treatments are the appropriate controls to test for MAPK activation.

172

S. Li and V.E. Franklin-Tong

4. In addition to these treatments, to verify whether a MAPK is implicated, MAPK-specific inhibitors are added to additional samples in parallel to those ones described in step 3. These comprise treatments where pollen is grown for 1 h at 25°C in the presence of 100 mM U0126 or U0124 prior to treatment (SI induction or alternative treatments, as described in step 3). Controls comprise addition of DMSO at a final concentration of 0.1% (v/v). The MAPK inhibitor U0126 is used at a concentration of 100  mM to inhibit p56-MAPK activation. Its inactive analog U0124 can be used as a negative control and does not prevent MAPK activation. 5. At appropriate time points, transfer pollen samples from Petri dishes with a pipette into fresh microcentrifuge tubes. Pellet pollen by centrifuging at 300 × g for 5  min at room temperature. 6. The following steps are carried out with precooled solutions, microcentrifuge tubes, and glassware; place these items on ice prior to use. Remove supernatants and leave the pollen pellet. Add 30 mL of 5× IP buffer and 120 mL of H2O. Resuspend pollen in this buffer and transfer to a prechilled ground-glass homogenizer. Homogenize samples on ice with approximately 100 strokes (see Note 5). 7. Transfer homogenates to 1.5-mL microcentrifuge tubes and spin at 14,000 × g for 20 min at 4°C to pellet pollen debris. 8. Transfer supernatants carefully to clean microcentrifuge tubes. Measure protein concentrations using the Protein Assay Kit II. Snap-freeze protein extracts in liquid nitrogen and store at −20°C; ready for use in the p56-MAPK activity assay (see Subheading 3.4). 9. The samples are then subjected to SDS-PAGE (Subheading 3.2) and Western blotting (Subheading 3.3). 3.2. SDSPolyacrylamide Gel Electrophoresis

1. Assemble glass plates and spacers for a 1.5-mm thick gel. 2. To prepare a 12% separating gel, add 4 mL of 30% acrylamide/ bis, 2.5 mL of 1.5 M Tris–HCl (pH 8.8), 100 mL of 10% (w/v) SDS, 100  mL of 10% (w/v) APS, and 4  mL of TEMED to 3.3 mL H2O to a total volume of 10 mL. Mix all components in the order given above, swirl the mixture rapidly without delay, cast ca. 10 mL of the separating solution into the gap between the two glass plates. Leave about 1-cm space below the wells of the comb for a stacking gel and overlay with isobutanol (see Note 6). 3. The gel should polymerize in ca. 30  min. When the gel has polymerized, pour off the isobutanol and rinse the top of the gel with H2O. 4. To prepare a 5% stacking gel, add 0.83 mL of 30% acrylamide/ bis, 0.63 mL of 1 M Tris–HCl (pH 6.8), 50 mL of 10% (w/v)

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen

173

SDS, 50  mL of 10% (w/v) APS, and 5 mL of TEMED to 3.4 mL H2O to a total volume of 5 mL. Mix all components in the order given above, cast the mixture rapidly without delay, and insert the comb immediately. The stacking gel should polymerize within ca. 30 min. 5. Prepare 1× running buffer by diluting 100 mL of 10× running buffer with 900 mL of H2O. 6. When the stacking gel has polymerized, carefully remove the comb, wash the wells with 1× running buffer, place in a vertical gel stand and immerse in 1× running buffer. 7. Add 5× loading buffer at a ratio of 4:1 to protein extracts in microcentrifuge tubes, and then boil for 5 min. Briefly centrifuge for 1 s to pellet any debris, then load 100 mg protein samples onto a 12% SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) gel. Include one well for 10 mL of SeeBlue Plus2 Prestained Standard. 8. Connect to a power supply and run at 50 V as the dye front moves through the stacking gel and then 100 V through the separating gel, until the dye front just reaches the bottom of the glass plates. 9. As the gel finishes running, have materials ready to perform blotting (see Subheading  3.3). Remove the gel kit from the running tank and carefully remove the gel from between the plates. Place the separating gel in 1× blotting buffer at room temperature until needed. 3.3. Western Blotting for MAPKs

1. Fill the cooling apparatus (e.g., BioRad Bio-Ice Cooling Unit) with dH2O and store it at −20°C until used. After use, refill and return it to −20°C. 2. Prepare 1  L of ice-cold 1× blotting buffer. Cut a piece of Hybond-ECL nitrocellulose membrane and four pieces of filter paper (slightly bigger than the separating gel). Always wear gloves when handling membranes to prevent contamination. 3. Equilibrate the separating gel and soak the nitrocellulose membrane, filter paper, and fiber pads in 1× blotting buffer at room temperature until needed. Assemble “sandwich” for blotting (e.g., using a BioRad Mini Trans-Blot Electrophoretic Transfer Cell). Place the gel holder cassette with the anode (here: gray side) down on a clean surface. Place one prewetted fiber pad on the gray side of the cassette. Place a sheet of filter paper on the fiber pad. Place the equilibrated gel on the filter paper. Place the prewetted membrane on the gel. Complete the sandwich by placing a piece of filter paper on the membrane. Add the last fiber pad (see Note 7).

174

S. Li and V.E. Franklin-Tong

4. Close the gel holder cassette firmly. Do not move the gel and filter paper sandwich. Lock the gel holder cassette with the latch. 5. Place the blotting module containing the “sandwich” and the Bio-Ice Cooling Unit in the buffer chamber and completely fill the chamber with 1× blotting buffer. Add a stir bar to help maintain an even buffer temperature and ion distribution in the chamber. Set the speed as fast as possible. 6. Put on the lid, plug cables into the power supply, and transfer at 400  mA for 1–2  h at room temperature (or overnight at 30 V, 4°C) on a stir plate. 7. Upon completion, disassemble “sandwich” and place the nitrocellulose membrane protein-side-up into 1× TBS-P buffer, wash for 5 min at room temperature on a platform-rocker (see Note 8). The blot can be kept at this stage, if you do not wish to proceed to the detection stage immediately. 8. Put the nitrocellulose membrane in 20 mL blocking buffer and incubate on a rocking platform for 2 h at room temperature or overnight at 4°C. 9. Discard the blocking buffer and wash three times for 5  min each with 20 mL TBS-T buffer on a rocking platform. 3.4. Detection of p56-MAPK Activity Using pTEpY Antibody

MAPK activity can be detected using a commercially available, anti-active MAPK pTEpY/pTDpY antibody, which recognizes dually phosphorylated MAPKs. This allows monitoring of activated MAPKs using Western blotting. The blots are probed using anti-pTEpY antibody (Subheading 3.4) to identify samples having MAPK activity. This method allows to establish how many MAPKs are activated by the treatment, their relative activity, and their molecular weights. 1. Incubate with 1,000-fold diluted anti-pTEpY antibody in 10 mL TBS-T buffer on a rocking platform for 2 h at room temperature or overnight at 4°C. 2. Remove the primary antibody (see Note 9) and wash three times for 10 min each with 20 mL TBS-T buffer on a rocking platform. 3. Incubate with the anti-rabbit horseradish peroxidase (HRP) conjugated secondary antibody diluted 1,000-fold in 10  mL TBS-T buffer on a rocking platform for 1  h at room temperature. 4. Discard the secondary antibody and wash three times for 10 min each with 20 mL TBS-T buffer on a rocking platform at room temperature. 5. Equilibrate ECL Western Blotting Detection Reagents to room temperature before use, and mix an equal volume of detection solution 1 with detection solution 2 to give a final volume

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen

175

Fig. 1. Detection of p56-MAPK activity using pTEpY antibody in different samples. Pollen samples from different treatments were separated by SDS-PAGE, blotted, and immunostained using pTEpY antibody to detect p56-MAPK activity. Only the section of the gel that displays the cross-reaction of p56-MAPK with pTEpY antibody is shown. No p56-MAPK activity was detected in controls: GM, DMSO, U0124, or U0126 treatment alone. A strong signal for MAPK activity at the appropriate mass for p56 was detected in incompatible SI-induced samples (Inc) and SI-induced samples pretreated with DMSO (Inc/DMSO). The p56-MAPK activity was inhibited in extracts from SI-induced pollen pretreated with 100 mM U0126 (Inc/U0126), but not inhibited in extracts from pollen pretreated with 100 mM U0124 (Inc/U0124). This demonstrates the specificity of the inhibitors used and shows that U0126 inhibits the p56-MAPK activity. (Reproduced from ref. 13 with permission from the American Society of Plant Biologists).

equivalent to 0.125 mL/cm2 membrane. Drain off the excess wash buffer from the washed membrane and soak the membrane briefly in the mixed detection reagent (see Note 10). 6. Drain off excess liquid, put the blot protein-side-down onto a piece of Saran Wrap, wrap up the blot, and gently remove air bubbles. 7. Place the wrapped blot protein-side-up in an X-ray film cassette. 8. In a dark room, place a sheet of autoradiography film on top of the wrapped blot, close the cassette, and expose for 10  s at room temperature. 9. Remove the film from the cassette and develop it immediately (see Note 11). Alternatively, a digital imaging system can be used, if available. 10. An example of Western blotting showing inhibitory effect of U0126 on p56-MAPK activation is shown in Fig. 1. 3.5. DNA Fragmentation Assay

This assay provides a useful marker for PCD in fixed cells. It is often used as evidence for PCD, although DNA fragmentation can be triggered by other events. It provides a sensitive way to colocalize the end-labeled fragmented DNA and nuclei stained with DAPI. One drawback is that it measures a long-term end point, rather than an actual activity. An advantage is that several commercial kits are available. In our hands, the DeadEnd Fluorometric TUNEL (TdTmediated dUTP Nick-End Labeling) System works well. The system is nonradioactive and provides simple, accurate and rapid detection of apoptotic cells in situ at the single-cell level. This system measures the fragmented DNA of apoptotic cells by catalytically incorporating fluorescein-12-dUTP at 3¢-OH DNA ends

176

S. Li and V.E. Franklin-Tong

using the enzyme terminal deoxynucleotidyl transferase (TdT), which forms a polymeric tail using the principle of the TUNEL assay. The fluorescein-12-dUTP-labeled DNA can then be visualized directly by fluorescence microscopy or quantitated by flow cytometry. 1. Hydration and growth of pollen, SI-induction, incubation for 8  h, and addition of MAPK inhibitors are described in Subheading 3.1. 2. After growing for 8 h, add 1 mL of 4% (w/v) paraformaldehyde for each treatment, mix by gentle swirling, and fix at room temperature for 45 min. 3. Transfer fixed samples to 15-mL Falcon tubes (see Note 12), add 5 mL of 1× TBS-D buffer into plates to wash and transfer pollen sticking on solid GM. Pellet samples at 300 × g for 5 min at room temperature. 4. Remove supernatants carefully, add 5 mL of 1× TBS-D buffer to resuspend and wash samples, and pellet again. 5. Repeat step 4. Twice. Leave ca. 100 mL of 1× TBS-D buffer for each sample. Washed samples can be stored at 4°C for 1 week. 6. Resuspend and transfer samples onto poly-l-lysine-coated glass slides. Drain off and absorb excess liquid with tissue. Incubate slides for 45 min at 60°C to make sure that the samples adhere to the slides after finishing subsequent steps. 7. Cool down samples at room temperature. Wash samples for 15 min at room temperature with 100 mL of 1× TBS-D buffer containing 0.1% (v/v) Triton X-100. Wash twice with 1× TBS-D buffer at room temperature for 5 min each. 8. Take slides out of staining dishes, place sample-side-up on clean tissue directly, and add 100 mL equilibration buffer (see Note 13) onto each slide. 9. Drain off excess liquid and add 50 mL incubation buffer composed of 44 mL of equilibration buffer, 5 mL of nucleotide mix and 1 mL of TdT. Carefully lay plastic cover slips on the slides and incubate in the dark for 1.5 h at 37°C (see Note 14). 10. Carefully remove cover slips, place slides into staining dishes containing 2× SSC, and incubate in the dark for 15  min at room temperature to stop reaction. 11. Wash slides three times with 1× TBS-D buffer for 5 min each. Transfer slides directly onto clean tissue and drain off excess liquid. Add two drops of VECTASHIELD mounting medium with DAPI, place coverslips onto slides, and seal with nail ­varnish. Wrap slides in aluminum foil and leave the slides in the dark for over 1 h at room temperature. The slides after this step can be stored at 4°C for 1 week before scoring.

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen

177

Fig.  2. Quantitation of TUNEL data obtained from pollen samples. DNA fragmentation, measured after 8 h by TUNEL, was quantified by counting the number of nuclei that had positive TUNEL staining. 50 pollen-tube nuclei from each sample were counted, with replicates from three to six independent experiments. These were plotted to give an indication of the level of DNA fragmentation. The plot here shows that SI-induced DNA fragmentation was low in controls (all shown as white bars): untreated (UT) pollen, pollen treated with 100  mM U0126 and U0124 alone, and compatible SI-induced samples (Comp). Incompatible SI-induced samples (Inc; black bar) had high levels of DNA fragmentation induced, which was alleviated by pretreatment with 100 mM U0126 (Inc-U0126; dark shaded bar), but not by pretreatment with 100 mM U0124 (Inc-U0124; speckled bar). These data show that the MAPK inhibitor U0126 inhibits DNA fragmentation. (Reproduced from ref. 13 with permission from the American Society of Plant Biologists).

12. Score 50 pollen tubes from each treatment for DNA fragmentation using a fluorescence microscope. Use FITC filters for detecting DNA fragmentation and UV filters for detecting DAPI. As shown in Fig. 2, U0126 inhibits DNA fragmentation induced by SI. 3.6. PARP Cleavage Assay 3.6.1. Preparation of Protein Extracts

Poly-(ADP-ribose) polymerase (PARP) is a classic substrate for caspase-3 activity in animal systems. This method uses bovine PARP as a substrate, to test cellular extracts for caspase-like protease activity. In conjunction with the use of caspase inhibitors, this assay provides further evidence, complementary to that obtained using DNA fragmentation, indicating that PCD is triggered. 1. Hydration and growth of pollen, SI-induction, incubation for 5  h, and addition of MAPK inhibitors are described in Subheading 3.1. 2. Transfer treated pollen to fresh 1.5-mL microcentrifuge tubes and pellet pollen at 300 × g for 5  min at room temperature. The following steps are carried out with precooled solutions, microcentrifuge tubes and glassware. Carefully remove supernatants and add 75  mL of HEPES extraction buffer, transfer

178

S. Li and V.E. Franklin-Tong

resuspended pollen to a ground-glass homogenizer, and homogenize pollen on ice with approximately 100 strokes. 3. Transfer homogenates to 1.5-mL microcentrifuge tubes and spin at top speed for 20 min at 4°C. 4. Transfer supernatants carefully to clean microcentrifuge tubes, measure protein concentrations using the Protein Assay Kit II, snap-freeze protein extracts in liquid nitrogen, and store at −20°C for the cleavage assay. 3.6.2. Cleavage Assay

1. Dilute protein extracts to 2 mg/mL in HEPES extraction buffer. Take 15 mL of diluted samples, add 250 ng of bovine PARP, and incubate for 30 min at 37°C. Include 250 ng of bovine PARP alone as a control. Caspase inhibitors (e.g., Ac-DEVD-CHO) may be added to selected samples to verify whether specific caspase-like activities are implicated in PARP cleavage activity. 2. Add 4  mL of 5× loading buffer to each sample, denature by boiling for 5 min, and load denatured samples. 3. Prepare and run an SDS-PAGE gel as described in Subheading 3.2. Blot and block the membrane as described in Subheading 3.3. 4. Incubate with 10 mL of TBS-T buffer containing 5 mL of antiPARP mouse monoclonal antibody on a rocking platform for 2 h at room temperature or overnight at 4°C (see Note 15). 5. Remove the primary antibody and wash four times for 10 min each with 15 mL of TBS-T buffer on a rocking platform. 6. Incubate with anti-mouse horseradish peroxidase (HRP) conjugated secondary antibody diluted 1,000-fold in 10  mL of TBS-T buffer on a rocking platform for 1  h at room temperature. 7. Discard the secondary antibody and wash six times for 20 min each with 20  mL of TBS-T buffer on a rocking platform at room temperature. 8. Detect the cleavage of bovine PARP by Western blotting as described in Subheading 3.3. The inhibitory effect of U0126 on bovine PARP cleavage is shown in Fig. 3.

3.7. Caspase-3-Like Activity Assay

This assay uses classic animal caspase tetrapeptide substrates (e.g., Ac-DEVD-AMC), which may be commercially available, to test for caspase-like activity in cellular extracts. They are nonfluorescent, but become fluorescent upon cleavage at the specific site. Thus, the level of caspase activity in an extract can be quantitatively measured, usually using a fluorescence plate-reader with suitable filter sets. In conjunction with caspase inhibitors, the activities detected can be verified, as, for example, DEVDase activity will be inhibited by the inhibitor Ac-DEVD-CHO, but not by Ac-YVAD-CHO.

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen

179

Fig. 3. Detection of PARP cleavage using anti-PARP antibody. This figure shows that bovine PARP, which has been incubated with various pollen extracts, was separated using SDSPAGE, Western-blotted, and probed with anti-PARP antibody. No protease inhibitors were added to these incubations; thus, the cleavage detected in control samples is due to endogenous protease activities, which can be seen in all samples. Uncleaved PARP (PARP) comprises a major band at 116 kDa (white arrow). Extracts from untreated pollen (UT), compatible SI-induced pollen (Comp), and pollen treated with 100 mM drugs alone (U0124 and U0126) show nonspecific proteolysis of PARP. Extracts from incompatible SI-induced pollen (Inc) showed an S-specific cleavage pattern: disappearance of the 116-kDa band (white arrow) and appearance of a doublet at 24 kDa (double arrow). Pretreatment with 100  mM U0126 before SI induction (Inc-U0126) retained the 116-kDa band and had reduced levels of the 24-kDa bands; pretreatment with 100 mM U0124 had no effect. This figure shows that SI-mediated PARP cleavage is inhibited by U0126. (Reproduced from ref. 13 with permission from the American Society of Plant Biologists). 3.7.1. Preparation of Protein Extracts

1. Hydration and growth of pollen, SI-induction, incubation for 5  h, and addition of MAPK inhibitors are described in Subheading 3.1. 2. Transfer treated pollen to clean 1.5-mL microcentrifuge tubes and pellet pollen at 300 × g for 5  min at room temperature. The following steps are carried out with precooled solutions, microcentrifuge tubes, and glassware. Carefully remove supernatants, add 75 mL of caspase extraction buffer, transfer resuspended pollen to a ground-glass homogenizer, and homogenize pollen on ice with approximately 100 strokes. 3. Transfer homogenates to 1.5-mL microcentrifuge tubes and spin at the top speed for 20 min at 4°C. 4. Transfer supernatants carefully to clean microcentrifuge tubes, measure protein concentrations at room temperature using the Protein Assay Kit II, snap-freeze protein extracts in liquid nitrogen, and store at −20°C for activity assay.

3.7.2. Activity Assay

1. Dilute protein extracts to 2  mg/mL with caspase extraction buffer.

180

S. Li and V.E. Franklin-Tong

2. Add 5 mL of diluted protein extracts, 2.5 mL of 2 mM fluorogenic caspase-3 substrate Ac-DEVD-AMC, and 92.5 mL of caspase extraction buffer to each well of a 96-well ELISA plate. To test the effect of caspase inhibitors on the cleavage of Ac-DEVDAMC, 100  mM of Ac-DEVD-CHO or Ac-YVAD-CHO is added to the reaction mixture of appropriate samples. 3. The assay comprises measuring the fluorescence obtained by substrate cleavage. The 96-well plate is loaded into a plate-reader, and fluorescence is measured using suitable filter sets (e.g., for FITC) every 5 min for 5 h at 27°C. The output of fluorescence units is converted to a suitable comparison between samples, for example, expressing fluorescence as percentage increase relative to the control sample. Figure 4 shows a typical example of quantitation for caspase-3-like activity using a fluorescent substrate.

Fig.  4. Quantitation of a caspase-3-activity using the fluorescent caspase-3 substrate Ac-DEVD-AMC. Pollen extracts from various treatments were mixed with the caspase substrate in the plate reader as described, and the output after 5 h was quantified. The baseline was subtracted and the actual units were converted to obtain relative fluorescence units. The higher the fluorescence, the more caspase activity is detected. Here, you can see that SI induces a caspase-3-like (DEVDase) activity that is alleviated by U0126 pretreatment. Controls comprising untreated pollen (UT) and pollen treated with 100 mM of U0126 or U0124 alone (white bars) gave low levels of caspase-3-like activity. Incompatible SI-induced pollen (Inc; black bar) had high levels of caspase-3-like activity. Incompatible SI-induced pollen pretreated with 100 mM of U0126 (Inc-U0126; black bar) had reduced levels of caspase-3-like activity, while incompatible SI-induced pollen pretreated with 100 mM of U0124 (Inc-U0124; gray bar) did not. Incubation of incompatible SI-induced pollen extracts with DEVD (Inc-DEVD; cross-hatched bar) inhibited the caspase-3-like activity while incubation of incompatible SI-induced pollen extracts with YVAD (Inc-YVAD; cross-hatched bar) did not, verifying the caspase-3-like specific activity. Caspase-3-like activity was measured using Ac-DEVD-AMC, and data are means ± SE of three independent experiments. The plot shows that the SI-induced caspase-3-like (DEVDase) activity is inhibited by pretreatment with U0126. (Reproduced from ref. 13 with permission from the American Society of Plant Biologists).

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen

181

4. Notes 1. PMSF is very toxic. Always wear gloves to avoid exposure when handling it. 2. Acrylamide is a potent neurotoxin and carcinogen that is absorbed through the skin. Always wear gloves when handling it and also potentially not fully polymerized gels. 3. Addition of 0.1% (w/v) SDS to the blotting buffer has been reported to increase transfer efficiency. However, this can greatly reduce the binding of transferred proteins to the membrane (for both PVDF and nitrocellulose). For proteins smaller than 100 kDa, try blotting in the standard Tris–glycine buffer with 20% (v/v) methanol lacking SDS. 4. To hydrate pollen, weigh out pollen with a weighing boat, wet the tissue with warm water, place wetted tissue at the bottom of a plastic tray, transfer the weighing boat with pollen to the tray, put on the lid, and incubate for 30 min at 25°C. If the pollen looks globular, the hydration is OK. 5. A sonicator can substitute for a ground-glass homogenizer to homogenize pollen samples. However, to obtain efficient protein extracts from pollen, a ground-glass homogenizer is preferred as the yields are much higher. 6. Seal the separating gel with 0.1% (w/v) SDS for gels containing <8% acrylamide or isobutanol for gels >10% acrylamide. The overlay prevents air from diffusing into the gel and inhibiting polymerization. 7. Removing any air bubbles, which may have formed between the filter papers, the gel, and the membrane, as this is very important for good transfer results. Use a glass tube (such as a 10 mL glass pipette) or rod to gently roll air bubbles out. 8. Check transfer efficiency by staining the blot with Ponceau S solution before further proceeding with immunoblotting. Wash the blot once with Ponceau S solution, add fresh Ponceau S solution and incubate for 15 min at room temperature with agitation. The proteins are stained pink. An image of the blot can be made at this stage (e.g., to provide evidence of equal loading). Afterward, destain the blot in H2O for immunoblotting. 9. If necessary, the primary antibody can be recycled; add 0.1% (w/v) NaN3 to prevent microbial growth and store at 4°C for reuse. 10. The mixed detection reagent elicits peroxidase-catalyzed oxidation of luminol and subsequently ECL (enhanced chemiluminescence). The resulting light is detected on Hyperfilm ECL in minutes or often only seconds.

182

S. Li and V.E. Franklin-Tong

11. If necessary, replace with a second sheet of film and estimate how long to continue the exposure on the basis of the appearance of the first sheet. 12. Use wide-mouthed tips to transfer pollen samples and thus prevent pollen tubes from bursting. 13. DeadEnd Fluorometric TUNEL System comprises 9.6 mL of equilibration buffer, 300  mL of nucleotide mix (6 × 50  mL), 3 × 20 mL of terminal deoxynucleotidyl transferase, 70 mL of 20× SSC, and 60 plastic coverslips. 14. To keep humidity, wet tissue with warm water, place it at the bottom of a plastic tray, put slides onto the wetted tissue, and wrap the tray with aluminum foil. 15. Bovine PARP is a 116-kDa monomeric protein, which is cleaved into 89 and 24  kDa fragments by caspase-3 during classic apoptosis. Anti-PARP mouse monoclonal antibody detects the 24-kDa cleavage fragment.

Acknowledgments The authors would like to thank Kim Osman, Chris Franklin, Barend de Graaf, Steve Thomas, and Maurice Bosch for helpful comments and technical assistance. This work was supported by the Royal Society and the Biotechnology and Biological Sciences Research Council (BBSRC). References 1. Samaj, J., Ovecka, M., Hlavacka, A., Lecourieux, F., Meskiene, I., Lichtscheidl, I., Lenart, P., Salaj, J., Volkmann, D., Bögre, L., Baluška, F., and Hirt, Heribert. (2002) Involvement of the mitogen-activated protein kinase SIMK in regulation of root hair tip growth. EMBO J. 2, 3296–3306. 2. Chang, L., and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37–40. 3. Ligterink, W., Kroj, T., Nieden, U., Hirt, H., and Scheel, D. (1997) Receptor-mediated activation of a MAP kinase in pathogen defense of plants. Science 276, 2054–2057. 4. Yang, K. Y., Liu, Y. D., and Zhang, S. Q. (2002) Activation of a mitogen-activated protein kinase pathway is involved in disease resistance in tobacco. Proc. Natl. Acad. Sci. USA 98, 741–746. 5. Zhang, S. Q., and Klessig, D. F. (2001) MAPK cascades in plant defense signaling. Trends Plant Sci. 6, 520–527.

6. Asai, T., Tena, G., Plotnikova, J., Willmann, M. R., Chiu, W. L., Gomez-Gomez, L., Boller, T., Ausubel, F. M., and Sheen, J. (2002) MAP kinase signalling cascade in Arabidopsis innate immunity. Nature 415, 977–983. 7. Wheeler, M. J., de Graaf, B. H. J., Hadjiosif, N., Perry, R. M., Poulter, N. S., Osman, K., Vatovec, S., Harper, A., Franklin, F. C. H., and Franklin-Tong, V. E. (2009) Identification of the pollen self-incompatibility determinant in Papaver rhoeas. Nature 459, 992–995. 8. Franklin-Tong, V. E., Ride, J. P., Read, N. D., Trewavas, A. J., and Franklin, F. C. H. (1993) The self-incompatibility response in Papaver rhoeas is mediated by cytosolic-free calcium. Plant J. 4, 63–77. 9. Snowman, B. N., Kovar, D. R., Shevchenko, G., Franklin-Tong, V. E., and Staiger, C. J. (2002) Signal-mediated depolymerization of actin in pollen during the self-incompatibility response. Plant Cell 4, 2613–2626.

9  Modulating and Monitoring MAPK Activity During Programmed Cell Death in Pollen 10. Thomas, S. G., Huang, S., Li, S. T., Staiger, C. J., and Franklin-Tong, V. E. ( 2006) Actin depolymerization is sufficient to induce programmed cell death in self-incompatible pollen. J. Cell Biol. 74, 22–29. 11. Poulter, N. S., Vatovec, S., and Franklin-Tong, V. E. (2008) Microtubules are a target for selfincompatibility signaling in Papaver pollen. Plant Physiol. 146, 1358–1367. 12. de Graaf, B. H. J., Rudd, J. J., Wheeler, M. J., Perry, R. M., Bell, E. M., Osman, K., Franklin, F. C. H., and Franklin-Tong, V. E. (2006) Selfincompatibility in Papaver targets soluble inorganic pyrophosphatases in pollen. Nature 444, 490–493. 13. Rudd, J. J., Osman, K., Franklin, F. C. H., and Franklin-Tong, V. E. (2003) Activation of a putative MAP kinase in pollen is stimulated by the self-incompatibility (SI) response. FEBS Letters 547, 223–227. 14. Li. S. T., Šamaj, J., and Franklin-Tong, V. E. (2007) A mitogen-activated protein kinase signals to programmed cell death induced by selfincompatibility in Papaver pollen. Plant Physiol. 45, 236–245. 15. Bosch, M., and Franklin-Tong, V. E. (2007) Temporal and spatial activation of caspase-like enzymes induced by self-incompatibility in Papaver pollen. Proc. Natl. Acad. Sci. USA 104, 18327–18332. 16. Thomas, S. G., and Franklin-Tong, V. E. (2004) Self-incompatibility triggers programmed cell death in Papaver pollen. Nature 429, 305–309. 17. Kroj, T., Rudd, J.J., Nurnberger, T., Gabler, Y., Lee, J., and Scheel, D. (2003) Mitogenactivated protein kinases play an essential role in oxidative burst-independent expression of pathogenesis-related genes in parsley. J. Biol. Chem. 278, 2256–2264.

183

18. Samuel, M. A., Miles, G. P., and Ellis, B. E. (2000) Ozone treatment rapidly activates MAP kinase signalling in plants. Plant J. 22, 367–376. 19. Lee, J., Klessig, D. F., and Nurnberger, T. (2001) A harpin binding site in tobacco plasma membranes mediates activation of the pathogenesis-related gene HIN1 independent of extracellular calcium but dependent on mitogen-activated protein kinase activity. Plant Cell 13, 1079–1093. 20. Piater, L. A., Nurnberger, T., and Dubery, I. A. (2004) Identification of a lipopolysaccharide responsive ERK-like MAP kinase in tobacco leaf tissue. Mol. Plant Pathol. 5, 331–341. 21. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. .L, Scherle, P. A., and Trzaskos, J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623–18632. 22. Schmid, R. S., Pruitt, W. M., and Maness, P. F. (2000) A MAP kinase-signaling pathway mediates neurite outgrowth on L1 and requires Srcdependent endocytosis. J. Neurosci. 20, 4177–4188. 23. Foote, H. C. C., Ride, J. P., Franklin-Tong, V. E., Walker, E. A., Lawrence, M. J., Franklin, F. C. H. (1994) Cloning and expression of a distinctive class of self-incompatibility (S) gene from Papaver rhoeas. Proc. Natl. Acad. Sci. USA 91, 2265–2269. 24. Kakeda, K., Jordan, N. D., Conner, A., Ride, J. P., Franklin-Tong, V. E., and Franklin, F. C. H. (1998) Identification of residues in a hydrophilic loop of the Papaver rhoeas S protein that play a crucial role in recognition of incompatible pollen. Plant Cell 10, 1723–1731.

wwwwwwwwwwwwwwwww

Chapter 10 Sensitizing Plant Protein Kinases to Specific Inhibition by ATP-Competitive Molecules Dor Salomon, Chao Zhang, Kevan M. Shokat, and Guido Sessa Abstract The highly conserved nature of the protein kinase catalytic domain and the low permeability of plant cell membranes pose a challenge to the development of specific inhibitors that target individual protein kinases in vivo. Here, we describe a chemical-genetic approach to specifically sensitize individual plant kinases to cell-permeable small molecules that do not inhibit wild-type kinases. In this approach, a single amino-acid substitution is introduced in the ATP-binding site of the enzyme enabling specific binding of ATPcompetitive molecules. Cell-permeable molecules can then be used to specifically target the sensitized allele in transgenic Arabidopsis thaliana plants that do not express the wild-type form of the kinase. This strategy provides a useful tool for the functional characterization of protein kinases in planta and for the dissection of the signaling pathways in which they are involved. Key words: Protein kinase, PP1, Gatekeeper, ATP-competitive molecules, Analog-sensitive, Arabidopsis, Kinase activity assay, Transgenic plants

1. Introduction Members of the protein kinase superfamily regulate a wide variety of cellular processes and signal-transduction pathways in plants (e.g. 1–6). A major objective in the field of protein kinase research is to delineate the functional role of individual kinases. To accomplish this aim, strategies based on single knockout mutations and gene silencing are widely employed. However, such efforts may be compromised by lethality, in the case of essential genes, or by functional redundancy and cellular homeostasis resulting in no apparent phenotypic alterations. To overcome these limitations, a chemical-genetic approach was developed to sensitize protein kinases to specific inhibition

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_10, © Springer Science+Business Media, LLC 2011

185

186

D. Salomon et al.

by cell-permeable ATP-competitive molecules (7, 8). A functionally silent substitution of a conserved, bulky hydrophobic residue, termed the gatekeeper, to a small residue (alanine or glycine) generates a novel pocket in the kinase ATP-binding site not present in any wild-type kinase. The sensitized mutant can be selectively and potently inhibited by ATP-competitive molecules containing substituents that occupy this additional pocket. Importantly, wild-type kinases are not inhibited by such inhibitors due to lack of the novel pocket. The PP1(1-tert-Butyl-3-p-tolyl-1H-pyrazolo[3,4-d] pyrimidine-4-ylamine)-derived inhibitors employed in this approach were shown to be cell permeable in various systems, including plants, yeast, and mammalian cell cultures (8–11, 17). Combined with the relative ease of generating transgenic Arabidopsis plants harboring the sensitized allele, this approach allows for modulation of the activity of individual kinases in the plant and for delineation of their biological function in vivo.

2. Materials 2.1. Site-Directed Mutagenesis

1. Quikchange II site-directed mutagenesis kit (Stratagene).

2.2. Purification of GST-Fusion Protein

1. Terrific broth (TB) medium: 1.2% (w/v) tryptone, 2.4% (w/v) yeast extract, 0.4% (v/v) glycerol, 17  mM KH2PO4, and 72  mM K2HPO4. Add filter-sterilized phosphate salts after autoclaving. 2. 1  M Isopropyl-b-d-thiogalactopyranoside (IPTG) in water, store in aliquots at −20°C. 3. Phosphate buffered saline (PBS) (10×): 1.37 M NaCl, 27 mM KCl, 100 mM Na2HPO4, and 18 mM KH2PO4, adjust to pH 7.4 with HCl, autoclave. 4. 100  mM Phenylmethylsulfonyl fluoride (PMSF, Roche) in isopropanol. Aliquot and store at −20°C. Thaw and vortex before use. 5. 5  mg/mL aprotinin (Sigma) and 5  mg/mL leupeptin (both Sigma) in water, stored in aliquots at −20°C. 6. Glutathione agarose beads (Sigma), incubate with water at 4°C overnight. After swelling, wash the beads with 10 volumes of water and resuspend as 50% (w/v) slurry in water. Store at 4°C. 7. Elution buffer: 50  mM Tris–HCl (pH 8.0), 5  mM reduced glutathione (Sigma). 8. Bradford protein assay solution (Bio-Rad). 9. Prestained molecular-weight markers.

10  Sensitizing Plant Protein Kinases to Specific Inhibition by ATP-Competitive Molecules

2.3. In Vitro Kinase Activity Assay

187

1. Reaction buffer (10×): 500 mM Tris–HCl (pH 7.0), 10 mM dithiothreitol (DTT), and 100  mM MgCl2 (see Note 1). Always prepare fresh. 2. ATP-mixture (10×): 200  mM ATP, 10  mCi [g-32P]-ATP (3,000 Ci/mmol; GE Healthcare). 3. 0.5  M EDTA in water. Adjust to pH 8.0 with NaOH, autoclave.

2.4. SDSPolyacrylamide Gel Electrophoresis

1. Stacking buffer (4×): 500 mM Tris–HCl, 0.4% (w/v) sodium dodecyl sulfate (SDS), adjust to pH 6.8 with HCl. 2. Separating buffer (4×): 1.5 M Tris, 2% (w/v) SDS, adjust to pH 8.8 with HCl. 3. 40% acrylamide/bis solution (37.5:1 with 2.6% C). Acrylamide is a neurotoxin when unpolymerized and so care should be taken not to receive exposure. 4. N,N,N¢,N¢-Tetramethyl-ethylenediamine (TEMED, Bio-Rad). Use in a chemical fume hood to avoid vapor inhalation. 5. 10% (w/v) ammonium persulfate (APS) in water. Store in aliquots at −20°C. 6. Running buffer (10×): 250 mM Tris base, 2 M glycine, and 1% (w/v) SDS. 7. SDS-PAGE sample buffer (3×): 30% (v/v) glycerol, 15% (v/v) b-mercaptoethanol, 37.5% (v/v) stacking buffer (4×), and a few grains of bromophenol blue (Sigma). 8. SDS-PAGE equipment (such as Mini-PROTEAN mini-gel system (Bio-Rad)).

2.5. Coomassie Stain and Autoradiography

1. Coomassie solution: 0.2% (w/v) Coomassie Brilliant Blue R-250, 50% (v/v) methanol, and 7% (v/v) acetic acid. 2. Destaining solution: 10% (v/v) acetic acid, 20% (v/v) isopropanol. 3. Fuji medical X-ray film superRX (Fujifilm).

2.6. Identification of Specific and Potent Kinase Inhibitors

1. 10 mM Src family tyrosine kinase inhibitor PP1 (Fig. 1, derivatives are synthesized as described (12–14)), in dimethyl sulfoxide (DMSO), store in aliquots at −20°C.

2.7. Identification of Homozygous T-DNA Insertion Mutant for the Kinase of Interest

1. Arabidopsis T-DNA insertion line mutants, available from the Arabidopsis Biological Research Center (ABRC, http://arabidopsis.org) or the Nottingham Arabidopsis Stock Centre (NASC, http://arabidopsis.info). 2. Genomic DNA extraction buffer: 400  mM LiCl, 200  mM Tris–HCl (pH 9.0), 1% (w/v) SDS, and 25 mM EDTA.

188

D. Salomon et al.

Fig. 1. Chemical structure of PP1 derivatives. PP1, 1-tert-Butyl-3-p-tolyl-1H-pyrazolo[3,4-d]pyrimidine-4-ylamine; Bn-PP1, 3-Benzyl-1-tert-butyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 1NA-PP1, 1-tert-Butyl-3-naphthalen-1-yl-1H-pyrazolo[3,4-d] pyrimidin-4-ylamine; 2NA-PP1, 1-tert-Butyl-3-naphthalen-2-y1-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 1NM-PP1, 1-tertButyl-3-naphthalen-1-ylmethyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 2NM-PP1, 1-tert-Butyl-3-naphthalen-2-ylmethyl1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; Ac-PP1, 3-Acenaphthen-5-yl-1-tert-butyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 3MB-PP1; 1-tert-Butyl-3-(3-methyl-benzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 23dMB-PP1; 1-tert-Butyl-3-(2,3dimethyl-benzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine.

2.8. Generating Arabidopsis Lines Expressing the Sensitized Kinase

1. Silwet L-77 surfactant (Lehle Seeds). 2. Plant agar (gel strength >1,100 g/cm2, Duchefa). 3. Murashige and Skoog (MS) medium including vitamins (Duchefa), used at a final concentration of 0.5% (w/v). 4. Luria broth (LB): 1% (w/v) tryptone, 1% (w/v) sodium chloride (NaCl), and 0.5% (w/v) yeast extract. 5. Domes to cover freshly transformed plants.

2.9. Effects of Kinase Inhibition in Planta

1. Inhibitor solution for plant treatment: dilute stock solution of the inhibitor (10 mM in DMSO) to 100 mM in water containing 0.01% (v/v) Silwet L-77. For mock treatment, use 1% (v/v) DMSO in water containing 0.01% (v/v) Silwet L-77.

3. Methods The ATP-binding site of protein kinases is highly conserved and a targeted modification of its structure results in sensitization of the kinase to specific inhibition by ATP-competitive molecules. Sitedirected mutagenesis is used to introduce in the ATP-binding site of the kinase of interest a functionally silent mutation that substitutes the bulky gatekeeper residue with a small residue such as

10  Sensitizing Plant Protein Kinases to Specific Inhibition by ATP-Competitive Molecules

189

alanine or glycine. Identification of the gatekeeper residue in the ATP-binding site of the kinase of interest is readily achieved by using tools provided by the Kinase Sequence Database (http:// sequoia.ucsf.edu/ksd/). A kinase assay is used to verify in  vitro that the bacterially expressed mutant kinase displays a similar catalytic activity as the wild-type enzyme, and to screen various PP1 analogs for their ability to inhibit activity of the sensitized kinase but not of the wildtype kinase. Measurement of half maximal inhibitory concentration (IC50) values for the various inhibitors is important to compare their potency and to determine their working concentrations. The effect of inhibition of the kinase of interest by ATP-competitive molecules is tested in transgenic Arabidopsis plants expressing the sensitized kinase, while the nonspecific effect of the inhibitors can be assessed in the control experiment with plants expressing the corresponding wild-type kinase. This strategy allows for the study of physiological processes regulated by the individual kinase in planta. 3.1. Engineering a Sensitized Kinase Mutant

1. Identify the gatekeeper residue in the kinase of interest by using the online Kinase Sequence Database resource. This Web site includes detailed instructions for use of the database (see Note 2). 2. Design primers for mutation of the gatekeeper to either alanine or glycine in the kinase of interest according to the instructions of the site-directed mutagenesis kit (see Note 3). 3. Perform site-directed mutagenesis on a plasmid containing the coding sequence of the kinase of interest. 4. Transform the reaction products of the mutagenesis to transformation-competent E. coli cells and plate transformants on appropriate selective media. 5. For each mutant, extract plasmid DNA from 2 to 5 colonies and sequence the nucleotides surrounding the location of the desired mutation to verify its presence.

3.2. Purification of GST-Fusion Protein

1. Transform an IPTG-inducible expression vector containing a GST-fusion of the wild-type or the sensitized kinases into competent E. coli cells. 2. Grow a 5 mL overnight culture prepared from a fresh bacterial colony in TB containing appropriate antibiotics. 3. Inoculate 500 mL TB containing appropriate antibiotics with the overnight culture. Grow on a shaker at 37°C until OD600 of approximately 0.5–0.6 (see Note 4). 4. Induce expression of the fusion protein by adding IPTG to a final concentration of 0.5 mM and continue growing for 5 h at 28°C (see Note 4).

190

D. Salomon et al.

5. Pellet bacteria by centrifugation at 2,000 × g for 20 min at 4°C. Discard the supernatant. 6. Gently resuspend the pellet in 10 mL PBS containing 1 mM PMSF, 5 mg/mL leupeptin, and 5 mg/mL aprotinin (see Notes 5 and 6). 7. Sonicate by 30 cycles of a 2-s pulse and 1-s break. Repeat sonication twice (or more, if necessary) until change in the color and viscosity of the suspension is apparent. From this step on, all procedures should be carried out at 4°C. 8. Centrifuge the suspension at 12,000 × g for 20 min at 4°C. 9. In the meantime, transfer 300 ml of 50% (w/v) slurry of glutathione agarose beads to a new 1.5-mL tube by using a blunt tip. Add 300 ml of PBS to the bead slurry and centrifuge for 30 s at 500 × g. Discard supernatant and resuspend in 300 ml of PBS. Repeat wash step three times. 10. Add cleared supernatant from step 8 into a 50-mL conical tube containing the 300  mL of washed glutathione agarose beads from step 9. Incubate on an end-over-end rotator for 30 min at 4°C. 11. Load the suspension into a plastic column kept at 4°C. Be careful not to suspend the beads in the column. Discard the flow-through. 12. Wash the column with 10 mL of ice-cold PBS with protease inhibitors (as described in step 6). 13. Add 2 mL of ice-cold elution buffer to the column and collect ten 50-mL fractions sequentially (approximately two drops of flow-through per fraction). 14. Measure protein concentration by Bradford assay. 15. Analyze purity by SDS-PAGE and Coomassie stain as detailed below. 3.3. In Vitro Kinase Activity Assay

1. Prepare an 18 mL kinase reaction solution containing 2 mL of 10× reaction buffer and 1  mg of the purified GST-fusion of wild-type or sensitized kinases. Keep on ice. 2. Add 2 mL of the 10× ATP-mixture. 3. Incubate at room temperature for 15 min (see Note 7). 4. Stop reactions by the addition of EDTA to a final concentration of 10 mM.

3.4. SDS-PAGE

1. These instructions assume the use of a Mini-PROTEAN minigel system, but are adaptable to other gel-electrophoresis systems. 2. Prepare a 1.5-mm thick, 10% gel by mixing 2.5 mL of 4× separating buffer with 2.5 mL of acrylamide/bis solution, 5 mL of

10  Sensitizing Plant Protein Kinases to Specific Inhibition by ATP-Competitive Molecules

191

water, 100 mL of 10% APS, and 10 mL of TEMED. Cast the gel and gently overlay it with 200  mL of water. The gel will polymerize in about 20 min. 3. Prepare the stacking gel by mixing 1.25  mL of 4× stacking buffer with 0.5 mL acrylamide/bis solution, 3.25 mL of water, 50 mL of 10% APS, and 5 mL of TEMED. Discard the water overlaying the separating gel, cast the stacking gel until it fills the space between the glasses, and insert the comb. Make sure that no air bubbles are caught between the comb and the gel. The stacking gel will polymerize within 20 min. 4. After gently removing the comb, assemble the gel into the gel unit. Add running buffer to the central chamber of the gel unit until full. Ensure that the buffer is not leaking and fill one third of the outer chamber with running buffer. 5. Add SDS-PAGE sample buffer (3×) to the kinase reactions and load up to 30 mL of each sample in a well. Include one well for molecular-weight markers. 6. Complete the assembly of the gel unit and connect to a power supply. Run the gel at 100 V through the stacking gel and at 120 V through the separating gel. The dye front will reach the bottom of the gel in approximately 1–2 h. 3.5. Coomassie Stain and Autoradiography

1. Disconnect the gel unit from the power supply and disassemble. Remove and discard the stacking gel. 2. Transfer the separating gel to a tray and incubate with Coomassie solution for 30 min with constant shaking. 3. Remove the Coomassie solution (see Note 8) and rinse with destaining solution. 4. Cover the gel with destaining solution and incubate for 1  h with constant shaking (see Note 9). If necessary, replace the used solution with fresh destaining solution, incubate the gel until blue protein bands are distinctly visible, and dry. 5. Expose the dry gel to an X-ray film and develop to visualize 32P incorporation. 6. Quantify band intensities by scanning densitometry of the films, provided that care is taken to ensure that the signal has not saturated. Alternatively, the radioactivity signal can be quantified digitally by a phosphorimager. 7. Compare autophosphorylation activity of the wild-type and sensitized kinases. An example of results produced for the tomato (Solanum lycopersicum) MAP kinase LeMPK3 is shown in Fig. 2 (see Note 10).

192

D. Salomon et al.

Fig. 2. In vitro kinase activity assay of wild-type and sensitized GST-LeMPK3. The tomato MAP kinase LeMPK3 (16) was expressed and purified from E. coli bacteria in wild-type and sensitized forms. The recombinant fusion proteins GST-LeMPK3, GST-LeMPK3(T123A), and GST-LeMPK3(T123G) were tested in vitro for autophosphorylation activity in a kinase assay in the presence of [g-32P]-ATP. The proteins were separated by SDS-PAGE, stained with Coomassie (lower panel) and the dry gel was autoradiographed (upper panel ).

3.6. Identification of Specific and Potent Kinase Inhibitors

1. Perform in vitro kinase activity assays for wild-type and sensitized kinases. Before addition of the ATP-mix, add to the reaction mixture individual inhibitors to a final concentration of 1 mM. Include a control reaction with DMSO at a similar concentration as in the reactions containing the inhibitor. 2. Separate reactions by SDS-PAGE, stain the gel with Coomassie solution, and expose to X-ray film. 3. Quantify band intensities and compare reactions containing inhibitor with the DMSO control. Identify inhibitors that specifically inhibit the sensitized kinase, but not the wild-type. An example of inhibition of sensitized and wild-type LeMPK3 by various PP1 derivatives is shown in Fig. 3. 4. To determine potency of the specific inhibitor identified in step 3, perform in vitro kinase activity assays in the presence of increasing concentrations of the inhibitor. Typical concentrations range from 1 nM to 10 mM. 5. After developing the exposed X-ray film, quantify band intensities and compare reactions containing the inhibitor with a control reaction containing DMSO. Calculate percentage of kinase activity for reactions containing inhibitor relative to the control reaction set as 100% kinase activity. 6. Plot percentage of kinase activity (Y-axis) against a logarithm of inhibitor concentration (X-axis). 7. Identify the concentration of inhibitor causing 50% inhibition of kinase activity (this is the IC50 value of the inhibitor). 8. Select a mutant-specific inhibitor with the lowest IC50 value for subsequent analysis.

10  Sensitizing Plant Protein Kinases to Specific Inhibition by ATP-Competitive Molecules

193

Fig. 3. Inhibition of wild-type and sensitized GST-LeMPK3 kinase activity by PP1 derivatives. In vitro kinase activity assays were performed for wild-type GST-LeMPK3 (white bars) and sensitized GST-LeMPK3(T123A) (gray bars) in the presence of [g-32P]-ATP and the indicated PP1 derivatives (1 mM). Percentage of inhibition (defined as 1 − V1/V0) was calculated by determining the ratio of V1 (activity in the presence of inhibitor)/V0 (activity in the absence of inhibitor). Data are the means of three technical repeats ± SE. The assay was repeated at least two times for each inhibitor with similar results.

3.7. Identification of Homozygous T-DNA Insertion Mutant for the Kinase of Interest

1. Order Arabidopsis T-DNA insertion lines for the gene encoding the kinase of interest from the stock center. If the available mutant line is heterozygous for the insertion, isolate a homozygous line after selfing and analyzing the progeny as follows. 2. Grow 12–20 seeds (2 seeds in each 9 cm2 pot) from the batch received from the stock center under long-day conditions (16 h light/8 h dark). 3. Harvest 3–4 young leaves and flowers from each 4-weeks-old plant and place in a 1.5-mL microcentrifuge tube. Immediately freeze in liquid nitrogen (samples can be stored at −80°C). 4. Grind the frozen tissue and add 500  mL of Genomic DNA extraction buffer. 5. Incubate on an end-over-end rotator (slow rotations) for 5 min at room temperature. 6. Centrifuge for 8 min at 16,000 × g at room temperature. 7. Transfer 350 mL of the cleared lysate to a clean 1.5-mL microcentrifuge tube and add 350 mL of isopropanol. Mix gently by inverting the tube ten times. 8. Centrifuge at 16,000 × g for 10  min at room temperature. Discard the supernatant and air-dry the pellet (it will take approximately 30 min). 9. Add 300 mL of water and incubate on an end-over-end rotator (at slow rotation) for 30  min at room temperature to allow DNA pellet to dissolve. Store at 4°C. 10. Use primers for PCR identification of a homozygous T-DNA insertion line designed by using the online T-DNA Primer

194

D. Salomon et al.

design tool of the Salk Institute Genomic Analysis Laboratory (http://signal.salk.edu/tdnaprimers.2.html). Insert the name of your T-DNA insertion line (e.g. SALK_000001) and retrieve the output sequences for the left primer (LP) and right primer (RP) that are located on the gene sequences flanking the T-DNA insertion site. 11. Perform PCR amplification using 2 mL of genomic DNA preparations as template. For each genomic DNA to be tested, perform two reactions. The first reaction should contain LP and RP, and the second one should contain RP and the left-border primer of the T-DNA insertion (see Note 11). If the DNA sample tested is homozygous for the T-DNA insertion, a PCR amplicon is obtained only from the second reaction. However, if the DNA sample tested is heterozygous, a product is obtained from both reactions. 12. Harvest seeds from plants homozygous for the T-DNA insertion and allow them to dry overnight at room temperature. Store seeds at 4°C in a dry environment. 3.8. Generating Arabidopsis Lines Expressing the Sensitized Kinase

1. Grow 40–50 seeds (2 seeds in each 9 cm2 pot) of the Arabidopsis homozygous mutant T-DNA insertion line for the gene of interest under long-day conditions (16  h light/8  h dark). Cover the soil with bridal veil or cheesecloth (the plants will flower after approximately 5 weeks). 2. Clip first bolts to encourage growth of secondary bolts and continue growing until plants have many immature flower clusters and not many fertilized siliques. 3. Grow 5 mL of overnight culture of Agrobacterium tumefaciens carrying a binary vector for the expression of the sensitized or the wild-type kinase (see Note 12). Cultures are prepared in LB medium containing appropriate antibiotics and inoculated with a fresh colony. 4. Inoculate 500  mL of LB containing appropriate antibiotics with the overnight culture. Grow at 28°C for 16 h. 5. Pellet cells by centrifugation at 3,700 × g for 15  min at 4°C. Discard the supernatant. 6. Resuspend cells in 200 mL of 5% (w/v) sucrose solution and transfer to a 250-mL beaker. 7. Add Silwet-L77 to a final concentration of 0.035% (v/v) and stir for 1 min. 8. Dip aboveground parts of plants in the bacterial suspension for 2–3 s. 9. Return dipped plants to tray and cover tray with a dome. Incubate in low light intensity condition for 16–24 h. 10. Remove the dome and continue growing plants under longday conditions.

10  Sensitizing Plant Protein Kinases to Specific Inhibition by ATP-Competitive Molecules

195

11. Repeat steps 3–10 for the same plants after 5–7 days and grow them until fertilized siliques are open. 12. To harvest the dry seeds, open siliques on top of a clean paper. Collect seeds from the paper to 1.5 mL tubes. Leave the tube open overnight at room temperature to dry seeds completely. Store seeds at 4°C in a dry environment. 13. Prior to germination, the collected seeds should be sterilized. For sterilization, dispense approximately 100–200 seeds into 1.5-mL tubes and place in a dessicator (leave tube caps open) within a chemical fume hood. In the middle of the dessicator place a beaker containing 100 mL of a 10% sodium hypochlorite solution. Add 5 mL of hydrochloric acid (HCl) and immediately close the dessicator. Incubate for 3 h. 14. Spread seeds (roughly 1,000) on 0.8% plant agar plate with 0.5% MS and appropriate antibiotics (of the T-DNA of the Agrobacterium transformation vector) to select for transformed seeds. Wrap plates with parafilm and incubate at 4°C overnight. 15. Transfer plate to long-day growth conditions for approximately 7 days. Transgenic seedlings will appear green and healthy, while nontransformed seedling will appear white and small. 16. Gently transplant each putative transgenic plant in soil and grow under long-day conditions. 17. Extract DNA from individual transformed plants as described above and test for the presence of the transgene by performing PCR on genomic DNA using primers that will amplify a segment of the T-DNA containing the desired transgenic kinase allele. 18. Harvest seeds from the transgenic plants (see Note 13). 3.9. Effects of Kinase Inhibition In Planta

1. Sow seeds of transgenic and wild-type Arabidopsis plants. Grow the plants to the desired developmental stage. 2. Apply inhibitor solutions either to the whole plant, by spraying, or locally, by using a brush with soft fine fibers. 3. Proceed with desirable assays to examine the effect of specific inhibition of the kinase of interest on selected phenotypes.

4. Notes 1. The choice and working concentration of the divalent cations (Mg2+ or Mn2+) and the pH of the buffer in the kinase reaction should be optimized beforehand for the individual kinases. 2. It is advisable to use the GenBank GI number or the commonly used name of the protein kinase of interest to search for the appropriate alignment using the “Search by: protein name”

196

D. Salomon et al.

option. The resulting sequence alignment can be either downloaded as a Microsoft Excel file or directly viewed in HTML format with a Web browser. In these alignments, the gatekeeper residue is highlighted in red and other ATP-contacting amino acids are highlighted in green. 3. It is possible to design mutagenesis primers that either introduce a novel restriction site or eliminate an existing restriction site through auxiliary silent mutation adjacent to the primary mutation. The alteration of a restriction site allows for a quick screen for mutated plasmid via restriction enzyme digestion, prior to nucleic-acid sequencing. 4. Induction conditions and incubation time should be calibrated and optimized for each application. 5. The half-life of PMSF in aqueous solutions is approximately 30  min. Therefore, it is advisable to add PMSF to the PBS solution right before use. 6. At this point, the suspension can be frozen in liquid nitrogen and kept at −80°C for up to 1 month. 7. Optimal incubation time during which the change in initial velocity of the reaction is linear should be determined in preliminary experiments. 8. The Coomassie staining solution can be reused several times. 9. It is advisable to add a piece of tissue paper to the tray. This will shorten the destaining procedure, since the tissue paper will keep the washed dye out of the destaining solution. 10. Introduction of a mutation at the gatekeeper may affect activity of the kinase as shown in Fig. 2 for LeMPK3(T123G). It is, thus, advisable to substitute the gatekeeper residue with alanine and glycine and select the mutation with the lowest effect on kinase activity. If the kinase of interest does not tolerate any mutation at the gatekeeper residue, a second site suppressor mutation can be introduced to restore activity (15). 11. For lines obtained from SALK, it is advisable to use the ­following oligonucleotide as left-border primer: 5¢-ATTTT GCCGATTTCGGAAC-3¢. 12. Strains of A. tumefaciens commonly used are EHA105 or GV3101. The binary vector used for expression should contain a selectable marker different from that present in the T-DNA insertion to allow appropriate selection of transformed seeds. It is advisable to drive the expression of wild-type and sensitized alleles with the kinase endogenous promoter to maintain the original expression patterns. 13. Functionality of the wild-type or sensitized kinase should be evaluated in transgenic plants as compared to wild-type plants.

10  Sensitizing Plant Protein Kinases to Specific Inhibition by ATP-Competitive Molecules

197

Acknowledgments We thank Tal Sherman for his advice on Arabidopsis plant transformations. This work was supported by the US–Israel Binational Agricultural Research and Development Fund (BARD; grant no. IS-4159-08C to G.S.) and by the Binational Science Foundation (BSF; grant no. 2007091 to G.S. and K.M.S.). References 1. Bergmann, D.C., and Sack, F.D. (2007) Stomatal development Annu Rev Plant Biol 58, 163–81. 2. Chang, C. (2003) Ethylene signaling: the MAPK module has finally landed Trends Plant Sci 8, 365–8. 3. Harper, J. F., and Harmon, A. (2005) Plants, symbiosis and parasites: A calcium signalling connection Nat Rev Mol Cell Biol 6, 555–66. 4. Morillo, S. A., and Tax, F. E. (2006) Functional analysis of receptor-like kinases in monocots and dicots Curr Opin Plant Biol 9, 460–9. 5. To, J. P. C., and Kieber, J. J. (2008) Cytokinin signaling: two-components and more Trends Plant Sci 13, 85–92. 6. Zhu, J. K. (2002) Salt and drought stress signal transduction in plants Annu Rev Plant Biol 53, 247–73. 7. Bishop, A. C., Buzko, O., and Shokat, K. M. (2001) Magic bullets for protein kinases Trends Cell Biol 11, 167–72. 8. Bishop, A.C., Ubersax, J.A., Petsch, D.T., Matheos, D.P., Gray, N.S., Blethrow, J., Shimizu, E., Tsien, J. Z., Schultz, P. G., Rose, M. D., Wood, J.L., Morgan, D. O., and Shokat, K.M. (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase Nature 407, 395–401. 9. Bohmer, M., and Romeis, T. (2007) A chemical-genetic approach to elucidate protein kinase function in planta Plant Mol Biol 65, 817–27. 10. Brodersen, P., Petersen, M., Nielsen, H. B., Zhu, S. J., Newman, M. A., Shokat, K. M., Rietz, S., Parker, J., and Mundy, J. (2006) Arabidopsis MAP kinase 4 regulates salicylic acid- and jasmonic acid/ethylene-dependent

11.

12.

13.

14.

15.

16.

17.

responses via EDS1 and PAD4 Plant J 47, 532–46. Lin, J. H., Li, H., Yasumura, D., Cohen, H. R., Zhang, C., Panning, B., Shokat, K. M., LaVail, M. M., and Walter, P. (2007) IRE1 signaling affects cell fate during the unfolded protein response Science 318, 944–9. Bishop, A. C., Kung, C.-y., Shah, K., Witucki, L., Shokat, K. M., and Liu, Y. (1999) Generation of monospecific nanomolar tyrosine kinase inhibitors via a chemical genetic approach. J Am Chem Soc 121, 627–31. Benjamin, K. R., Zhang, C., Shokat, K. M., and Herskowitz, I. (2003) Control of landmark events in meiosis by the CDK Cdc28 and the meiosis-specific kinase Ime2 Genes Dev 17, 1524–39. Blethrow, J., Zhang, C., Shokat, K. M., and Weiss, E. L. (2004) Design and use of analogsensitive protein kinases Curr Protoc Mol Biol Chapter 18, Unit 18 11. Zhang, C., Kenski, D. M., Paulson, J. L., Bonshtien, A., Sessa, G., Cross, J. V., Templeton, D. J., and Shokat, K. M. (2005) A second-site suppressor strategy for chemical genetic analysis of diverse protein kinases Nat Methods 2, 435–41. Mayrose, M., Bonshtien, A., and Sessa, G. (2004) LeMPK3 is a mitogen-activated protein kinase with dual specificity induced during tomato defense and wounding responses J Biol Chem 279, 14819–27. Salomon, D., Bonshtien, A., Mayrose, M., Zhang, C., Shokat, K.M., and Sessa, G. (2009). Bypassing kinase activity of the tomato Pto resistance protein with small-molecule ligands. J Biol Chem 284, 15289–98.

wwwwwwwwwwwwwwwww

Chapter 11 Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization Mark A. Hink, Sacco C. de Vries, and Antonie J.W.G. Visser Abstract Receptor kinases are essential for the cellular perception of signals. The classical model for activation of the receptor kinase involves dimerization, induced by the binding of the ligand. The mechanisms by which plant receptors transduce signals across the cell surface are largely unknown but plant receptors seem to dimerize as well. In this chapter, we describe two fluorescence fluctuation techniques, fluorescence crosscorrelation spectroscopy and photon counting histogram analysis, to study the oligomerization state of receptor kinases in living plant cells in a quantitative manner. Key words: SERK1, SERK3, BRI1, Receptor kinase, Dimerization, Fluorescence cross-correlation spectroscopy, Photon counting histogram, Plasma membrane, Protoplast

1. Introduction The somatic embryogenesis receptor kinase (SERK) was isolated as a marker for single cells in carrot (Daucus carota) cell suspension cultures that had acquired the ability to initiate somatic embryogenesis (1). SERK1 is a plasma membrane localized leucine-rich repeat (LRR)-receptor-like kinase (RLK) and consists of an N-terminal leucine zipper (LZ) domain, five LRRs, a proline-rich stromal processing peptidase (SPP) domain, a transmembrane domain, and an active intracellular serine/threonine kinase (2, 3). Förster Resonance Energy Transfer (FRET) studies have verified the interaction between SERK1 and BRI1-associated receptor kinase (BAK1)/SERK3, Brassinosteroid insensitive 1 (BRI1) and other proteins in confined regions at the plasma membrane (4, 5). To study BRI1, SERK1, and SERK3 by

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_11, © Springer Science+Business Media, LLC 2011

199

200

M.A. Hink et al.

fluorescence techniques its cDNA has been C-terminally fused to the cyan (CFP) or yellow (YFP) variant of enhanced green fluorescent protein (EGFP) (3) and transiently expressed in plant cells. Both BRI1 and SERK1 receptors were shown to be present in an oligomerized state in the plasma membrane (3). Elimination of the extracellular LZ domain reduced the FRET efficiency to control levels, indicating that SERK1 lacking the LZ domain (SERK1∆LZ) is monomeric (3). However, standard imaging techniques to visualize FRET with high-spatial resolution such as confocal microscopy (6) and fluorescence lifetime imaging microscopy (FLIM) (7) require a relatively large amount of fluorescently tagged molecules (>1 mM). This may be well above physiologically relevant concentrations. In addition, it is difficult to retrieve information about the oligomeric status of the studied proteins. Techniques such as photon counting histogram (PCH) analysis (8) and fluorescence correlation spectroscopy (FCS) (9) can provide this information and operate at the single-molecule detection level, allowing to measure at physiologically relevant concentrations instead of using overexpression conditions. For FCS and PCH, the fluorescence intensity is monitored in a small observation volume that is continuously illuminated. A particle with a given molecular brightness, h, produces an intensity fluctuation as it passes the observation volume. Particles with a higher molecular brightness will result in stronger intensity fluctuations. Since small particles will diffuse more rapidly through the observation volume than large molecules, the duration of the fluorescence bursts contains information on the diffusion speed of the particles. PCH and FCS use the same experimental data, but each technique focuses on a different property of the signal. FCS analyses the time-dependent decay of the fluorescence fluctuations, while PCH calculates the amplitude distribution of these fluctuations. This latter technique yields the distribution of molecular brightness per particle where molecular brightness is defined as the average fluorescence photon count rate detected per particle. Müller et al. (10) showed that PCH analysis is capable of resolving particles having a brightness ratio of two. Therefore, PCH has the sensitivity to resolve the number of SERK or BRI1 proteins present in oligomeric complexes, since oligomers consisting of n monomers are expected to be n times as bright as the monomer. Since the resolving power of FCS to distinguish particles of different molecular size is limited (11), dual-color fluorescence cross-­correlation spectroscopy (FCCS) has been developed (12). Here, two spectrally different fluorescent probes, e.g., ECFP and EYFP, are used to label each of the interacting partners. Each probe is excited and detected by separate light sources and detectors. Molecular interactions can be studied by following the coincidence of the fluorescence fluctuations in the two detectors. The amplitude and decay of the cross-correlation curves correspond to the number and dynamics of those complexes that carry both

11  Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization

201

fluorescent probes. In this chapter, we describe how both techniques can be used to study fluorescently tagged Arabidopsis thaliana SERK1 receptors.

2. Materials 2.1. Cowpea Mesophyl Protoplast Transfection

1. Enzyme solution: 10 mM CaCl2, 0.5 M mannitol, 0.1% (w/v) cellulase R10 (Yakult Honsha), 0.05% (w/v) pectinase (Sigma; pH 5.5). 2. Prewashing solution I: 10  mM CaCl2, 0.5  M mannitol (pH 5.5). 3. Prewashing solution II: 10  mM CaCl2, 0.6  M mannitol (pH 5.5). 4. Prewashing solution III: 0.1  M Ca(NO3)2, 0.6  M mannitol, 40% (w/v) PEG MW 6,000 (pH 5.5). 5. Washing solution: 0.5 M mannitol, 15 mM MgCl2, and 0.1% (w/v) 2-(N-morpholino)ethanesulfonic acid (MES, pH 5.5). 6. 4- to 5-week-old cowpea plants grown under fluorescent light at 22°C with a 16-h light 8-h dark cycle.

2.2. Constructs

1. Full-length wild-type fusions of SERK1 to fluorescent probes under the control of the CaMV 35S promoter in pMON as pMON:SERK1:ECFP and pMON:SERK1:EYFP. 2. Mutated and truncated fusions of SERK1 to fluorescent probes under the control of pMON: pMON:SERK1kinase:ECFP/EYFP (intracellular kinase domain only) and pMON:SERK1∆LZ:ECFP/ EYFP (deleted LZ domain) as described by Shah et al. (3). 3. SERK3 fusions: pMON:SERK3:ECFP/EYFP and pMON:BRI1:ECFP/EYFP constructs as described by Russinova et al. (13). 4. pMon999 (Monsanto): control vector lacking a fluorescent protein to estimate the contribution of autofluorescence. 5. PCH control fusion proteins: a CAAX-box (14) fused to single or double copies of a ECFP/EYFP or (ECFP/EYFP)2 moiety. 6. A positive FCCS control, CAY, an ECFP moiety fused via a 25 Alanine amino acid linker to an EYFP moiety as described by Hink et al. (15). 7. Negative FCCS controls: unfused cytoplasmic fluorescent proteins generated by the promoter reporter lines pMON:ECFP and pMON:EYFP (3) (see Note 1).

202

M.A. Hink et al.

2.3. Calibration Probes, Microscopy, and Software

1. Phosphate-buffered saline (PBS): 137  mM NaCl, 2.7  mM KCl, 10  mM sodium phosphate dibasic, 2  mM potassium phosphate monobasic (pH 7.4). 2. Rhodamine 110 (Invitrogen). 3. Purified ECFP and EYFP in PBS pH 7.4. The fluorescent proteins are purified using the IMPACT (New England Biolabs) system, which utilizes inducible self-cleavage activity of an intein splicing element to separate the FP from the affinity tag. Transformed bacteria are collected by centrifugation and resuspended in 50 mM PBS. Cells are lysed by passage through a French pressure cell. Soluble protein is obtained after centrifugation at 20,000 × g for 30 min at 4°C. The protein binds to the chitin beads and after extensive wash with PBS the FPS are eluted from the column by incubating the beads overnight in 50  mM dithiothreitol (DTT). Protein purity is checked on SDS-PAGE. Protect these solutions from light and keep them on ice. Dilute to approximately 200  nM for FCS calibration measurements. 4. 96-Well microtiter plates with borosilicate bottom (Whatman). 5. Microscopy equipment: LSM510 Laser Scanning Microscope (LSM) equipped with a ConfoCor2 FCS unit and a 40× C-Apochromat water immersive lens with a numerical aperture (N.A.) of 1.2. (all Carl Zeiss) (see Note 2). 6. Dual dichroic filters for CFP (458  nm in current work) and 514 nm, a longpass filter LP510, bandpass filters (e.g., BP470500 for CFP and BP527-562 for YFP). 7. FFS data processor 2.1 software package (Scientific Software Technologies Centre). 8. Igor Pro (Wavemetrics Inc.).

3. Methods 3.1. Protoplast Isolation

1. Cowpea (Vigna unguiculata) mesophyll protoplasts are prepared by first peeling off the lower epidermis of the primary leaves of 10 days old cowpea, using forceps (see Note 3). 2. Three leaves are floated on 15 ml of enzyme solution for 3.5 h at room temperature with gentle shaking. 3. The cells are washed twice with 2 ml of prewashing solution I followed by centrifugation for 5 min at 40 × g.

3.2. Transfection

1. Add 10 mg of purified plasmid in 30 ml of water to (0.5–1) × 106 protoplasts in 75–150 ml of prewashing solution II. 2. Mix gently and add 3 ml of prewashing solution III.

11  Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization

203

3. Incubate the protoplast suspension for 10  s under gentle shaking followed by the addition of 4.5 ml washing solution in order to stop the transfection. 4. Incubate at room temperature for 20 min, wash the cells three times with washing buffer and incubate in Petri dishes at room temperature under constant lab illumination. 3.3. Microscope Calibration

1. The microscope is placed in an air-conditioned room to ensure temperature stability and the samples are stored in the described 96-well plates. In order to reduce the amount of background light, a protective blackened aluminum cover was placed on top of the sample during the measurements. 2. Turn on the microscope and the Argon-ion laser 30 min before starting the measurements. 3. Configure the FCS unit: the ECFP-labeled samples will be excited with the 458 nm laser line (if available, use the 405 or 440 nm lines that work better) and the EYFP samples with the 514  nm line of an Argon-ion laser. The fluorescence is separated from the excitation light by a dual dichroic filter, reflecting both the CFP (458 nm in current work) and 514  nm excitation lines. A secondary dichroic filter, LP510, separates the emission light into two different detection channels. Appropriate bandpass filters (e.g., BP470-500 for CFP (at 458 nm excitation) and BP527-562 for YFP, respectively) are used for spectral selection (see Note 4). 4. Since the confocal images and FCS curves will be acquired using different detection heads, the two units should be fully aligned: acquire with the LSM unit a confocal image of a layer of rhodamine 110, dried on a coverslip. Use the same zoom factor (approximately 10×) that will be used for the acquisition of the protoplast images later. 5. Assign two FCS measurement spots in the confocal image, one at the upper left and one at the lower right corner and mark these spots. Close the pinholes in the FCS unit to the minimum, in order to protect the sensitive avalanche photodiodes detectors (APD) and perform a FCS measurement in both spots for ca. 15 s using 100% power of the 514 nm laser line. 6. Take a new confocal image at lower laser power and validate how well the two bleached spots coincide with the marked measurement spots. Correct the positioning of the FCS beampath in the software until the beams are fully aligned. 7. Measure the fluorescence of a ~100 nM solution of rhodamine 110 in PBS at a laser power of approximately 10–50 kW/cm2. Adjust the correction ring of the objective to the position where the highest fluorescence countrate is observed in the YFP detection channel (see Note 5). In order to prevent that one optimizes scattered excitation light or adsorbed probe

204

M.A. Hink et al.

from the bottom of the sample holder instead of observing the true fluorescence signal, the focus should be set at least 100 mm into the solution. 8. The fluorescence emission is detected with avalanche photodiodes, placed behind size adjustable pinholes. To maximize the overlap of the blue and red observation volume, the position and diameter of the pinholes are optimized. Thereto a solution of approximately 200  nM purified ECFP in PBS is measured at a laser power of approximately 10–50 kW/cm2. As a default, the pinhole diameters are set to 55  mm for the CFP and 70 mm for the YFP detection channel. Optimize the X-, Y- and Z-position of the pinhole of the CFP channel by running the semi-automatic pinhole adjustment protocol in the software. For all axes, a Gaussian-like curve should appear where a single maximum peak indicates the optimal position for the pinhole. Repeat this procedure for the pinhole of the YFP detector, using the same ECFP solution but at a two- to threefold higher laser power. Due to the limited movement of the pinholes along the Z-axis one might encounter the problem that the maximum in either the CFP or the YFP channel is located just outside the observable pinhole range. By modifying the position of the collimator lens and repeating the pinhole optimization one can try to move both pinhole maxima into the range. If this procedure is unsuccessful, the collimator should be set in such a way that the pinhole maximum of the weakest channel is within the range, while the pinhole maximum of the other channel is just outside the range. In our biological samples, the detected ECFP brightness is much lower than the detected EYFP brightness. Therefore, the collimator lens will be set to have the pinhole of the CFP detector just within the range while the pinhole position of the YFP channel was set to the maximum value, corresponding to an intensity of approximately 95% of the peak. 9. Perform a FCS measurement of purified ECFP and EYFP in PBS using their corresponding laser lines at 3.2 (458 nm) and 4.0 kW/cm2 (514 nm) (see Note 6). Adjust the measurement time such that the resulting correlation curve is smooth in the decaying part of the curve. The autocorrelation curves are imported into the FFS data processor 2.1 software and fitted to a model including terms for triplet state kinetics and threedimensional Brownian diffusion (16):

 −t  1  1 1 − T + Te τTRIP G (t ) = 1 + ·  · N  N (1 − T )  

   1 · 2   t t  w xy   1 + t  1 + t ·  w    z d d

(1)

11  Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization

205

The autocorrelation function, G(t) contains parameters like N, which corresponds to the average number of fluorescent particles in the detection volume. td is the average diffusion time of the molecules, wxy is the equatorial radius, and wz is the axial radius of the observation volume. T is the fraction of molecules present in the dark state and tTRIP is the average time a molecule resides in the dark state. From these fits the shape factor, a, of the green and red observation volumes (a = wz/wxy) and the td for ECFP and EYFP are obtained (see Note 7). By solving Eq. 2, using the translational diffusion coefficient (D) of 90 mm2/s for ECFP and EYFP in buffer, the dimensions of the detection volumes can be calculated by approximating these to be cylinders (see Note 8).

td =

ω xy2 4D

V = 2· π · a ·ω 3xy

(2) (3)

10. Measure a positive cross-correlation sample, e.g., a fusion protein of ECFP linked to EYFP by a small amino acid linker, like the CAY sample (15), and a negative control. These control proteins should preferably be targeted to the same subcellular location as where the samples will be measured. As a negative control we have measured protoplasts co-transfected with free ECFP and free EYFP (cytoplasmic) or CAAX-box-tagged ECFP with CAAX:EYFP (in the plasma membrane). Although the amplitude of the positive cross-correlation curve should lie between the two amplitudes of the two autocorrelation curves, often this is not the case. By making small adjustments in the pinhole diameters, which should not exceed >10% of change to the original pinhole diameters, one could optimize the observation volume overlap and therefore increase the cross-correlation amplitude with respect to the autocorrelation amplitudes. When one is only interested in PCH analysis, and not in FCCS, the pinholes can be opened slightly more (<25% of change) since the PCH analysis is less sensitive to the shape of the observation volumes. 3.4. Fluorescence Fluctuation Measurements

1. Measurements are performed in protoplasts 5–9 h after transfection. Select only transfected cells that have a subcellular (cytoplasmic or plasma membrane-localized) fluorescence intensity that is higher than the highest autofluorescence intensity observed at that location in wild-type cells. For crosscorrelation measurements only cells are selected that express both the ECFP and EYFP fusion proteins (see Note 9). 2. The observation volume is positioned in the cytoplasm or in the middle of the upper plasma membrane that can be identified by acquiring a fluorescence intensity scan along the

206

M.A. Hink et al.

optical (Z-) axis. No spots are selected that are closely located to chloroplasts, since these organelles will scatter light and absorb the fluorescence light, thereby reducing the signal-tonoise ratio (SNR) (see Note 10). 3. The laser power is set not more than 2.5  kW/cm2 for the 458 nm laser line and 3.1 kW/cm2 for the 514 nm laser line to prevent photobleaching, cellular damage, and photophysical effects. These excitation intensities are still sufficient to achieve reasonable SNRs (5–10) within measurement times of 60–180  s. Above 3.2 (458  nm) or 4.0  kW/cm2 (514  nm) photobleaching and probe saturation lead to significant distortions of the correlation and PCH curves. 4. The raw fluorescence intensity files are saved for processing. Data sets containing large intensity spikes (>10 times the intensity standard deviation around the mean intensity), significant signal drift or photobleaching (>20% loss) is discarded. 3.5. Photon Counting Histogram Analysis

1. After loading the raw data into the FFS data processor software, a region, that contains at least 50,000 photons, is selected out of the complete raw data traces. The selected intensity trace should be stable, thus lacking a drift in intensity, and the presence of (small) intensity spikes should be minimal. The experimental intensity trace, originally stored using a sampling frequency of 200 kHz is re-binned to 5 kHz (see Note 11). The curve is fitted in the FFS data processor software to an one- or two-species PCH model including autofluorescence background, assuming a 2D-Gaussian detection volume for the membrane targeted proteins and a 3D-Gaussian detection volume for SERK1kinase-dead−FP and the free fluorescent proteins (8). The brightness of the autofluorescence is fixed to the values obtained in mock transfected cells. For correct fitting, it is important to have good starting values for the fit parameters and therefore “initial guesses” should be generated (16). The quality of the fitted curves should be judged by visual inspection of the amplitude and randomness of the fitting residuals and by the Chi square value, c2, of the fitting. An example PCH curve of SERK1:ECFP in cowpea protoplasts is shown in Fig. 1. 2. To validate if the number of species included in the PCH fitting model was sufficient, PCH traces and fits are imported into the Igor Pro software. The reduced c2dn (Eq. 4) (17) indicates the quality of the fit model used and gives a measure of the ability to distinguish between the PCH curves of n and (n − 1) species systems. Values of c2dn lower than one indicate that the data statistics are not sufficient to resolve the species completely, whereas a c2dn larger than one indicates that more species than assumed in the fitting model are present:

11  Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization

 M ∑ k = kmin   kmax

χδ2n = Min {N , h}

∏ (k; N , N 1

2

, …, N n , h1, h2 , …, hn ,) − ∏(k; N 1, …, N n −1, h1, …, hn −1    sk kmax − kmin − d

207

2



(4)

Here, M is the number of data points, d the number of fitting parameters, and kmin and kmax are the minimal and maximal number of photon counts per bin, respectively. Nn and hn represent the number of particles and molecular brightness of the

Fig. 1. Representative photon counting histogram (PCH) of SERK1:ECFP in cowpea protoplasts. (a) Complete fluorescence intensity trace, including drift at the end of the measurement. Indicated are the borders that define the section that has been used in data analysis (dashed gray lines). (b) PCH after binning the data to 5 kHz. The data points (squares) were fitted to a two-species 2D-PCH model (gray line) with background. (c) Normalized fitting residuals of (b), indicating the fit quality.

208

M.A. Hink et al.

nth species. sk is the standard deviation of finding k counts r times out of M trials and P (k; N1,…,Nn, h1,…, hn) are the theoretical nth species PCH functions (17). 3.6. Auto- and Cross-Correlation Analysis

1. After loading the raw data into the FFS data processor software, a region, that contains at least 50,000 photons in each channel, is selected out of the two complete raw data traces. The selected intensity trace should be stable, so without an intensity drift, and the presence of (small) intensity spikes should be minimal in both channels. The selected intensity trace is auto- and cross-correlated resulting in the two autocorrelation curves GC(t) (for the CFP channel) and GY(t) (for the YFP channel) and the cross-correlation curve GCY(t). 2. The autocorrelation curves can be fitted according to (see Note 12): 2

Fbackground   · G (t ) = 1 +  1 − Ftotal  



 t  t  1 1 − T + T e TRIP  N · (1 − T )  

  1  Φ ∑ m  + offset   w m   t t xy  1 + t  1 + t . w        dif ,m dif z with Φm =

(h

2 m

Ym

)

   ∑ hm Ym  m

2

(5)

where the first term corrects for the background fluorescence in the corresponding detection channel (Fbackground). The value of this parameter is determined by averaging the fluorescence intensity in the subcellular region of interest (cytoplasm or membrane) in wild-type protoplasts. In order to correct for the noncorrelating cross-talk of ECFP in the YFP channel, the background fluorescence in the YFP channel was raised by 0.30 times the intensity observed in the CFP channel. This bleed-through factor of 30% was determined by comparing the intensities in both detection channels using an ECFP-only sample. Each molecular species, m, contributes to the correlation curve function according to its fraction (Ym) and molecular brightness (hm) (see Note 13). The ratio wxy/wz is fixed to the value obtained from the calibration measurement. An offset can be included to correct for the effect of small intensity drifts in the selected data trace. PCH analysis revealed the presence of monomers and dimers in the sample and this information (m = 2 and h2 = 2 × h1) is included in the fitting model.

11  Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization

209

Fig. 2. Representative auto- and cross-correlation curve of SERK1:ECFP and SERK1:EYFP in cowpea protoplasts. (a) CFP (open diamonds) and YFP (filled diamonds) auto-correlation, and cross-correlation curves (gray line). The curves were corrected for bleed-through and background and fitted to 3D-Brownian triplet-diffusion models (black lines). Note the difference in scaling for the auto- and cross-correlation curves. (b) The fitting residuals of (a), indicating the fit quality. This figure is displayed in greyscale in the print edition but available in color in the electronic version.

An  example FCCS-curve of SERK1:ECFP in cowpea protoplasts is shown in Fig. 2. 3. The amplitude of the cross-correlation curve GCY(0) contains the information of the number of doubly labeled particles, NCY, observed in the cross-correlation observation volume, Veff. The effective cross-correlation observation volume was estimated from the cross-correlation curve, measuring a sample of ECFP. Here, we make use of the cross-talk of ECFP since some emission of ECFP will be detected in the YFP detection channel. The emission of EYFP in the CFP channel could be omitted. Equations 6 and 8 (18) contain corrections for this cross-talk. From the PCH analysis of single fluorescent protein (FP)-labeled SERK1 and BRI1 it became evident that the observed oligomeric structures consist of dimers. In our experimental system, these dimers do not only consist of particles that carry both the ECFP and the EYFP label (19), but ECFP2- or EYFP2-labeled dimers have to be taken into account as well. The molecular brightness of these homodimers is twice the value of the monomeric form, as has been determined by PCH. We assume that the dimerization does not depend on the FP that is fused to the SERK1. Hence, since the contribution

210

M.A. Hink et al.

of each species to the correlation curve scales with the square of the relative brightness, the amplitude of the correlation curves now reads: GCY (0) = 1 +

h   YYY 

 

(NC + NCY



   h   h  + 2 N CC ) N Y + 2 N YY +  (N C + 2 N CC ) CCY   + N CY 1 + CCY    hYYY    hYYY    

GC (0) = 1 +



 YYY 

h

(NC + 4 NCC ) hCCY  + NCY 1 + hCCY 

GY (0) = 1 +

1



1   hCCY   N Y + 4 N YY + N CY +   hYYY  

(7)

(N C + N CY + 4 N CC ) 2

2   2hCCY  + + N N ( C CY )  h  NCC   YYY  

(6)



(8)

where NC, NY are the number of monomers labeled with ECFP or EYFP. NCC and NYY represent the number of homodimers where each monomer is labeled with ECFP or EYFP, respectively and NCY is the heterodimer labeled with ECFP and EYFP. The hprobe,excitation,emission values correspond to the molecular brightness values for the probes as detected for the different excitation and emission wavelengths. For example hCCY should be read as the molecular brightness of ECFP as detected in the YFP channel using the 458 nm “CFP” laser line. These values were obtained by the calibration measurements using the same laser settings as for the samples. To solve the equations above numerically we include Eqs. 9 and 10 (20):

N CY + 2 N YY + N Y N YY = N CY 2 (N CY + 2 N CC + N C )

(9)



N CC N CY + 2 N CC + N C = N CY 2 (N CY + 2 N YY + N Y )

(10)

Equations  6–10 are linked and fitted globally including a weight factor for Eqs. 6–8 to correct for the different detection volume sizes. An example of our experimental values is given in Table 1 (19).

C

M

M

C

M

M

M

ECFP

CAAX:ECFP

CAAX:(ECFP)2

CAY

SERK1:ECFP

SERK1: ECFP/EYFP

SERK1DLZ: ECFP/EYFP

4.2 ± 0.9

4.2 ± 1.3

4.0 ± 0.5

352 ± 36

5.1 ± 0.8

5.3 ± 0.7

370 ± 41

n.f.

2.6 ± 0.7

n.f.

329 ± 31

n.f.

n.f.

n.f.

0

15 ± 5

0

100

0

0

0

a

% interaction

17.3 ± 5.2

24.3 ± 0.7

10.1 ± 1.5 8.9 ± 1

22.3 ± 0.2

n.f.

20.3 ± 0.8

n.f.

n.f.

h2 (CFP channel) (kHz/mol)

10.9 ± 1.3

8.2 ± 1.2

9.6 ± 3.1

10.6 ± 1.8

8.9 ± 0.5

h1 (CFP channel) (kHz/mol)

D (cross-correlation channel) (× 1013 m2/s)

D (CFP channel) (× 1013 m2/s)

3 ± 2a

16 ± 9a

14 ± 11

0

98 ± 2

0

0

% dimer

The diffusion coefficient D and percentage dimerized protein were retrieved by FCCS analysis by fitting 3D Brownian diffusion models including the PCH-result that the only fraction of oligomerized SERK1:ECFP consists of dimers. The molecular brightness h and percentage dimer were retrieved by PCH analysis fitting a dual species 2D (membrane) or 3D (cytoplasmic) model. The standard deviations represent the variation of the parameter over experiments in different cells (n = 30–40). loc localization (cytoplasmic of membrane), n.f. not found a The percentage interaction was corrected for the nonvisible homodimers in FCCS and the nonvisible heterodimers in PCH

Loc

Construct(s)

PCH analysis

FCCS analysis

Table 1 Characteristic values obtained from FCCS and PCH analysis of SERK1:CFP and control constructs in cowpea plant protoplasts

11  Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization 211

212

M.A. Hink et al.

4. Notes 1. Although ECFP–EYFP is a popular pair to study molecular interactions, especially by FRET (21), there are some disadvantages in its practical application. ECFP is relatively dim and sensitive to photobleaching and EYFP is susceptible to photophysics which can turn a fraction of the molecules into a dark nonvisible state. The rapid development of new FP variants has produced many brighter and more photostable FPs (22). In the FCCS experiments, it is desirable to diminish the spectral cross-talk from the green probe into the red detector, since this will lead to false-positive cross-correlation. In our experimental setup, the amount of ECFP bleed-through into the YFP channel is 30% and thus significant. Therefore, we could improve the quality of the measurements by choosing a pair that is spectrally more separated. However, when choosing such a pair, the overlap between the two detection volumes (which depends inversely on the spectral separation) will become less and the maximum observable cross-correlation, and therefore sensitivity, will decrease. Thus, a trade-off should be found between spectral separation and detection volume overlap. A good alternative for ECFP–EYFP is the EGFP-mCherry pair (23), having high molecular brightness values, low photobleaching rates, and a reasonable spectral separation. 2. The quality of the objective highly determines the quality of the FCCS curves. It is essential to use an objective with a high N.A. and having the best chromatic corrections, in order to have the best overlap of the two excitation and detection volumes. The Zeiss C-Apochromat objectives fulfill these requirements. For biological samples only water immersed lenses are used since oil immersed objectives, despite their higher N.A. values, lead to shape distortions of the detection volume and therefore result in poor fits. 3. For details concerning the isolation and preparation of the transfected cowpea protoplasts see Notes 1–6 from Kwaaitaal et al. (Chapter 13). 4. The introduction of new lasers such as the 405 and 440 nm diodes has made it possible to excite the ECFP at the “blue” edge of the absorption spectrum. This allows using broader emission filters. 5. The optimal setting of the ring, where the highest count rate is observed, corresponds very often not to the printed value on the ring that indicates the sample glass thickness. 6. Many fluorescent probes like the FPs are susceptible to ­photobleaching and show blinking behavior, due to ­continuous

11  Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization

213

conversions between fluorescent and dark states. Both processes become more pronounced at higher laser powers. In addition, at higher laser intensities, probe saturation might occur in the center of the focus. This will change the effective shape of the detection volume, resulting in a deviation from the 3D-Gaussian-shaped detection volume that is assumed in the fitting models. Therefore, a trade-off should be found using a laser power where the brightness of the molecule (expressed as detected counts s−1 molecule−1) is as high as possible but where artifacts caused by the processes described above are minimized. 7. For our system the value for a (=wz/wxy) ranges from 4 to 12 and the td for ECFP or EYFP ranges from 140 to 170 ms. The observed brightness values vary between 8 and 12  kHz per molecule. The “optimal” values might differ for other microscope systems. In general, the higher the brightness per particle the better the obtained data will be. The system has to be calibrated until the highest possible brightness is reached without having photobleaching and/or saturation artifacts. 8. Although the shape of the detection volumes is close to a 3D-Gaussian in “ideal conditions,” the optical aberrations introduced by measuring inside the living protoplast allow to approximate the detection volumes by cylinders. The amplitude of the autocorrelation function, G(0), equals to g/N where g corresponds to the shape of the detection volume. In all the equations used in this chapter, cylindrical detection volumes are assumed with g = 1. 9. FCS and PCH are used to analyze the relative fluctuations of the fluorescence intensity. Therefore, at high fluorescence intensities (e.g., high expression levels) the relative fluctuations become too small and the techniques cannot give accurate estimates for the fitting parameters anymore. Typical concentrations for FCS range between 1  nM and 1  mM. In order to achieve this concentration of fluorescently labeled proteins in the cell, one can optimize the promotor sequence (lower expression and/or tunable promotors), the amount of DNA used in the transfection procedure or the incubation time after transfection. 10. Since intracellular FCS experiments are typically performed with nanomolar concentrations of the fluorescent probe, the autofluorescence of the cell could become a significant fraction of the total detected fluorescence. When the autofluorescence is not giving rise to an autocorrelation curve, a correction factor, as outlined in Subheading 3.6 step 2, could be used. It should be prevented that autofluorescence generates an autocorrelation curve since it is difficult to (quantitatively) correct

214

M.A. Hink et al.

for this contribution. It might be worth to put some effort in reducing the autofluorescence by optimizing growth conditions like varying the amount of light exposure to the plant, the composition of the growth media, or consider a change of the experimental setup by shifting to another spectral detection region. In general, the autofluorescence in animal cell systems will become lower toward the red excitation region, while in plant cells the autofluorescence increases again above 640 nm due to the presence of chloroplasts. 11. The binning is chosen such that at least in 15 different channels photons were detected. To retrieve molecular brightness values are affected by the variable diffusion times (24), going, e.g., from free ECFP to membrane-bound SERK1:ECFP. To ensure that the obtained brightness values can be compared directly, PCH curves are generated for every sample, using different binning settings (e.g. 20, 5, 1, and 0.1 kHz). Only above a certain binning value, where the molecular brightness starts to remain stable, values can be compared. 12. Although theoretically the free fluorescent protein (FP) and SERK1DLZ-FP should be fitted with a 3D Brownian diffusion model and the FP-fusions of SERK1, SERK3, and BRI1 with a 2D + 3D-model (9), due to the relative low SNR in living protoplast measurements no difference between the fitting models could be observed. Thus, all the experimental curves can be fitted with the 3D Brownian motion model. 13. When the fusion proteins give rise to FRET, this might complicate the analysis. FRET will lower the molecular brightness of the donor molecule. Since the contribution of a molecule to the correlation curve scales to the square of the molecular brightness (see Eq. 4), non-FRETting donor molecules, that are brighter, will dominate the correlation curve. This effect becomes apparent when the energy transfer efficiency is larger than 20%. Therefore, analysis can be simplified when a probe pair is chosen that will have a low FRET efficiency, e.g., due to a large spectral difference (see also Note 1).

Acknowledgments The authors would like to thank Khalid Shah, Eugenia Russinova, Frank van Breukelen, and Jeroen Pouwels for assistance during the experiments and Jan Willem Borst for valuable discussions. This work was supported by the Council of Earth and Life Sciences of the Netherlands Organization for Scientific Research (ALW-NWO).

11  Fluorescence Fluctuation Analysis of Receptor Kinase Dimerization

215

References 1. Schmidt, E. D., Guzzo, F., Toonen, M. A., and de Vries, S. C. (1997) Development 124, 2049–2062 2. Hecht, V., Vielle-Calzada, J. P., Hartog, M. V., Schmidt, E. D., Boutilier, K., Grossniklaus, U., and de Vries, S. C. (2001) Plant Physiol 127, 803–816. 3. Shah, K., Gadella, T. W., Jr., van Erp, H., Hecht, V., and de Vries, S. C. (2001) J Mol Biol 309, 641–655. 4. Karlova, R., Boeren, S., Russinova, E., Aker, J., Vervoort, J., and de Vries, S. (2006) Plant Cell 18, 626–638. 5. Albrecht, C., Russinova, E., Hecht, V., Baaijens, E., and de Vries, S. (2005) Plant Cell 17, 3337–3349. 6. Xia, Z., and Liu, Y. (2001) Biophys. J. 81, 2395–2402. 7. Bastiaens, P. I. H., and Squire, A. (1999) Trends Cell Biol. 9, 48–52. 8. Chen, Y., Müller, J.D., So, P.T. C. and Gratton, E. (1999) Biophys. J. 77, 553–567. 9. Hess, S. T., Huang, S., Heikal, A. A., and Webb, W.W. (2002) Biochemistry 41, 697–705. 10. Chen, Y., Wei, L. N., and Müller, J. D. (2003) Proc. Natl. Acad. Sci. USA. 100, 15492–15497. 11. Meseth, U., Wohland, T., Rigler, R., and Vogel, H. (1999) Biophys. J. 76, 1619–1631. 12. Schwille, P., Meyer-Almes, F. J., and Rigler, R. (1997) Biophys. J. 72, 1878–1886.

13. Russinova J., Borst, J. W., Kwaaitaal, M., Yin, Y., Caño-Delgado, A., Chory, J., and de Vries, S. C. (2004) Plant Cell 16, 3216–3229. 14. Rodríguez-Concepción, M., Yalovsky, S., Zik, M., Fromm, H., and Gruissem, W. (1999) EMBO J. 18, 1996–2007. 15. Hink, M. A., Borst, J. W. and Visser, A. J. W. G. (2003) Methods Enzymol. 361, 93–111. 16. Skakun, V. V, Hink, M. A., Digris, A. V., Engel, R., Novikov, E. G., Apanasovich, V. V. and Visser, A. J. W. G. (2005) Eur. Biophys. J. 34, 323–334. 17. Müller, J. D., Chen, Y., and Gratton, E. (2000) Biophys. J. 78, 474–486. 18. Rigler, R., Földes-Papp, Z., Meyer-Almes, F.J., Sammet, C., Völcker, M., and Schnetz, A. (1998) J. Biotechnol. 63, 97–109. 19. Hink, M. A., Shah, K., Russinova, E., de Vries, S. C., and Visser, A. J. W. G. (2008). Biophys. J. 94, 1052–1062. 20. Liu, P., Sudhaharan, T., Koh, R. M. L., Hwang, L. C., Ahmed, S. Maruyama, I. N., and Wohland, T. (2007) Biophys. J. 93, 684–698. 21. Gadella, T. W. J. Ed. (2009) Lab. Techn. Biochem. Mol. Biol. 33, Elsevier, Amsterdam, the Netherlands, pp 534. 22. Shaner, N. C., Patterson G. H., Davidson M. W. (2007) J Cell Sci. 120, 4247–4260. 23. Maeder, C. I., Hink, M. A., Kinkhabwala, A., Mayr, R., Bastiaens, P.I.H., and Knop, M. (2007) Nat. Cell Biol. 9, 1319–1326. 24. Müller, J. D. (2004) Biophys. J. 86, 3981–3992.

wwwwwwwwwwwwwwwww

Chapter 12 Quantifying Degradation Rates of Transmembrane Receptor Kinases Niko Geldner Abstract Transmembrane receptor-kinases are widespread throughout eukaryotes and their activities are known to regulate all kinds of cellular responses in diverse organs and cell types. In order to guarantee the correct amplitude and duration of signals, receptor levels at the cellular surface need to be tightly controlled. The regulation of receptor degradation is the most direct way to achieve this and elaborate mechanisms are in place to control this process. Therefore, the rate of receptor degradation is a parameter of central importance for understanding the dynamics of a signal transduction cascade. Unfortunately, degradation of transmembrane receptors is a complicated multistep process that involves internalization from the plasma membrane, invagination into the lumen of endosomal compartments, and finally fusion with the vacuole for degradation by vacuolar proteases. Therefore, degradation should be measured in an as noninvasive way as possible, such as not to interfere with the complicated transport processes. Here, a method for minimally invasive, in vivo turn-over measurements in intact organs is provided. This technique was used for quantifying the turn-over rates of the Brassinosteroid receptor kinase BRI1 (BRASSINOSTEROID INSENSITIVE 1) in Arabidopsis thaliana root meristems. Pulse-chase expression of a fluorescently labeled BRI1 variant was used and its turn-over rate was determined by quantitative confocal microscopy. This method is well suited to measure turn-over of transmembrane kinases, but can evidently be extended to measure turn-over of any types of transmembrane proteins. Key words: Receptor kinases, Degradation rates, BRI1, Brassinosteroids, Endocytosis, Vacuolar transport, Arabidopsis, Quantitative confocal microscopy

1. Introduction Regulated degradation of cytosolic proteins is achieved by the action of a plethora of E3 ubiquitin ligases which ubiquitinate the target protein, leading to its recruitment to the proteasome machinery (1). Degradation of transmembrane proteins, by contrast, occurs in specialized cellular compartments, termed lysosomes in

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_12, © Springer Science+Business Media, LLC 2011

217

218

N. Geldner

animal cells and vacuoles in yeast and plant cells. Therefore, ­recruitment of a plasma membrane protein for degradation will require its re-targeting to a different membrane compartment by means of successive membrane transport steps. After internalization from the plasma membrane, a protein is found in endosomes from which it can either be recruited into a recycling pathway back to the plasma membrane or be placed into an intraluminal vesicle of a maturing multivesicular body (2). Eventual fusion of such a multivesicular compartment with the vacuole will release the vesicle containing the transmembrane protein into the vacuolar lumen. This allows access of vacuolar proteases to both the cytosolic and extracellular/luminal part(s) of a transmembrane protein. The machinery that recruits the proteins into the multivesicular body consists of a series of so-called ESCRT complexes and all the evidence indicates that their function is conserved in all eukaryotic model organisms (3, 4). Different methods have been used for quantifying protein degradation rate. The easiest way probably consists in treating cells with cycloheximide (CHX) in order to block translation of new protein and measure the rate of disappearance of the pre-existing protein. However, this approach is based on the assumption that a generalized block of protein synthesis does not interfere with the effectiveness and functionality of the degradation machinery. This might apply to cytosolic proteins showing a high turn-over. However, it is much more problematic for transmembrane proteins, especially when their turn-over is not rapid, which would require prolonged treatment with CHX. Receptor turn-over has also been assessed by metabolic pulse-chase labeling with 35S-methionine and subsequent pull-downs (see ref. 5, for example). This technique is challenging, especially when used on whole organisms. It necessitates high doses of radioactivity, specific antibodies and cannot give any good temporal or spatial resolution of degradation rates. Therefore, we set out to develop an improved technique in order to measure the turn-over rate of the cell-surface receptor kinase Brassinosteroid-insensitive 1 (BRI1) in Arabidopsis. BRI1 is a receptor for Brassinosteroids – steroidal plant growth regulators, which are crucial for plant cell elongation (6). Instead of using metabolic pulse-chase labeling, we established a transgenic line that expresses an YFP-tagged BRI1 variant under the control of a heat-shock promoter. In contrast to other inducible systems, heat-shock promoters can be induced as a sharp transient by short heat exposure (Fig. 1a). This allowed the tracing of a protein pulse as an increase and decrease of YFP-signal intensity, using quantitative confocal microscopy. In the absence of any new mRNA, the decrease represented the protein degradation rate. The advantage of this system lies in the fact that it is minimally invasive (simply requiring a short heat-shock at 37°C) and allows read-outs of high temporal and spatial resolution. In contrast to other techniques, for example, we were able to measure protein

12  Quantifying Degradation Rates of Transmembrane Receptor Kinases

219

Fig. 1. In vivo analysis of receptor degradation with heat-shock mediated pulse-chase analysis. (a) Analysis of RNA accumulation after heat shock, as assessed by quantitative RT-PCR. Note rapid induction and disappearance of the RNA. Importantly, upon start of the analysis of protein degradation at 5 h after start of heat shock, RNA expression is already back close to baseline. (b) Overview of sample preparation for quantitative confocal microscopy. (c) Example of protein degradation read-out of five untreated wild-type roots. Numbers at the bottom right designate hours after peak signal strength. Selected pictures from time stacks taken at 5 min intervals. (d) Example showing choice of ROI for signal intensity measurements of one root. Degradation rates of BRI1:YFP after CHX treatment (50 mM; gray ) are compared with an untreated control (black ). Note that CHX apparently stabilizes the receptor. (e, f ) Examples of final quantitative read-outs of protein degradation. Display of degradation rates of BRI1:YFP after MG-132 treatment (100 mM; gray ) as compared to untreated (black ). MG-132 is a proteasome inhibitor which surprisingly also has an effect on BRI1:YFP degradation, probably by an indirect interference with vesicular transport.

220

N. Geldner

levels exclusively in the root meristem, where the BRI1 receptor has shown to be naturally expressed and required, with read-out intervals of a few minutes (7). We applied this technique to establish the half-life of the BRI1 receptor in root meristems (about 5–6 h) and to illustrate its ligand-independent endocytic trafficking (7). Moreover, we showed that inhibitors of vesicular trafficking indeed interfered with transport of BRI1 to the vacuole and accordingly stabilized the proteins. Figure 1e, f shows two other, unpublished examples, showing that BRI1-YFP degradation is apparently blocked by addition of the protein synthesis inhibitor CHX. This suggests that the use of CHX is indeed problematic when it comes to transmembrane proteins, because it can interfere not only with their translation, but also with their rate of degradation. Figure 1f shows that the proteasome inhibitor MG1-32 can also interfere with degradation of membrane proteins. This should not be interpreted as a direct role of proteasome in the degradation of transmembrane proteins. It is more easily explained by an indirect interference caused by cytosolic protein stabilization and ubiquitination. It is important to note that MG1-32 leads to slight increases in signal strength, even after 5 h. This observation suggests that this drug treatment could interfere with the tight control of the heat-shock promoter leading to some low levels of continuous expression. This evidently interferes with the quantification of the protein degradation rate. Thus, a prerequisite for our way of measuring turn-over rate is a continued tight regulation of the heat-shock promoter. Under some conditions it might be necessary to ensure by quantitative RT-PCR that this is indeed the case. In general, an artificial, chemically repressed promoter would be preferable for protein degradation measurements. Unfortunately, we are unaware of any promoter that would work in such a fashion in Arabidopsis.

2. Materials 2.1. Plant Material, Microscope Equipment, and Software

1. Homozygous PROHS:BRI1:YFP transgenic lines (promoter of the soybean heat shock gene) in the background of the Arabidopsis thaliana Columbia-0 (Col-0) ecotype and wildtype control plants. Therefore, the two primers gatcgaccaagtacATGGTAGACCAATCCTAACCAA (sense) and gatgggtaccTTTCTCTTATCAGTCTTGTGTAAA (antisense) are needed, matching primer sequences in capital letters. 2. 4–6-day-old seedlings grown at 22°C at 24 h light in Percival incubators. 3. 0.5 MS plant growth medium: 0.5× Murashige and Skoog (MS) basal salt medium without sugar (pH 5.8).

12  Quantifying Degradation Rates of Transmembrane Receptor Kinases

221

4. 0.5 MS plates with 8 g/L agar. 5. Chambered coverglasses (CWCS 4R-1.0; GraceBiolabs). 6. Inverted SP/2 confocal microscope (Leica). 7. ImageJ software package (National Institutes of Health).

3. Methods 3.1. Generation of Transgenic Conditional BRI1:YFP Expression Lines

1. Expression is driven by a heat-shock promoter fragment from a soybean heat shock gene (Genbank number: X01104), described by Schöffl et al. (8) and first used in Arabidopsis by Knox et al. (9). 2. A 343-bp fragment is amplified by the two indicated primers. 3. The above generated amplified fragment is placed directly in front of the BRI1 open reading frame.

3.2. Heat-Shock Induction

1. Carefully place five to ten 4–6-day-old seedlings into a 2-mL microcentrifuge tube (see Note 1), containing a minimal volume of liquid necessary for submerse seedlings (about 200 mL of 0.5 MS). 2. Place tubes into a 37°C water bath for 25 min (see Note 2). 3. After the heat shock, transfer the seedlings to a fresh agar plate at room temperature. Straighten seedling roots on the plate; reseal the plate and put it back into the growth chamber in an upright position for 4.5 h.

3.3. Mounting and Treatment of Samples

1. After incubation in growth chambers, mount the seedlings for observation. For this, melt small pieces (about 1–2 mL) of 0.5 MS agar in a 15-mL Falcon tube by putting them in the microwave oven for 10–30 s. 2. Pipette liquid agar into the silicon forms of the chambered coverglass, filling them until their upper edge. 3. When solidified, excise root tips from the seedlings on the agar plate and place them onto the agar pill in the silicon form (Fig. 1b). Cut with a sharp razor blade, 0.5–1 cm above the root tip, to disturb the root meristem itself as few as possible. 4. Place excised root parts in parallel on the agar block, as closely together as possible, about five to seven roots, if possible (see Note 3). 5. Remove the silicon form carefully, so as to leave the agar block exposed on the coverslip. Then, slide a razor blade under the agar block (Fig.  1b), turn, and carefully push the block into another, empty silicon form attached to the coverglass (use a

222

N. Geldner

second razor blade or forceps for pushing). This should place the root between the cover slip and the agar (see Note 4). 6. Press a slide onto the silicon form, which will seal the agar block and tightly attach the entire surface of the silicon form to the coverslip. At this point, a certain pressure has to be applied. However, damage to the root does not occur, because the very soft agar will disperse the pressure (see Note 5). 3.4. Confocal Data Acquisition

1. Use a 10× air objective for maximum field of vision allowing observation of all five to seven root meristems simultaneously (Fig.  1c). At the same time, sufficient field of vision has to remain around the root meristems, such that the remaining X/Y-movement of the root meristems (probably caused by continued elongation growth of the root cells), does not push the root tips out of the field of analysis. 2. Acquire Z-stacks of five images per time point (generating a 4D stack) with the upper and lower image of the stack set beyond the upper and lower limit of the root tip. Doing this guarantees that slight Z-axis movements (object or focus drift) does not lower the total fluorescence of the root meristem captured in the stack. Since Z-axis resolution is not required, the detection pinhole can be opened to up to 2.5  AU (for the Leica confocal microscope), so as to allow detection with the lowest laser power as possible. 3. Choose time intervals between 2 and 5 min. In our case, stacks were acquired over a time period between 3 and 8 h at a resolution of 512 × 512 pixel. It is critical to choose detector settings below pixel saturation. Maximal pixel intensities values should be at about 180. This makes sure that additional increases in signal intensity are captured, without leading to saturation (255 pixel intensity value). In our case, acquisition is started at about 5  h after start of heat-shock. At this time point, signal intensity is close to maximum for our protein variant (see Note 6).

3.5. Quantitative Analysis of Data

1. Image analysis is done with ImageJ. Before data evaluation, carefully inspect stacks in order to insure that there was no sudden Z-axis shift or drift beyond the depth of acquisition or other anomalies. Then, collapse the Z-axis into a maximum projection. This effectively corrects for any changes in intensity caused by slight Z-axis drift. If there is a significant X/Y-drift, align the stack with the TurboReg function of ImageJ. 2. Determine the time point of maximum average pixel intensity in the stack discard pictures before this point. This should give rise to time stacks as depicted in Fig. 1c. 3. Choose five circular regions-of-interest (ROI) per root meristem and read out the pixel intensity values of the time stack

12  Quantifying Degradation Rates of Transmembrane Receptor Kinases

223

into Microsoft Excel (Fig.  1d). Transform into relative pixel intensity values, with the value of the first image in the stack set to 100. We average values of at least five individual roots for the reading of one experiment (Fig. 1e, f).

4. Notes 1. Great care was taken in handling of seedlings at any step of the procedure, since the read-out was done on living, intact organs. Specifically, only spring steel forceps were used to manipulate and transfer seedlings. If possible seedlings were only touched at cotyledons, not used for analysis. At no point the roots were left without immediate contact of either liquid medium or agar for any more than a few seconds. Care was taken when transferring seedlings into and out of the microcentrifuge tube. At this step roots easily adhere to the wall of the tube, which can easily be overlooked and will lead to their drying out during the incubation. The entire seedling must be completely submerged in the liquid 0.5 MS medium, if possible without touching the root itself. 2. Using a water bath and a small sample volume leads to a rapid heat transfer and allows to obtain reproducible induction of heat shock even after the relatively short time of 25  min. If other than the described way of applying the heat shock is used (such as on plates or with seedlings grown on chambered coverglasses) longer incubations at 37°C might have to be used (up to 1 h). 3. It is very important to minimize the stress the root tips are exposed to. Ensure that the root tips are always in contact with the agar. Make clean cuts, take root tips at the differentiated extremity, and transfer them as quickly as possible, again taking care that the whole length of the root tip is placed in contact with the agar. We recommend doing these manipulations under a binocular using incident light. 4. Care should be taken not to cause inclusion of air bubbles. However, if this occurred, these can normally be removed by slight pressure on the agar block. 5. For overnight observation it can be necessary to additionally seal the edges with parafilm (by taking care not to cover the area to be observed). 6. The exact timing of maximum signal after heat shock is probably dependent on the translation and maturation of the protein of interest and the maturation of the fluorophore and has to be determined for each protein individually.

224

N. Geldner

Acknowledgments I would like to thank Joanne Chory in whose lab the author established this protocol as a postdoctoral fellow of the Human Frontiers Science Program (HFSP). Current research in the author’s lab is supported by grants from the Swiss National Science Foundation (SNF) and the European Research Council (ERC). References 1. Schwechheimer, C., Willige, B. C., Zourelidou, M., and Dohmann, E. M. (2009) Examining protein stability and its relevance for plant growth and development. Methods Mol Biol 479, 1–25. 2. Williams, R. L., and Urbe, S. (2007) The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol 8, 355–68. 3. Stuffers, S., Brech, A., and Stenmark, H. (2008) ESCRT proteins in physiology and disease. Exp Cell Res. 4. Winter, V., and Hauser, M. T. (2006) Exploring the ESCRTing machinery in eukaryotes. Trends Plant Sci 11, 115–23. 5. Lill, N. L., Douillard, P., Awwad, R. A., Ota, S., Lupher, M. L., Jr., Miyake, S., Meissner-Lula, N., Hsu, V. W., and Band, H. (2000) The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the

epidermal growth factor receptor. J Biol Chem 275, 367–77. 6. Vert, G., Nemhauser, J. L., Geldner, N., Hong, F., and Chory, J. (2005) Molecular mechanisms of steroid hormone signaling in plants. Annu Rev Cell Dev Biol 21, 177–201. 7. Geldner, N., Hyman, D. L., Wang, X., Schumacher, K., and Chory, J. (2007) Endosomal signaling of plant steroid receptor kinase BRI1. Genes Dev 21, 1598–602. 8. Schöffl, F., Rieping, M., Baumann, G., Bevan, M., and Angermuller, S. (1989) The function of plant heat shock promoter elements in the regulated expression of chimaeric genes in transgenic tobacco. Mol Gen Genet 217, 246–53. 9. Knox, K., Grierson, C. S., and Leyser, O. (2003) AXR3 and SHY2 interact to regulate root hair development. Development 130, 5769–77.

Chapter 13 Fluorescence Correlation Spectroscopy and Fluorescence Recovery After Photobleaching to Study Receptor Kinase Mobility In Planta Mark Kwaaitaal, Marieke Schor, Mark A. Hink, Antonie J.W.G. Visser, and Sacco C. de Vries Abstract Plasma-membrane-localized receptor kinases are essential for cell–cell communication and as sensors for the extracellular environment. Receptor function is dependent on their distribution in the membrane and interaction with other proteins that are either membrane-localized, present in the cytoplasm, or in the extracellular space. The organized distribution and mobility of receptor kinases is, therefore, thought to regulate the efficiency of downstream signaling. This chapter describes two methods to study receptor mobility in the plasma membrane. Fluorescence Correlation Spectroscopy (FCS) and Fluorescence Recovery After Photobleaching (FRAP). Especially, the combination of FRAP and FCS provides a better insight into plasma membrane receptor mobility. Key words: SERK1, Plasma membrane, Receptor kinase, Fluorescence correlation spectroscopy, FCS, Fluorescence recovery after photobleaching, FRAP, Diffusion, Mobility, Protoplast

1. Introduction The somatic embryogenesis receptor kinase (SERK) was isolated as a marker for single cells in carrot (Daucus carota) cell suspension cultures that had acquired the ability to initiate somatic embryogenesis (1). SERK1 is a plasma-membrane-localized leucine-rich repeat (LRR) receptor-like kinase (RLK) and consists of an N-terminal leucine zipper (LZ) domain, five LRRs, a proline-rich SPP domain, a transmembrane domain, and an active intracellular serine/threonine kinase (2, 3).

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_13, © Springer Science+Business Media, LLC 2011

225

226

M. Kwaaitaal et al.

At the cellular level, Förster Resonance Energy Transfer (FRET)-based techniques have verified the interaction between SERK1 and 14-3-3 (4), CDC48 (5), KAPP (6), SERK2 (7), BRI1 and BAK1/SERK3 (5). These studies showed that the interaction between SERK1 and its partners is highly dynamic. As reported for BRI1 and BAK1/SERK3 (8), SERK1 also interacts with SERK2, BAK1/SERK3, BRI1, and CDC48 in confined regions at the plasma membrane (5, 7, 9, 10) and with KAPP only after internalization (6). For BRI1 and BAK1/SERK3, it was postulated that the interaction occurs just prior to endocytosis (8). Both BRI1 and SERK1 receptors are also present in a homodimerized state in the plasma membrane (3, 8, 9, 11). SERK1 homodimerization depends on the presence of the extracellular LZ domain (3). Photon counting histogram analysis and fluorescence cross-correlation microscopy in plant protoplasts showed that 13% of the SERK1 receptor and 20% of the BRI1 receptor proteins are present in a homodimerized state. BRI1 homodimerization in protoplasts seems independent of the presence of brassinosteroids (12). Mass spectrometry-based data suggest that BRI1 activation results in increased interaction with the BAK1/SERK3 coreceptor (13). A Fluorescence Recovery After Photobleaching (FRAP) mobility study of FLS2, the plant receptor for flagellin, showed in protoplasts that both the FLS2 mobile fraction and diffusion coefficient are reduced in response to its ligand (14). Fluorescence Fluctuation Spectroscopy (FFS)-based techniques enable the measurement of protein dynamics and interactions in living cells at physiological protein concentrations. FFS utilizes a confocal microscope with high numerical aperture (NA) objective that reduces the observation volume to less than 1  fL (15, 16). This also enables measurements at the single molecule level using sensitive avalanche photodiode detectors. Since these techniques are noninvasive, they are very attractive tools for use in living cells (16–18). In an FFS experiment, spontaneous fluorescence fluctuations around an equilibrium caused by continuously excited single molecules diffusing into and out of the observation volume are observed (15, 19). Fluorescence Correlation Spectroscopy (FCS) studies the temporal behavior of fluctuations in fluorescence intensity and is analyzed by calculating the autocorrelation function G(t) of a large number of fluctuations. The fluorescence intensity at time t is compared with the amplitude at a later time t + t. G(t) is the sum of the products of pairs resulting from this comparison. As the correlation of the position of a particle with its earlier position decays as the particle diffuses out of the detection volume, the average value of the products of points separated by a longer time t are smaller than those separated by a short time. Correlations between individual particles are random and will average out due to the large number of fluorescence fluctuations. The decay of the

13  FCS and FRAP to Study Receptor Kinase Mobility In Planta

227

autocorrelation curve gives information about diffusion times, and the amplitude of the curve is inversely linked to the number of particles in the detection volume (15, 17, 19). This chapter describes two methods to study receptor dynamics in the plasma membrane of intact plant cells at endogenous protein levels and in Arabidopsis thaliana protoplasts. As a model system, plants expressing the SERK1 receptor fused to YFP (Yellow Fluorescent Protein) and regulated by its own promoter were used (20, 21). It is shown how FCS can be used to study diffusion of receptors in planta and in protoplasts. Interference from factors such as autofluorescence and cell movement should be taken into account. As a supportive method, FRAP measurements can be used and its usage is described for intact plant cells and protoplasts.

2. Materials 2.1. Plant Growth and Arabidopsis Mesophyll Protoplast Transfection

1. MS plates: half-strength (0.5) Murashige and Skoog (MS) medium (pH 5.8; Duchefa Biochemie) agar plates containing 1% (w/v) sucrose. 2. 10 mM Tris–HCl (pH 7.5). 3. Enzyme solution: 1% cellulase R10 (Yakult Honsha), 0.2% (w/v) pectinase (Sigma), 0.4 M mannitol, 20 mM KCl, 10 mM CaCl2, and 20  mM 2-(N-morpholino)ethanesulfonic acid (MES; pH 5.7). 4. PEG/Calcium solution: 4  g PEG 4000, 5  mL H2O, 0.36  g mannitol, and 1 mL 1 M Ca(NO3)2. Fill up to 10 mL, heat the solution twice for 6 s at 300 W in a microwave to dissolve the PEG and keep in warm water until needed. 5. W5 solution: 154 mM NaCl, 125 mM CaCl2, 5 mM KCl, and 2 mM MES (pH 5.7). 6. MMG solution: 0.2 M mannitol, 15 mM MgCl2, and 4 mM MES (pH 5.7). 7. 4- to 5-week-old Arabidopsis plants grown under fluorescent light at 22°C with a 16 h light–8 h dark cycle. 8. Needles and razor blades. 9. Two-well chambered coverslip (Nunc). 10. 100-mm nylon mesh and round-bottomed tubes. 11. FCS data processor version 1.4 (build 3; Scientific Software Technologies Software Centre). 12. AIM Software package (Carl Zeiss). 13. Microsoft Excel or Igor Pro (Wavemetrics Inc, USA).

228

M. Kwaaitaal et al.

2.2. Constructs, Reagents, and Microscopy

1. pMON:SERK1:EYFP (Enhanced Yellow Fluorescent Protein) is previously described by Shah et  al. (2001) and pMON:BRI1: EYFP by Russinova et al. (2004). 2. pMON:EYFP:CAAX: the CAAX-box is attached to EYFP to target it to the plasma membrane as a reference for lateral membrane diffusion, see also Chapter 9. A CAAX-box typically consists of a cysteine followed by two aliphatic amino acids and either an alanine, glutamine, leucine, methionine, or serine as a C-terminal residue (22). The CAAX-box used consisted of a cysteine, threonine, isoleucine, and leucine. 3. pSERK1:SERK1:EYFP as described by Kwaaitaal et al. (20). 4. 50  mM rhodamine green (Invitrogen) in water. Shield from light and keep on ice. Dilute approximately 2,000× for FCS calibration and reference measurements. 5. LSM510 Laser Scanning Microscope equipped with the ConfoCor 2 FCS Scan head. For FCS measurements a 40× C-Apochromat water immersive lens with a NA of 1.2 was used. For FRAP measurements, a 40× Plan-Neofluar oilimmersive lens with an NA of 1.3 was used (all Carl Zeiss). 6. Coverslips. 7. 0.01% (v/v) Tween 20.

3. Methods 3.1. Plant Growth

1. Surface sterilize seeds and transfer them to 0.5 MS plates. 2. After 2 days at 4°C, transfer the plates to a growth chamber under fluorescent light at 22°C with a 16  h light/8  h dark cycle. 3. After 1 week, seedlings can be used directly or transferred to soil and grown to maturity under the same conditions. In our studies, Col-0 (Arabidopsis thaliana ecotype Columbia-0) was used as wild-type control and the pSERK1:SERK1:EYFP line as reporter.

3.2. Preparation Ovules

1. Transfer a flower bud to a drop of 10 mM Tris–HCl (pH 7.5). 2. For ovule preparation isolate the carpel from the flower and open the carpel longitudinally with a needle and transfer to a drop of 10 mM Tris–HCl (pH 7.5) in a two-well chambered coverslip. 3. Gently press the tissue between the bottom of the chamber and a coverslip to release the ovules (see Note 1).

13  FCS and FRAP to Study Receptor Kinase Mobility In Planta

3.3. Arabidopsis Mesophyll Protoplast Transfection

229

The modified Arabidopsis mesophyll protoplast transfection protocol described by Aker et al. (9) is used, which is based on the protocol described by Sheen (23). 1. Take as many rosette leaves of 4- to 5-week-old Arabidopsis plants to cover a 10-cm Petri dish. One dish is enough for approximately five transfections (see Note 2). 2. Cut leaves in small pieces with two razor blades. 3. Add 15 mL of enzyme solution to the leaf fragments. 4. Vacuum-infiltrate the leaf fragments for 30 min. 5. Incubate the leaf fragments for 2.5 h at room temperature in light on a shaking platform at 75 rpm. 6. Release the protoplast by swirling the Petri dish by hand for 2 min. 7. Filter the protoplasts through a 100-mm nylon mesh into a round-bottomed tube. 8. Pellet the protoplasts at 500 rpm for 3 min. 9. Wash the protoplasts once with 5 mL of W5 solution. Be gentle with the material at all times, avoid unnecessary turbulence and use blue cut 1-mL tips when transferring the protoplasts. 10. Pellet the protoplasts at 500 rpm for 3 min and resuspend in 1 mL of MMG solution. 11. Transfer 200 mL of protoplast suspension with a cut 1-mL tip (see Note 3). 12. Add 30 mg of plasmid DNA in total (see Note 4). 13. Add 220 mL of PEG–Calcium solution, mix well immediately, and incubate for 5 min. 14. Add 800 mL of W5 solution and mix well immediately. 15. Pellet the protoplasts at 500 rpm for 3 min. 16. Add 5 mL of W5 solution and pellet the protoplasts again at 500 rpm for 3 min (see Note 5). 17. Resuspend the protoplasts in 500 mL of W5 medium containing 1 mM Glucose. 18. Incubate protoplasts in light at 25°C until the appropriate level of expression of the proteins of interest is reached (see Note 6).

3.4. Fluorescence Correlation Spectroscopy

1. Excite rhodamine green and YFP with the 514 nm argon laser line and detect emission between 530 and 600 nm. Employ an excitation intensity of maximally 4.3  kW/cm2, which corresponds for our 30 mW argon laser to an output setting of 50% (approximately 6  Ampere) and the acoustical optical tunable filter (AOTF) set to 1%.

230

M. Kwaaitaal et al.

2. Calibrate the system with a rhodamine green solution in water (25  nM). Set the pinhole diameter to 70  mm and optimize signal intensity using the correction collar of the lens. Dilute the rhodamine green solution to a signal intensity between 20 and 50  kHz. Optimize the pinhole settings using the AIM software. Iteratively, optimize the pinholes in the X-, Y-, and Z-directions (see Note 7). 3. To align the ConfoCor2 laser scan head with the LSM scan head use a coverslip, where on a solution of rhodamine green in water containing 0.01% (v/v) Tween 20 is dried. After focussing on the fluorescent rhodamine green layer, acquire an image. In the FCS mode, select several positions in the image and bleach these positions for 15 s with the AOTF set to 100%. Acquire a new image and correct the discrepancy between the ConfoCor2 scan head and the LSM scan head in the AIM software. Repeat the procedure until the scan heads are fully aligned. 4. Perform three measurements of 2 min at 1 mW at the focus in a rhodamine green solution. In the AIM software, fit the autocorrelation curves to the following equation (Eq.  1) taking into account triplet-state kinetics and 3D-Brownian diffusion. For the analysis, we have used the FCS data processor software (24):   w xy  t 1  t  G (t ) = 1 +  1 +  1 +  N  td   w z  t d 

2

−t −1  Ttrip  F e   1 + trip   1 − Ftrip 

    

(1)

In Eq. 1, G(t) is the autocorrelation function, N is the average number of fluorescent particles in the detection volume, td is the average diffusion time of the molecules. wxy is the equatorial radius, and wz is the axial radius of the detection volume. Ftrip is the fraction of molecules present in the triplet state and Ttrip is the average time a molecule resides in the triplet state (usually in the order of a few microseconds). From this fit, the shape of the detection volume (a = wz /wxy) and the td and N for rhodamine green are obtained. Then by using Eq.  2 with a translational diffusion coefficient (D) of rhodamine green of 280  mm2/s the dimensions of the detection volume can be calculated (see Note 8).

td =

w xy 2

(2)

4D

5. Always include these reference measurements to be able to compare data from different days.

13  FCS and FRAP to Study Receptor Kinase Mobility In Planta

231

Fig. 1. Localization of YFP fusions used for FCS in planta and in Arabidopsis protoplasts. (a) Confocal image taken from wild-type ovule showing a merged intensity image of the YFP and the Chlorophyll channels. (b, c) SERK1:YFP localization in stage IV ovule in Arabidopsis plant containing a SERK1 promoter:SERK1 cDNA:YFP construct, before (b) and after (c) the FCS measurement. (d) SERK1:YFP localization in Arabidopsis protoplast. (e) YFP:CAAX localization in Arabidopsis protoplast. The crosses mark the positions of the observation volumes positioned at the plasma membrane, where the FCS data was recorded. Scale bar = 5 mm.

6. Acquire an image of the tissue or cells expressing the fluorescent proteins to be examined. For examples, see Fig. 1a, b, d, e. 7. Within the FCS mode of the AIM software, select several positions on the plasma membrane where the measurements will be performed. For examples, see crosshairs in Fig. 1. Include measurements at “dark” positions and within cells to check for autocorrelating species in the medium or within cells not originating from the plasma membrane and to estimate the background signals (see Note 9). 8. Program the software to perform a prebleach pulse before initiating the measurements to bleach immobile proteins or autofluorescent material (see Note 10). 9. Measure three times at each position for about 30–60 s (see Note 11) and record raw data for all measurements (see Note 12). 10. Acquire a new image to investigate sample movement. For an example see Fig. 1c.

232

M. Kwaaitaal et al.

11. Select measurements with a stable intensity trace. The intensity trace should not contain aggregate peaks or fluctuate more than about 20% from the average. Alternatively, the raw data trace can be used to select regions that fulfil the criteria and discard regions containing aggregate peaks or exclude areas with large variations in the average fluorescence intensity. 12. Perform identical measurements in wild-type plant material or untransfected protoplasts to estimate the contribution of tissue or cellular autofluorescence (see Note 13). 13. Import the autocorrelation data in the analysis software. 14. From the wild-type autocorrelation curves determine if any correlating species are present. If so include an extra term in the fit formulas and take into account the difference in brightness between the autofluorescent and the labeled species (see step 15(b) and Note 14). For an example see Fig. 2a, b. 15.  (a) To model 2D-Brownian diffusion (e.g., for diffusion in the membrane) with fast triplet-state kinetics, use Eq. 3

−t   −1 Ttrip Ftrip e 1  t   G (t ) = 1 +  1 +  1 + 1 − Ftrip N  td    

    + offset  

(3)

For explanation of variables in Eq. 3, see description with Eq. 1. The offset parameter is included to correct for artifacts in the autocorrelation curve due to small intensity drifts in the average fluorescence intensity (25). (b) To model 2D-Brownian diffusion with fast triplet-state kinetics and a “fast” diffusing autofluorescent species showing 3D-diffusion, use Eq. 4





 w xy  t 1    G (t ) = 1 +  F1* Φ1  1+ t  1+   t d1   wz  t d 1 N  



2  −1    

−t  −1  Ttrip   Ftripe   t  + 1 − F * Φ 1 +  1+  + offset 1 2 1 − Ftrip   t    d2    

(

(4)

)

with : Φm =

(hm 2Ym ) (∑m hmYm )2



For explanation of variables in Eq. 4, see descriptions with Eqs. 1 and 3. Additionally, F1 is the fraction of molecules

13  FCS and FRAP to Study Receptor Kinase Mobility In Planta

233

Fig. 2. Representative autocorrelation curves of FCS measurements. (a) Fluorescence intensity trace obtained from wild-type ovule with “aggregate peaks” (arrowheads) having an intensity more than three times the average signal. (b) Autocorrelation curve of the intensity trace not cleaned for aggregate peaks shown in (a). Figures (c)–(e) show representative autocorrelation curves fitted with a model taking into account triplet state kinetics, slow blinking of the fluorophore, 2D diffusion and an offset value to correct for intensity drifts. The residuals of the fit are shown below the autocorrelation curves. (c) Autocorrelation curve and fit residuals of SERK1:YFP in ovules. (d) Autocorrelation curve and fit residuals of fit of SERK1:YFP ectopically expressed in Arabidopsis protoplasts. (e) Autocorrelation curve and fit residuals of YFP:CAAX in protoplasts. Note the increased residuals for the SERK1:YFP in ovules FCS measurements compared to the other measurements. Arrow points at dark blinking component in curves. Asterisk above curve marks slow component showing 2D diffusion.

showing 3D-diffusion, td1 is the diffusion time of molecules showing 3D-diffusion and td2 is diffusion time of molecules showing 2D-diffusion. Fm corrects for the difference in molecular brightness (hm) of the species m (= 1 or 2) according to its fraction Ym (12). (c) To model 2D-diffusion with fast triplet-state kinetics and slow blinking of the fluorophore (26), use Eq. 5.

234

M. Kwaaitaal et al.

Table 1 Characteristic values obtained from FCS and FRAP measurements and fits for SERK1:YFP in ovules and protoplasts, YFP:CAAX in protoplasts and BRI1:GFP in roots and protoplasts Nmobile

DFCS (mm2/s)

DFRAP (mm2/s)

Mobile fraction (%)

SERK1 – YFP ovules

  6.5 ± 3.7

3.0 ± 1.6

ND

28 ± 5

SERK1 – YFP transiently expressed in protoplasts

10.8 ± 6.0

4.6 ± 1.0

3.2 ± 0.8

70 ± 13

CAAX – YFP

17.5 ± 8.0

5.8 ± 1.4

ND

ND

BRI1 – GFP roots

ND

ND

ND

10 ± 10

BRI1 – YFP transiently expressed in protoplasts

ND

ND

2.2 ± 0.7

70 ± 17

Nmobile = average amount of mobile molecules in the detection volume, DFCS (mm2/s) diffusion coefficient as determined with FCS, DFRAP (mm2/s) diffusion coefficient as determined by FRAP and the mobile fraction (%) of fluorescence molecules as determined by FRAP. ND not determined. Values are shown with standard deviation



−t   −1 Ttrip F e   1 t  trip G (t ) = 1 +  1 +  1 + 1 − Ftrip N  td    

−t  Tblink Fblink e   1 + 1 − F blink   

      (5) 

+ offset For explanation of variables in Eq.  5, see descriptions with Eqs.  1 and 3. Additionally, Fblink is the fraction of molecules present in the dark state between two blinking events and Tblink the average time a particle stays in the dark blinking state (26). For examples, see Fig. 2d, e and note the arrow, which marks the blinking component and the asterisk, which marks the diffusing component (see Note 14). 16. The fit procedure will provide information about the number of particles N present in the detection volume and the diffusion times td of the different components. Use Eq. 2 and the wxy value obtained from the rhodamine green calibration measurements to calculate the diffusion coefficient D of the different components (see Note 15). For our determined values see Table 1. 3.5. Fluorescence Recovery After Photobleaching

1. Excite YFP with the 514 nm argon laser line and detect emission light between 530 and 600  nm. Excite GFP with the 488 nm argon laser line and detect emission light between 505 and 550 nm. 2. Select regions of interest (ROI) of a fixed size at a fixed scan zoom (see Note 16). One ROI, positioned at the plasma membrane, will be used for the actual fluorescence recovery after

13  FCS and FRAP to Study Receptor Kinase Mobility In Planta

235

photobleaching (FRAP) measurement (ROIbleach). Position one ROI away from the bleached area to follow scanning bleaching (ROIscan) and one ROI at a “dark” position to correct for background signal (ROIbackground). 3. Program the software to bleach ROIbleach to around 30% of the initial intensity. The bleach time should be as short as possible. The bleaching efficiency can be optimized by varying the laser power and the amount of scanning iterations of the ROI (see Note 17). 4. Program in the “Time series” mode a procedure with five ­prebleach scans, followed by a bleach of the ROIbleach and a number of scans after the bleach. Take care to limit scanning bleaching by using a laser power where the ROIscan does not show or shows a minimal decrease in fluorescence intensity. The timing between the images was set such that as many images as possible of the recovery phase of the bleached spot are obtained. Continue the time series until a plateau value in the signal intensity of ROIbleach is reached (see Notes 18 and 19). 5. Extract the intensity values from the ROI’s from the images and use analysis software such as Microsoft Excel or Igor Pro for the calculations. 6. Subtract the average intensity of ROIbackground from ROIbleach and ROIscan (see Note 19). 7. Normalize the data using Eq. 6.

Fnormalized (t ) =

Ft − F0 Fb − F0

(6)

In Eq. 6, Fnormalized(t) is the normalized recovery curve, Ft is the fluorescence intensity at time t (s), F0 is the fluorescence intensity just after the bleach, and Fb is the fluorescence intensity just before the bleach. 8. Using Eq. 7 the mobile fraction (R) can be calculated. For our experimental values, see Table 1.

R=

F∞ − F0 Fb − F0

(7)

In Eq. 7, R is the mobile fraction of proteins, F∞ is the fluorescence intensity after full recovery, F0 is the fluorescence intensity just after the bleach, and Fb is the fluorescence intensity just before the bleach. 9. From the recovery curve, the diffusion time for a molecule undergoing 2D Brownian diffusion can be calculated using Eqs. 8 and 9. To make the fitting procedure easier, transform the data such that the first point is the first measurement directly after the bleaching at t = 0:

236



M. Kwaaitaal et al.

Fnormalized (t ) = F0 + ( F∞ − F0 ) * (1 − ek* t ) t 1/ 2 =

ln(2) k

(8) (9)

In Eqs. 8 and 9, k is the recovery constant and t1/2 is the time for half recovery. 10. The diffusion constant (D) can be calculated using Eq. 10.

t 1/ 2 = t d b = b

r2 4D

(10)

where r2 is the bleached area, b is a correction factor for the degree of bleaching, and D is the diffusion coefficient. The value of b = 1.30 when 70% of the initial fluorescence is bleached. For values of b at other degrees of bleaching see ref. 27. The value for t1/2 is considered sufficient to compare relative coefficients of molecules when ROIbleach is kept constant. For our determined values, see Table 1 (see Note 20).

4. Notes 1. In time, autofluorescence levels in isolated ovules increase, which interferes with the measurements. Prevent the use of the same tissue sample for extended periods of time (more than 20  min). Also, growth conditions and health of the plants influence tissue autofluorescence. Take care in using optimal growth conditions and avoid the use of plants stressed by drought or pathogens. For SERK1, stage-II to stage-IV ovules (20, 28) proved to be the most suitable for FCS. For examples, see Fig. 1a, b. 2. Take care to take healthy leaves to obtain sufficient transfected protoplasts. 3. Take care not to let the protoplasts dry out and treat them as gently as possible. 4. When transfecting multiple constructs, add equal amounts making a total of 30 mg. 5. Check the viability of the protoplasts during the procedure. The protoplasts should be perfectly round, and the chloroplasts should be brightly red under epifluorescent light. For examples, see Fig. 1d, e. 6. To ensure that the fluorescence levels from the fluorescent fusion proteins are not too high for FCS, the final incubation step after transfection should be limited to less than 9  h. Hereafter, cycloheximide (CHX; Sigma) can be applied up to

13  FCS and FRAP to Study Receptor Kinase Mobility In Planta

237

a concentration of 50 mM to inhibit protein synthesis and limit the increase in fluorescence levels during the course of the measurements. 7. Occasionally, no optimum in the Z-direction was found, which could be solved by adjusting the collimator position followed by a recalibration of the pinholes. 8. For our system, the value for a (=wz /wxy) ranges from 4 to 6 and the td for rhodamine green ranges from 22 to 26 ms. Our brightness value for rhodamine green (average fluorescence intensity (kHz)/N) varies between 4 and 6  kHz per molecule. Values within this range suggested an optimal calibration of our microscope system. The “optimal” values might differ for other microscope systems. In general, the higher the brightness per particle, the better the obtained data will be. So, calibrate your system until you reach the highest possible brightness. 9. Measurements with no correlating species, large intensity drifts, or many and large aggregate peaks were excluded from analysis, which left in our experience on average 15–20% of useable autocorrelation curves. Measurements at multiple positions increase the chance that the plasma membrane is present in the detection volume at some positions. 10. We observed that especially in ovules a large fraction of SERK1:YFP is immobile (see Table 1). This fraction interferes with the measurement and will cause, because of photobleaching, a gradual decrease in the fluorescence intensity during a measurement. A 2-s prebleach with the AOTF set to 70%, stabilizes the signal intensity. Include if necessary this prebleach step for your measurement if a continuous decrease in fluorescence intensity is observed. However, when the goal of the experiment is to estimate particle numbers (N), no prebleaching should be included. If the decrease in fluorescence intensity is limited, it can later be analyzed and used to correct the value for N retrieved from the fit to include the immobile particles. The gradual decrease in fluorescence intensity might also be caused by a too high laser power. If so, reduce laser power for the measurements. 11. The measurement time needed to obtain autocorrelation curves of sufficient quality depends on factors such as diffusion time, the amount of autofluorescence, brightness of the fluorophores, the amount of particles in the detection volume, and movement of the sample or cellular structures. In an ideal situation, measurement times should be >1,000× the diffusion time of the molecule of interest. In our experience, much longer measurement times are needed (>30–60 s). Longer acquisition times result in a better quality of the autocorrelation

238

M. Kwaaitaal et al.

curves. However, aggregation peaks or movement of the sample might limit the time per measurement. Alternatively, many shorter measurements can be averaged or globally analyzed to get an accurate value. These parameters should be optimized for your particular system. 12. The autocorrelation curves can later be recalculated from the raw data, which makes it possible to interpret only part of the intensity trace and exclude aggregate peaks or part of the measurements showing drifts in the average fluorescence intensity. 13. In our experience, tissue autofluorescence regularly causes a fast diffusing component in the autocorrelation curves. This component can be fitted by including a 3D-Brownian diffusion component in the fitting procedure. Occasionally, we also observed a “slow” diffusing species in wild-type material. For an example, see Fig. 2b. The presence of this component was mostly linked to aging of the sample or stress of the plants and could often be traced back to aggregate peaks in the intensity trace. For examples, see arrowheads in Fig. 2a. These measurements were discarded. These observations stress the importance to limit sample usage to up to 20 min and to use healthy plant material. 14. We observed that a large portion of the YFP flickers or blinks (26) during a measurement. This is clearly visible as an extra “fast” component in the autocorrelation curves of the SERK1:YFP and YFP:CAAX measurements in protoplasts. See arrow in Fig. 2c–e. To take this extra component into account we used Eq. 5 for our data analysis. 15. To quality of the fit is indicated by the c2 value calculated by the FCS data processor. For measurements on rhodamine green in solution for our system for a good fit, this value is smaller than 5 × 10−6. Owing to increased noise in the autocorrelation curves in cellular or tissue measurements the c2 value in our case was smaller than 5 × 10−4 for protoplast and 5 × 10−3 for tissue measurements. The residuals of the fit should not show a trend above or below zero, but should be randomly distributed around zero. Fluctuations at later time points in the autocorrelation curve (>1,000 ms) are generally caused by drifts in the fluorescence intensity trace and can hamper a proper fit of the data. These later time points can be excluded from analysis to increase reliability of the fit. To assess the reliability per parameter (for example N or tD), a confidence interval (C.I.) per parameter can calculated. To improve the reliability of the fit, known parameters should be fixed before calculation. For example, the value a (=wz/wxy), defining the detection volume as obtained from the calibration measurements, or measured diffusion times (tD) of autofluorescent species obtained from wild-type material. In addition, boundary values for parameters can be assigned.

13  FCS and FRAP to Study Receptor Kinase Mobility In Planta

239

In FCS data processor, multiple curves can be analysed simultaneously. In addition, values known to be the similar between measurements can be fit globally. One should take care not to fit more components than needed (e.g., multiple 2D- or 3D-diffusing species). With more components, the fit will probably improve slightly, but will most likely not reflect the true physiological situation. 16. Typically, we choose a ROIbleach size of 1 mm × 1 mm. 17. To prevent interference of the bleaching process with the fluorescence recovery, bleaching times should be kept as short as possible. For measurements on “slow” membrane-associated components, the bleach time is normally not a problem; however, for FRAP measurements on “fast” diffusing cytoplasmic components a large part of the recovery phase might coincide with the bleaching pulse. In this case, a decrease of the bleaching time and an increase of the bleach laser power is needed. Alternatively, a ROIbleach shaped as a strip in the scan direction can be used (29), which strongly reduces bleach time. For a review on the use of FRAP to study cellular dynamics, see ref. 30 and for a review of various FRAP methods, FRAP data analysis, and pitfalls of the method see ref. 29. Experiments based on photobleaching can be misinterpreted and disturbed by the existence of dark states of the fluorophores, which can be misinterpreted as a recovery by diffusion. To investigate the portion of the increase in fluorescence due to recovery from dark states of the fluorophore, a fixed sample can be used. Alternatively, bleach the whole cell and follow subsequent recovery of fluorescence. 18. To increase scan speed, decrease the scan resolution and zoom the image until the pixel size equals the diffraction limit (approximately 200  nm) and limit the area scanned in the Y-direction. 19. A limited amount of scanning bleaching, visible as a continuous decrease in signal in ROIscan, can be corrected, e.g., by normalizing the data to the signal intensity in ROIscan or to the signal intensity of the whole cell (31). Such a correction is, however, undesirable and might lead to misinterpretation of the FRAP data (29). 20. Both FCS and FRAP are partly complementary methods, but there are differences in their possibilities and limitations. FCS has a large dynamic time range (ms to s), can be used at low fluorophore concentrations (low expression levels typically in the nanomolar range), and can be used to model many processes. Owing to relatively large time delay between the bleaching pulse and the first data acquisition point in standard confocal microscopes, FRAP has difficulties in resolving fast diffusion

240

M. Kwaaitaal et al.

processes such as that for small cytoplasmic proteins, which makes it more suitable to study slower processes (ms to s), for example membrane diffusion. Furthermore, FRAP unlike FCS needs high fluorophore concentrations (high expression levels). The bleaching procedure applied in FRAP has several unwanted phototoxic side effects (production of reactive oxygen species due to reaction between the triplet state of the fluorophore and oxygen), which might interfere with cellular function. FCS, on the contrary, is noninvasive and thus does not interfere with cellular function. FRAP can be performed on most commercially available confocal systems, while for FCS the confocal system must be equipped with special detectors, high-quality high NA objectives and the alignment and calibration of the system are more critical. In addition, FRAP model functions are relatively simple compared to FCS models where several terms need to be included to take into account interfering processes. Owing to the way FRAP and FCS measurements are performed, there might be a difference in the diffusion coefficients obtained. FCS measurements show a bias to faster diffusing species due to the photobleaching of the slower components and the invisibility of nonmobile components, while FRAP recovery curves take into account the slow transit of molecules from membrane domains into the bleached region. For an assessment of this difference, see ref. 32.

Acknowledgments The authors would like to thank Boudewijn van Veen, Jan-Willem Borst, and Adrie Westphal for the fruitful discussions and maintenance of the microscope systems, and Ruchira Engel for critical reading of the original manuscript and help with data interpretation and analysis, and Jose Aker for optimization of the Arabidopsis protoplast transfection protocol. This work was supported by Wageningen University, Department of Agrotechnology and Food Sciences to M.K. and S.d.V. References 1. Schmidt, E. D., Guzzo, F., Toonen, M. A., and de Vries, S. C. (1997) A leucine-rich repeat containing receptor-like kinase marks somatic plant cells competent to form embryos. Development 124, 2049–62. 2. Hecht, V., Vielle-Calzada, J. P., Hartog, M. V., Schmidt, E. D., Boutilier, K., Grossniklaus, U., and de Vries, S. C. (2001) The Arabidopsis SOMATIC EMBRYOGENESIS RECEPTOR

KINASE 1 gene is expressed in developing ovules and embryos and enhances embryogenic competence in culture. Plant Physiol 127, 803–16. 3. Shah, K., Gadella, T. W., Jr., van Erp, H., Hecht, V., and de Vries, S. C. (2001) Subcellular localization and oligomerization of the Arabidopsis thaliana somatic embryogenesis receptor kinase 1 protein. J Mol Biol 309, 641–55.

13  FCS and FRAP to Study Receptor Kinase Mobility In Planta 4. Rienties, I. M., Vink, J., Borst, J. W., Russinova, E., and de Vries, S. C. (2005) The Arabidopsis SERK1 protein interacts with the AAA-ATPase AtCDC48, the 14-3-3 protein GF14lambda and the PP2C phosphatase KAPP. Planta 221, 394–405. 5. Karlova, R., Boeren, S., Russinova, E., Aker, J., Vervoort, J., and de Vries, S. (2006) The Arabidopsis SOMATIC EMBRYOGENESIS RECEPTOR-LIKE KINASE1 Protein Complex Includes BRASSINOSTEROIDINSENSITIVE1. Plant Cell 18, 626–38. 6. Shah, K., Russinova, E., Gadella, T. W., Jr., Willemse, J., and De Vries, S. C. (2002) The Arabidopsis kinase-associated protein phosphatase controls internalization of the somatic embryogenesis receptor kinase 1. Genes Dev 16, 1707–20. 7. Albrecht, C., Russinova, E., Hecht, V., Baaijens, E., and de Vries, S. (2005) The Arabidopsis thaliana SOMATIC EMBRYOGENESIS RECEPTOR-LIKE KINASES1 and 2 control male sporogenesis. Plant Cell 17, 3337–49. 8. Russinova, E., Borst, J. W., Kwaaitaal, M., Cano-Delgado, A., Yin, Y., Chory, J., and de Vries, S. C. (2004) Heterodimerization and endocytosis of Arabidopsis brassinosteroid receptors BRI1 and AtSERK3 (BAK1). Plant Cell 16, 3216–29. 9. Aker, J., Borst, J. W., Karlova, R., and de Vries, S. (2006) The Arabidopsis thaliana AAA protein CDC48A interacts in  vivo with the somatic embryogenesis receptor-like kinase 1 receptor at the plasma membrane. J Struct Biol 156, 62–71. 10. Aker, J., Hesselink, R., Engel, R., Karlova, R., Borst, J. W., Visser, A. J. W. G., and de Vries, S. C. (2007) In vivo hexamerization and characterization of the Arabidopsis AAA ATPase CDC48A complex using forster resonance energy transfer-fluorescence lifetime imaging microscopy and fluorescence correlation spectroscopy. Plant Physiol 145, 339–350. 11. Wang, X., Li, X., Meisenhelder, J., Hunter, T., Yoshida, S., Asami, T., and Chory, J. (2005) Autoregulation and homodimerization are involved in the activation of the plant steroid receptor BRI1. Dev Cell 8, 855–65. 12. Hink, M. A., Shah, K., Russinova, E., de Vries, S. C., and Visser, A. J. W. G. (2008) Fluorescence fluctuation analysis of Arabidopsis thaliana somatic embryogenesis receptor-like kinase and brassinosteroid insensitive 1 receptor oligomerization. Biophys J 94, 1052–62. 13. Wang, X. F., Goshe, M. B., Soderblom, E. J., Phinney, B. S., Kuchar, J. A., Li, J., Asami, T., Yoshida, S., Huber, S. C., and Clouse, S. D. (2005) Identification and functional analysis of in vivo phosphorylation sites of the Arabidopsis

14.

15. 16.

17. 18.

19.

20.

21.

22.

23. 24.

25.

26.

241

BRASSINOSTEROID-INSENSITIVE1 receptor kinase. Plant Cell 17, 1685–1703. Ali, G. S., Prasad, K. V., Day, I., and Reddy, A. S. (2007) Ligand-Dependent Reduction in the Membrane Mobility of FLAGELLIN SENSITIVE2, an Arabidopsis Receptor-Like Kinase. Plant Cell Physiol 48, 1601–11. Elson, E. L. (2001) Fluorescence correlation spectroscopy measures molecular transport in cells. Traffic 2, 789–796. Medina, M. A., and Schwille, P. (2002) Fluorescence correlation spectroscopy for the detection and study of single molecules in Biology. Bioessays 24, 758–764. Chen, Y., Muller, J. D., Berland, K. M., and Gratton, E. (1999) Fluorescence fluctuation spectroscopy. Methods 19, 234–52. Bacia, K., and Schwille, P. (2003) A dynamic view of cellular processes by in  vivo fluorescence auto- and cross-correlation spectroscopy. Methods 29, 74–85. Hess, S. T., Huang, S., Heikal, A. A., and Webb, W. W. (2002) Biological and chemical applications of fluorescence correlation spectroscopy: a review. Biochemistry 41, 697–705. Kwaaitaal, M. A., de Vries, S. C., and Russinova, E. (2005) Arabidopsis thaliana Somatic Embryo­ genesis Receptor Kinase 1 protein is present in sporophytic and gametophytic cells and undergoes endocytosis. Protoplasma 226, 55–65. Kwaaitaal, M. A. C. J., and de Vries, S. C. (2007) The SERK1 gene is expressed in procambium and immature vascular cells. J Exp Bot 58, 2887–2896. Hurwitz, H. I., and Casey, P. J. (2002) Prenylation of CaaX-type proteins: Basic principles through clinical applications. PeptideLipid Interactions 52, 531–550. Sheen, J. (2001) Signal transduction in maize and Arabidopsis mesophyll protoplasts. Plant Physiol 127, 1466–75. Skakun, V. V., Hink, M. A., Digris, A. V., Engel, R., Novikov, E. G., Apanasovich, V. V., and Visser, A. J. W. G. (2005) Global analysis of fluorescence fluctuation data. Eur Biophys J 34, 323–334. Ruchira, Hink, M. A., Bosgraaf, L., van Haastert, P. J., and Visser, A. J. (2004) Pleckstrin homology domain diffusion in Dictyostelium cytoplasm studied using fluorescence correlation spectroscopy. J Biol Chem 279, 10013–9. Schwille, P., Kummer, S., Heikal, A. A., Moerner, W. E., and Webb, W. W. (2000) Fluorescence correlation spectroscopy reveals fast optical excitation-driven intramolecular dynamics of yellow fluorescent proteins. Proc Natl Acad Sci USA 97, 151–6.

242

M. Kwaaitaal et al.

27. Yguerabide, J., Schmidt, J. A., and Yguerabide, E. E. (1982) Lateral mobility in membranes as detected by fluorescence recovery after photobleaching. Biophys J 40, 69–75. 28. Schneitz, K., Hulskamp, M., and Pruitt, R. E. (1995) Wild-Type Ovule Development in Arabidopsis-Thaliana – a Light-Microscope Study of Cleared Whole-Mount Tissue. Plant J 7, 731–749. 29. Houtsmuller, A. B. (2005) Fluorescence recovery after photobleaching: application to nuclear proteins. Adv Biochem Eng Biotechnol 95, 177–99.

30. Klonis, N., Rug, M., Harper, I., Wickham, M., Cowman, A., and Tilley, L. (2002) Fluorescence photobleaching analysis for the study of cellular dynamics. Eur Biophys J 31, 36–51. 31. Dundr, M., Misteli, T., and Olson, M. O. (2000) The dynamics of postmitotic reassembly of the nucleolus. J Cell Biol 150, 433–46. 32. Adkins, E. M., Samuvel, D. J., Fog, J. U., Eriksen, J., Jayanthi, L. D., Vaegter, C. B., Ramamoorthy, S., and Gether, U. (2007) Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching. Biochemistry 46, 10484–97.

Part IV Identification of Kinase Substrates and Phosphorylation-Site Detection

wwwwwwwwwwwwwwwww

Chapter 14 Bimolecular-Fluorescence Complementation Assay to Monitor Kinase–Substrate Interactions In Vivo Stefan Pusch, Nico Dissmeyer, and Arp Schnittger Abstract Enzyme–substrate interactions are weak and occur only transiently and thus, a faithful analysis of these interactions typically requires elaborated biochemical methodology. The bimolecular-fluorescence complementation (BiFC) assay, also referred to as split YFP assay, is a powerful and straightforward tool to test protein–protein interactions. This system is commonly used due to many advantages and especially due to its simple ease of use. BIFC relies on the reconstitution of an N-terminal and C-terminal half of YFP into a functional, i.e., fluorescent protein. Noteworthy, the dissociation constant of the two YFP halves is much lower than the association constant leading to a stabilization of the protein–protein interaction to be monitored. Whereas this property is sometimes critical, it also increases the sensitivity of the detection system by stabilizing transient interactions. Here, we exploit this property to detect and monitor interaction between a kinase and its substrate. In particular, we characterize with the BiFC system kinase-variants that show an altered substrate binding. Key words: Bimolecular, Complementation, BiFC, Enzyme–substrate interaction, Cyclin-dependent kinase, CDK, Cell cycle, Fluorescence, Quantification

1. Introduction Biological processes are driven by interaction of proteins with other molecules and often these binding partners are other proteins themselves, for example, transport proteins interact with structural proteins, and peptide hormones interact with their receptors, apoenzymes interact with their co-factors, enzymes interact with their substrates. Over the last decades, a multitude of different methods has been developed to detect and monitor protein–protein interactions (Table 1). Each of these approaches has its strengths and weaknesses, especially with regard to the sensitivity and specificity of the method, for review, see (1, 2). These techniques typically N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_14, © Springer Science+Business Media, LLC 2011

245

246

S. Pusch et al.

Table 1 Techniques to study protein–protein interactions Technique

Type of interaction monitored*

Biochemistry and molecular biology Affinity chromatography Co-immunoprecipitation (Co-IP) Cross-linking Far western blotting/gel overlay assays Phage display Pull-downs Split-ubiquitin system (SUS) Tandem affinity purification (TAP) Yeast-two-hybrid (Y2H)

Stable Stable Stable Stable Stable Stable Stable and transient Stable Stable

Biophysics and microscopy Bimolecular-fluorescence complementation (BiFC) Differential scanning calorimetry (DSC) Fluorescence correlation spectroscopy (FCS) Fluorescence cross-correlation spectroscopy (FCCS) Fluorescence/Förster or/bioluminescence resonance energy transfer (FRET or BRET) Intracellular co-localization and confocal laser scanning microscopy (CLSM) Isothermal titration calorimetry (ITC) Sedimentation equilibrium Surface plasmon resonance (SPR) Ultracentrifugation

Stable and transient Stable Stable and transient Stable and transient Stable and transient Stable and transient Stable Stable Stable Stable

Bioinformatics and computational biology Molecular docking Molecular dynamics (MD) simulations

Stable and transient Stable and transient

Most technologies presented here are well established for stable but not for transient interactions.

*

do not indicate the actual nature of the observed interaction, i.e., whether the proteins transiently bind to each other or whether they form a stable complex. Typically most of these methods favor the detection of stable interactions. However, there is large interest to detect and monitor transient interaction as found for enzyme– substrate pairs. Classically, enzyme–substrate interactions are characterized biochemically by determining enzyme kinetics by, e.g., calorimetric and spectroscopic methods or flow methods. More recently, many enzyme–ligand and –substrate associations could be determined by crystallography and the protein chip or microarray technology (3, 4). In addition, live-cell imaging of enzyme–substrate interactions was reported (5). However, all these techniques require advanced technology or knowledge and typically require that the proteins to be tested are purified. Thus, there is a huge demand for a simple and easy to use assay.

14  Bimolecular-Fluorescence Complementation Assay to Monitor Kinase–Substrate…

1.1. Detecting Protein–Protein Interactions with Two-Hybrid Systems

247

One of the most commonly used techniques to study protein–protein interactions are the so-called two-hybrid systems in which one reporter protein is split into two separated fragments that are each fused to the two proteins that are be tested for interaction. Through a positive interaction of the proteins in question the reporter will be reconstituted leading to a measurable read-out. The most prominent “two-hybrid” system is the “yeast two-hybrid” (Y2H) system (6). In the classical Y2H system, a transcription factor (GAL4) is split into one fragment harboring the DNA binding domain (BD) and a second fragment containing the activation domain (AD). Both fragments are fused to the proteins to be tested and their interaction causes the restoration of a functional transcription factor. This transcription factor will bind to an engineered UAS promoter region to drive the expression of a reporter such as b-galactosidase (encoded by the lacZ gene) that produces a blue coloration of the yeast colony through the metabolism of X-gal (5-bromo-4-chloro-3-indolyl-b-d-galactoside). Alternatively, the transcription factor can activate the expression of a biosynthetic enzyme causing the complementation of an auxotrophy, e.g., for histidine, leucine, or uracil (7). In particular, the selection system through the complementation of biosynthetic mutants allows highthroughput screening for interactions of protein partners encoded by cDNA libraries including genome- and proteome-wide identification of putative interactors with a protein of interest. One of the many variants of the Y2H system that has been developed is the so-called split-ubiquitin system (SUS) (8) that does not rely on an interaction reporter system in the nucleus and thus is also suitable for the detection of the interactions of membrane-bound proteins (9). The only methodological requirement is that interactions can only be monitored in a compartment containing ubiquitin protease (UBP), see below. In the SUS, the proteins to be tested for interaction are combined with the N- or C-terminal half (Nub and Cub) of ubiquitin (ub). In addition, the Cub part is fused to two more proteins: a reporter (metabolic or visual) and a strong destruction signal, which stays, however, inactive in this fusion. If then two proteins interact they will also bring the two halfs of ub into close proximity resulting in a reconstitution of an entire ub. This ub moiety is recognized by UBP that cleaves off the reporter and with it the destruction signal. The destruction signal then leads to successful degradation of the reporter. Thus, in yeast colonies with interacting proteins, the absence of the reporter rather than its presence, as in the classical Y2H, is selected for (8). An often used selective drug is 5-fluoroorotic acid (5-fluorouracil-6-carboxylic acid, FOA, or 5-FOA) which detects URA3 gene expression in yeast. It encodes the yeast reporter enzyme orotine-5¢-monophosphate (OMP) dicarboxylase and this metabolizes 5-FOA into the cell toxin fluorodeoxyuridine resulting in death of the colonies that do not contain interacting proteins. Yeast strains carrying a mutation in URA3 grow in the presence of 5-FOA solely if the media is supplemented with uracil (6, 10).

248

S. Pusch et al.

1.2. BimolecularFluorescence Complementation

The bimolecular-fluorescence complementation (BiFC) assay – also called split YFP assay – is based on the same principle as the split-ubiquitin yeast hybrid system, i.e., the complementation of reporter system. In the BiFC assay, the reporter is a fluorescent protein that is separated into two halves with each half fused to the proteins to be tested for interaction (Fig. 1). Through interaction of the proteins to be tested, the two nonfluorescent N- and C-terminal halves of a variant of the green fluorescent protein (GFP and its derivatives CFP (cyan), YFP (yellow), BFP (blue), and RFP (red)) reconstitute into a functional fluorescent protein (Fig. 1c, d). Thus, the BiFC system gives a direct readout, i.e. fluorescence, and does not require any exogenous reagent to be added to detect the reassembled reporter. BiFC was in particular developed by Tom Kerppola and co-workers (11) (for further reference see also the Kerppola lab webpage at http://sitemaker.umich.edu/ kerppola.lab/home which provides excellent background information on the BiFC technique). One of the main advantages of the BiFC method is that it also gives an in  vivo indication of the

Fig. 1. Principle of the bimolecular fluorescence complementation (BiFC) detection mechanism of protein–protein interaction. The possible interaction of two proteins, 1 and 2, is to be tested. (a) Protein 1 and 2 do not interact with each other. The two N- and C-terminal fragments of the fluorescent protein (FP) used as reporter gene fusion partners (FP-N and FP-C) are not fluorescent. No emission occurs even if excited with the correct wavelength for the entire FP molecule because the fluorophore is not intact. (b) Proteins A and B start to interact by forming a transient association of the moieties and thus bring the FP fragments to close proximity. (c) The interaction of the two proteins stabilizes and leads to a molecular complementation of the two halves of the FP to the full reporter protein. (d) After maturation of the complemented full FP, energy transfer via fluorescence becomes possible and light of the specific emission wavelength can be observed and thus documents the interaction of the two test proteins 1 and 2.

14  Bimolecular-Fluorescence Complementation Assay to Monitor Kinase–Substrate…

249

subcellular place of interaction. Given that GFP derivatives are known to express, fold, mature, and fluoresce in virtually every cell type and every subcellular environment and that of the mentioned methods using fluorescence microscopy (Table 1), BiFC is the simplest one, it is not surprising that BiFC is now widely used in many research fields and different cells and organisms, e.g. in animal and human cell cultures (11) in Arabidopsis (12, 13) and many more. Recently, multicolor variations of BiFC have been developed that are based on the complementation of fragments of differently colored fluorescent probes. This multicolor fluorescence complementation allows the detection of different interactions at the same time and also oligomeric complexes can be assayed (14, 15). However, as for every protein–protein interaction system the BiFC has also certain limitations: As typical for techniques that rely on fusion proteins the monitored interaction depends on the sterical liberties/restrictions that are induced by actual fusions. Thus, many different fusions might be needed and have to be tested carefully. In contrast to the resonance energy transfer-based FRET/BRET involving entire GFP variants, BiFC does not allow a timely resolution of the molecular interaction due to the slow maturation of the split fluorophore. This prevents real-time detection of rapid changes in interactions. Furthermore, as for all in vivo methods, one has to keep in mind that for monitored interaction of two proteins there might be another (or even more than one) binding-partners mediating the proper association in a multimeric complex (bridging). It has been estimated that a distance of approximately 10 nm between the GFP halves is sufficient to allow fluorescence complementation (11). One feature of the BiFC as a complementation-based assay is the high affinity of the GFP halves and the stability of the mature BiFC complexes (the association constant is much higher than the dissociation constant of the two protein halves). On the one hand, this is a drawback because it might lead to false-positive interaction data. On the other hand, this system allows detecting very weak or shorttime associations between different protein partners. 1.2.1. Application in the Plant Field

The BiFC methodology and its protocols were adopted by the groups of Klaus Harter (Eberhardt-Karls-Universität Tübingen, Germany) and Nir Ohad (Tel Aviv University, Israel) for usage in plants (12, 13, 16). A few examples of usage in plants are the test for interaction of subunits of the Arabidopsis Protein Farnesyl transferase (PFT), and within the group of polycomb proteins, that of Fertilization-Independent Endosperm (FIE) and Medea (MEA) (13). The homodimerization of the basic leucine zipper (bZIP) transcription factor bZIP63 and the zinc finger protein Lesion Simulating Disease 1 (LSD1) from Arabidopsis as well as the dimer formation of the tobacco 14-3-3 protein T14-3c were also visualized as a pioneer work (12). Heterodimeric interactions of the 1-aminocyclopropane-1-carboxylate synthase were also studied in the early

250

S. Pusch et al.

days of BiFC in Arabidopsis (17, 18). More examples and a ­comparison of the advantages and limitations of BiFC versus FRET/BRET have been recently reviewed (19). 1.3. Cell Cycle Regulation and Application of BiFC

Progression through the cell cycle is controlled by a heterodimeric enzyme comprised of a kinase subunit, called cyclin-dependent kinase (CDK), and a cyclin co-factor (see also Chapter 6). Different CDKs together with different cyclin govern the major checkpoints in the cell cycle, i.e., the transition from a G1 phase into the DNA replication phase (S-phase) and entry from a G2 phase into mitosis. Therefore, the enzymatically active CDK-cyclin complexes are also known as SPF (S-phase promoting complex) and MPF (M-phase promoting complex). Despite the importance of cell-cycle regulation for development and disease of any organism it took until 2003 to obtain a first proteome-wide set of CDK substrates (20). This work was done in yeast and a list of CDK substrates in multicellular eukaryotes is still far from being complete exemplifying the difficulties when monitoring and detecting enzyme–substrate interactions. In our group, we have used BiFC to study enzyme–substrate interaction during cell cycle control in the flowering plant Arabidopsis. The major CDK in Arabidopsis thaliana is CDKA;1. This kinase shows high homology to well studied CDKs of other organisms, namely Cdk1 from humans, Cdc28 from fission yeast or Cdc2 from budding yeast. This high homology and the conservation of all crucial residues lead to the hypothesis that the regulatory mechanisms are the same. To test this, we have generated different kinase mutant version (see Chapter 6 by Dissmeyer & Schnittger) (21, 22) and analyzed them in a BiFC assay for their binding properties with CDK cofactors and well-known substrates from yeast and animals, i.e., CDT1 and CDC6. Indeed, it was possible to distinguish the two classes of interaction partners of CDKA;1: Whereas proteins which form complexes with CDKA;1 showed no altered fluorescence intensity with the different CDKA;1 constructs (Fig. 2g), the bona fide substrates of CDKA;1 displayed a strongly reduced fluorescence and a lower number of YFPpositive cells for the mutant CDK versions versus the wild-type CDK (Fig. 2h). With this we could assign a conserved function in substrate binding to the T-loop region of the kinase. In addition,

Fig. 2. Infiltration of tobacco leaves. (a) On a 6-week-old tobacco (Nicotiana benthamiana) plant, arrows mark the leafs optimally used for infiltration. (b) Infiltration technique from the abaxial (lower) side of the leaf, (c) infiltrated area seen from abaxial, and (d) infiltrated area seen from the axial (upper) side of the leaf. (e, f) Measurement of the fluorescence with the Fig. 2. (continued) ImageJ software package. (e) The area for measurement of a nuclear interaction is set (circle) and (f) possible areas for measurement of a cytoplasmic (square) and nuclear (circle) interaction. (g, h)The relative fluorescence intensities of interactions from protein–protein interactions with (g) CDKA;1 phospho-site variants (D: T161D; V: T161V; VF: T14V/ Y15F; DE: T14D/Y15E) in pSYC and interactor CKS1 in pSYN, and (h) kinase–substrate interactions of the different CDKA;1 phospho-site variants with the two bona fide substrates CDT1 and CDC6 (21, 22]. For vectors used, please consult the Subheadings 2 and 3.

14  Bimolecular-Fluorescence Complementation Assay to Monitor Kinase–Substrate…

251

252

S. Pusch et al.

we could show that mimicking of inhibitory phosphorylation of the P-loop of the Arabidopsis CDKA;1 is likely to result in reduced substrate binding as recently demonstrated for human Cdk2 (23).

2. Materials 2.1. Cloning and Vectors

1. Gateway BP- and LR-Kits (Invitrogen). 2. Binary Destination vectors for BiFC: pSYC and pSYN (24). 3. Plasmid pEXSG-YFP (21, 25).

2.2. Bacterial Culture

1. Agrobacterium tumefaciens strain GV3101 pMP90RK, compatible with the binary destination vectors mentioned under Subheading 2.1 (26). 2. A. tumefaciens strain with the p19 silencing plasmid (12, 27) (see Note 1). 3. 1 M MgSO4. 4. 25 mg/mL kanamycin in water (1,000× stock solution). 5. 50 mg/mL carbenicillin in water (1,000× stock solution). 6. 50 mg/mL rifampicin in DMSO (1,000× stock solution). 7. YEB liquid media: 5  g of meat extract (dry, granulated, for microbiology; Merck), 5 g of peptone (Roth), 5 g of sucrose (for microbiology, Merck), 1 g of yeast extract (Roth), 2 mL of 1 M MgSO4 in 1 L of water. Autoclave and add the respective antibiotics: 50 mg/mL rifampicin, 25 mg/mL kanamycin, and 50 mg/mL carbenicillin for GV3101 pMP90RK or only rifampicin and kanamycin for p19. 8. YEB plates: add 16 g/L of agar agar before autoclaving; use antibiotics as in liquid medium. 9. 15 mL plastic tubes. 10. Roller drum. 11. Incubator set to 28°C.

2.3. Infiltration

1. Tobacco (Nicotiana benthamiana) seeds are grown on professional soil (Type ED 73, pH: 5.9; Balster Einheitserdewerk) at 20°C and with 16 h light. After 14 days the plants are separated into single pots (6 cm diameter) with the same soil and kept under the same conditions. One- to two-month-old tobacco plants are used for infiltration. 2. 1  M 2-(N-morpholino)ethane sulfonic acid (MES; pH 5.6 with 1 M KOH): sterilize by filtration. Store at room temperature in the dark (see Note 2). 3. 3 M MgCl2, sterilize by filtration.

14  Bimolecular-Fluorescence Complementation Assay to Monitor Kinase–Substrate…

253

4. 150  mM 3,5-dimethoxy-4-hydroxy acetophenone (>97%, TLC; Fluka; sensitive to light, temperature, and oxidation) in N,N-dimethylformamide (DMF, >99,9%; toxic). Store at −20°C in the dark (see Note 3). 5. Infiltration buffer: 500 mL of 1 M MES (pH 5.6), 167 mL of 3 M MgCl2, 50 mL of 150 mM 3,5-dimethoxy-4-hydroxy acetophenone, fill up to 50 mL with water. Always prepare fresh directly before use. 6. 1 mL insuline syringe for injection (no needles needed). 2.4. Signal Analysis

1. Microscopical slides and cover slips. 2. Confocal laser scanning microscope (CLSM) such as a TCS SP2 AOBS CLSM system and the respective filters (all Leica Microsystems). 3. ImageJ (http://rsbweb.nih.gov/ij) for signal quantification.

3. Methods 3.1. Cloning

All cloning and BP-/LR-recombination procedures were performed as described by the manufacturer (Invitrogen).

3.2. Bacterial Culture

For each interaction, three tubes are needed: two tubes for the interaction partners and one for the control strain p19. One bacterial plate is sufficient for maximal six tubes (see Note 4). 1. Pick Agrobacteria from stock culture into 50 mL of water and streak them out on plates containing the respective antibiotics. 2. Incubate the plates for 2 days at 28°C. The plates should be fully covered with bacteria. 3. Fill 7  mL of YEB liquid medium complemented with the respective antibiotics into each 15 mL tube. Pick a pee-sized amount of bacteria into each tube. 4. Incubate the cultures overnight at 28°C in a roller drum (see Note 5). 5. On the next day, proceed with Subheading 3.3 step 2.

3.3. Infiltration

1. Two days prior to infiltration the tobacco plants were intensively watered (see Note 6). 2. Mix the cultures of the interaction partners 1:1 and spin them down at low speed for 15 min at room temperature. Spin down p19 separately under the same conditions. 3. Remove supernatant and add 400 mL of infiltration buffer.

254

S. Pusch et al.

4. Carefully resuspend the pellet by vortexing. 5. Check the optical density (OD) of the resuspended culture, therefore use 5 mL of the suspension and add 995 mL of water. The OD600 should be around 0.5 (see Note 7). 6. Incubate the bacteria for 2–5 h at 28°C. 7. Combine the putative interactors with 500 mL of p19 and mix well. 8. Use a 1-mL syringe to take up the culture and to inject it into the abaxial site of a tobacco leaf. The best leaves are the ones with a roundish shape and a plane surface (Fig. 2a, arrows, see Note 8). 9. Carefully press the syringe onto the leaf and counter it with a finger from the other side of the leaf. Inject the culture with little pressure. It is easy to see whether the culture has spread in the leaves since successfully injected regions appear darker (Fig. 2b, see Note 9). 10. Keep the tobacco plants under normal culture conditions for at least 5 days (see Note 10). 3.4. Signal Analysis

1. It is very important to adjust the settings at the microscope, so that there is no overflow in the signal strength. Keep those settings for all pictures of one series (see Note 11). 2. Take at least ten pictures for each pair of interaction partners. No stacks are needed. 3. Open the pictures with ImageJ. 4. Use the selection brush from ImageJ to mark the region of interest (Fig. 2e, f). 5. Measure the region (use the file commands “Analyze,” “Measure,” or the short-cut “Strg + M”). A new window will open with the measured data. All following measurements will be added into this window. 6. Use this data to calculate the mean fluorescence strength of all pictures of one pair of interactors. Repeat these steps for all other pairs of interactors. 7. Plot the mean value of fluorescent units of all interaction pairs.

4. Notes 1. The p19 strain is not necessarily needed, but the signal strength is tremendously increased and can be detected over a much longer period (up to 10 days vs. 3 days without p19). Some substrate interactions could not be measured without p19.

14  Bimolecular-Fluorescence Complementation Assay to Monitor Kinase–Substrate…

255

2. If the buffer is not stored in the dark it will get brown and should not be used anymore. 3. Always order small batches of this chemical, directly dissolve it in DMF and aliquot it into small samples. It can also be dissolved in DMSO, which is not so toxic, but freezes at −20°C and needs to be thawed before use. After more than two times thawing it should not be used further. 4. The main problem of this infiltration technique is to grow enough bacteria to be injected into the plants. The protocol above describes the way that worked best in our hands, however, there are several other methods and the experimenter is encouraged to consider them, especially if this protocol will not give a strong reconstituted YFP signal. Picking single colonies is possible, but this procedure will last much longer to grow until an appropriate OD will be reached. It is possible to grow the bacteria in Erlenmeyer flasks in a bigger volume of YEB media to reduce the number of tubes per experiment. However, if one flask gets contaminated, a whole series of experiments has to be discarded. 5. The incubation in a roller drum works best for tubes. The use of a shaker with minimum 200  rpm for at least 16  h is also possible. 6. The tobacco may even stand in 2–3  cm of water for these 2 days. This procedure makes it much easier to infiltrate the leaves, because all of the stomata will open up. 7. The OD600 of 0.5 is best, but every OD600 between 0.2 and 0.8 will work for analysis. An OD600 below 0.2 will be enough to infect cells, but the concentration is not sufficient for analysis. Every OD600 above 0.8 is hard to infiltrate and often causes the death of the surrounding cells. It also often leaves a smear of bacteria on the leaf surface, which disturbs fluorescent imaging. 8. Theoretically, it is possible to use all leafs of one plant for infiltration but the youngest leafs often break when injected. The oldest ones do not give rise to good signals. The injection should always be placed in a region between the major leaf veins; otherwise the infected region tends to die. 9. This part needs a lot of practice. Some tests with water are recommended to get a feeling for the right pressure. There should be no holes in the leaf after infiltration, yet the place of injection should be visible. 10. Although a signal can be detected as early as 3 days after injection, the best results were achieved after 5 days. The signal can be detected for several more days (at least for 10  days). However, these time estimates are only applicable in combina-

256

S. Pusch et al.

tion with p19; in the absence of p19 the tobacco cells should be measured after 3 days. 11. If available, use the overflow/underflow coloring option with the confocal software to adjust the right levels. Search for the brightest spot and reduce the gain of the corresponding channel so that there is no overflow anymore. This calibration step is very crucial because you have to keep these settings for the rest of one series. To keep the measurements within one experiment comparable, the settings must not be changed between different cells.

Acknowledgments We thank Annika K. Weimer for critical reading and comments on the manuscript and Klaus Harter and Jane Parker for sharing the plasmids. N.D. is a fellow of the International Max Planck Research School and funded by the Max Planck Society, work in the laboratory of A.S. is supported through an ATIP grant from the Centre National de la Recherche Scientifique (CNRS) and an ERC starting grant from the European Union. References 1. Fu, H. (2004) Protein-protein interactions: methods and applications, Vol. 261, Humana Press, Totowa, N.J. 2. Werther, M., and Seitz, H. (2008) Protein– Protein Interaction, Vol. 110, Springer-Verlag Berlin Heidelberg, Berlin, Heidelberg. 3. Templin, M. F., Stoll, D., Schrenk, M., Traub, P. C., Vohringer, C. F., and Joos, T. O. (2002) Protein microarray technology. Trends Biotechnol 20, 160–6. 4. Zhu, H., and Snyder, M. (2003) Protein chip technology. Curr Opin Chem Biol 7, 55–63. 5. Yudushkin, I. A., Schleifenbaum, A., Kinkhabwala, A., Neel, B. G., Schultz, C., and Bastiaens, P. I. (2007) Live-cell imaging of enzyme-substrate interaction reveals spatial regulation of PTP1B. Science 315, 115–9. 6. Fields, S., and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245–6. 7. Causier, B., and Davies, B. (2002) Analysing protein-protein interactions with the yeast twohybrid system. Plant Mol Biol 50, 855–70. 8. Johnsson, N., and Varshavsky, A. (1994) Split ubiquitin as a sensor of protein interactions in vivo. Proc Natl Acad Sci USA 91, 10340–4.

9. Wittke, S., Lewke, N., Muller, S., and Johnsson, N. (1999) Probing the molecular environment of membrane proteins in  vivo. Mol Biol Cell 10, 2519–30. 10. Boeke, J. D., LaCroute, F., and Fink, G. R. (1984) A positive selection for mutants lacking orotidine-5¢-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet 197, 345–6. 11. Hu, C. D., Chinenov, Y., and Kerppola, T. K. (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell 9, 789–98. 12. Walter, M., Chaban, C., Schutze, K., Batistic, O., Weckermann, K., Nake, C., Blazevic, D., Grefen, C., Schumacher, K., Oecking, C., Harter, K., and Kudla, J. (2004) Visualization of protein interactions in living plant cells using bimolecular fluorescence complementation. Plant J 40, 428–38. 13. Bracha-Drori, K., Shichrur, K., Katz, A., Oliva, M., Angelovici, R., Yalovsky, S., and Ohad, N. (2004) Detection of protein-protein interactions in plants using bimolecular fluorescence complementation. Plant J 40, 419–27.

14  Bimolecular-Fluorescence Complementation Assay to Monitor Kinase–Substrate… 14. Hu, C. D., and Kerppola, T. K. (2003) Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat Biotechnol 21, 539–45. 15. Shyu, Y. J., Suarez, C. D., and Hu, C. D. (2008) Visualization of ternary complexes in living cells by using a BiFC-based FRET assay. Nat Protoc 3, 1693–702. 16. Schütze, K., Harter, K., and Chaban, C. (2009) Bimolecular fluorescence complementation (BiFC) to study protein-protein interactions in living plant cells. Methods Mol Biol 479, 189–202. 17. Tsuchisaka, A., and Theologis, A. (2004) Heterodimeric interactions among the 1-amino-cyclopropane-1-carboxylate synthase polypeptides encoded by the Arabidopsis gene family. Proc Natl Acad Sci USA 101, 2275–80. 18. Tsuchisaka, A., and Theologis, A. (2004) Unique and overlapping expression patterns among the Arabidopsis 1-amino-cyclopropane1-carboxylate synthase gene family members. Plant Physiol 136, 2982–3000. 19. Bhat, R. A., Lahaye, T., and Panstruga, R. (2006) The visible touch: in planta visualization of protein-protein interactions by fluorophorebased methods. Plant Methods 2, 12. 20. Ubersax, J. A., Woodbury, E. L., Quang, P. N., Paraz, M., Blethrow, J. D., Shah, K., Shokat, K. M., and Morgan, D. O. (2003) Targets of the cyclin-dependent kinase Cdk1. Nature 425, 859–64. 21. Dissmeyer, N., Nowack, M. K., Pusch, S., Stals, H., Inze, D., Grini, P. E., and Schnittger, A. (2007) T-loop phosphorylation of Arabidopsis CDKA;1 is required for its function and can be partially substituted by an aspartate residue. Plant Cell 19, 972–85.

257

22. Dissmeyer, N., Weimer, A. K., Pusch, S., De Schutter, K., Kamei, C. L., Nowack, M. K., Novak, B., Duan, G. L., Zhu, Y. G., De Veylder, L., and Schnittger, A. (2009) Control of cell proliferation, organ growth, and DNA damage response operate independently of dephosphorylation of the Arabidopsis Cdk1 homolog CDKA;1. Plant Cell 21, 3641–54. 23. Welburn, J. P., Tucker, J. A., Johnson, T., Lindert, L., Morgan, M., Willis, A., Noble, M. E., and Endicott, J. A. (2007) How tyrosine 15 phosphorylation inhibits the activity of cyclindependent kinase 2-cyclin A. J Biol Chem 282, 3173–81. 24. Jakoby, M. J., Weinl, C., Pusch, S., Kuijt, S. J., Merkle, T., Dissmeyer, N., and Schnittger, A. (2006) Analysis of the Subcellular Localization, Function, and Proteolytic Control of the Arabidopsis Cyclin-Dependent Kinase Inhibitor ICK1/KRP1. Plant Physiol 141, 1293–305. 25. Feys, B. J., Wiermer, M., Bhat, R. A., Moisan, L. J., Medina-Escobar, N., Neu, C., Cabral, A., and Parker, J. E. (2005) Arabidopsis SENESCENCE-ASSOCIATED GENE101 stabilizes and signals within an ENHANCED DISEASE SUSCEPTIBILITY1 complex in plant innate immunity. Plant Cell 17, 2601–13. 26. Koncz, C., and Schell, J. (1986) The promoter of TL-DNA gene 5 controls the tissue-specific expression of chimaeric genes carried by a novel type of Agrobacterium binary vector. Mol Gen Genet 204, 383–396. 27. Voinnet, O., Rivas, S., Mestre, P., and Baulcombe, D. (2003) An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of  tomato bushy stunt virus. Plant J 33, 949–56.

wwwwwwwwwwwwwwwww

Chapter 15 Chemical Genetic Analysis of Protein Kinase Function in Plants Maik Böhmer, Michael Bölker, and Tina Romeis Abstract Identification of protein kinase targets and specific inhibition of individual kinase isoforms on the protein level in planta are important techniques to elucidate signal transduction pathways. The use of ATP-binding pocket mutants, the so-called gatekeeper mutants, that accommodate N6-enlarged nucleotides and kinase inhibitors has allowed a dramatic increase in kinase isoform selectivity. In this chapter, we describe protocols for the identification and mutation of the gatekeeper residue, radiolabeling of N6-modified nucleotides, analysis of protein targets by using [32P]-labeled N6-modified nucleotides, and in vivo inhibition of kinase activity combined with subsequent molecular readouts. The chapter includes alternative approaches for the described techniques, considerations for other kinases and recommendations toward a setup of a substrate labeling experiment using total cell lysate. Key words: Calcium-dependent protein kinase, CDPK, CPK1, Gatekeeper, N6-benzyl-ATP, 1-Naphthyl-PP1, In vitro kinase assay, Chemical genetics

1. Introduction The attribution of individual protein kinases to specific signaling pathways and phosphorylation of substrates is often hampered by the sheer number of protein kinases and phosphorylation events present in the cell. Phosphorylation is probably the most universal and abundant posttranslational modification in proteins. In eukaryotic cells, about one third of all proteins are phosphorylated (1) with 99% of all phosphorylations appearing on serine and threonine residues (2). Current annotations of the Arabidopsis thaliana genome account for 1,003 proteins harboring a protein kinase domain (Pfam protein family database code: PF00069), representing about 4% of all Arabidopsis proteins. In vitro protein substrate labeling using radioactive [g-32P]-ATP therefore produces a high background of phosphorylation by other kinases, making it difficult N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_15, © Springer Science+Business Media, LLC 2011

259

260

M. Böhmer et al.

to detect specific changes in phosphorylation patterns. Pharmacological inhibition of kinases is also hindered by low specificity of kinase inhibitors, preventing analysis of individual kinase isoforms. A major breakthrough in the development of specific kinase inhibitors was the introduction of the “chemical genetics” approach, which was developed and refined by Kevan Shokat and co-workers (3–9). It is based on the genetic engineering of protein kinases to introduce specific amino acid substitutions into the conserved ATP-binding pocket to accommodate modified nucleotides and kinase inhibitors that carry bulky side chains. Since these modified substrates and inhibitors are not recognized by wild-type kinases this approach allows specific inhibition of individual kinases and even of specific isoforms in vivo without interfering with all other signaling kinases. In the original study, two residues of the ATPbinding pocket of the viral kinase v-Src (Val323 and Ile338) are identified that lie in close vicinity (5 Å) to the N6-amine of ATP (Table 1). It could be shown that a variant of this kinase, in which both of these residues are substituted by alanine, accepts the ATP analogue N6-cyclohexyl-ATP as phosphate donor (3). Further improvement of the method has shown that only the Ile338 residue controls binding of N6-modified nucleotides (10). Therefore, this residue has been termed “gatekeeper” residue.

Table 1 Structure-based sequence alignment of various kinases that have been modified for the chemical-genetic approach b-sheets Kinase

b2

b3

b4

References

v-Src

E V W

V A I K T

L

V323 Q

Y

I

V

I338

(3)

CDK2 (H.s.)

V V Y

V A L K K

I

V

K

Y

L V

F80

(8)

CamKIIa (H.s.)

V V R

Y

A A K I

I

V

R

Y

L I

F89

(6)

Fus3 (S.c.)

V V C

V A I K K

I

I

T

Y

I

I

Q93

(6)

Don3 (U.m.)

T V Y

V A I K Q

V T

R

W I

I

M157 (11)

MPK4 (A.t.)

I

V C

V A I K K

V I

A

Y

I

V

Y124 (12)

Pto (S.l.)

K V Y

V A L K R

L

V

S

V

L I

CPK1 (A.t.)

T T F

F

A C K S

V I

S

H L V

M228 (13)

CDPK2 (N.t.)

T T F

Y

A C K S

V I

S

H V V

M195 (13)

b5

Y114 (9)

Bold letters mark residues that have been shown to have an effect on the stability of the ATP binding pocket (9). Numbers indicate the positions of the respective residues in the protein Phylogenetic groups: Homo sapiens (H.s.), Saccharomyces cerevisiae (S.c.), Ustilago maydis (U.m.), Arabidopsis thaliana (A.t.), Solanum lycopersicum (L.e.), Nicotiana tabacum (N.t.)

15  Chemical Genetic Analysis of Protein Kinase Function in Plants

261

The conservation of a hydrophobic residue at this site in basically all tyrosine- and serine/threonine-kinases, allows a general application of this technique to a large number of protein kinases. In most cases, modification of the gatekeeper residue has only little effect on kinase activity and substrate binding. The gatekeeper residue is buried deep within the ATP-binding pocket and is apparently not involved in substrate binding and regulation. However, in some cases it has been reported that exchange of the gatekeeper residue to glycine has an effect on the folding of the ATP-binding pocket thereby changing or impairing kinase activity. This adverse effect of the gatekeeper mutation can at least be partially compensated by secondary mutations that stabilize the b-sheets of the ATPbinding pocket thus allowing the broad use of this technique (9). Selective labeling of specific protein kinase substrates by modified kinases and [g-32P]-labeled N6-modified ATP analogues has been successfully applied in yeast and mammalian cell lysates. Protocols for enzymatic radiolabeling of N6-modified ATPanalogues and in vitro kinase assays are described in this chapter. In A. thaliana, gatekeeper mutants have so far been used to inhibit the activity of selected kinase isoforms in vivo, followed by phenotypical analyses (11–14). A general method to detect molecular changes in response to stimuli and inhibitor treatment in plants is presented.

2. Materials 2.1. Mutagenesis

1. Basic molecular biology reagents and equipment for agarose gel electrophoresis: a thermocycler, restriction endonucleases, E. coli strains and growth media, antibiotics. 2. CPK1 (A. thaliana calcium-dependent protein kinase 1) cDNA in plasmid pENTR/D-TOPO (13). 3. Two oligonucleotides primers (about 30 nt long), containing the gatekeeper mutation (underlined in the sequence) that are reverse complement to each other; sense 5'-ccttgtagcgga­ gtgttgtgcaggcg-3'; antisense 5'-cgcctgcacaacactccgctacaagg-3' (see Note 1). 4. QuikChange Site-Directed Mutagenesis kit (Stratagene). 5. Genomic region of CPK1 in plasmid pXC-HAStrepII (Genbank accession AY457636 (15)). 6. A. thaliana seeds of the homozygous mutant CPK1 T-DNA insertion line cpk1-2 (13) (SALK_096452; availability in Europe: Nottingham Arabidopsis Stock Center (NASC) and in nonEurope: Arabidopsis Biological Ressource Center (ABRC)). 7. BASTA (glufosinate-ammonium; Bayer Cropscience). 8. PPT (phosphinothricin; Duchefa Biochemie).

262

M. Böhmer et al.

2.2. Chemo-Enzymatic Labeling of N 6-BenzylATP with 32P

1. E. coli nucleoside diphosphate kinase (Ndk) produced in bacteria: His-Ndk (Mr = 18,000). The enzyme is expressed as an N-terminal His-fusion protein from the pET15 vector (13). 2. 3.7 mBq (6,000 Ci/mmol) [g-32P]-ATP (GE Healthcare). 3. N6-benzyl-ADP (Biolog). 4. Microbiospin column P6 in 10 mM Tris–HCl (pH 7.4) (Biorad). 5. Stock solutions for labeling buffer: 5  M NaCl; 1  M HEPES (pH 7.4); 3  M MgCl2; 10% (v/v) Triton X-100; 1  M DTT (−20°C). Sterilize by filtration. 6. Labeling buffer: 150  mM NaCl, 20  mM HEPES (pH 7.4), 5 mM MgCl2, 0.07% (v/v) Triton X-100, 0.67 mM DTT. 7. Scintillation counter LS6500 (Beckman Coulter).

2.3. Ion-Exchange Thin-Layer Chromatography

1. Solvent: 0.75 M KH2PO4 (pH 3.4 with HCl). 2. Polyethyleneimine-cellulose thin-layer sheets (Polygram CEL 300 PEI, 0.1 mm layer; Macherey-Nagel). 3. Chromatography tank for 5 × 20  cm plates, autoradiography cassette and X-ray films (Fuji or Kodak), beta shielding equipment and beta racks. 4. Silicone grease.

2.4. In Vitro Kinase and Kinase Inhibition Assays

1. Immunoprecipitated or Talon resin-immobilized CDPK (such as Arabidopsis CPK1). 2. Waterbath/thermomixer at 30°C. 3. Elution buffer: 50 mM Tris (pH 7.5), 300 mM NaCl, 100 mM imidazole. 4. CDPK kinase buffer stock solutions: 1  M HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid); 3  M MgCl2; 0.5 M EGTA; 1 M DTT (store at −20°C). Sterilize by filtration. 5. CDPK peptide substrate syntide-2 (PLARTLSVAGLPGKK; Sigma Aldrich), store as a 10 mg/mL stock solution at −20°C. 6. CDPK kinase buffer (10×): 400  mM HEPES (pH 7.4), 100 mM MgCl2, 20 mM DTT, 1 mM EGTA, 10 mM CaCl2, 1 mg/mL syntide-2. 7. ATP/[g-32P]-ATP stock solution (5×): 0.5  mM ATP, 0.6  mCi/mL [g-32P]-ATP. Be sure to account for radioactive decay when calculating the amount of added [g-32P]-ATP and the radioactive ATP should be added last. From this step on you must exercise radioactive safety precautions. 8. P81 phosphocellulose paper (Waters) squares, about 1  cm × 1 cm, numbered with a pencil. 9. 1% (w/v) H3PO4, plastic box, and horizontal shaker for washing filters.

15  Chemical Genetic Analysis of Protein Kinase Function in Plants

263

10. Scintillation counter, scintillation fluid, and vials. 11. 1-NA-PP1 (1-naphthyl PP1 or 1-(1,1-dimethylethyl)-3(1-naphthalenyl)-1H-pyrazolo[3, 4-d]pyrimidin-4-amine; Toronto Research Chemicals). 12. N6-benzyl-ATP (Biolog). 2.5. Hydroponic Cultures and Inhibition Studies

1. Col-0 (A. thaliana ecotype Columbia-0) seeds as control, transgenic line pCPK1:CPK1M228A (gatekeeper-mutated) in cpk1-2. 2. Six sterile 200 mL Erlenmeyer flasks. 3. 300  mL Murashige and Skoog (MS) Medium (Sigma Aldrich) + 1% (w/v) sucrose. 4. Growth chamber 1: temperature set to 21°C, continuous light, 100 mEinstein/m2 s and 65% humidity. 5. Growth chamber 2: temperature set to 4°C (with ice/water bath), continuous light, 100 mEinstein/m2 s and 65% humidity. 6. 10 mM 1-NA-PP1 in DMSO, store at −20°C. 7. Erlenmeyer flask, funnel, and Miracloth (Calbiochem).

2.6. Total Protein Extraction, 2D-Gel Electrophoresis, and Phosphoprotein Stain

1. Rehydration buffer: 7 M urea, 2 M thiourea, 2% (w/v) CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate), 0.5% NuPAGE ZOOM Carrier Ampholytes (pH 3–10 or pH 4–7; Invitrogen), 20 mM DTT and 0.1% (w/v) bromophenol blue. Store at −20°C. 2. NuPAGE ZOOM Benchtop Proteomics system (Invitrogen). 3. IEF (isoelectric focusing) strips pH 3–10 (Invitrogen). 4. NuPAGE LDS (lithium dodecyl sulfate) sample buffer (4×; Invitrogen). 5. Sample reducing agent (10×; Invitrogen, Karlsruhe). 6. 125 mM iodoacetamide. 7. NuPAGE Novex 4–12% Bis-Tris ZOOM gels (Invitrogen). 8. MES-SDS running buffer (Invitrogen). 9. Protein stains: ProQ-Diamond (Invitrogen), Imperial Protein Stain (Pierce). 10. 2D-gel analysis software Proteomweaver (Biorad). 11. Scanner with an excitation of 532, 543, or 555 nm and emission filter at 580 nm (see Note 2).

3. Methods 3.1. Mutagenesis of the ATP-Binding Pocket

This section presents an overview of the steps involved in mutation and cloning of the CPK1 cDNA into a plant expression plasmid and transformation of the expression plasmid into Arabidopsis.

264

M. Böhmer et al.

The investigator should be familiar with basic molecular biology and plant transformation methods, which are not described in detail. In order to generate an ATP-binding pocket variant, the gatekeeper residue has to be mutated to alanine or glycine to allow binding of N6-modified nucleotides. Due to the high homology among the kinase superfamily, the gatekeeper residue can be identified by sequence alignment with kinases that have been successfully modified before as shown in Table 1. The gatekeeper residue is located in the b-sheet 5 of the kinase domain. In the case of CPK1, Met228 could be identified as the gatekeeper residue. Site-directed mutagenesis (16–18) is used to exchange the gatekeeper residue in pENTR/D-TOPO CPK1 to alanine or glycine, respectively (see Note 3). After confirmation of the mutation by sequencing, a fragment of the mutated gene containing the gatekeeper mutation is used to replace the wildtype fragment in the plant expression vector pXC1-HAStrepII CPK1 using conventional restriction enzyme/ligation methods (13). The resulting plasmid is then transformed into Arabidopsis by a standard floral dip transformation (19) and selected on soil using BASTA (glufosinate-ammonium, active compound is PPT or phosphinothricin). The transformed lines are tested by RT-PCR for comparable expression levels to wild-type CPK1 and homozygous transgenics are isolated in the next generations. In the T3 generation (third generation after transformation), homozygous lines are tested on MS-plates with PPT. In parallel, CPK1HAStrepII is transiently expressed from the same vector in tobacco (Nicotiana benthamiana) to assay for the expression levels and to purify the engineered kinase for in vitro inhibition assays. 3.2. Chemo-Enzymatic Labeling of N 6-BenzylATP with 32P

To test the binding and metabolization of N6-modified nucleotides, an enzymatic approach to label these under laboratory conditions is used. The method utilizes the enzyme nucleoside diphosphate kinase (Ndk) to transfer g-phosphate groups from nucleotides to nucleosides with little selectivity. During this reaction the phosphate group is first bound to the enzyme and then transferred to the substrate nucleoside. The intermediary radiolabeled enzyme can be purified and used to label the desired nucleoside diphosphate. This approach has been described before by Habelhah et  al. (20) and has been modified for our E. coli Ndk clone (13). The following experiments involve the use of [g-32P]-ATP. Special care has to be taken in order to perform these experiments. Wearing safety goggles for shielding the eyes, using Plexiglas shielding for the storage and experimental containers and working areas, and performing thorough and frequent surveys of the work area, lab coat and body will significantly reduce the risk of exposure.

15  Chemical Genetic Analysis of Protein Kinase Function in Plants

265

1. 6×His-tagged bacterial Ndk can be affinity-purified from E. coli using a nondenaturing His-tag purification method. Protein is eluted with imidazole (see Note 4) and concentration can be determined using a Bradford protein assay. 2. Incubate 100 mg Ndk with 3.7 MBq [g-32P]-ATP for 5 min in labeling buffer at room temperature. 3. The Ndk can be separated from excess [g-32P]-ATP by gel filtration. To prepare the gel filtration columns, exchange the packing buffer with labeling buffer in three to four washes according to manufacturer’s protocol. 4. Activated Ndk can now be applied to the Microspin column as directed. 5. After loading the sample, centrifuge the column for 4 min at 1,000 × g. 6. Dispose the used column into radioactive waste and incubate Ndk with 6.25 mM N6-benzyl-ADP for 5 min at room temperature (see Note 4). 7. The Ndk can be separated from radiolabeled N6-benzyl-ATP by heat denaturation and precipitation. Incubate the Ndk mix at 80°C for 2 min and precipitate by centrifugation for 5 min at full speed. Transfer the supernatant into a new vial. 8. The labeling efficiency can be measured via scintillation counting and is generally found to be in a range of 40–50% of the applied [g-32P]-ATP (see Note 5). 3.3. Ion-Exchange Thin Layer Chromatography

The purity of the [g-32P]-N6-benzyl-ATP can be assayed qualitatively by ion-exchange thin layer chromatography (TLC) followed by exposure of X-ray film (13, 21). All TLCs are run at room temperature (20–25°C) in closed chromatography tanks. 1. Pour solvent into the tank so that the height of the solution at the bottom of the tank is 5–6 mm. The tanks are kept under a wellventilated chemical fume hood and solvent is poured in advance to allow good saturation with solvent vapors (see Note 6). 2. The starting line of the deposit and a finish line about 1  cm below the top are marked on the TLC plate with a soft pencil. 3. 1–2  mL aliquots of the 32P-labeled nucleotides, obtained in Subheading  3.2, are spotted along the starting line using a graded capillary or pipette. Pipetting is done slowly to give spots no more than 3–4 mm in diameter. 4. Plates are placed into the chromatography tank and a lid is sealed to the top of the tank using silicone grease. 5. When the solvent reaches the finish line, the plate is withdrawn from the tank and dried thoroughly under the chemical fume hood for a few hours or using a hair dryer.

266

M. Böhmer et al.

Fig. 1.  Autoradiogram of a TLC with reaction products of Ndk-labeling, showing the mobility of radiolabeled triphosphate nucleotides. Numbers correspond to the addition of nucleosides as follows: (1) N6-benzyl-ADP, (2) CDP, (3) ADP, and (4) no nucleoside added.

6. After drying, the plate is put into an autoradiography cassette and an X-ray film is put on top under safety light conditions. Exposure times may vary, but we found 24  h to give good results (see Fig. 1 and Note 7). 3.4. In Vitro Kinase Assay

To test the utilization of N6-modified nucleotides or for protein substrate labeling in  vitro kinase assays can be performed. This protocol makes use of a small synthetic peptide substrate known to be phosphorylated by CDPKs. To identify protein substrates from cell extract, the only major change that would need to be made to this basic protocol is the substitution of cell lysate (or cell lysate fractions) as substrate for the kinase reaction. Putative substrates can then be separated using 1D- or 2D-gels. As discussed in Subheading 3.2, be sure to follow all precautions and regulations regarding the handling of radioactivity. Tobacco (Nicotiana tabacum) NtCDPK2 has been expressed in E. coli and purified as His-tagged fusion protein under nondenaturing conditions. Arabidopsis CPK1 has been expressed transiently in tobacco and purified as described before (15) (see Note 8). 1. Determine the amount of kinase purified from E. coli by Bradford assay or from purified plant proteins by Western blot. Dilute proteins to equal concentration by adding elution buffer.

15  Chemical Genetic Analysis of Protein Kinase Function in Plants

267

2. For each reaction prepare 3 mL of 10× CDPK kinase buffer. 3. Preheat a water bath or a thermomixer to 30°C. 4. Incubate 100  ng of enzyme or aliquots of protein kinase (equivalent to 5  mL beads) in 23  mL of water. Add 1  mL of CDPK kinase buffer (10×). Perform all pre-incubation reactions at 4°C in an ice bath. 5. Start a lab timer (counting up from 0), add 6 mL of ATP/N6benzyl-ATP stock (5×) to each tube in 15- to 20-s increments (if it is difficult to add this fast, slow down to a comfortable speed). Place the reactions at 30°C. 6. After 10 min, stop the reaction by removing 15 mL from the first tube that received ATP/N6-benzyl-ATP stock and pipet slowly onto the center of a P81 phosphocellulose paper square. Allow the radiolabeled substrate to bind the filter paper for 30 s before immersing the paper into a beaker containing 1% phosphoric acid. Sequentially from the subsequent reactions, spot sample in the same time increments used to add the ATP/ N6-benzyl-ATP stock (see Note 9). 7. Wash P81 paper squares three times for 5  min with about 150 mL of 1% (w/v) phosphoric acid. 8. Let the paper squares dry on filter paper. 9. Transfer the papers into polypropylene scintillation vials, add enough scintillation cocktail to cover the papers, and determine the incorporation of 32P by scintillation counting. The amount of 32P incorporated into syntide-2 can be calculated from the counts per minute (cpm) and the specific activity of ATP (cpm/pmol ATP) according to the following formula (see Note 10): (pmol phosphate incorporated)/(min·mg) = cpm/((cpm/pmol ATP)·10 min·0.1mg) 3.5. Kinase Inhibition Assay

The kinase assay described above can be modified in order to determine Ki values for ATP-analogous kinase inhibitors, such as 1-NA-PP1 or to test competition between ATP and N6-benzyl-ATP. In order to diminish the influence of different KM values for ATP between wild-type kinase and the ATP-binding pocket variant, the kinase assays are performed in the absence of nonradiolabeled cold ATP. 1. Inhibition assays are conducted in the presence of 33 nM of [g-32P]-ATP and increasing concentrations of 1-NA-PP1 in DMSO in the reaction mix. 2. Ki values are calculated based on the IC50 values: Ki = IC50/ (1 + (c[ATP]/KMATP)). At very low ATP concentration, IC50 equals Kiinhibitor.

268

M. Böhmer et al.

3.6. Hydroponic Cultures and Inhibition Studies

Hydroponic cultures facilitate the application of defined inhibitor concentrations. Therefore, seeds of transgenic lines carrying the CPK1 ATP-binding pocket variant in a cpk1 mutant background and seeds of Col-0 wild type are grown as hydroponic cultures. 1. About 120 seeds per line are sterilized using chlorine gas (19). Six 200 mL culture flasks with 50 mL of 0.5 MS/1% (w/v) sucrose are autoclaved. 2. About 30–40 seeds are placed into each flask using a small sterile spoon. 3. The culture flasks are incubated at 4°C for 3 days in the dark. 4. The culture flasks are incubated for 12 days on a shaking platform at 100 rpm in growth chamber 1. 5. 10 mM 1-NA-PP1 in DMSO is added to a final concentration of 100 mM. 6. After incubation for 30 min, two culture flasks of each line are transferred to an ice-cold water bath in growth chamber 2. All culture flasks are incubated for 1 h. 7. Plants are harvested by filtration through Miracloth and dried with tissue paper before shock freezing in liquid nitrogen (see Note 11).

3.7. Total Protein Extraction, 2D-Gel Electrophoresis, and Phosphoprotein Stain

1. Total protein is extracted with phenol/SDS based on the protocol by Wang et al. (22). Rehydration buffer is added to the acetone precipitated sample (165 mL/100 mg). 2. 2D-polyacrylamide gel electrophoresis is performed using the NuPAGE ZOOM Benchtop Proteomics system as described (23). 3. Prior to IEF, passively rehydrate the ZOOM strips (pH 3–10) in the sample containing rehydration solution for 16 h. 4. IEF is conducted using the following gradient steps: 0–175 V (1 min), 175 V (15 min), 175–2,000 V (45 min), and 2,000 V (25 min). 5. Strips are then equilibrated in 4.5 mL of NuPAGE LDS sample buffer together with 0.5 mL of sample reducing agent (10×), followed by incubation in the same solution containing 125  mM iodoacetamide but lacking the reducing agent for 15 min each. 6. Samples are separated in the second dimension on NuPAGE Novex 4–12% Bis–Tris ZOOM gels in MES-SDS running buffer. 7. Proteins are visualized with colloidal Coomassie Blue using Imperial Protein Stain. Alternatively, phospho-proteins are selectively stained with ProQ-Diamond. Proteins are quantified on 2D-gels using Proteomweaver. 8. The peak absorbance and emission of the ProQ-Diamond phosphoprotein stain are at 555 and 580  nm, respectively.

15  Chemical Genetic Analysis of Protein Kinase Function in Plants

269

Any scanner, equipped with a 532 or 543 nm laser can be used to excite the ProQ-Diamond dye. Scanners utilizing a white light arc lamp source can also be used with the appropriate bandpass excitation filter. Since the peak emission is at 580 nm, bandpass filters at or near 580 nm or longpass filters allowing transmittance of light at 555 nm and beyond are appropriate for capturing the fluorescence of ProQ-Diamond dye.

4. Notes 1. Primers should be designed according to the directions in the QuikChange Site-Directed Mutagenesis kit. Additional silent mutations leading to changes in the restriction enzyme pattern facilitate the identification of positive mutants, thereby reducing the amount of sequencing reactions necessary. 2. Alternatively to ProQ-Diamond, Phos-tag phosphoprotein stain (Perkin Elmer) can be used. This stain is available with excitation and emission spectra compatible with most UV-gel documentation systems. This lowers the sensitivity but allows the analysis in most laboratories. 3. The DpnI-mediated site-directed mutagenesis protocol is prone to generate secondary mutation in the vector backbone. Further cloning of the mutated cDNA into an expression vector prevents the carry-over of these mutations within the vector backbone potentially having a negative effect on expression or resistance screening. If an expression vector is directly used for mutagenesis, the cDNA that has been sequenced should be re-ligated into fresh backbone of the same vector. 4. The described protocol is based on elution of the Ndk after IMAC. This allows recycling of the resin and the application of automated purification procedures, such as FPLC. Alternatively, when batch purification is performed, the Ndk can be left bound to resin and unbound [g-32P]-ATP can be removed by washing with labeling buffer. The buffer then has to be aspirated off before addition of N6-benzyl-ADP. 5. We keep Ndk at −80°C after purification. However, no longterm stability assays have been performed yet. Another option is to keep pelleted E. coli cells after induction of Ndk expression at −20°C until purification. 6. If small chromatography tanks are used, the walls of the tank may be lined with Whatman 3MM paper on four sides to help maintain a buffer-equilibrated gas phase in the tank. 7. Often additional spots can be seen at the top of the TLC. This probably represents a certain amount of orthophosphate that is generally present in small amounts in addition to the labeled nucleotides.

270

M. Böhmer et al.

8. Buffer compositions, pH, ionic strength, and divalent cation concentrations have to be determined for each kinase under study. The buffer presented builds a starting point to develop a protocol. Other aspects for buffers to be considered are (a) Tris–HCl or PIPES as buffering agents generally applied in the range of 20–50 mM and with a pH range from 6.8 to 8.0, (b) phosphatase inhibitors, when working with crude extracts, and (c) MgCl2 or MnCl2 when working with serine/threonine or tyrosine kinases, respectively. Use saturating concentrations of ATP, with most KM values for kinases being between 5 and 200 mM. 9. Suitable blanks should always be performed to correct for nonspecific binding of [g-32P]-ATP and its breakdown products to the phosphocellulose paper. Controls for endogenous phosphorylation of proteins in the sample extract can be performed, by leaving out the kinase. 10. Alternatively to synthetic peptide substrates, proteins can be used as kinase substrates. Typical proteins used are Myelin basic protein, histones, calmodulin, and alpha and b-casein. After kinase assay proteins are separated by SDS-PAGE, blotted to membrane and incorporation of 32P into protein is measured by autoradiography. 11. Alternatively to the hydroponic culture system plants can be grown on soil or plate for 2–3 weeks and sprayed with a 100-mM 1-NA-PP1 solution in 1% DMSO, 0.01% (v/v) Silwet (12).

Acknowledgments This project was supported by the Deutsche Forschungsgemeinschaft (DFG; SFB 635), the ZIP program from the German ministry of education and science, the Alexander von Humboldt-Foundation, the Max Planck Society, and a DFG long term Research Fellowship to Maik Böhmer. We thank David G. Mendoza-Cózatl for critical reading of the manuscript. References 1. Zolnierowicz, S., and Bollen, M. (2000) Protein phosphorylation and protein phosphatases. De Panne, Belgium, September 19–24, 1999. Embo Journal 19, 483–8. 2. Hunter, T., and Sefton, B. M. (1980) Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proceedings of the National Academy of Sciences of the United States of America 77, 1311–5.

3. Shah, K., Liu, Y., Deirmengian, C., and Shokat, K. M. (1997) Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. Proc Natl Acad Sci USA 94, 3565–70. 4. Liu, Y., Shah, K., Yang, F., Witucki, L., and Shokat, K. M. (1998) A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src. Bioorg Med Chem 6, 1219–26.

15  Chemical Genetic Analysis of Protein Kinase Function in Plants 5. Witucki, L. A., Huang, X., Shah, K., Liu, Y., Kyin, S., Eck, M. J., and Shokat, K. M. (2002) Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phosphoacceptor specificity of the wild-type enzyme. Chem Biol 9, 25–33. 6. Bishop, A. C., Ubersax, J. A., Petsch, D. T., Matheos, D. P., Gray, N. S., Blethrow, J., Shimizu, E., Tsien, J. Z., Schultz, P. G., Rose, M. D., Wood, J. L., Morgan, D. O., and Shokat, K. M. (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407, 395–401. 7. Dephoure, N., Howson, R. W., Blethrow, J. D., Shokat, K. M., and O’Shea, E. K. (2005) Combining chemical genetics and proteomics to identify protein kinase substrates. PNAS 102, 17940–17945. 8. Kraybill, B. C., Elkin, L. L., Blethrow, J. D., Morgan, D. O., and Shokat, K. M. (2002) Inhibitor scaffolds as new allele specific kinase substrates. J Am Chem Soc 124, 12118–28. 9. Zhang, C., Kenski, D., Paulson, J., Bonshtien, A., Sessa, G., Cross, J., Templeton, D., and Shokat, K. (2005) A second-site suppressor strategy for chemical genetic analysis of diverse protein kinases. Nat Methods 2, 435–41. 10. Liu, Y., Shah, K., Yang, F., Witucki, L., and Shokat, K. M. (1998) Engineering Src family protein kinases with unnatural nucleotide specificity. Chem Biol 5, 91–101. 11. Böhmer, C., Böhmer, M., Bölker, M., and Sandrock, B. (2008) Cdc42 and the Ste20-like kinase Don3 act independently in triggering cytokinesis in Ustilago maydis. J Cell Sci 121, 143–148. 12. Brodersen, P., Petersen, M., Bjorn Nielsen, H., Zhu, S., Newman, M. A., Shokat, K. M., Rietz, S., Parker, J., and Mundy, J. (2006) Arabidopsis MAP kinase 4 regulates salicylic acid- and jasmonic acid/ethylene-dependent responses via EDS1 and PAD4. Plant J 47, 532–46. 13. Böhmer, M., and Romeis, T. (2007) A chemicalgenetic approach to elucidate protein kinase function in planta. Plant Molecular Biology 65, 817–827.

271

14. Salomon, D., Bonshtien, A., Mayrose, M., Zhang, C., Shokat, K. M., and Sessa, G. (2009) Bypassing kinase activity of the tomato Pto resistance protein with small molecule ligands. J Biol Chem 284, 15289–98. 15. Witte, C. P., Noel, L. D., Gielbert, J., Parker, J. E., and Romeis, T. (2004) Rapid one-step protein purification from plant material using the eight-amino acid StrepII epitope. Plant Mol Biol 55, 135–47. 16. Weiner, M. P., Costa, G. L., Schoettlin, W., Cline, J., Mathur, E., and Bauer, J. C. (1994) Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction. Gene 151, 119–23. 17. Li, S., and Wilkinson, M. F. (1997) Sitedirected mutagenesis: a two-step method using PCR and DpnI. Biotechniques 23, 588–90. 18. Fisher, C. L., and Pei, G. K. (1997) Modification of a PCR-based site-directed mutagenesis method. Biotechniques 23, 570–1, 574. 19. Clough, S. J., and Bent, A. F. (1998) Floral dip: a simplified method for Agrobacteriummediated transformation of Arabidopsis thaliana. Plant J 16, 735–43. 20. Habelhah, H. (1998) [Induction of manganese superoxide dismutase by an immunopotentiator as a mechanism of inhibiting of malignant progression of murine tumor cells]. Hokkaido Igaku Zasshi 73, 519–29. 21. Goody, R. S., and Eckstein, F. (1971) Thiophosphate analogs of nucleoside di- and triphosphates. Journal of the American Chemical Society 93, 6252–6257. 22. Wang, W., Scali, M., Vignani, R., Spadafora, A., Sensi, E., Mazzuca, S., and Cresti, M. (2003) Protein extraction for two-dimensional electrophoresis from olive leaf, a plant tissue containing high levels of interfering compounds. Electrophoresis 24, 2369–75. 23. Böhmer, M., Colby, T., Böhmer, C., Bräutigam, A., Schmidt, J., and Bölker, M. (2007) Proteomic analysis of dimorphic transition in the phytopathogenic fungus Ustilago maydis Proteomics 7, 675–685.

wwwwwwwwwwwwwwwww

Chapter 16 Modified Metal-Oxide Affinity Enrichment Combined with 2D-PAGE and Analysis of Phosphoproteomes Thomas Colby, Horst Röhrig, Anne Harzen, and Jürgen Schmidt Abstract Protein phosphorylation is a dynamic process of widespread regulatory significance. Phosphoproteomics attempts to provide a global view of this process during biological processes, but the approach is generally limited by the low relative amounts of phosphoproteins in biological samples. Although mass spectrometry (MS)-based technologies exist for the in-depth characterization of protein phosphorylation, these techniques are typically highly focused, have low throughput, and generally require special equipment and expertise. These specialized techniques are best used to support hypotheses generated by an initial broadbased survey, like the one described here. In this chapter, we outline a 2D gel-based phosphoproteomic methodology based on relatively inexpensive materials and basic, widely available MS technology. The goal is to provide a preparative and analytical laboratory framework that can generate the samples and hypotheses for phosphoproteomic MS, as well as a set of tools for biologically relevant phosphoproteomics for investigators who do not have ready access to phospo-MS technology. The combination of 2D gel-compatible metal-oxide affinity chromatography (MOAC)-based phosphoprotein enrichment and phospho-specific staining provides both the sensitivity necessary to make low-level phosphoproteins observable and identifiable, and the twofold phosphoselectivity to support their identity as phosphoproteins. An on-blot dephosphorylation assay for verifying the phospho-specificity of the enrichment method is also described here and provides a general tool for the validation of protein phosphorylation. Key words: Phosphoproteomics, 2D-PAGE, 2DGE, Phosphoprotein enrichment, On-blot phosphatase assay, MOAC, Metal-oxide affinity chromatography

1. Introduction Protein phosphorylation is one of the most prevalent and significant regulatory mechanisms in living systems (1). Consequently, the study of protein phosphorylation – how and when it happens, how it is regulated, and what it, in turn, controls – is the focus of many diverse research groups. Though some regulatory phosphorylation cascades and networks have been at least partially dissected N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_16, © Springer Science+Business Media, LLC 2011

273

274

T. Colby et al.

and understood, much remains to be investigated (2). Due to their interconnectedness, a highly focused view provides only a fragmentary look at these networks. Phosphoproteomics can offer a dynamic, global view of protein phosphorylation during biological processes or under the influence of chemical or genetic perturbations, but the approach is limited by the difficulty of detection and identification of phosphoproteins (3). Phosphoproteins pose particular problems for proteomics, particularly for mass spectrometry (MS)-based proteomic approaches. First, phosphorylated proteins are not typically the most abundant proteins in an organism’s proteome. Second, the extent of phosphorylation (the ratio of posttranslationally modified to unmodified protein) is often low, meaning that most of a given protein, even when it is a phosphorylation substrate, is present in the non-phosphorylated form. Third, phosphopeptides are “handicapped” with respect to MS detection compared to their non-phosphorylated forms; the additional negatively charged phosphate reduces the signal acquired in the “positive mode” typically used for measuring and fragmenting peptides. These factors combine to make the detection and identification of phosphoproteins a particular challenge. Given the regulatory importance of protein phosphorylation, any technique which can raise the relative quantity of phosphoprotein in a sample and help to discriminate between phosphorylated and non-phosphorylated proteins is immensely valuable. While selective phosphopeptide enrichment can help to identify phosphoproteins as such, it is best used following a broader approach that makes it possible to isolate candidate phosphoproteins from others. Though not included in the methods described in this chapter, phosphopeptide enrichment and analysis can be used to verify the hypotheses generated in the procedure outlined here. Many phosphoprotein and phosphopeptide enrichment procedures are based on the affinity of metal ions for the negatively charged phosphate groups. Immobilized metal ion affinity chromatography (IMAC)-based methodologies can be used to enrich phosphopeptides or -proteins (reviewed in ref. 4), but the matrix is relatively expensive and requires a charging step in order to load it with the desired metal ions. Metal oxides, in particular titanium dioxide (TiO 2), provide a pre-charged ready-to-use metalcontaining matrix. In matrices such as Titansphere (GL Science), the oxide is bound to high performance liquid chromatography (HPLC) media. Wolschin and Weckwert, however, proposed a more economical alternative using aluminum hydroxide hydrate (Al(OH)3), a cheap bulk material (5). In their procedure – as well as in ours – the washed and equilibrated aluminum hydroxide matrix is used to preferentially bind phosphoproteins present in a soluble protein preparation. All metal affinity-based enrichment schemes suffer from some non-specific protein binding, primarily that of non-phosphorylated

16  Modified Metal-Oxide Affinity Enrichment Combined with 2D-PAGE…

275

acidic proteins. As in the original metal-oxide affinity chromatography (MOAC) procedure, free amino acids are used to compete against these acidic interactions (5). Both acidic competition and competitive elution with phosphate are used to maximize the specificity of the protein enrichment. The primary focus of this protocol is describing the 2D gelcompatible MOAC enrichment and precipitation steps (see Subheadings  3.2 and 3.3). The soluble protein extraction from Arabidopsis thaliana (see Subheading 3.1) provides an example of a possible sample preparation. The 2D gel and MS analysis protocols (see Subheading 3.4) describe established methods that we use in our facility. Subheading 3.5 describes an on-blot dephosphorylation assay, presented here to validate the basic technique, but which could also be used to confer a third layer of phospho-specificity to the protocol. This process has been used to analyze the dynamics of the phosphoproteome of the resurrection plant Craterostigma plantagineum (6).

2. Materials Unless otherwise noted, deionized water (Millipore) and pro analysi (p.a.) grade solvents are used to prepare all of the following solutions. Unless other temperatures are specified, chilled solvents and solutions can be kept on ice at the bench. 2.1. Protein Extraction

1. 10% (w/v) trichloroacetic acid (TCA) in acetone, store at −20°C. Prepare fresh if the solution appears yellowish, use chilled. 2. 100% (w/v) TCA stock: 10 g in 4.54 mL water. This solution is light sensitive and can be stored for 6 months at room temperature in the dark. Prepare fresh if the solution appears yellowish. 3. 20% (w/v) TCA in water: 4 parts water and 1 part 100% TCA. Prepare fresh from the stock, prepare fresh if the solution appears yellowish, use chilled. 4. Dense sodium dodecyl sulfate (SDS): 100 mM Tris–HCl (pH 8.0), 30% (w/v) sucrose, 2% (w/v) SDS, and 5% (v/v) 2-mercaptoethanol. 5. Phenol (Biomol). 6. 0.1 M ammonium acetate in methanol, use chilled. 7. 80% (v/v) acetone in water, use chilled. 8. Ice-cold acetone. 9. Liquid nitrogen. 10. SiO2 for grinding.

276

T. Colby et al.

11. 15- and 50-mL tubes (Falcon). 12. Corex tubes or equivalent. 13. Microcentrifuge tubes. Additional equipment: Sonication bath. 2.2. MOAC Enrichment and Preparation

1. Aluminum hydroxide hydrate (Al(OH)3; Sigma). 2. Incubation buffer Part A (IB/A): 30 mM 2-(N-morpholino) ethanesulfonic acid (MES), pH 6.1, 0.25% (w/v) 3-[(3cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 7  M urea, 2  M thiourea, and 30  mM imidazole. Can be stored for 6 months at −20°C (see Note 1). Chill to ~10°C. 3. Incubation buffer Part B (IB/B): 30  mM MES, pH 6.1, 0.23 M sodium glutamate, 0.23 M potassium aspartate, 0.25% CHAPS, 8 M urea, and 30 mM imidazole. Can be stored for 6 months at −20°C (see Note 1). Chill to ~10°C. 4. Washing buffer (WB): 30 mM MES, pH 6.1, 0.20 M sodium glutamate, 0.20 M potassium aspartate, 0.25% CHAPS, 8 M urea, 20 mM imidazole. Chill to ~10°C. 5. Elution buffer (EB): 300  mM potassium pyrophosphate and 8 M urea, adjust pH to 9.0 with phosphoric acid. This buffer can be stored for 6 months at −20°C but must be warmed up to room temperature before use because precipitation may occur below 20°C. This solution will be used at room temperature.

2.3. DOC-TCA Protein Precipitation and Wash

1. 2% (w/v) sodium deoxycholate (DOC) in water; can be kept for 6 months at 4°C. 2. 100% (w/v) TCA, see Subheading 2.1. 3. 25% (w/v) TCA: 1 part 100% TCA and 3 parts water; mix fresh, use chilled. 4. Tris/acetone: 20% (v/v) 50 mM Tris–HCl, pH 7.5, and 80% (v/v) acetone, use chilled. 5. Ice-cold acetone. 6. Amicon Ultracel -10K centrifugal filter device (Millipore), one per protein batch needed.

2.4. 2D Polyacrylamide Gel Electrophoresis and Phospho-Specific Staining

Requirements depend on the gel system and the manufacturer’s instructions. We typically use the Zoom isoelectric focusing (IEF) system (Invitrogen). Do not use pre-stained markers in your gel since they can disturb subsequent fluorescent staining. 1. IEF buffer: Buffer composition depends on the manufacturer’s instructions, but we recommend an IEF buffer containing both urea and thiourea in order to ensure thorough resolubilization of the pellet. 2. ProQ-Diamond phosphoprotein stain (Invitrogen).

16  Modified Metal-Oxide Affinity Enrichment Combined with 2D-PAGE…

277

3. Coomassie PageBlue stain (Fermentas). 4. FLA-3000 scanner (Fuji) or other fluorescent scanner with a green (532 nm) laser. 5. Proteineer SP and Proteineer DP systems (Bruker Daltonics). 6. Anchorchip TM steel targets (Bruker). 2.5. Blotting, On-Blot Dephosphorylation, and Staining

1. Immobilon-P PVDF Membrane (pore size: 0.45 m; Millipore). In our experience, these membranes have the lowest background signal. 2. Tris-buffered saline (TBS): 20 mM Tris, pH 7.5, and 150 mM NaCl. 3. Phosphate-buffered saline (PBS): 100 mM pyrophosphate and 100 mM NaCl, pH 7.3 (~100 mL needed per blot). 4. Methanol. 5. Blocking solution: 1% (w/v) bovine serum albumin (BSA) in TBS and 0.1% (v/v) Triton X-100; mix fresh. 6. Lambda protein phosphatase (800  U/mL, ~20  mL/blot needed; New England Biolabs). 7. Phosphatase buffer: 0.1% (v/v) Triton X-100, 1% (w/v) BSA, and 2 mM MnCl2 in TBS (~10 mL per blot needed). 8. 500 mM sodium acetate (pH 4.0). 9. Fixing solution: 7% (v/v) acetic acid and 10% (v/v) methanol in water. 10. Destaining buffer: 20% (v/v) acetonitrile in 50  mM sodium acetate (pH 4.0). 11. Blot staining solution: 0.001% (v/v) ProQ-Diamond phosphoprotein blot stain (Invitrogen).

3. Methods 3.1. Protein Extraction

This is the protocol we use for extracting soluble proteins from Arabidopsis leaves and seeds (see Fig. 1). This is not the focus of this chapter, but it provides an example of raw material preparation. The outlined protocol yields soluble proteins virtually free of substances which might interfere with the subsequent enrichment steps such as DNA, RNA, metal ions, or metal chelators. The solubility selected for by this extraction method should also ensure that the proteins enriched via MOAC can be brought back into solution following the various precipitation steps. Extract proteins as follows: 1. Grind tissue under liquid nitrogen with 10% (w/w) SiO2. 2. Put approximately 4  mL of ground plant tissue (including sand) into a 15-mL tube.

278

T. Colby et al.

Fig.  1.  MOAC-enriched Arabidopsis proteins from seeds: total protein (left ) compared to an overlap (right ) of MOACenriched proteins and total protein input. The selectivity and enrichment ratio of the procedure can be appreciated by examining the relative positions and intensities of blue (MOAC-enriched) spots versus orange (MOAC-depleted) spots in the overlap. The circled areas emphasize sets of spots barely visible in the total protein gel which were dramatically enriched in the MOAC eluate. The spots in these regions have been identified as Rab18 (1, 2), 60S Ribosomal Protein P0 (3), putative dehydrins (4), RD29B (5), HSP101 (6), and a stress responsive protein similar to RD29B (7). Other MOAC-enriched spots have been identified as 60S RPP2A and elongation factors. The dark brown spots in the overlap represent abundant proteins that are retained by the MOAC procedure. These spots have been identified as various LEAs and cruciferin, which are confirmed abundant phosphoproteins. Two marker proteins added to the total protein sample are marked “M.” The gels were run using 18-cm pH 4–7 IEF strips (GE Healthcare) with 12% SDS second dimension. All gels were visualized with Coomassie Page Blue (Fermentas) and identifications were performed by MALDI MS and MS/MS as described elsewhere (6) (see Note 1). This figure is displayed in greyscale in the print edition but available in color in the electronic version.

3. Add 10 mL of ice-cold acetone and vortex vigorously. 4. Centrifuge at 5,000 × g for 5 min in a swing-out rotor. Discard the supernatant. 5. Add 10 mL of ice-cold acetone and vortex vigorously. Repeat step 4 once. 6. Add 10 mL of 10% TCA in acetone, break the pellet with the pipet tip, and sonicate for 10 min. 7. Wash the pellet (as in steps 3 and 4 above): once with chilled 10% TCA in acetone, once with chilled 20% TCA in water, and twice with chilled 80% acetone in water. 8. After the last centrifugation step, discard the supernatant. Centrifuge the pellet one last time and carefully pipet off the residual acetone. The pellet should be left wet. 9. Resuspend the wet pellet in 6  mL of dense SDS solution at room temperature. 10. Sonicate briefly for 1–5 min, if desired.

16  Modified Metal-Oxide Affinity Enrichment Combined with 2D-PAGE…

279

11. Add 6 mL of phenol. 12. Vortex for 1 min. 13. Centrifuge the sample at 5,000 × g for 5 min at room temperature. The phenol phase containing the protein will rise to the top. 14. Collect the phenol fraction in Corex tubes (max. 4 mL), being careful not to perturb the phase interface with the pipet. Reserve a 100 mL aliquot of each sample in a microcentrifuge tube for a Bradford assay. The assay aliquots will be handled in parallel in the following steps. 15. Add 5× the sample volume of chilled 0.1 M ammonium acetate in methanol and put the sample on ice for 1–4 h to precipitate the soluble proteins. 16. Pellet the proteins by centrifugation at 10,000 × g for 10 min at 4°C. 17. Wash the pellet as in steps 3 and 4 above: twice with 0.1 M ammonium acetate in methanol and twice with 80% acetone in water. (For the assay pellets reduce all volumes to 1 mL.) 18. Collect the pellet for the assay aliquot as in step 8 above. Store the sample aliquot in the last 80% acetone wash at −20°C until the protein concentration has been determined. 19. Dissolve the assay pellet directly in 100 ml of 7 M urea, 2 M thiourea at room temperature for at least 1 h (or overnight) before determining the protein content by Bradford. Use this value to determine the volume of incubation buffer to be added in the first step of Subheading 3.2. 20. When you are ready to continue, collect the pellet and remove the acetone as described in step 8 above. 3.2. MOAC Enrichment and Preparation

The following protocol is tailored to total protein batches of 3 mg protein (based on the Bradford assay performed at the end of the extraction). This amount of total protein typically yields enough enriched phosphoproteins for a Coomassie stainable gel. The expected extent of phosphorylation should also be taken into account – perhaps using less protein when strong phosphorylation is expected – although we have not yet observed saturation phenomena in the phosphoprotein enrichment procedure. For the following steps, the incubation and washing buffers should be kept cold (preferably at 10°C), and the elution buffer equilibrated at room temperature. 1. Dissolve the protein pellet (~3 mg) in 1 mL incubation buffer Part A (IB/A). Sonicate and agitate the sample to assure that the pellet is mechanically disrupted. 2. Incubate the pellets 4–6 h at room temperature or overnight at 10°C. Stubborn pellets can be sonicated multiple times or freeze-thawed in order to enhance protein solubility (see Note 2). Do not exceed 30°C.

280

T. Colby et al.

3. Add 2 mL of IB/B and vortex. The sample now has a concentration of approximately 1 mg/mL and may be stored at this point at −20°C. 4. Prepare the MOAC matrix as follows: To ensure equal distribution of the matrix, weigh out 80 mg of Al(OH)3 for every mg of sample protein into a Falcon tube. Add 1 mL of washing buffer for every 80 mg of matrix. Pipet 1.5 mL of the slurry rapidly into each microcentrifuge tube, vortexing the slurry periodically in between to ensure equal distribution of Al(OH)3. Spin the tubes down at 12,000 × g and remove the supernatants. For the 3  mg batch described here, we will load two 2-mL microcentrifuge tubes with 120 mg of Al(OH)3 apiece. 5. Wash the material twice as follows: add 1.5 mL of washing buffer, vortex, spin down at 12,000 × g, and discard the supernatant. Set the tubes aside. 6. Transfer the dissolved protein pellet solution to 2-mL microcentrifuge tubes. Centrifuge for 10 min at 14,000 × g to pellet any insoluble material. 7. Transfer 1.5 mL of soluble protein supernatant to each of the tubes containing the Al(OH)3 from step 5 and incubate for 1 h at 10°C in a rotator or orbital shaker. 8. Centrifuge the tubes for 1  min at 10,000 × g in a swing-out rotor in order to pellet the Al(OH)3. 9. Discard the supernatant and wash six times with washing buffer. Carefully resuspend the Al(OH)3 pellet after each addition of buffer, agitating gently. Then spin the Al(OH)3 down as in step 8 and discard the supernatant. 10. Elute the phosphoproteins by adding 1 mL of elution buffer and agitating for 30 min at room temperature in a rotator or orbital shaker. 11. Spin down for 5 min at 14,000 × g at room temperature to pellet any residual Al(OH)3. 12. Carefully transfer 800 mL of the phosphoprotein solution into new tubes, making sure not to transfer any of the Al(OH)3. We recommend only transferring 800 mL, since it is better at this point to leave a little sample behind than to risk contamination with MOAC material (see Note 3). Spin the samples down again for 5 min at 14,000 × g before proceeding if there is any reason to believe that they still contain MOAC matrix. 3.3. DOC-TCA Protein Precipitation

This precipitation protocol is modified from the DOC-TCA precipitation described by Peterson (7). 1. Transfer the clear phosphoprotein solution (up to 3.5 mL – at this point, samples that have been split can be recombined) into Amicon Ultracel-10K centrifugal concentrators (Millipore) and

16  Modified Metal-Oxide Affinity Enrichment Combined with 2D-PAGE…

281

concentrate the samples to 100 ml by spinning at 4,000 × g for approximately 30 min. Keep in mind that the protein concentration may be quite high (>1 mg/mL) following this step. 2. Transfer the retentate (~100 ml) to a 1.5-mL microcentrifuge tube and add 500 ml of water (some protein precipitation may occur due to dilution of the urea). 3. Add 7 ml of 2% (w/v) DOC solution, vortex the sample briefly, and incubate at room temperature for 5 min. 4. Add 70 ml of 100% TCA and vortex again. Place the tubes on ice to precipitate for 120 min. 5. Centrifuge at 20,000 × g at 4°C for 10 min to pellet the protein. Discard the supernatant. 6. Wash the pellets once by pipetting, vortexing, and/or sonicating with 1  mL 25% (w/v) TCA at 4°C. The pellet is often invisible at this stage and smeared over a large area of the tube, so care should be taken to resuspend the pellet thoroughly. Centrifuge again as in step 5 and discard the supernatant. This step removes residual Al(OH)3. 7. Wash the pellet once more in 1 mL of ice-cold Tris/acetone. Collect pellet as in step 5 and discard the supernatant. 8. Wash once more with 1 mL of ice-cold acetone. Collect pellet as in step 5 and discard the supernantant. Depending on the amount and nature of the pelleted protein, the acetone-washed pellet may be more fragile than the previous one. One should be very careful when removing supernatant at this stage. Alternatively, one can perform this wash with ice-cold 80% (v/v) acetone, which may make the pellet more handleable. 9. Add 1 mL of ice-cold acetone to the pellet and disrupt it by vortexing or sonication. The sample can now be stored indefinitely at −80°C. 10. When you are ready to continue to the IEF, centrifuge the sample again as in step 5 and remove the supernatant (see note on step 8 – some residual pure acetone can be removed by vacuum-drying the sample if pipetting proves difficult). Do not dry the final pellet completely: it should still be acetonewet when taken up in IEF buffer. In our experience, pellets are significantly harder to resolubilize once they have been fully dried. In any case, allow the pellets to redissolve for a few hours in IEF buffer with frequent disruption. 3.4. 2DGE and Phospho-Specific Staining

1. 2D gels should be run according to the manufacturer’s instructions. For this study, ZOOM 2D gels are used. As stated above in the materials section, the most critical aspects of running the gels are that the pellet is properly resolubilized and that prestained markers are not used due to possible interference with fluorescent phospho-stains.

282

T. Colby et al.

2. Gels are stained with ProQ-Diamond phosphoprotein stain according to the manufacturer’s instructions. The second overnight fixation step may help reduce background, but it is not essential. Once scanned and punched, gels are re-stained with Coomassie PageBlue and repunched if desired. In our experience, MOAC enriches many verified phosphoproteins which do not stain well with phospho-stain. Thus, while Coomassiestained spots that did not stain with Pro-Q Diamond may represent non-phosphorylated protein background, they may also represent Pro-Q false negatives. 3. Phospho-stained gels are scanned on a FLA-3000 scanner using a green laser (532 nm) and high-sensitivity settings. 4. Coomassie gels are scanned on a daylight scanner as part of the Proteineer SP system. 5. Spots for MS analysis are excised from phospho-stained gels, digested robotically, and spotted on Anchorchip TM steel targets for MALDI analysis using the Proteineer DP system. Hand excision (at a UV table) and hand digestion are a viable lowthroughput alternative if equivalent equipment is not available. 3.5. Blotting, On-Blot Dephosphorylation, and Staining

We have good experience with this blotting methodology starting with a 1D or preferably 2D gel run as outlined in Subheading 3.4. Ideally, a blot should be cut in half, with the one half undergoing phosphatase treatment and the other half the control treatment. 1. Electroblot the peptides onto the Immobilon membrane at 30 V for 1 h (see Note 5). 2. Block the membrane by incubating for 1 h in blocking solution at room temperature (see Note 6). 3. Split the blot for phosphatase and control treatment. Incubate one half of the blot for 4 h at 25°C with agitation in 5 mL of blocking solution containing 2  mM MnCl2 and 10  ml of 800 U/mL lambda phosphatase. Incubate the control blot in blocking buffer lacking the phosphatase. 4. Stop the phosphatase reaction by agitating the blots for 5 min in PBS. 5. Wash the membranes five times in water and allow them to dry. 6. Moisten the membranes briefly with methanol. 7. Fix the membranes by soaking for 15 min in fixing solution. 8. Wash the blots for 5 min in water. Repeat washing three more times. 9. Stain the phosphoproteins on the blots for 15 min in 25 mL of blot staining solution containing ProQ-Diamond. 10. Destain for 10 min in destaining solution. Repeat the destaining three times (see Note 7).

16  Modified Metal-Oxide Affinity Enrichment Combined with 2D-PAGE…

283

11. Allow the blots to dry. 12. Scan according to the manufacturer’s instructions, e.g., by using a FLA-3000 scanner with an excitation wavelength of 532 nm and monitor emission of 580  nm. Use the lowest sensitivity setting on the scanner due to background issues (see Note 8).

4. Notes 1. The Arabidopsis seed proteins presented in Fig. 1 were enriched in the presence free amino acids under the conditions described here. The selectivity of the phosphoprotein enrichment can be seen by comparing the superimposed eluate and flowthrough from the MOAC protocol with a gel of the total input protein. In our experience, aspartic and glutamic acid concentrations between 100 and 200 mM appear to enhance specificity without dramatically affecting sensitivity. At higher competitor concentrations, some phosphorylated species (especially singly phosphorylated) may get lost. Here a balance must be struck. Since the use of one or more phospho-specific stains and the on-blot phosphatase assay can confer an additional specificity, one can – and probably should – perform the enrichment under more liberal conditions, sacrificing some specificity for the sake of phosphoprotein yield. This would also be the case if the phosphoprotein candidates are to undergo further phosphospecific MS analysis. In our experience, incubation and wash buffers should be matched such that the incubation takes place at a slighly lower competitor concentration than the wash. 2. In order to avoid losing soluble proteins, especially when pellets contain a large amount of insoluble debris, we recommend performing multiple sonication cycles. One should also consider overnight solubilization or freeze-thawing of the sample to break down the pellet. 3. Even though the subsequent washing steps with TCA should solubilize and remove the remaining Al(OH)3, it is better to accept losing some sample at this step rather than risking a large amount of contaminating matrix in the pellet. If the matrix is not entirely removed, it could selectively recapture exactly those proteins we are attempting to enrich as well as disturb the subsequent IEF run in general. The motivation behind the TCA-based precipitation is the removal of this residual matrix, conferring the 2DGE compatibility. We recommend to avoid anything that might interfere with this purification step. 4. The technique offers a semi-quantitative enrichment of phosphoproteins as illustrated in the gel of MOAC-enriched test

284

T. Colby et al.

Fig.  2.  Semi-quantitative phosphoprotein enrichment and precipitation from a mixture of phosphorylated and nonphosphorylated test proteins. The gel on the left hand is stained with Coomassie, the gel on the right hand with ProQDiamond. Sample A: 50 mg of ovalbumin and 50 mg of casein (both phosphorylated) as well as 200 mg of BSA and 200 mg of lysozyme (both non-phosphorylated). Sample B: 100 mg of ovalbumin, 100 mg of casein, 100 mg of BSA, and 100 mg of lysozyme. Sample C: 200 mg of ovalbumin, 200 mg of casein, 50 mg of BSA, and 50 mg of lysozyme (see Note 4). This figure is displayed in greyscale in the print edition but available in color in the electronic version.

mixtures (Fig.  2). The test mixtures contained different proportions of four test proteins: BSA and lysozyme (nonphosphorylated), ovalbumin, and casein (phosphorylatyed). In this gel stained with Coomassie and ProQ-Diamond, the three lanes on the left of each gel represent the unbound proteins precipitated from the supernatant solution of the MOAC procedure (labeled “flowthrough”) (Fig.  2). The three lanes on the right hand contain the proteins precipitated from MOAC eluents. The A lanes represent a mixture of 50 mg each of the phosphoproteins ovalbumin and casein and 200  mg each of non-phosphorylated BSA and lysozyme. The B lanes represent a mixture of 100 mg of all four proteins, and the C lanes a 200 mg of each phosphoprotein and 50 mg of each nonphosphoprotein. During the enrichment process, BSA is only partially retained, while both phosphoproteins are completely depleted in the flowthrough. A comparison of the eluent lanes A, B, and C in both images correlates well to the changing levels of the phosphoproteins in the respective samples. The fact that lysozyme only appears in the flowthrough indicates that it was not significantly retained by the MOAC matrix, but the fact that the lysozyme signal is so faint, even in the flowthrough, points out a weakness of the protocol which must be kept in mind. Since lysozyme was present in all samples in amounts similar to the other proteins, its relatively faint signal indicates that much of it probably remains in solution during

16  Modified Metal-Oxide Affinity Enrichment Combined with 2D-PAGE…

285

Fig. 3.  On-blot dephosphorylation with lambda phosphatase. Blots of a range of amounts of phosphoprotein test mixtures were stained first with ProQ-Diamond blot stain (top) and subsequently with Coomassie (bottom). The blots on the right hand were treated with lambda phosphatase as described, while the blots on the left hand were not. Coomassie staining shows that equal amounts of protein were present before and after phosphatase treatment (see Note 5).

the precipitation step. Although DOC-TCA precipitation is recommended for recovery proteins present in very low concentrations (7), some highly soluble, low-molecular weight proteins may not precipitate, especially if their concentration is low. Considering this factor and since the elution volume here is lower than the flowthrough volume, the fact that lysozyme only appears in the flowthrough indicates that it is not significantly retained by the MOAC matrix. 5. Various membranes from a variety of manufacturers were tested and we found that Immobilon membranes (Millipore) gave a significantly lower background Fig. 3. With a stain as sensitive as ProQ-Diamond blot stain, this is absolutely critical to obtain interpretable blots (see Note 8). 6. Depending on the blot stain manufacturer (Invitrogen or Perkin Elmer), blocking may or may not be recommended for the phospho-blot staining. Our impression is that the blocking is not the critical factor in terms of background reduction, but it is necessary for the phosphatase assay. 7. In attempts to reduce background we washed as long as times 30 min. This extended washing did not eliminate background problems on membranes other than Immobilon. When the membrane of choice led to good signals, the recommended short wash cycles are sufficient.

286

T. Colby et al.

8. In our experience, the blot stain is not only extremely sensitive but also very prone to background binding to the blot – with or without blocking. The result of these two phenomena is that blot scanning may result in fully overstained images, with no distinguishable signals. We found that exciting these blots at the wrong wavelength effectively reduces the sensitivity of the system by a few orders of magnitude, yielding visible and interpretable signals with high background. Using the least sensitive setting of the Fuji FLA-3000 and Immobilon-P PVDF membranes was the only combination we found yielding good clear signals with relatively low background at the correct wavelength. In our experience the, choice of membrane has much more effect in reducing background than extended washing steps. References 1. Pawson, T. and Scott, J.D. (2005) Protein phosphorylation in signalling – 50 years and counting. Trends in Biochemical Sciences 30, 286–290 2. De la Fuente van Bentem, S. and Hirt, H. (2007) Using phosphoproteomics to reveal signalling dynamics in plants. Trends in Plant Science 12, 405–411 3. Reinders, J. and Sickmann A. (2005) State-ofthe-art in phosphoproteomics. Proteomics 5, 4052–4061. 4. Nuehse, T., Yu, K., and Salomon, A. (2007) Isolation of phosphopeptides by immobilized metal ion affinity chromatography, in Current Protocols in Molecular Biology. John Wiley and Sons, Inc., Chapter 18: Unit 18.13.

5. Wolschin, F. and Weckwerth, W. (2005) Combining metal oxide affinity chromatography (MOAC) and selective mass spectrometry for robust identification of in  vivo protein phosphorylation sites. Plant Methods. 1:9. 6. Roehrig, H., Colby, T., Schmidt, J., Harzen, A., Facchinelli, F., and Dorothea Bartels (2008) Analysis of desiccation-induced candidate phosphoproteins from Craterostigma plantagineum isolated with a modified metal oxide affinity chromatography procedure. Proteomics. 8:17 7. Peterson, G.L. (1983) Determination of total protein. Methods Enzymol. 91, 95–121.

Chapter 17 Phosphoproteomics Using iTRAQ Alexandra M.E. Jones and Thomas S. Nühse Abstract The identification of phosphorylation on proteins has become practicable for many laboratories in recent years, largely due to improvements in mass spectrometry (MS) and the development of methods to selectively enrich for phosphorylated peptides and proteins. However, phosphorylation is a dynamic and reversible modification which plays a central role in many biological processes including intracellular signalling. Therefore, the quantitative analysis of phosphorylated proteins and peptides is a subject of intense interest. We discuss three applications of isobaric tags for relative and absolute quantitation (iTRAQ) to the analysis of phosphopeptides from a variety of sample materials. Key words: Phosphorylation, iTRAQ, Isobaric tags for relative and absolute quantitation, Quantitation, Signalling, Dynamic modification, Mass spectrometry, Stable isotope labelling

1. Introduction A mechanistic understanding of signalling pathways requires the identification of kinases and their targets. Identification of the site(s) of phosphorylation on a protein is only part of the information required to understand their function. The dynamic interplay of phosphorylation and dephosphorylation has important consequences for signalling, as does the stoichiometry of phosphorylation. Traditionally, the majority of phosphorylation events were discovered on a protein-by-protein basis. Global, unbiased studies rely on the selective enrichment and/or detection of phosphoproteins or phosphopeptides, their identification, and quantification. Experimental approaches on the protein level typically use in vivo pulse labelling with 32P (1, 2) or phosphoprotein affinity chromatography (3, 4) followed by 2D-PAGE. Alternatively (or in combination (5)), phospho-specific stains (6) or immunoblotting (7) are

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9_17, © Springer Science+Business Media, LLC 2011

287

288

A.M.E. Jones and T.S. Nühse

used for the detection of phosphorylated proteins. Phosphoproteins displaying changes in abundance or staining intensity on 2D-gels still need to be identified. For this reason – and because many proteins, notably membrane proteins, cannot be resolved satisfactorily on 2D-gels – new approaches based on peptide separation and mass spectrometric (MS) identification have been developed. Immobilized metal ion affinity chromatography (IMAC) with chelated Fe3+, Ga3+, and other metals has been used in a range of large-scale studies in yeast (8), plant (9), and human (10) cell cultures. Titanium dioxide (TiO2) has been described as a novel affinity matrix for phosphopeptides by Larsen et al. (11) and is beginning to outstrip IMAC in popularity. Although successful large-scale phosphopeptide sequencing is possible without prefractionation (12), in the vast majority of cases the complex peptide mixture is separated with either cation (13) or anion exchange (9). In an effort to “dig” deeper and deeper into the phosphoproteome, subcellular fractionation has uncovered phosphorylation sites of plant chloroplasts (14), plasma membranes (15), and tonoplasts (16). For quantitative proteomics of animal or bacterial samples, stable isotope labelling with amino acids (SILAC) in cell culture has become the predominant method (17). In plant cells, however, SILAC labelling is relatively inefficient (18). Complete metabolic labelling with 15N via inorganic nitrate and/or ammonia is an alternative that is better suited to plants (19). However, 15N-labelling and SILAC, like most alternative methods, are limited to comparisons of two or three samples at the most. 15N-labelling adds a variable mass increment that depends on the size of the peptide; a fact that complicates analysis. The isobaric tag for relative and absolute quantification (iTRAQ) has four (or recently eight) differential mass tags. This approach can, therefore, combine more time points, treatments, or replicates and reduce the amount of time spent on a mass spectrometer. The differential mass tags described in this chapter are aminereactive iTRAQ reagents. iTRAQ tags are applied to peptides and are designed to be isobaric during precursor MS (full scan, MS1) and to reveal differential low mass ions after collision-induced fragmentation (MS/MS or MS2). Combining labelled peptides from different treatments improves protein identification as low levels of protein from each treatment all contribute to the same fragmentation spectrum. Relative quantification occurs within a single MS2 spectrum. Different peptides from the same protein are expected to present the same iTRAQ ratios. The method was described in detail by Ross et al. (20) who used three yeast strains and spiked extracts with synthetic peptides to provide absolute quantification. iTRAQ tags have now become well established with several hundred papers in animal and plant fields. Several alternatives are now marketed (e.g. TNT from Thermo Fisher Scientific and ExacTag from Perkin Elmer), which are not be discussed here.

17  Phosphoproteomics Using iTRAQ

289

In contrast to metabolic labelling strategies, the labelling of peptides by iTRAQ occurs at a relatively late stage in the preparation of proteins for MS; after tryptic digestion. This makes it universally applicable both to different biological samples [cell cultures, differentiated tissues, subcellular fractions, or (partially) purified samples] and different treatments or developmental stages. Post-digestion labelling could be viewed as a disadvantage because variation may be introduced into samples during extraction procedures; however, with due care our experience indicates that this is not a significant source of variation. The advantage of tryptic peptide labelling is that it is suitable when metabolic labelling is not possible (e.g. from plants collected in the field) and that it permits great flexibility in experimental design. Two main approaches may be taken for the analysis of phosphorylated proteins: Intact phosphorylated proteins may be isolated through the use of specific antibodies (a variation with anti-phosphotyrosine immunoprecipitation is frequently used) or affinity resins and then digested with trypsin prior to iTRAQ labelling and mass spectrometry (e.g. (21, 22)). This approach offers the following benefits: (1) protein identification is improved with increasing numbers of sequenced peptides; (2) more than one mass tagged peptide per protein improves quantification, allowing assessment of reproducibility and statistical testing. However, the cost is increased complexity in the peptide mixture and an associated loss of sensitivity; the peptides from less abundant and smaller proteins may be obscured by the plentiful peptides from highly abundant proteins. The increased complexity of the peptide mixture will reduce the probability of observing individual phosphorylated peptides and is likely to prevent determination of the site of phosphorylation. Proof of phosphorylation will, therefore, be missing for most of the identified proteins. This approach also assumes that changes in phosphorylation status lead to changes in affinity to the chosen resin, which may not be the case in multiply phosphorylated proteins with several nonresponsive sites. In summary, where proof of phosphorylation is required, this approach needs to be complemented with other biochemical methods. An overview of this approach is presented in Fig. 1. Alternatively, phosphopeptides may be enriched, using selective antibodies, Fe3+ or Ga3+ IMAC resins, or TiO2 affinity chromatography (e.g. (23, 11, 24)). Labelling of peptides may occur either before or after selection of phosphopeptides. As the amount of protein that can be labelled with an iTRAQ kit is limited to 100 mg per reagent, we recommend enrichment of phosphopeptides before labelling so that a significant (mg to multi-mg) amount of protein can be used as starting material. Very complex mixtures may be fractionated after phosphopeptide enrichment and iTRAQ labelling, for example by cation exchange chromatography. The latter is recommended as a clean-up step anyway and can simply be extended

290

A.M.E. Jones and T.S. Nühse

Fig.  1. Schema for the enrichment of soluble phosphoproteins and iTRAQ labelling of tryptic peptides.

from batch elution to salt steps. Another consideration is that working with peptides circumvents solubility problems associated with membrane proteins and often enables the determination of the site of phosphorylation. However, a protein may be identified only by a single peptide, and this requires more replication for good reproducibility and statistical assessment of differentials. One may, of course, analyze the flow-through from phosphopeptide enrichment strategies to provide additional confirmation of protein identity and to assess if the total amount of the protein is altering. However, the complexity of the mixture may mean that the same proteins are not identified in both flow-though and phosphopeptide fractions. An overview of the phosphopeptide approach is presented in Fig. 2. Finally, a targeted approach combines both of the concepts discussed above to address the stoichiometry of phosphorylation. iTRAQ reagents can be used to estimate the proportion of specific sites on a protein which are phosphorylated (25). Additionally, this approach can be useful if the phosphopeptide is not observed in MS but the non-phosphorylated form is, although the reasons for such a discrepancy are not necessarily due to differential ionization efficiencies but are probably specific for each particular peptide (26). The method we present here is based on Pflieger et al. (25) and is summarized in Fig.  3. Briefly, the protein is isolated by immunoprecipitation (or a suitable affinity strategy), digested, and peptides labelled with iTRAQ tags. The digest is then divided into two portions and one half is treated with phosphatases (the other

17  Phosphoproteomics Using iTRAQ

291

Fig. 2. Schema for the enrichment of phosphopeptide and subsquent iTRAQ labelling.

Fig. 3. Schema for the comparison of phosphorylated and phosphatase-treated peptides from a purified protein.

half is not treated). After recombining the two labelled samples, unphosphorylated peptides on the protein should show a ratio of 1, while phosphorylated peptides will have differential ratios. Several mass spectrometers may be used for the analysis of iTRAQ-labelled peptides. If a choice is available, then the QStar or the QTrap 4000 triple quadrupole MS from Applied Biosystems is ideal, as the tags are optimized for this type of MS. Furthermore, Analyst software (ProQuant) has been developed specifically for

292

A.M.E. Jones and T.S. Nühse

iTRAQ data analysis from these instruments and it is quite straightforward. Note that the newer QTrap 5500 is less suitable for iTRAQ analysis due to its limited m/z range. If not, a time-offlight (TOF) machine (such as a QTof; Waters) is also appropriate, but the radio frequency (RF) offset may need adjusting (e.g. on a QTof2 the usual RF offset of 1 is lowered to 0.3) and the collision energies increased. Finally, ion trap MS such as the LTQ or LTQOrbitrap (ThermoScientific) may be used with careful optimization of parameters to circumvent the typical loss of the lower third m/z ions (27, 28, 29).

2. Materials 2.1. Enrichment of Soluble Phosphoproteins

1. Protein quantification reagents (e.g. Bradford assay; BioRad), store at 4°C. 2. iTRAQ reagent kit (Life Technologies), can be stored at −20°C for up to a year. The kit contains dissolution buffer: 500 mM triethylammonium bicarbonate (TEAB; pH 8.0); reducing agent: 50 mM tris-(2-carboxyethyl)phosphine (TCEP); cysteine blocking reagent: 200 mM methyl methanethiosulfonate (MMTS) in isopropanol; differential mass iTRAQ reagents; single iTRAQ labels (114, 115, 116, 117); ethanol, and trypsin. iTRAQ© Reagents Methods Development Kit: starter kit also contains a 0.4 ml isotope coded affinity tag (ICAT) cation exchange column (store at 4°C). 3. 2.5% (v/v) formic acid in 30% (v/v) acetonitrile. 4. Solvent A: 5 mM ammonium formate (pH 2.7 adjusted with formic acid) in 30% (v/v) acetonitrile. 5. Solvents B1 to B4: Solvent A plus ammonium formate to give final concentrations of each of: 10, 30, 50, 100 mM ammonium formate. 6. 0.5% (v/v) formic acid. 7. Denaturant: 2% (w/v) sodium dodecyl sulphate (SDS). 8. Benchtop centrifuge. 9. SpeedVac lyophilization system. 10. PhosphoProtein Purification Kit (Qiagen). The kit contains purification columns, lysis and elution buffers, nuclease, protease inhibitors (store all this material at 2–8°C), and ultrafiltration columns (10 kDa molecular weight cut-off; store at room temperature). 11. Desalting columns (e.g. PD10; Amersham).

2.2. Tryptic Digestion for iTRAQ

1. Ultra-pure water. 2. iTRAQ reagent kit (Life Technologies).

17  Phosphoproteomics Using iTRAQ

293

3. ZipTip (Millipore) or Stage tips (Proxeon). 4. Methanol. 5. Tip equilibration, loading and wash buffer: 0.1% (w/v) TFA (trifluoroacetic acid) in water. 6. Elution buffer: 80% (v/v) acetonitrile, 0.1% (v/v) formic acid in water. 2.3. iTRAQ Labelling of Enriched Phosphopeptides

1. Ultra-pure water.

2.3.1. Fractionation and Tryptic Digestion of Peptides from Membrane Proteins

4. 50 and 500 mM TEAB.

2. Trypsin (Promega). 3. 100 mM sodium carbonate. 5. TFA. 6. Additional reducing agent: 50 mM TCEP. 7. Additional cysteine blocking reagent 200  mM MMTS in isopropanol. 8. 0.1% (w/v) Rapigest SF (Waters).

2.3.2. Enrichment of Phosphopeptides by Titanium Dioxide

1. Titanium dioxide beads (Glygen TopTips, Chromatography Consulting): 30 mg TiO2 beads per mg starting material or 25–30  mg beads per strong cation exchange (SCX) fraction (1.5 × 107 cells). Store dry at room temperature. 2. Loading buffer: 2% (w/v) TFA, 65% (v/v) acetonitrile, in water, saturated with glutamic acid (ca. 140  mM or 2.2 % (w/v), (24)). 3. Wash buffer A: 0.5% (w/v) TFA, 65% (v/v) acetonitrile in water. 4. Wash buffer B: 0.1% (w/v) TFA, 65% (v/v) acetonitrile in water. 5. Elution buffer: aqueous 300  mM ammonium hydroxide in acetonitrile (1 part of 25% (w/v) NH3 and 50 parts of 50% (v/v) acetonitrile). 6. 0.1% (v/v) formic acid. 7. SepPak Classic C18 cartridges 360 mg (Waters). 8. Reverse phase loading buffer: 0.5% (w/v) TFA in water. 9. Reverse phase (RP) elution buffer: 50% (v/v) acetonitrile in water.

2.4. Comparative Phosphorylation for Purified Proteins

1. Ultra-pure water. 2. 100 mM sodium carbonate. 3. 50 and 500 mM TEAB. 4. iTRAQ kit (Life Technologies). 5. Calf intestinal phosphatase (CIP; Thermo Fisher, Promega).

294

A.M.E. Jones and T.S. Nühse

6. Shrimp alkaline phosphatase (SAP; Promega). 7. Solvent A: 5 mM ammonium formate, pH 2.7 adjusted with formic acid, in 30% (v/v) acetonitrile. 8. Solvent B1 to B4: Solvent A plus ammonium formate to give final concentrations of: 10, 30, 50, 100 mM. 9. Denaturant: 2% (w/v) sodium dodecyl sulphate (SDS). 2.5. Mass Spectrometry

1. Nano-flow liquid chromatography system (Surveyor, Thermo Scientific). 2. LTQ-Orbitrap XL (Thermo Scientific). 3. Pre-column (C18 pepmap100; LC Packings). 4. Analytical column: self-packed picotip (8  cm; resin: C18 BioBasic; ThermoScientific; Picotip 75 μm id, 15 mm tip; New Objective). 5. HPLC buffer A: 0.1% (v/v) formic acid in MS-grade water. 6. HPLC buffer B: 0.1% (v/v) formic acid in MS-grade acetonitrile.

2.6. Data Analysis

1. Bioworks/extract.msn Scientific).

script

(version

3.3.1;

Thermo

2. merge.pl script (Matrix Science). 3. Mascot software (v 2.2 Matrix Science).

3. Methods 3.1. Enrichment of Soluble Phosphoproteins

1. Soluble proteins should be dissolved in the phosphoprotein lysis buffer provided with the kit containing protease inhibitors, DNase, and RNase (see Note 1). 2. Centrifuge samples at 35,000 × g for 10  min and discard the pellet. 3. Desalt the supernatant into more phosphoprotein lysis buffer (lacking phosphatase inhibitors) using PD10 columns (see Note 2). 4. Determine protein concentration (e.g. Bradford assay). 5. Apply 2.5 mg of total soluble protein to the affinity columns in duplicate and wash with two volumes of the phosphorpotein lysis buffer. 6. Elute phosphoproteins from the columns in five 500  mL of washes. 7. Pool fractions if desired.

17  Phosphoproteomics Using iTRAQ

3.2. Tryptic Digestion for iTRAQ

295

1. Concentrate proteins with a buffer exchange to 500 mM TEAB using Nanosep ultrafiltration columns (see Note 3). 2. Prepare aliquots of 50–100  mg of purified protein for each iTRAQ labelling reaction (see Note 4). 3. Add denaturant (1/20 vol, final 0.1% SDS) to the samples and mix well (see Note 5). 4. Reduce the proteins with TCEP (1/10 vol, final 5 mM TCEP): incubate at 60°C for 1 h. 5. Block cysteine residues with MMTS (1/20 vol, final 10 mM MMTS) and incubate at room temperature for 10 min. 6. Reconstitute the vial of trypsin with 25 ml of water and apply 10 ml of reconstituted trypsin to each sample. Incubate at 37°C overnight (see Note 6). 7. Allow iTRAQ reagents to reach room temperature and add 70 ml of ethanol to each vial of label. 8. Transfer the contents of each vial to the appropriate sample tube and mix well. 9. Incubate at room temperature for 1 h. 10. Analyze a small portion of each reaction to ensure complete labelling (see Note 7). 11. If the labelling is complete, dilute reaction mixture with 100 ml of water (see Note 8), combine labelled samples, and lyophilize. 12. Redissolve peptides in 2.5% (v/v) formic acid–30% (v/v) acetonitrile and clear by centrifugation (10 min at 15,000 × g at room temperature). 13. Load peptides onto a 0.4-ml ICAT cation exchange cartridge (see Note 9). 14. Wash with 2 ml of solvent A. 15. Elute peptides in four steps of 0.5 ml of solvents B1 to B4 (see Note 10). 16. Concentrate samples in the SpeedVac to remove solvent, lyophilize samples, store at −20°C, and resuspend in 0.5% (v/v) formic acid just before MS analysis.

3.3. iTRAQ Labelling of Enriched Phosphopeptides 3.3.1. Fractionation and Tryptic Digestion of Peptides from Membrane Proteins

1. Wash the membrane pellet once in 100 mM sodium carbonate, 500 mM TEAB, and 50 mM TEAB, consecutively, by resuspension and centrifugation for 45 min at 100,000 × g at 4°C. 2. After the last wash, resuspend the pellet in 200–500  ml of 50 mM TEAB. 3. Determine the protein concentration (e.g. by Bradford assay). 4. Each sample (1  mg or more) is denatured with 0.1% (w/v) Rapigest SF.

296

A.M.E. Jones and T.S. Nühse

5. Reduce the proteins with TCEP (5 mM final conc.) and incubate at 60°C for 1 h. 6. Block cysteine residues with MMTS (10 mM final conc.) and incubate at room temperature for 10 min. 7. See Note 11. 8. Add sequencing-grade modified trypsin in 50 mM TEAB for a 1:50 trypsin–protein ratio and digest overnight at 37°C. 9. Stop the digestion by adding TFA to 0.1% (w/v). 10. Separate the peptides from the membranes by 20 min of ultracentrifugation at 150,000 × g. 11. Adjust the digest supernatant to loading buffer conditions (Subheading 2.3.2) by adding acetonitrile, TFA, and glutamic acid and use for affinity chromatography immediately. 3.3.2. Enrichment of Phosphopeptides by Titanium Dioxide

1. Remove 30 mg of TiO2 beads per mg protein digest from TopTips and place in an 1.5-ml microcentrifuge tube. 2. Wash beads twice in loading buffer. No centrifugation is necessary; the beads settle quickly. 3. Dissolve the peptides in loading buffer and incubate with the prepared beads for 1 h with end-over-end rotation. 4. Transfer the beads back to the empty TopTip. 5. Wash once with loading buffer and twice each with wash buffers A and B, consecutively, using at least 100 ml each time. 6. Elute the peptides with elution buffer. 7. Concentrate phosphopeptides to less than half the original volume (see Note 12). 8. Add TFA to a final concentration of 0.5% (w/v) to the eluate and load onto a SepPak cartridge (see Note 13). 9. Wash with 1 ml of 0.5% (w/v) TFA and then elute with 1 ml of RP elution buffer. 10. Concentrate the eluate to less than half the original volume in the SpeedVac and then freeze-dry peptides. 11. Redissolve the peptides in 20 ml of 500 mM TEAB.

3.3.3. iTRAQ Labelling

1. Allow iTRAQ reagents to reach room temperature and add 70 ml of ethanol to each vial of label. 2. Transfer the contents of each vial to the appropriate sample tube and mix well. 3. Incubate at room temperature for 1 h. 4. Analyze a small portion of each reaction to ensure complete labelling (see Note 7). 5. If labelling is complete, dilute reaction mixture with 100 ml of water (see Note 8), combine labelled samples, and lyophilize.

17  Phosphoproteomics Using iTRAQ

297

6. Redissolve peptides in 2.5% (v/v) formic acid–30% (v/v) acetonitrile and clear by centrifugation (10 min at 15,000 × g at room temperature). 7. Load peptides onto a 0.4-ml ICAT cation exchange cartridge. 8. Wash with 2 ml of solvent A. 9. Elute peptides in four steps of 0.5 ml of solvent B1 to B4. 10. Lyophilize samples, store at −20°C, and resuspend in 0.5% (v/v) formic acid just before MS analysis. 3.4. Comparative Phosphorylation for Purified Proteins

1. Prepare a clean sample of the protein (co-immunoprecipitated or tagged protein; see Notes 3 and 14). 2. Add denaturant (1/20 vol, final 0.1% SDS) to the samples and mix well (see Note 5). 3. Reduce the proteins with TCEP (5 mM final conc.); incubate at 60°C for 1 h. 4. Block cysteine residues with MMTS (10 mM final conc.) and incubate at room temperature for 10 min. 5. Reconstitute the vial of trypsin with 25 ml of water and apply 10 ml of the reconstituted trypsin to each sample. Incubate at 37°C overnight (see Note 6). 6. Split samples into two halves and concentrate under vacuum so that the volume is <30 ml. 7. Allow iTRAQ reagents to reach room temperature and add 70 ml of ethanol to each vial of label. 8. Transfer the contents of each vial to the appropriate sample tube and mix well. 9. Incubate at room temperature for 1 h. 10. Check a small portion of each mixture for complete iTRAQ labelling (see Note 7). 11. If labelling is complete, dilute reaction mixture with 100 ml of CIP buffer (see Note 8). 12. Treat one half of each protein preparation with 2 U of CIP and 2 U of SAP and incubate at 37°C for 2 h (see Note 15). 13. Heat all samples at 85°C for 15  min to inactivate the phosphatases. 14. Pool the labelled samples and add 1 mg of trypsin and incubate for 2 h at 37°C. 15. Load peptides onto a 0.4-ml ICAT cation exchange cartridge. 16. Wash with 2 ml of solvent A. 17. Elute peptides in four steps of 0.5 ml of solvent B1 to B4 (see Note 10). 18. Lyophilize samples, store at −20°C, and resuspend in 0.5% (v/v) formic acid just before MS analysis.

298

A.M.E. Jones and T.S. Nühse

3.5. Mass Spectrometry

This protocol is adapted from (27, 28). 1. Liquid chromatography (LC)-MS/MS analysis is performed using a LTQ-Orbitrap XL mass spectrometer and high performance liquid chromatography (HPLC) system adapted for nano-flow using a T-splitter and a nano-electrospray source. The MS is operated in positive ion mode with a capillary temperature of 200°C; no sheath gas is employed, and the source and focusing voltages are optimized for the transmission of angiotensin. 2. Apply peptides to a pre-column connected to a self-packed C18 8-cm analytical column. 3. Elute peptides using a gradient of 2–40% (v/v) acetonitrile in 0.1% (v/v) formic acid over 60 min at 250 nL/min (see Note 16). 4. Acquire full scan MS in profile mode from 300–2,000 m/z at 60,000 resolution using an internal lock mass (30). Maximal accumulation time for MS1 is set to 1 s to a target fill of 1 × 106. 5. A minimum signal of 3,000 counts is required to trigger datadependent acquisition of MS2 spectra. These are acquired in a data-dependent mode consisting of selection of the six most abundant ions in each cycle. For iTRAQ analysis, alternate between collision-induced disassociation (CID) and pulsed Q-disassociation (PQD) modes for each selected precursor ion so that, effectively, only three precursor ions are analyzed per cycle. CID collision energy is 35% and PQD collision energy 47%. For both fragmentation modes, ions are accumulated to 5 × 104, and spectra are centroided at acquisition by the MS (see Note 17). 6. Dynamic exclusion parameters allow two repeat hits before the precursor m/z is added to an exclusion list for 300 s.

3.6. Data Analysis

1. Extract MS/MS spectra from the raw file using BioWorks and set the dta file generation parameters such that grouping value is 2. This will combine the CID and PQD spectra into one dta file (see Note 18). 2. Use the merge.pl script to concatenate the dta files into the generic mascot format (an mgf file). 3. Search the appropriate database with Mascot using iTRAQ quantitation parameters (see Note 19).

4. Notes 1. The Qiagen columns are only recommended for soluble proteins, and these should be free of cellular debris (which may block the column) and contain as little chlorophyll as possible.

17  Phosphoproteomics Using iTRAQ

299

Phosphatase inhibitors are not included in the kit as these interfere with protein binding to the Qiagen affinity columns. One can optionally add low amounts to this first extraction. If not, it is critical to work quickly, keeping the samples cold. 2. If working with green leaf material, it is essential to have an additional buffer exchange step. This helps to remove compounds that interfere with binding to the Qiagen columns. If phosphatase inhibitors have been added in step 1, they must not be included here. 3. It is important to desalt thoroughly either using ultrafiltration devices or by precipitation with acetone as iTRAQ labelling is sensitive to buffer conditions e.g. the primary amines in Tris–HCl buffer will inhibit the reaction. Similarly, the portion of aqueous solution should not exceed the volumes given in the protocol or the labelling reaction will be inhibited. 4. It is important to quantify the protein accurately at this stage; excessive protein will result in incomplete labelling and/or bias in the quantification. 5. Rapigest SF can be used instead of SDS, as it is free of primary amines. The advantage is (at least for larger digests) that a lower amount of trypsin can be used. The SDS concentration recommended in the iTRAQ protocol (0.1%) significantly inhibits trypsin and hence the high protein–trypsin ratio of 1:10 to 1:5. 6. An overnight incubation is recommended to avoid partial digests. 7. This step is strongly advised; partial labelling is not uncommon. A ZipTip is suitable for cleaning and concentrating a small fraction of the peptides before MS. A second portion of the iTRAQ labelling reagent may be required to complete the reaction. 8. This step is not in the iTRAQ manual but should quench the reaction. 9. Alternatively, a larger HPLC column packed with a cation exchange resin may be used to fractionate the peptides more thoroughly if the amount of iTRAQ-labelled peptides is approximately 400 mg (i.e. 4 × 100 mg of reaction mixtures; e.g. PolySULFOETHYL 2.1 mm ID × 100 mm; PolyLC). 10. For less complex samples, one elution step may be sufficient. 11. The amounts of TCEP and MMTS available from iTRAQ kits will not be sufficient for this; prepare fresh solutions from Sigma chemicals. 12. The SpeedVac used should be suitable for handling corrosive chemicals.

300

A.M.E. Jones and T.S. Nühse

13. Steps 6–7 are necessary specifically for the glutamate protocol because the competitive glutamic acid “coating” of the beads comes off when the phosphopeptides are eluted. The glutamate would react with the iTRAQ reagent and hence needs to be removed before labelling. 14. It is advisable to prepare biological replicates and a control sample. 15. Alternatively, immobilized alkaline phosphatase from MoBiTec or VH Bio can be used. The advantage is that there is no glycerol and protein in the peptide mix at the end. 16. The gradient used depends on the complexity of the peptide mixture and the available HLPC. 17. Alternatively, high energy collisional dissociation (HCD) fragmentation may be used in the XL model of Orbitrap please refer to Bantscheff et al. (27) for a discussion of the parameters and iTRAQ. 18. Setting the dta file generation grouping parameter to 1 will separate CID and PQD spectra, if desired. 19. There are many other programs for the analysis of iTRAQ data (e.g. (31, 32, 33)).

Acknowledgements A.M.E.J. would like to thank Yong-Xi Chen (Jiaotong University, Shanghai) and Rod Watson (Applied Biosystems) for useful discussions. A.M.E.J. is funded by the Gatsby Charitable Foundation and T.S.N. by a BBSRC David Phillips Fellowship. References 1. Peck, S. C., Nuhse, T. S., Hess, D., Iglesias, A., Meins, F., and Boller, T. (2001) Directed proteomics identifies a plant-specific protein rapidly phosphorylated in response to bacterial and fungal elicitors. Plant Cell 13, 1467–75. 2. Nuhse, T. S., Boller, T., and Peck, S. C. (2003) A plasma membrane syntaxin is phosphorylated in response to the bacterial elicitor flagellin. J Biol Chem 278, 45248–54. 3. Tang, W., Deng, Z., Oses-Prieto, J. A., Suzuki, N., Zhu, S., Zhang, X., Burlingame, A. L., and Wang, Z. Y. (2008) Proteomics studies of brassinosteroid signal transduction using prefractionation and two-dimensional DIGE. Mol Cell Proteomics 7, 728–38. 4. Rohrig, H., Colby, T., Schmidt, J., Harzen, A., Facchinelli, F., and Bartels, D. (2008) Analysis

of desiccation-induced candidate phosphoproteins from Craterostigma plantagineum isolated with a modified metal oxide affinity chromatography procedure. Proteomics 8, 3548–60. 5. Laugesen, S., Messinese, E., Hem, S., Pichereaux, C., Grat, S., Ranjeva, R., Rossignol, M., and Bono, J. J. (2006) Phosphoproteins analysis in plants: a proteomic approach. Phytochemistry 67, 2208–14. 6. Agrawal, G. K., and Thelen, J. J. (2006) Large scale identification and quantitative profiling of phosphoproteins expressed during seed filling in oilseed rape. Mol Cell Proteomics 5, 2044–59. 7. Ndimba, B. K., Chivasa, S., Hamilton, J. M., Simon, W. J., and Slabas, A. R. (2003) Proteomic

17  Phosphoproteomics Using iTRAQ

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

analysis of changes in the extracellular matrix of Arabidopsis cell suspension cultures induced by fungal elicitors. Proteomics 3, 1047–59. Ficarro, S. B., McCleland, M. L., Stukenberg, P. T., Burke, D. J., Ross, M. M., Shabanowitz, J., Hunt, D. F., and White, F. M. (2002) Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 20, 301–5. Nuhse, T. S., Stensballe, A., Jensen, O. N., and Peck, S. C. (2003) Large-scale analysis of in vivo phosphorylated membrane proteins by immobilized metal ion affinity chromatography and mass spectrometry. Mol Cell Proteomics 2, 1234–43. Ficarro, S. B., Salomon, A. R., Brill, L. M., Mason, D. E., Stettler-Gill, M., Brock, A., and Peters, E. C. (2005) Automated immobilized metal affinity chromatography/nano-liquid chromatography/electrospray ionization mass spectrometry platform for profiling protein phosphorylation sites. Rapid Communications in Mass Spectrometry 19, 57–71. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., and Jorgensen, T. J. (2005) Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics 4, 873–88. Sugiyama, N., Nakagami, H., Mochida, K., Daudi, A., Tomita, M., Shirasu, K., and Ishihama, Y. (2008) Large-scale phosphorylation mapping reveals the extent of tyrosine phosphorylation in Arabidopsis. Mol Syst Biol 4, 193. Beausoleil, S. A., Jedrychowski, M., Schwartz, D., Elias, J. E., Villen, J., Li, J., Cohn, M. A., Cantley, L. C., and Gygi, S. P. (2004) Largescale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci USA 101, 12130–5. Vener, A. V., Harms, A., Sussman, M. R., and Vierstra, R. D. (2001) Mass spectrometric resolution of reversible protein phosphorylation in photosynthetic membranes of Arabidopsis thaliana. J Biol Chem 276, 6959–66. Nuhse, T. S., Stensballe, A., Jensen, O. N., and Peck, S. C. (2004) Phosphoproteomics of the Arabidopsis plasma membrane and a new phosphorylation site database. Plant Cell 16, 2394–405. Whiteman, S. A., Serazetdinova, L., Jones, A. M., Sanders, D., Rathjen, J., Peck, S. C., and Maathuis, F. J. (2008) Identification of novel proteins and phosphorylation sites in a tonoplast enriched membrane fraction of Arabidopsis thaliana. Proteomics 8, 3536–47. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

301

Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1, 376–86. Gruhler, A., Schulze, W. X., Matthiesen, R., Mann, M., and Jensen, O. N. (2005) Stable isotope labeling of Arabidopsis thaliana cells and quantitative proteomics by mass spectrometry. Mol Cell Proteomics 4, 1697–709. Niittyla, T., Fuglsang, A. T., Palmgren, M. G., Frommer, W. B., and Schulze, W. X. (2007) Temporal analysis of sucrose-induced phosphorylation changes in plasma membrane proteins of Arabidopsis. Mol Cell Proteomics 6, 1711–26. Ross, P. L., Huang, Y. L. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., BartletJones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Molecular & Cellular Proteomics 3, 1154–69. Blagoev, B., Ong, S. E., Kratchmarova, I., and Mann, M. (2004) Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat Biotechnol 22, 1139–45. Jones, A. M., Bennett, M. H., Mansfield, J. W., and Grant, M. (2006) Analysis of the defence phosphoproteome of Arabidopsis thaliana using differential mass tagging. Proteomics 6, 4155–65. Nuhse, T. S., Bottrill, A. R., Jones, A. M., and Peck, S. C. (2007) Quantitative phosphoproteomic analysis of plasma membrane proteins reveals regulatory mechanisms of plant innate immune responses. Plant J 51, 931–40. Wu, J., Shakey, Q., Liu, W., Schuller, A., and Follettie, M. T. (2007) Global profiling of phosphopeptides by titania affinity enrichment. J Proteome Res 6, 4684–9. Pflieger, D., Junger, M., Muller, M., Rinner, O., Lee, H., Gehrig, P., Gstaiger, M., and Aebersold, R. (2007) Quantitative proteomic analysis of protein complexes: Concurrent identification of interactors and their state of phosphorylation. Mol Cell Proteomics 23, 23. Steen, H., Jebanathirajah, J. A., Rush, J., Morrice, N., and Kirschner, M. W. (2006) Phosphorylation analysis by mass spectrometry: myths, facts, and the consequences for qualitative and quantitative measurements. Mol Cell Proteomics 5, 172–81. Bantscheff, M., Boesche, M., Eberhard, D., Matthieson, T., Sweetman, G., and Kuster, B. (2008) Robust and sensitive iTRAQ quantification

302

A.M.E. Jones and T.S. Nühse

on an LTQ Orbitrap mass spectrometer. Mol Cell Proteomics 7, 1702–13. 28. Guo, T., Gan, C. S., Zhang, H., Zhu, Y., Kon, O. L., and Sze, S. K. (2008) Hybridization of Pulsed-Q Dissociation and Collision-Activated Dissociation in Linear Ion Trap Mass Spectrometer for iTRAQ Quantitation. Journal of Proteome Research 7, 4831–40. 29. Griffin, T. J., Xie, H., Bandhakavi, S., Popko, J., Mohan, A., Carlis, J. V., and Higgins, L. (2007) iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer. J Proteome Res 6, 4200–9. 30. Olsen, J. V., de Godoy, L. M., Li, G., Macek, B., Mortensen, P., Pesch, R., Makarov, A., Lange, O., Horning, S., and Mann, M. (2005)

Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 4, 2010–21. 31. Boehm, A. M., Putz, S., Altenhofer, D., Sickmann, A., and Falk, M. (2007) Precise protein quantification based on peptide quantification using iTRAQ. BMC Bioinformatics 8, 214. 32. Yu, C. Y., Tsui, Y. H., Yian, Y. H., Sung, T. Y., and Hsu, W. L. (2007) The Multi-Q web server for multiplexed protein quantitation. Nucleic Acids Res 35, W707–12. 33. Shadforth, I. P., Dunkley, T. P., Lilley, K. S., and Bessant, C. (2005) i-Tracker: for quantitative proteomics using iTRAQ. BMC Genomics 6, 145.

Index A ABA. See Abscissic acid (ABA) Abscisic acid-insensitive 2 (ABI2)...........................152, 154 Abscissic acid (ABA)...........................................30, 98, 154 Acceptor molecule.......................................................... 7, 8 Acceptor side chain............................................................ 8 Acid anhydride................................................................... 8 Activation domain.......................................................... 247 Activation loop................................ 14, 15, 18–20, 115, 151 Activation segment............................................... 14, 17–20 Activatory phosphorylation.................................15, 18, 130 Active site................................................................... 15, 17 Activity monitoring............................................................ 4 Acyl....................................................................................8 Acylation..........................................................................21 Acyl phosphate................................................................... 8 Adenosine–5’-triphosphate (ATP)............................. 7, 108 ATP-analogous compound........................................... 5 ATP-binding pocket............................ 15, 17, 260, 261, 263–264, 267, 268 ATP-binding site.............................. 14, 15, 17, 65, 124, 158, 186, 188, 189 ATP-competitive molecule........................... 5, 185–196 ATP-mix.................................................................. 192 Affinity-coupled kinase assay............................................. 5 Affinity purification.................................30, 61, 65–77, 265 Agarose..................................56, 58–61, 101, 102, 108, 116, 117, 119, 120, 124, 128, 131, 167, 186, 190, 261 AGC.................................................... 17, 19, 22, 23, 26–28 Agrobacterium (tumefaciens)..................... 103, 112, 194, 252 AHK. See Arabidopsis histidine kinase (AHK) Alanine.............................186, 189, 196, 201, 228, 260, 264 Alcohol..........................................................7, 11, 105, 115 Aluminum hydroxide.............................................. 274, 276 Amaranthus.......................................................................141 Amino........................................8, 13–15, 18, 20, 21, 23, 24, 69, 80, 95, 128, 150, 196, 201, 205, 228, 260, 275, 283 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF)............................... 107, 108, 126, 127 Amino-terminal lobe........................................................ 15 Aminotransferase............................................................... 8 AmiRNA.......................................................................... 81

Amplitude....................................... 200, 205, 206, 209, 210, 213, 226, 227 Analogue-sensitive......................................................... 185 Anaphase-promoting complex/cyclosome (APC/C)........................................................ 21 Antibiotic................................126, 129, 141–144, 189, 194, 195, 252, 253, 261 Antibody..................................67, 69, 71, 75, 76, 80, 82, 86, 87, 91, 101, 110, 111, 121–123, 133, 134, 166, 169, 170, 174–175, 178, 179, 181, 182, 218, 289 APC/C. See Anaphase-promoting complex/cyclosome (APC/C) APD. See Avalanche photodiode detectors (APD) APE.................................................................16, 18, 19, 23 Aphidicolin....................................................................... 66 Apoenzyme.................................................................... 245 Arabidopsis ...........................3, 21, 66, 81, 94, 141, 149–160, 186, 218, 227, 249, 259, 277 A. thaliana.......................... 9, 17, 20, 33–35, 80, 81, 103, 104, 115, 141, 201, 220, 227, 228, 250, 259, 275 histidine kinase (AHK)............................................ 142 PP2C-type phosphatase (AP2C1).........................152, 154 Arginine........................................... 8, 11, 15, 17, 18, 23, 91 Arg50.......................................................................... 17 Arg126........................................................................ 17 Arg150........................................................................ 17 Arsenate reductase............................................................ 95 Aspartate...............................................8, 11, 15, 17–19, 91, 95, 98, 276 Asp125....................................................................... 17 Asp143....................................................................... 17 Asp166....................................................................... 18 based phosphatase.................................................... 150 Assembly platform........................................................... 20 ATP. See Adenosine–5’-triphosphate (ATP) Atypical protein kinase..................................................... 22 Autocorrelation.............................. 204, 205, 208, 209, 213, 226, 227, 230, 232, 233, 237, 238 Autofluorescence............................ 201, 205, 206, 213, 214, 227, 232, 236–238 Autophosphorylation................................ 15, 18, 24, 91, 97, 98, 191, 192 Autoradiography........................74–76, 83, 87, 88, 110, 111, 122–124, 154, 169, 175, 187, 191, 262, 266, 270

N. Dissmeyer and A. Schnittger (eds.), Plant Kinases: Methods and Protocols, Methods in Molecular Biology, vol. 779, DOI 10.1007/978-1-61779-264-9, © Springer Science+Business Media, LLC 2011

303

Plant Kinases 304  Index

  

Auxin................................................................................ 30 Auxotrophy..................................................................... 247 Avalanche photodiode detectors (APD)........................................... 203, 204, 226

B Bacmid....................................................................... 68, 72 Bacterial assay................................................... 32, 139–146 Bacterial expression system................................................. 4 Baculovirus................................................................. 65–77 BAK1. See BRI1-associated receptor kinase (BAK1) BASTA. See Phosphinothricin (PPT) Bead dispenser........................................................ 105, 113 Beads.......................................59, 61, 62, 66–74, 76, 77, 86, 87, 101, 102, 105, 108, 113, 115–120, 124, 129, 131, 157, 186, 190, 202, 267, 293, 296, 300 b-galactosidase........................................140, 142–146, 247 b-glucuronidase................................................................ 88 BiFC. See Bimolecular fluorescence complementation (BiFC) Bilayer system........................................................58, 60, 61 Bimolecular fluorescence complementation (BiFC)............................. 5, 20, 30, 80, 245–256 Binary vector.............................................90, 129, 194, 196 Binding domain................................ 13, 14, 24, 30, 91, 101, 102, 247 BioMükk®............................................................... 103, 125 Black cottonwood. See Poplar Blotting......................................75, 103, 111, 121, 124, 128, 129, 131, 166, 168–169, 172–175, 178, 181, 246, 277, 282–283 Brachypodium distachyon.........................................10, 26, 33 Bradford.....................................................71, 82, 83, 86, 89, 127, 130, 155, 157, 186, 190, 265, 266, 279, 292, 294, 295 Brassica napus. See Rape seed Brassinosteroid..................................................31, 218, 226 Brassinosteroid insensitive 1 (BRI1)................................. 31, 97, 98, 199, 218 BRI1-associated receptor kinase (BAK1)............................................97, 199, 226 Bright Yellow–2 (BY–2)................................................... 66

C Caenorhabditis elegans.....................................................9, 26 Cak. See Cdk-activating kinase (Cak) Calcium-dependent protein kinase 1 (CPK1)............................ 31, 261–264, 266, 268 Calibration..................................86, 89, 116, 144, 157, 202, 203, 208, 210, 228, 234, 237, 238, 240, 256 Callus.............................................................................. 141 Calmodulin........................................................21, 102, 270 CaMK.............................................12, 17, 19, 22, 23, 27, 28

CAMP. See Cyclic adenosine monophosphate (cAMP) cAMP-dependent protein kinase (cAPK)................. 15, 17–20, 23, 155, 157–159 cAPK. See cAMP-dependent protein kinase (cAPK) Capsular polysaccharide synthesis.................................. 140 Carbenicillin........................................ 56, 59, 104, 113, 252 Carboxy......................................................................... 8, 15 Carboxyl........................................................................... 11 Carboxy-terminal lobe...................................................... 15 Carrot..................................................................... 199, 225 Cascade......................................5, 14, 19, 22–24, 27–32, 80, 93, 94, 151, 165, 166, 273 Casein.................................23, 142, 154, 155, 157–158, 284 Caspase............................................................171, 177–180 Catalytic base............................................................. 16, 18 Catalytic core...................................................15, 16, 20, 23 Catalytic glutamate........................................................... 15 Catalytic residue................................................... 15–17, 20 Catalytic strand................................................................ 17 CDC6............................................................................. 250 CDC25..................................................................... 95, 100 CDC48........................................................................... 226 Cdk-activating kinase (Cak)....................................... 19, 23 Cdk/CDKA;1/Cdc2/CDC28. See Cyclindependent kinase cDNA library................................................................. 247 CDPK......................................17, 23, 25, 31, 262, 266, 267 CDT1............................................................................. 250 CECF. See Continuous-exchange cell-free system (CECF) Cell cycle..............................................17, 30, 65, 66, 94–96, 100, 101, 110, 250–252 Cell-free system............................................................ 4, 56 Cell suspension culture......................................30, 199, 225 CFP.......................................... 200, 202–204, 208–211, 248 C-helix.............................................................15–17, 19, 30 Chemical genetics.............................. 4, 5, 31, 185, 259–270 Chemo-enzymatic labeling..............................262, 264–265 Chi.................................................................................. 206 Chloroplast........................................ 98, 206, 214, 236, 288 Chromatography.....................................262, 265, 269, 293 C-Jun................................................................................ 29 CK1..................................................... 18, 19, 22, 23, 27, 28 CK2............................................................................ 18, 23 CKI1. See Cytokinin-insensitive 1 (CKI1) CKL/CLK......................................................22, 23, 26, 30 CKS.........................................................100–102, 124, 131 CKS-beads..................................................................... 102 Classification.............................................21–29, 36, 38, 39 CLAVATA 1.................................................................... 31 Cloning....................................... 56, 58, 103–105, 111–112, 252, 253, 263, 269 CLSM. See Confocal laser scanning microscopy (CLSM) CMGC kinase............................................................ 20, 23 Codon usage........................................................... 111, 129

Plant Kinases 305 Index     

Co-factor................................................................ 245, 250 Collection block..............................................105, 113, 114 Comparative phosphorylation.........................293–294, 297 Complementation....................................139, 140, 247–249 Confocal laser scanning microscopy (CLSM).............................................5, 246, 253 Conformation...................................... 14, 15, 17, 19, 20, 69 Conformational change.........................................14, 15, 18 Constitutive triple response 1 (CTR1)............................. 32 Continuous-exchange cell-free system (CECF)......... 58–62 Conventional PTK..................................................... 17, 22 Coomassie.............................57, 60, 61, 68, 83, 87, 91, 127, 134, 155, 157, 187, 190–192, 196, 268, 277–279, 282, 284, 285 COP9 signalosome (CSN)............................................... 29 Cowpea.............................201, 202, 206, 207, 209, 211, 212 CPK1. See Calcium-dependent protein kinase 1 (CPK1) Craterostigma plantagineum. See Resurrection plant CRE1. See Cytokinin response 1 (CRE1) Crystallography................................................................ 18 CSN. See COP9 signalosome (CSN) Cub................................................................................. 247 Cyanogen bromide......................................................... 124 Cyclic adenosine monophosphate (cAMP)................12, 15, 20, 21 Cyclin......................................14, 17, 20, 21, 29, 30, 65–77, 94, 96, 100–102, 110, 116–118, 120, 124, 128, 130, 131, 133, 250 Cyclin-depenent kinase (Cdk)........................12, 20, 22, 23, 30, 66, 94–96, 100–104, 106, 110–113, 121, 133, 134, 250, 252 Cdk1...................................... 14, 15, 20, 23, 30, 94, 250 Cdk2........................................ 17, 20, 30, 101, 124, 252 Cycloheximide........................................................ 218, 236 Cysteine.......................................8, 106, 126, 170, 171, 228, 292, 293, 295–297 Cytochrome.................................................................... 166 Cytokinin..................................... 30, 31, 139–143, 145, 146 Cytokinin-insensitive 1 (CKI1)....................................... 32 Cytokinin response 1 (CRE1)........... 32, 139–142, 145, 146

D Data analysis............................ 207, 238, 239, 292, 294, 298 Database............................................. 4, 21, 26, 32–40, 150, 159, 189, 259, 298 Daucus carota. See Carrot DE.......................................................................... 100, 250 Degradation............................................ 13, 21, 29, 60, 106, 217–223, 247 De-phosphomutant........................................................ 100 Dephosphorylation............................. 21, 29, 30, 65, 93, 95, 150, 152, 154, 156, 158, 159, 275, 277, 282–283, 285, 287 Destaining.......................................69, 74, 83, 87, 134, 155, 187, 191, 196, 277, 282

Destination vector...........................................103, 112, 252 Detection volume........................... 205, 206, 210, 212, 213, 226, 227, 230, 234, 237, 238 Development...................................... 3, 30–32, 80, 99, 130, 212, 250, 260 DFG........................................................................... 16–19 2DGE. See 2D polyacrylamide gel electrophoresis (2DGE) Diacyl glyerol................................................................... 21 Dianion....................................................................... 13, 18 Diffusion...................................58, 200, 204, 205, 209, 214, 226–228, 230, 232–240 Dimerization...............................................21, 31, 199–214 Direct buffer........................................................... 105, 114 Dismozon............................................................... 104, 113 DNA fragmentation................ 166, 167, 169–170, 175–177 DOC. See Sodium deoxycholate (DOC) Docking.........................................................20, 21, 23, 246 Donor phosphate.............................................................. 15 DP......................................................................14, 277, 282 2D-PAGE.....................................................5, 39, 273–287 2D polyacrylamide gel electrophoresis (2DGE)........................ 268, 276–277, 281–283 Drosophila melanogaster........................................................9 Dual-color...................................................................... 200 Dual-specificity kinase..........................................12, 13, 95

E Eau de Javel..............................................................105, 129 EC 2................................................................................... 8 EC 2.7.......................................................................... 8, 11 ECL. See Enhanced chemiluminescence (ECL) Edman degradation.......................................................... 13 E2F................................................................................... 14 EGFR. See Epidermal growth factor receptor (EGFR) EIN4. See Ethylene insensitive 4 (EIN4) Elicitor...................................................................30, 80, 86 Elution buffer..........................................155, 157, 186, 190, 262, 266, 276, 279, 280, 292, 293, 296 Endocytosis.................................................................... 226 Endosome....................................................................... 218 Enhanced chemiluminescence (ECL)................... 110, 122, 134, 169, 173, 174, 181 Environment....................................................18, 102, 194, 195, 249 Enzyme-substrate interaction............................21, 246, 250 Epidermal growth factor receptor (EGFR).............................................. 19, 24, 28 ERECTA...........................................................................31 ERS. See Ethylene sensor (ERS) Escherichia coli.................................... 55, 56, 66, 69, 77, 100, 103, 112, 128, 129, 139, 140, 142, 144–146, 154–159, 189, 192, 261, 262, 264–266, 269 ESCRT........................................................................... 218 Ester.............................................................................. 8, 13 Ethylene...................................................27, 30–32, 97, 106

Plant Kinases 306  Index

  

Ethylene insensitive 4 (EIN4).......................................... 32 Ethylene response (ETR)................................................. 32 Ethylene sensor (ERS)..................................................... 32 ETR. See Ethylene response (ETR) E3 ubiquitin ligase.................................................... 29, 217 Expression.................................................... 4, 5, 30, 34, 35, 55–63, 65–77, 80, 81, 86, 88, 91, 100, 102, 103, 110–112, 129, 130, 139, 140, 150, 156, 159, 189, 194, 196, 213, 219–221, 229, 239, 240, 247, 263, 264, 269 Expression clone..............................................103, 111–112

F FCCS. See Fluorescence cross-correlation spectroscopy (FCCS) FCS. See Fluorescence correlation spectroscopy (FCS) FFA. See Fluorescence fluctuation analysis (FFA) FFS. See Fluorescence fluctuation spectroscopy (FFS) Fibrosarcoma.................................................................... 22 Field poppy..............................................................166, 167 FITC.......................................................170, 171, 177, 180 Fitting model...........................................206, 208, 213, 214 Fixing..............................................................134, 277, 282 FLAG...................................................................66, 68, 73, 74, 76, 102 Flagellin.......................................................................... 226 FLIM. See Fluorescence lifetime imaging microscopy (FLIM) Floral dip.................................................................112, 264 Flow cytometry.............................................................. 176 Flower......................................102, 111, 116, 123, 124, 130, 193, 194, 228 FLS2............................................................................... 226 Fluorescence correlation spectroscopy (FCS)........... 5, 200, 202–204, 213, 225–240, 246 Fluorescence cross-correlation spectroscopy (FCCS)........................5, 200, 201, 205, 209, 211, 212, 246 Fluorescence fluctuation analysis (FFA)................................................ 5, 199–214 Fluorescence fluctuation spectroscopy (FFS)............................. 202, 204, 206, 208, 226 Fluorescence lifetime imaging microscopy (FLIM).................................. 5, 200 Fluorescence microscopy........................................ 176, 249 Fluorescence recovery after photobleaching (FRAP)............................................ 5, 225–240 Fluorimeter.....................................................83–84, 89–91 Fluoroorotic acid (FOA)............................................... 247 FOA. See Fluoroorotic acid (FOA) Förster/fluorescence resonance energy transfer (FRET)................................................ 5 measurements................................ 5, 199, 226, 246, 249

FRAP. See Fluorescence recovery after photobleaching (FRAP) FRET. See Förster/fluorescence resonance energy transfer (FRET) Full scan.................................................................. 288, 298 Functional assay.................................................................. 5

G G1.......................................................................66, 94, 250 G2....................................................... 66, 94, 100, 101, 250 GAL4............................................................................. 247 Gametogenesis................................................................. 66 Gap phase......................................................................... 94 Gatekeeper............................................. 186, 188, 189, 196, 260, 261, 263, 264 pocket......................................................................... 17 Gateway®................................................................ 103, 112 Gel-tracking dye............................................................. 105 Genotyping.............................................105, 106, 113–115 Germination medium............................................. 167, 171 GFP........................ 66, 67, 71, 72, 75, 80, 90, 234, 248, 249 Glufosinate ammonium. See Phosphinothricin (PPT) Glutamate...............................8, 15, 18, 80, 91, 95, 276, 300 Glutathione S-transferase (GST)...................59, 61, 62, 77, 102, 108, 120, 131, 152, 156, 157, 186, 189–193 Glycine-rich loop............................................................. 15 Glycosyltransferase............................................................. 8 G2/M....................................................................... 66, 101 Grapevine................................................................3, 10, 26 G1/S................................................................................. 66 GST. See Glutathione S-transferase (GST) GTP. See Guanosine–5’-triphosphate (GTP) Guanidinium................................................................ 8, 14 Guanosine–5’-triphosphate (GTP).............................. 7, 98 GUS..................................................................... 83, 88–90 GV3101-pMP90RK.......................................103, 112, 252

H HAB1. See HOMOLOGY TO ABI1 (HAB1) Half maximal inhibitory concentration (IC50)..............................................189, 192, 267 Hedgehog......................................................................... 28 Helix dipole...................................................................... 14 Heterologous complementation..................................... 139 High performance liquid chromatography (HPLC)................................ 274, 294, 298, 299 Histidine............................................ 8, 12, 28, 32, 139–146 Histogram............................................ 5, 200, 206–207, 226 Histone H1....................................... 68, 69, 74–77, 96, 102, 108, 118, 120–123, 133, 134 Home-made Taq polymerase......................................... 105 HOMOLOGY TO ABI1 (HAB1)....................... 152, 154 Hormone receptor.................................................... 29, 141 Household sugar............................................................. 104

Plant Kinases 307 Index     

HPLC. See High performance liquid chromatography (HPLC) HR. See Hypersensitive response (HR) HRD.......................................................................... 16, 18 HRDLKxxN motif........................................................... 18 Hydrogen bond.......................................................... 14, 20 Hydrophobic pocket......................................................... 17 Hydroponic culture......................................................... 270 Hydrosulphide.................................................................... 8 Hydroxy............................................... 7, 8, 18, 95, 104, 253 Hypersensitive response (HR).........................31, 67, 70, 98

I IC50. See Half maximal inhibitory concentration (IC50) Identification of kinase substrates and phosphorylationsite detection via interaction assays, substrate labeling protocols and proteomics................. 4, 5 IEF. See Isoelectric focusing (IEF) IEF buffer............................................................... 276, 281 Igepal...................................................................... 107, 108 IMAC. See Immobilized metalion affinity chromatography (IMAC) ImageJ.............................................. 221, 222, 250, 253, 254 Imidazole......................................... 8, 57, 61, 262, 265, 276 Immobilized metal ion affinity chromatography (IMAC).................................269, 274, 288, 289 Immunoblotting................................ 91, 101, 123, 181, 287 Immunocomplex....................................................80, 83, 87 Immunoprecipitation............................ 4, 30, 65–77, 80, 82, 86–87, 100, 168, 246, 289, 290 In-gel kinase assay...................................................... 83, 87 Inhibitor...................................................... 5, 17, 21, 31, 67, 90, 106, 107, 126, 127, 154, 159, 166, 167, 171, 172, 177, 187, 188, 192, 193, 195, 219, 220, 261, 267, 268 molecule....................................................................... 5 sensitive kinase variant.................................................. 5 Inhibitory phosphorylation.................................15, 65, 252 In planta...............................5, 102, 111, 188, 189, 223–240 Insect cell................................................. 67, 68, 72, 73, 100 Interaction assay............................................................. 4, 5 Interleukin–1 receptor associated kinase (IRAK)................................................19, 22, 24 Intramolecular change...................................................... 15 Invariant aspartate...................................................... 18, 19 In vitro translation...........................................56–58, 60, 62 Ion-exchange...................................................262, 265–266 IRAK. See Interleukin–1 receptor associated kinase (IRAK) Isobaric tags for relative and absolute quantization (iTRAQ)........................................... 5, 287–300 Isocitrate dehydrogenase................................................... 15 Isoelectric focusing (IEF).............................. 263, 268, 276, 278, 281, 283 Isopentenyladenine................................................. 141, 143

Isotope..................5, 103, 118, 124, 127, 131, 132, 288, 292 iTRAQ. See Isobaric tags for relative and absolute quantization (iTRAQ)

J Jak/STAT.......................................................................... 28

K KAPP.............................................................................. 226 Ki2................................................................................... 267 KIM........................................................................ 151, 152 Kinase assay.............................61, 66, 68, 74–76, 80, 83, 87, 88, 100, 102, 111, 117, 118, 123, 124, 128, 130, 133, 189, 192, 266–267, 270 Kinase buffer................................ 67, 68, 71–74, 77, 82, 87, 108, 118, 262, 267 Kinase-dead.................................................................... 206 Kinase function..........................................4, 5, 29, 259–270 Kinase inhibition assay....................................262–263, 267 Kinase-substrate interaction............................... 5, 245–256 KinBase.............................................................9, 26, 27, 36 Kinome..............................................................9, 24–27, 36 Km9...............................................................7, 133, 267, 270 KMI001.......................................................................... 142

L Labeling buffer................................................262, 265, 269 LacZ................................................................140, 142, 147 LAMMER......................................................22, 23, 26, 30 Laser power............................................ 203, 204, 206, 213, 222, 235, 237, 239 Leucine-rich repeat (LRR)................................28, 199, 225 LIC. See Ligation-independent cloning (LIC) Ligand...............................................27, 141, 220, 226, 246 Ligation-independent cloning (LIC)....................58, 59, 62 Live-cell imaging............................................................ 246 Loading buffer.................................... 83, 87, 155–157, 168, 173, 178, 293, 296 Loss-of-function.................................................... 154, 158 Lowry............................................................................. 127 LRR. See Leucine-rich repeat (LRR) Lycopersicum esculentum. See Tomato Lys30................................................................................ 17 Lysine...................................................... 8, 17, 91, 170, 176 pocket......................................................................... 17 Lysis buffer.....................................................130, 154, 157, 159, 294 Lysosome........................................................................ 217 LZ domain..............................................199–201, 225, 226

M M9.......................................................................... 142–144 Magic buffer........................................................... 105, 114

Plant Kinases 308  Index

  

MagneHis..............................................................57, 59, 61 Maize............................................. 3, 10, 17, 26, 33, 34, 141 Maltose-binding protein (MBP)................................... 102 Mammals.......................................................13, 21, 24, 151 MAPK. See Mitogen-activated protein kinase (MAPK) MAP2K/MAPKK............................. 12, 19, 22, 23, 26, 32, 80, 151, 152, 155–156, 158, 166 MAP3K/MAPKKK.................... 12, 22, 23, 26, 32, 80, 166 MAP4K/MAPKKKK.....................................22, 23, 26, 80 Mass-spectrometry................................... 5, 29, 38, 39, 226, 274, 289, 294, 298 MBP. See Maltose-binding protein (MBP) Medicago (trunculata)........................... 33, 34, 150, 152, 154 MEK....................................12, 19, 22, 23, 32, 80, 151, 166 MEKK............................................... 12, 22, 23, 32, 80, 166 Meristem..................................... 31, 97, 102, 130, 220–222 Mesophyll..................................................81, 202, 227–229 Metabolic labelling................................................. 288, 289 Metallo-dependent......................................................... 150 Metal oxide affinity chromatography (MOAC)............................5, 275–280, 282–285 Methyl methanethiosulfonate (MMTS)................292, 293, 295–297, 299 4-Methyl-umbelliferyl...........................84, 88–90, 143, 144 4-Methyl-umbelliferyl-b-glucuron................83–84, 88–90, 140, 142–144 Mg2+-binding loop............................................................ 18 Microscopy..................................... 4, 5, 176, 200, 202, 218, 219, 226, 228, 246, 249 Microtube cap........................................................ 105, 114 Mik1........................................................................... 24, 95 Minimal motif.................................................................. 20 Mitogen-activated protein kinase (MAPK).............................................12, 15, 17, 19, 20, 22, 23, 26, 27, 30–32, 79–91, 151, 152, 154–156, 158, 159, 165–182 Mitosis........................................... 22, 94, 96, 100, 102, 250 Mixer mill............................................................... 105, 114 MKK....................................22, 24, 32, 80, 86, 91, 151, 166 MMTS. See Methyl methanethiosulfonate (MMTS) MOAC. See Metal oxide affinity chromatography (MOAC) Mobility............................................. 87, 119, 225–240, 266 Model plants.........................................................3, 34, 227 MP2C.............................................................150–152, 154 MPK.................................................. 22, 32, 80, 86, 91, 166 MPK3.................................31, 82, 86, 87, 91, 191, 192, 196 MPK4.............................................. 82, 86, 87, 91, 152, 260 MPK6....................................................... 31, 82, 86, 87, 91, 152, 154, 158 MPK9......................................................................... 31, 60 MS. See Mass-spectrometry MS1........................................................................ 288, 298 MS2........................................................................ 288, 298 MS/MS.....................................................35, 278, 288, 298

MU. See 4-methyl-umbelliferyl MUG. See 4-methyl-umbelliferyl-b-glucuron Mutagenesis........................................... 104, 128, 186, 188, 189, 196, 261, 263–264, 269 Myt1........................................................................... 24, 95

N 1-Naphthyl-PP1............................................................. 263 N6-benzyl-ATP..............................................263, 265, 267 Ndk. See Nucleoside diphosphate kinase (Ndk) NEK........................................................................... 22–24 Never in mitosis-A (NIMA)..................................... 22–24 Nick-end labeling........................................................... 175 Nicotiana benthamiana. See Tobacco Nicotiana tabacum. See Tobacco NIMA. See Never in mitosis-A (NIMA) Nitrogenous.................................................................. 8, 11 Nonidet...............................................................67, 82, 107 Nonradioactive....................................................... 125, 175 Non-receptor PSTKs....................................................... 22 Notch................................................................................ 28 N-phosphate....................................................................... 8 N-phosphono..................................................................... 8 N-terminal sequencing..................................................... 13 Nub................................................................................. 247 Nucleophilic attack........................................................... 15 Nucleophilic center............................................................. 7 Nucleoside diphosphate kinase (Ndk).....................................262, 264–266, 269

O Okadaic acid....................................................150, 155–159 OMP. See Orotine–5’-monophosphate (OMP) On-blot phosphatase assay............................................. 283 O-phosphate...................................................................... 8 O-phosphono..................................................................... 8 Orange G....................................................................... 105 Orbitrap...................................................292, 294, 298, 300 Orotine–5’-monophosphate (OMP).............................. 247 Orphan sequence.............................................................. 22 Orthovanadate...................................................67, 107, 126 Oryza sativa. See Rice Ovule..............................................................228, 231, 233, 234, 236, 237

P PAGE. See Polyacrylamide gel electrophoresis (PAGE) pAM-PAT.............................................................. 103, 112 Papaver rhoeas. See Field poppy Papaver rhoeas stigma S-proteins (PrsS)......................... 166 PARP-cleavage assay...............................167, 170, 177–178 Pathogen defense.............................................................. 30 PBS. See Phosphate-buffered saline (PBS) PCD. See Programmed cell death (PCD)

PCH. See Photon counting histogram (PCH) p9Cks1....................................................................... 101, 102 p10CKS1.................................................................... 101, 102 PCR.........................................56, 58, 59, 62, 105, 111–115, 128, 129, 193–195 PDHK. See Pyruvate dehydrogenase kinase (PDHK) PEG.........................................56, 82, 85, 90, 201, 227, 229 PEPRK............................................................................. 26 Peptide substrate............................ 18, 20, 97, 262, 266, 270 PEST domain................................................................... 21 Phenylalanine................................................................... 19 Phenylmethylsulfonyl fluoride (PMSF)...................82, 107, 108, 126, 127, 168, 181, 186, 190, 196 PhK. See Phosphorylase kinase (PhK) Phosphatase...............................5, 21, 30, 31, 35, 67–69, 71, 73, 80, 95, 115, 126, 127, 149–160, 270, 277, 282, 283, 285, 290, 291, 293, 294, 297, 299, 300 inhibitor.................................... 67–69, 71, 73, 126, 150, 270, 294, 299 Phosphate-buffered saline (PBS)...................57, 61, 67, 68, 70, 131, 186, 190, 196, 202–204, 277, 282 Phosphate ester............................................................ 8, 13 Phosphate thioester............................................................ 8 Phosphatidyl inositol 3’ kinase-related kinase ( PIKK).......................................... 22, 24 Phosphatidylinositol–4-phosphate 5’kinase (PPK1)...................................................... 22, 24 Phosphinothricin (PPT).........................104, 125, 261, 264 Phospho......................... 8, 12, 13, 15, 18, 19, 30, 35, 36, 80, 93–135, 150, 152, 154, 159, 250, 268, 275–277, 281–283, 285, 287, 289, 290 Phosphodegron................................................................ 29 Phosphoenolpyruvate carboxylase kinases (PPCKs)............................................ 25 Phosphomimetic............................................20, 95, 97, 119 Phosphomimicry.............................................................. 93 Phosphomotif................................................................... 14 Phosphonic......................................................................... 8 Phosphono................................................................... 7, 15 Phosphopeptide.................................. 5, 274, 287–291, 293, 295–297, 300 Phosphoprotein enrichment............................... 274, 279, 283, 284, 287, 290, 292, 294 purification............................................................... 292 Phospho-protein stain............. 263, 268, 269, 276, 277, 282 Phosphoproteome...........................................273–286, 288 Phosphoproteomics...................................35, 274, 287–300 Phosphoramidate.......................................................... 8, 13 Phosphorimager.....................83, 87, 88, 110, 122, 124, 191 Phosphorous acid............................................................... 8 Phosphoryl..................................................8, 13–15, 18, 20 Phosphorylase kinase (PhK)........................... 12, 18, 19, 23 Phosphorylatable........................................................ 20, 95

Plant Kinases 309 Index      Phosphorylation......................5, 7, 8, 12–15, 17–23, 28–31, 35, 36, 62, 65, 66, 69, 80, 88, 91, 93–135, 140, 149–151, 154–158, 166, 252, 259, 260, 270, 273, 274, 279, 287–290, 293–294, 297 Phosphorylation-site................................................ 4, 5, 95 Phosphoryl transfer...............................................13, 15, 20 Phospho-site..........................................19, 30, 93–135, 250 Phosphotransfer................................................... 7–13, 133 Phosphotransferase.............7, 11, 12, 80, 81, 83, 87–88, 129 Photobleaching............................ 5, 206, 212, 213, 225–240 Photon counting histogram (PCH)................... 5, 200, 201, 205–209, 211, 213, 214, 226 Phylogenetic group................................................... 22, 260 Phytohormone.......................................................27, 31, 97 PIKK. See Phosphatidyl inositol 3’ kinase-related kinase (PIKK) Pinhole............................................203–205, 222, 230, 237 PKA. See cAMP-dependent protein kinase (cAPK) pKa1............................................................................... 3, 14 Plant kinase.........................................................3–5, 22, 62 PlantsP database....................................................21, 26, 35 Plasma membrane.................................... 28, 145, 199, 200, 205, 218, 225–228, 231, 234, 237, 288 Plasmid..........................................56, 59, 60, 62, 69, 82, 85, 86, 90, 110, 112, 128, 129, 156, 189, 196, 202, 229, 252, 256, 261, 263, 264 Plexiglas................................... 105, 109, 118, 131, 132, 264 P-loop.............................................. 15–17, 94–96, 100, 252 P+1 loop................................................................16, 18, 20 Pollen................................................................ 31, 165–182 Pollination........................................................................ 31 Polyacrylamide gel electrophoresis (PAGE).................................... 5, 39, 57, 60, 61, 68–69, 74–76, 80, 83, 87–88, 109, 111, 117–120, 130, 133, 134, 154, 157, 168, 172–173, 175, 178, 179, 187, 190–192, 202, 263, 268, 270, 273–287 Poplar.....................................................................10, 26, 34 PopulusDB................................................................. 26, 34 Populus trichocarpa. See Poplar Post-transcriptional modification..................................... 65 Post-translational modification.........................56, 259, 274 PP1................... 159, 186–189, 192, 193, 263, 267, 268, 270 PP2A. See Protein phosphatase 2A (PP2A) PP2C. See Protein phosphatase (PP2C) PPCK. See Phosphoenolpyruvate carboxylase kinases (PPCKs) PP2C-type protein phosphatase....................... 31, 149–160 PPK1. See Phosphatidylinositol–4-phosphate 5’kinase (PPK1) P38 pocket........................................................................ 17 PPT. See Phosphinothricin (PPT) Precipitation........................... 127, 265, 275–277, 280–281, 283–285, 299 Prefractionation.............................................................. 288

Plant Kinases 310  Index

  

Programmed cell death (PCD)......................... 31, 165–182 Proline-directed kinase..................................................... 20 Proline rich stromal processing peptidase (SPP).................................................... 199, 225 Proofreading polymerase........................................ 103, 128 Propyzamide..................................................................... 66 Protease inhibitor........................... 67, 71, 73, 90, 106, 107, 127, 154, 156, 157, 159, 179, 190, 292, 294 Protection....................................................................... 131 Protein extraction................................... 82, 83, 86, 89, 160, 167–168, 263, 268–269, 275–279 Protein kinase............................. 4, 7–40, 55–63, 65, 79–91, 94, 149, 165, 185–196, 259–270 fold.............................................................................. 15 Protein phosphatase (PP2C)........................... 31, 149–160 Protein phosphatase 2A (PP2A)............................ 126, 159 Protein production............................... 4, 55, 56, 58, 66, 171 Protein-protein interactions........................5, 152, 245–250 Protein purification................. 5, 57, 59, 186, 189–190, 292 Protein serine/threonine kinase (PSTKs).................... 8, 12, 18, 22, 24, 26–29, 31, 39, 65, 94 Protein stability.......................................................... 14, 29 Protein tyrosine kinase............................................8, 12, 39 Proteome....................................3, 22, 39, 58, 247, 250, 274 Proton trap....................................................................... 18 Protoplast................................... 80–82, 84–86, 88–91, 154, 201–203, 205–209, 211–214, 226, 227, 229, 231–234, 236, 238, 240 PrsS. See Papaver rhoeas stigma S-proteins (PrsS) PSTAIRE....................................... 17, 19, 30, 66, 101, 110, 121–123, 133 P13suc1....................................... 66–67, 69–71, 75, 101, 102, 108, 116–118, 120, 123, 131 Purification..................4, 5, 30, 31, 55–63, 65–77, 100–102, 110, 160, 186, 189, 246, 265, 269, 283, 292 Pyruvate dehydrogenase kinase (PDHK)................... 22, 24

Q Quantitation....................................................177, 180, 298

R Radiation hazard............................................................ 118 Radioactive............................... 91, 102, 109–111, 117, 118, 120–122, 124, 125, 127, 130, 131, 133, 134, 175, 259, 262, 265 Radiolabel............................................. 74, 80, 87, 111, 133, 261, 264–267 Raf....................................................... 17, 19, 22–24, 28, 32 Rape seed...................................................................... 3, 31 Ras.................................................................................... 28 RcsC receptor......................................................... 140, 142 RD kinase........................................................16, 18, 19, 26 Receptor................................................ 12, 81, 95, 139, 166, 199, 218, 225, 245

Receptor guanylate cyclase (RGC)............................. 22, 23 Receptor-like kinase (RLK)..................... 22, 24–26, 28, 30, 31, 199, 225 Recognition...........................14, 18, 20, 21, 23, 26, 31, 112, 141, 150, 166 Recombinant protein................... 66, 91, 152, 154, 156, 159 Recruitment.................................................20, 21, 217, 218 Rehydration buffer................................................. 263, 268 Reporter gene........................................ 4, 5, 31, 79–91, 248 Resurrection plant.......................................................... 275 Reticulocyte.............................................................. 56, 100 Retinoblastoma........................................................... 14, 77 RGC. See Receptor guanylate cyclase (RGC) Rhodamine.......................202, 203, 228–230, 234, 237, 238 Rice.......................................3, 9, 21, 22, 26–28, 34, 35, 150 Rice Kinase Database............................ 26, 27, 37, 150, 159 Right open reading frame (RIO)................................ 22, 24 RIO. See Right open reading frame (RIO) RLK. See Receptor-like kinase (RLK) RNAi.......................................................................... 81, 88 Root.................................................................. 98, 219–223 Rossmann motif......................................................... 15, 16 Running buffer..................................... 68, 74, 91, 109, 119, 155, 156, 168, 173, 187, 191, 263, 268

S Saccharomyces cerevisiae............................... 9, 23, 29, 94, 101 SCF. See S-phase kinase-associated protein (Skp)Cullin-F-box containing complex ( SCF) Schizosaccharomyces pombe...........................96, 101, 102, 131 SDS. See Sodium dodecyl sulphate (SDS) SDS-PAGE.................................5, 7, 60, 61, 68, 74–76, 83, 87–88, 109, 111, 117–120, 130, 133, 134, 154, 157, 172, 173, 175, 178, 179, 187, 190–192, 202, 270 Sealing mat............................................................. 105, 114 Self-incompatibility.................................................. 31, 166 Sensor............................................................... 32, 139–146 Sensor histidine kinase..................................... 32, 139–176 Separating buffer.........................................68, 74, 187, 190 Sepharose.....................................67, 70, 71, 77, 82, 86, 108, 117–118, 124, 155, 157, 160 Serine.........................................12, 65, 91, 94, 97, 106, 126, 127, 150, 199, 225, 228, 259, 261, 270 SERK. See Somatic embryogenesis receptor kinase (SERK) Sf9.............................................................................. 72, 73 SH2...................................................................................20 SH3...................................................................................20 Shielding...........................109, 118, 119, 131, 132, 262, 264 Signal to noise ratio (SNR).................................... 206, 214 Signal transduction................................... 26, 27, 29–31, 79, 139, 165, 185 SILAC. See Stable isotope labeling (SILAC) Silent mutation........................................129, 188, 196, 269

Plant Kinases 311 Index     

Silvet L–77................................................................... 1255 S-locus glycoprotein (SLG).............................................. 31 SNF1-related kinase (SnRK).................................... 26, 98 SNR. See Signal to noise ratio (SNR) SnRK. See SNF1-related kinase (SnRK) SOC.............................................................................56, 59 Sodium deoxycholate (DOC)................. 276, 280–281, 285 Sodium dodecyl sulphate (SDS)................................ 68–69, 74, 83, 88, 109, 110, 168, 181, 187, 263, 268, 275, 278, 292, 294, 295, 297, 299 Software...........................202, 203, 206, 208, 220–221, 227, 230–232, 235, 250, 256, 263, 291, 294 Soil mixture.................................................................... 103 Somatic embryogenesis receptor kinase (SERK)................................................. 199, 225 SERK1..............................199–201, 206, 207, 209, 211, 214, 225–228, 231, 233, 234, 236–238 SERK3..............................................199, 201, 214, 226 Soybean...............................................3, 107, 126, 220, 221 Spectrometric analysis........................................................ 5 Spectrometry.................................... 5, 29, 38, 39, 226, 274, 289, 294, 298 Spectroscopy.................................... 4, 5, 200, 225–240, 246 S-phase................................................................29, 96, 250 S-phase kinase-associated protein (Skp)-Cullin-F-box containing complex ( SCF)............................. 29 S-phosphate........................................................................ 8 S-phosphono group............................................................ 8 Split-ubiquitin system (SUS)........................... 21, 246, 247 Split YFP. See Bimolecular fluorescence complementation SPP. See Proline rich stromal processing peptidase (SPP); Stromal processing peptidase (SPP) S-receptor-like kinase (SRK)........................................... 31 SRK. See S-receptor-like kinase (SRK) Stable isotope labelling with amino acids (SILAC)................................................... 5, 288 Stacking buffer............................................68, 74, 187, 191 Staining...............................56, 57, 60, 68, 75, 91, 122, 124, 134, 155, 176, 177, 181, 187, 191, 196, 276, 277, 281–282, 285, 288 STE........................................................... 19, 22, 23, 27, 28 Steel bead........................................................104, 113, 115 Stigma.....................................................................166, 171 Stoichiometry............................................21, 131, 287, 290 Stress cold heat UV salinity drought reactive oxygen................................................ 31 Stromal processing peptidase (SPP)....................... 199, 225 Structure......................................14–21, 26, 28, 34, 38, 101, 150, 188, 209, 237, 260–261 Subcellular fractionation......................................... 288, 289 Subcellular localization..................................................... 21 Substitution........................... 20, 30, 93–135, 186, 260, 266 Substrate..................................4, 8, 57, 77, 80, 94, 140, 150, 162, 245, 259, 274

binding.......................................... 15, 24, 250, 252, 261 labeling......................................................4, 5, 259, 266 Suc1.............................................. 66, 69–71, 75, 82, 86, 90, 101, 108, 116–118, 120, 123, 124, 131 Suc1-bead......................................................................... 69 Sucrose solution/buffer................................................... 114 Sulfate...................................... 109, 155, 165, 187, 263, 275 Sulfhydryl...........................................................................8 Sulphur........................................................................... 7, 8 SUS. See Split-ubiquitin system (SUS)

T TAE.................................................................................. 56 TAIR. See The Arabidopsis Information Resource (TAIR) Tandem-affinity purification (TAP)...................... 102, 246 TAP. See Tandem-affinity purification (TAP) Taq polymerase, home-made.......................................... 105 TB. See Terrific broth (TB) medium TBS. See Tris-buffered saline (TBS) TCEP. See Tris-(2-carboxyethyl)phosphine (TCEP) TdT. See Terminal deoxynucleotidyl transferase (TdT) TEAB..............................................................292, 295, 296 Terminal deoxynucleotidyl transferase (TdT).................................................... 175, 176 Terrific broth (TB) medium................................... 186, 189 TEV protease........................................................57, 61, 63 The Arabidopsis Information Resource (TAIR)................................................ 26, 34, 35 Thioester............................................................................. 8 Thio phosphate.................................................................. 8 Threonine..................................8, 12, 18, 19, 24, 28, 30, 36, 39, 65, 91, 94, 95, 115, 126, 150, 166, 199, 225, 228, 259, 261, 270 Titanium dioxide.....................................274, 288, 293, 296 TKL. See Tyr kinase-like (TKL) T-loop...............................16–18, 20, 23, 65, 75, 94–96, 250 Tobacco....................................30, 66, 67, 70, 75, 76, 98, 99, 141, 249, 250, 252–256, 260, 264, 266 Tomato.......................................3, 31, 34, 99, 191, 192, 260 Tonoplast........................................................................ 288 TOUSLED...........................................................22, 24, 31 Trafficking...................................................................... 220 Transcription factor............................ 14, 29, 31, 80, 88, 95, 97, 98, 151, 152, 247, 249 Transfection........................................ 68, 81, 201–203, 205, 213, 227, 229, 236 Transferase group......................................................... 8, 11 Transformation............. .30, 81, 82, 84–86, 88, 90, 102, 103, 110, 112, 113, 125, 129, 144, 189, 195, 263, 264 Transgenic...............................103, 111, 113, 115, 125, 129, 141, 186, 189, 195, 196, 218, 220, 263, 264, 268 Transient....................................5, 15, 80, 86, 200, 218, 234, 246, 248, 264, 266 associations................................................................... 5

Plant Kinases 312  Index

  

Translation.......................................... 56–62, 205, 218, 220, 223, 230, 259, 274 Transmembrane................................... 28, 31, 199, 217–225 Tris-buffered saline (TBS)......................... 68, 73, 110, 277 Tris-(2-carboxyethyl)phosphine (TCEP)......................... 292, 293, 295–297, 299 Tryptic digestion.....................................289, 292, 293, 295 TUNEL...................................................170, 175–177, 182 Tween.............................82, 83, 88, 107, 108, 110, 228, 230 Two-component signal transduction pathway................ 139 Two-hybrid system......................................................... 247 T-x-Y signature................................................................. 19 Type II inhibitor pocket................................................... 17 Tyr kinase-like (TKL)......................... 17, 19, 22–24, 26–28 Tyrosine............................... 8, 12, 14, 18, 19, 24, 30, 36, 39, 65, 80, 95, 126, 150, 166, 187, 261, 270, 289

U U0126...................................... 166, 167, 172, 175, 177–180 Ubiquitin protease (UBP).............................................. 247 Ubiquitin proteasome system (UPS)................................ 29 UBP. See Ubiquitin protease (UBP) UPS. See Ubiquitin proteasome system (UPS) URA3............................................................................. 247

V Vacuoles.................................................................. 218, 220 Valine................................................................................ 20 Valine-rich segment.......................................................... 20 Vanadate..........................................................126, 127, 130 VF................................................................................... 100 Vigna unguiculata. See Cowpea Viral expression system....................................................... 4 Vitis vinifera. See Grapevine

W Washing buffer........................................203, 276, 279, 280 Waste disposal.........................................120, 127, 134, 265 Web tool....................................................................... 4, 32 Wee1................................................................17, 19, 24, 95 Western...............................75, 76, 103, 109–111, 121–122, 124, 128, 129, 131, 133, 134, 166, 168–169, 172–175, 178, 179, 246, 266 Wheat germ extract.................................................... 55–63 Wingless........................................................................... 28 Wounding......................................................................... 30

X Xenopus (laevis)............................................................... 101 X-Gal.......................................................140, 142, 143, 247 Xylene cyanol................................................................. 105

Y Yeast....................................................... 8, 9, 21, 26, 28, 30, 56, 65, 66, 79, 91, 94–96, 100, 102, 104, 130, 139, 141, 151, 152, 186, 188, 218, 246–248, 250, 252, 261, 288 Yeast-two-hybrid (Y2H).................................152, 246, 247 YEB................................................. 104, 112, 252, 253, 255 Yellow fluorescent protein (YFP).............................. 5, 200, 202–204, 208–210, 212, 218–221, 227, 229, 231, 233, 234, 237, 238, 248, 250, 252, 255 YFP. See Yellow fluorescent protein (YFP) Y2H. See Yeast-two-hybrid (Y2H)

Z Zea mays. See Maize Zeatin..............................................................141–143, 146